data_1a7f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1a7f _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.49 -18.3 58.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.652 -0.655 . . . . 0.0 110.049 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -42.1 82.38 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.253 -0.905 . . . . 0.0 109.987 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -146.53 43.49 1.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.45 -0.781 . . . . 0.0 109.897 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -63.3 -43.02 99.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.398 -0.814 . . . . 0.0 109.157 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -97.24 29.51 3.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.714 -0.616 . . . . 0.0 109.552 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p -161.07 -174.17 4.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.556 -0.715 . . . . 0.0 109.263 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.16 98.62 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 m -84.41 -85.76 0.13 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.587 -0.696 . . . . 0.0 110.423 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -173.97 151.43 1.76 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.068 -1.02 . . . . 0.0 109.975 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -67.18 -21.51 65.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.648 -0.658 . . . . 0.0 110.106 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -24.78 34.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.064 -1.023 . . . . 0.0 109.91 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -79.02 -47.28 16.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.384 -0.822 . . . . 0.0 109.218 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 mt -65.78 -15.14 62.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.632 -0.667 . . . . 0.0 110.129 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.38 -18.8 41.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.261 -0.899 . . . . 0.0 110.288 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -94.32 28.35 2.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.924 . . . . 0.0 109.988 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -115.99 18.55 15.48 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.377 -0.827 . . . . 0.0 110.211 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.1 m -109.62 30.11 6.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m120 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.469 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.409 ' CD2' HG13 ' B' ' 2' ' ' VAL . 66.5 t80 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . 0.409 HG13 ' CD2' ' B' ' 1' ' ' PHE . 13.3 p -165.34 -33.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.192 -0.942 . . . . 0.0 110.488 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -157.88 -42.26 0.06 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.012 -1.055 . . . . 0.0 109.587 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -76.06 159.91 30.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.473 -0.767 . . . . 0.0 109.012 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -83.26 -178.61 7.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.615 -0.678 . . . . 0.0 109.518 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 33.7 mt -127.4 53.53 1.73 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.546 -0.722 . . . . 0.0 110.422 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -135.53 132.16 36.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.407 -0.808 . . . . 0.0 109.181 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.28 -137.4 13.71 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 53.9 p -85.47 3.76 38.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.499 -1.0 . . . . 0.0 110.101 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -76.36 -34.23 58.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.101 -1.0 . . . . 0.0 109.211 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -66.53 -51.38 57.23 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.6 t -55.32 -48.31 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.587 -0.695 . . . . 0.0 110.17 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -60.55 -29.89 69.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.434 -0.791 . . . . 0.0 109.51 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.78 -32.08 67.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.518 -0.739 . . . . 0.0 109.453 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.444 ' CB ' ' CD1' ' B' ' 25' ' ' PHE . 41.4 mt -65.69 -41.27 92.58 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.47 -37.85 88.86 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.406 ' CD2' ' CZ ' ' B' ' 1' ' ' PHE . 2.7 tp -64.71 -28.72 69.78 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 42.0 t -73.22 -69.38 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 109.792 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -94.91 -76.37 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.478 -0.764 . . . . 0.0 109.288 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.87 -13.03 10.71 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.787 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -87.33 145.15 26.46 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.151 -1.205 . . . . 0.0 109.489 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -76.48 152.14 36.2 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.76 25.63 63.94 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.52 -28.11 4.15 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.444 ' CD1' ' CB ' ' B' ' 15' ' ' LEU . 30.5 p90 -131.48 -173.94 3.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.621 -0.929 . . . . 0.0 109.569 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.424 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 9.5 t80 -61.73 108.61 1.03 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 109.491 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 45.6 p -123.48 87.98 51.82 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . 0.424 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 1.6 Cg_endo . . . . . 0 N--CA 1.483 0.906 0 C-N-CA 122.709 2.272 . . . . 0.0 110.217 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.02 42.16 1.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 109.677 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.14 -46.99 2.17 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.2 m -125.97 25.39 6.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.675 -0.641 . . . . 0.0 109.621 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.0 -58.55 6.37 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.39 -0.819 . . . . 0.0 109.472 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.401 HG21 ' N ' ' A' ' 9' ' ' SER . 3.5 t -72.08 -33.75 68.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.483 -0.761 . . . . 0.0 110.043 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.401 ' N ' HG21 ' A' ' 8' ' ' THR . 3.6 m -86.11 165.48 16.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.433 -0.792 . . . . 0.0 108.884 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.99 69.81 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.286 -0.884 . . . . 0.0 109.043 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.7 m -64.98 178.74 0.78 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.53 -0.731 . . . . 0.0 109.753 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.428 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 50.1 m -72.9 115.0 11.67 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.405 ' CD1' ' CD1' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -69.25 -8.18 43.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.667 -0.646 . . . . 0.0 110.975 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.428 ' CD1' ' HB3' ' A' ' 12' ' ' SER . 0.1 OUTLIER -67.28 -18.73 65.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.967 -1.083 . . . . 0.0 109.934 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.409 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 0.8 OUTLIER -69.35 -10.64 58.82 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.258 -0.901 . . . . 0.0 110.764 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.406 ' CD2' ' CD2' ' B' ' 15' ' ' LEU . 5.8 mt -65.47 -12.06 49.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.164 -0.96 . . . . 0.0 110.656 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -59.51 -19.53 48.8 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.105 -0.997 . . . . 0.0 110.196 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -97.13 29.61 3.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.288 -0.883 . . . . 0.0 109.775 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -118.38 19.78 13.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.645 -0.659 . . . . 0.0 109.632 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.7 m -103.59 27.27 7.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.247 -0.908 . . . . 0.0 110.026 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.911 -1.042 . . . . 0.0 109.484 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.421 ' CZ ' ' CB ' ' B' ' 17' ' ' LEU . 34.8 p90 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 120.613 0.244 . . . . 0.0 110.51 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 40.4 t -51.31 -38.86 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.005 -1.06 . . . . 0.0 110.55 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -134.03 30.01 3.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.439 -0.788 . . . . 0.0 109.668 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' B' ' 5' ' ' HIS . 18.6 mt-30 -117.66 -84.5 0.64 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.66 -0.65 . . . . 0.0 109.394 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.433 ' CG ' ' O ' ' B' ' 4' ' ' GLN . 0.6 OUTLIER -178.99 -172.53 0.25 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.449 -0.782 . . . . 0.0 109.059 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 40.3 mt -133.77 43.34 2.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.594 -0.691 . . . . 0.0 109.448 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 58.6 m -114.68 137.17 52.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.524 -0.735 . . . . 0.0 109.596 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.46 -140.58 23.75 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.3 -0.67 29.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.567 -0.961 . . . . 0.0 110.652 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -66.94 -31.18 71.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.013 -1.054 . . . . 0.0 109.271 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 63.4 tp -68.52 -57.43 5.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.576 -0.702 . . . . 0.0 109.182 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 24.7 t -51.65 -44.48 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.657 -0.652 . . . . 0.0 110.843 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -63.78 -34.45 77.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.449 -0.782 . . . . 0.0 109.646 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.419 ' HB3' ' CD2' ' B' ' 1' ' ' PHE . . . -68.9 -29.74 68.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.53 -0.731 . . . . 0.0 109.4 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.406 ' CD2' ' CD2' ' A' ' 16' ' ' LEU . 40.4 mt -70.71 -37.51 73.55 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -63.49 -41.62 98.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.66 -0.65 . . . . 0.0 109.505 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.421 ' CB ' ' CZ ' ' B' ' 1' ' ' PHE . 0.2 OUTLIER -63.31 -55.67 22.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.68 . . . . 0.0 109.603 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 43.6 t -55.59 -72.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.652 -0.655 . . . . 0.0 110.238 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.68 -74.28 0.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.835 . . . . 0.0 109.277 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.62 -16.11 61.87 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -60.42 160.95 7.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.171 -1.193 . . . . 0.0 109.841 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.53 108.65 17.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.642 -0.661 . . . . 0.0 109.512 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.2 40.19 61.62 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.1 -24.27 6.06 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -112.56 -175.63 2.72 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.437 -1.037 . . . . 0.0 109.964 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -52.02 138.84 24.17 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.481 -0.762 . . . . 0.0 110.138 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.11 93.15 31.16 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 N--CA 1.482 0.831 0 C-N-CA 122.264 1.976 . . . . 0.0 109.913 -179.798 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -61.09 -17.64 53.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.514 -0.741 . . . . 0.0 110.117 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -48.24 -60.57 2.54 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.233 -0.917 . . . . 0.0 111.294 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.1 m -111.56 7.48 20.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.393 -0.817 . . . . 0.0 110.477 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.61 -28.98 64.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.003 -1.061 . . . . 0.0 109.408 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 m -80.79 -52.96 6.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.474 -0.766 . . . . 0.0 109.802 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.18 -177.36 4.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.0 109.883 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.496 HG12 ' CD2' ' B' ' 5' ' ' HIS . 0.4 OUTLIER -84.78 136.46 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.4 p -122.58 -160.23 0.87 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.373 -0.829 . . . . 0.0 110.085 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.07 139.69 46.22 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.439 ' CD2' ' CD1' ' B' ' 1' ' ' PHE . 0.1 OUTLIER -66.05 -13.18 59.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.457 -0.777 . . . . 0.0 110.527 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -60.03 -20.22 56.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.846 -1.159 . . . . 0.0 109.979 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -88.8 -41.45 12.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.372 -0.83 . . . . 0.0 109.892 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mt -66.15 -22.13 66.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.509 -0.744 . . . . 0.0 110.038 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.07 -19.18 41.81 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.189 -0.944 . . . . 0.0 110.378 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -94.98 29.66 2.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.242 -0.911 . . . . 0.0 109.688 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -106.62 10.72 31.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.481 -0.762 . . . . 0.0 109.922 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.9 m -95.21 36.15 1.25 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.176 -0.952 . . . . 0.0 109.823 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.6 -179.917 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.439 ' CD1' ' CD2' ' A' ' 13' ' ' LEU . 3.3 p90 . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 120.38 0.133 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.64 -35.08 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.792 -1.192 . . . . 0.0 108.496 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -150.35 22.35 0.83 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . 0.473 ' O ' ' CG ' ' B' ' 5' ' ' HIS . 57.8 mt-30 -101.03 -94.54 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.496 ' CD2' HG12 ' A' ' 10' ' ' ILE . 0.9 OUTLIER 178.12 168.27 0.77 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.267 -0.895 . . . . 0.0 109.029 178.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.425 ' N ' ' CD2' ' B' ' 6' ' ' LEU . 0.4 OUTLIER -129.66 85.89 2.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.536 -0.728 . . . . 0.0 109.574 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.22 141.07 17.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.572 -0.705 . . . . 0.0 109.623 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.62 -106.01 2.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.6 p -109.25 -13.66 14.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.519 -0.989 . . . . 0.0 110.066 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -64.5 -34.24 77.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.111 -0.993 . . . . 0.0 109.34 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.412 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 58.4 tp -63.93 -54.83 28.48 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 17.2 t -52.72 -50.16 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.607 -0.683 . . . . 0.0 110.745 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -30.66 68.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.476 -0.765 . . . . 0.0 109.801 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.428 ' HB3' ' CD2' ' B' ' 1' ' ' PHE . . . -73.27 -30.85 63.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.539 -0.726 . . . . 0.0 109.691 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' B' ' 11' ' ' LEU . 39.4 mt -69.37 -39.17 78.2 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.357 -0.839 . . . . 0.0 109.291 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -73.22 -29.62 62.93 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.682 -0.636 . . . . 0.0 109.99 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.3 -28.32 53.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.516 -0.74 . . . . 0.0 109.794 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -79.46 -67.1 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.417 -0.802 . . . . 0.0 109.404 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -86.95 -60.05 2.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.586 -0.696 . . . . 0.0 109.352 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.72 30.21 40.38 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -86.36 160.52 19.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.646 -0.914 . . . . 0.0 109.079 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -83.59 82.3 8.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.568 -0.708 . . . . 0.0 109.116 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.52 53.27 3.28 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.81 27.78 5.35 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -165.03 -175.15 3.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.344 -1.092 . . . . 0.0 109.984 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -52.47 108.54 0.31 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.582 -0.698 . . . . 0.0 109.81 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.8 p -121.42 92.15 48.53 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.483 0.905 0 C-N-CA 122.611 2.207 . . . . 0.0 110.288 -179.679 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -59.39 -27.14 65.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.6 -0.688 . . . . 0.0 109.846 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -77.32 -31.13 54.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.421 -0.8 . . . . 0.0 109.336 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.6 m -108.65 30.65 6.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.483 -0.76 . . . . 0.0 109.877 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 46.0 t -114.27 -45.32 3.05 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.407 -0.808 . . . . 0.0 109.755 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 93.2 m -58.66 -82.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.414 -0.804 . . . . 0.0 110.289 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.7 m -84.87 -172.04 3.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.118 -0.989 . . . . 0.0 109.575 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.488 ' CD1' ' CE1' ' B' ' 5' ' ' HIS . 4.4 mm -84.35 101.36 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.55 -162.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.635 -0.665 . . . . 0.0 109.552 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.9 m -116.71 155.92 28.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.39 -0.818 . . . . 0.0 109.334 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.88 -30.23 70.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.448 -0.782 . . . . 0.0 109.703 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -61.84 -27.74 68.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.529 -0.732 . . . . 0.0 109.684 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -67.99 -46.82 70.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.632 -0.667 . . . . 0.0 110.202 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.424 ' CD2' ' CD2' ' B' ' 15' ' ' LEU . 5.5 mt -66.38 -16.16 63.85 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.355 -0.841 . . . . 0.0 109.778 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.26 -19.02 42.4 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.226 -0.921 . . . . 0.0 110.101 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -94.31 29.98 2.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.189 -0.944 . . . . 0.0 109.909 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.437 ' CD2' HD23 ' B' ' 15' ' ' LEU . 5.6 m-85 -115.01 9.31 16.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.445 -0.784 . . . . 0.0 110.359 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.0 m -108.15 34.45 3.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.04 -1.038 . . . . 0.0 109.153 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.232 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 8.8 p -46.56 -33.0 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.46 -0.775 . . . . 0.0 110.631 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -160.45 135.21 7.62 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.33 43.53 1.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.131 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.488 ' CE1' ' CD1' ' A' ' 10' ' ' ILE . 3.0 m170 -106.8 129.76 54.61 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 mt -126.8 120.81 30.22 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.566 -0.709 . . . . 0.0 109.859 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.66 142.91 0.15 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.525 -0.734 . . . . 0.0 109.421 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.75 -111.24 4.02 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.64 -22.22 16.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.99 . . . . 0.0 109.529 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -58.11 -34.24 69.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.321 -0.862 . . . . 0.0 109.697 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 62.4 tp -63.67 -53.77 46.1 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -53.31 -55.47 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.564 -0.71 . . . . 0.0 110.657 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.4 -26.13 64.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.32 -0.863 . . . . 0.0 109.902 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.01 -34.94 69.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.479 -0.763 . . . . 0.0 109.524 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.437 HD23 ' CD2' ' A' ' 19' ' ' TYR . 24.8 mt -70.78 -34.91 72.29 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -73.02 -28.39 62.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.61 -0.682 . . . . 0.0 109.34 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.53 -29.89 52.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.681 . . . . 0.0 109.608 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 61.1 t -85.12 -72.03 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.526 -0.734 . . . . 0.0 109.432 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.16 -56.61 3.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.382 -0.824 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.49 28.15 55.95 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -83.66 150.06 26.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.454 -1.027 . . . . 0.0 109.326 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.415 ' NH1' ' HG3' ' B' ' 22' ' ' ARG . 1.3 mmm-85 -80.21 89.55 5.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.452 -0.78 . . . . 0.0 109.007 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.35 32.22 28.84 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.49 2.9 46.28 Favored Glycine 0 N--CA 1.492 2.396 0 O-C-N 121.512 -0.993 . . . . 0.0 110.985 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.429 ' CG ' ' HB3' ' B' ' 15' ' ' LEU . 5.1 p90 -143.7 -178.88 6.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.945 -1.326 . . . . 0.0 110.259 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.467 ' CE1' ' HD3' ' B' ' 28' ' ' PRO . 8.2 t80 -58.38 109.13 0.72 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.693 0.759 . . . . 0.0 110.429 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.84 91.43 6.64 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . 0.467 ' HD3' ' CE1' ' B' ' 26' ' ' TYR . 3.3 Cg_exo . . . . . 0 N--CA 1.49 1.267 0 C-N-CA 123.526 2.817 . . . . 0.0 111.433 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.211 0.529 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -74.83 -3.1 29.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.747 . . . . 0.0 111.026 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -90.59 -17.44 26.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.008 -1.058 . . . . 0.0 110.685 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.5 m -135.87 19.23 3.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.121 -0.987 . . . . 0.0 110.666 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.0 t -83.58 -32.31 25.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.216 -0.927 . . . . 0.0 109.508 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -73.35 -52.67 13.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.364 -0.835 . . . . 0.0 109.647 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.9 p -109.89 -169.38 1.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.629 -0.669 . . . . 0.0 109.721 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.414 HG12 ' CE1' ' B' ' 5' ' ' HIS . 58.3 mt -110.0 99.95 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.696 -0.628 . . . . 0.0 109.766 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.1 m -61.95 -174.24 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.544 -0.723 . . . . 0.0 109.386 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.446 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -107.55 175.61 5.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.595 -0.691 . . . . 0.0 109.216 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.63 -12.13 59.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.728 -0.608 . . . . 0.0 110.792 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 12' ' ' SER . 15.4 p90 -68.07 -22.34 64.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.127 -0.983 . . . . 0.0 110.412 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.06 -58.68 2.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.323 -0.861 . . . . 0.0 110.106 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.403 ' CD2' ' CD2' ' B' ' 15' ' ' LEU . 32.6 mt -64.31 -14.22 54.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.526 -0.734 . . . . 0.0 110.875 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -30.34 71.41 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.104 -0.997 . . . . 0.0 109.4 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -97.8 29.53 3.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.547 -0.721 . . . . 0.0 109.771 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -110.5 8.77 23.17 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.53 -0.731 . . . . 0.0 110.138 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.5 m -97.49 29.26 3.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.205 -0.934 . . . . 0.0 109.56 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.27 -179.958 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.463 ' N ' ' CD1' ' B' ' 1' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . 0.426 HG23 ' CD2' ' B' ' 1' ' ' PHE . 17.3 m -88.98 -34.39 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.412 ' N ' HG21 ' B' ' 2' ' ' VAL . 17.3 p30 -156.76 34.2 0.3 Allowed 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.69 155.85 37.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.779 -0.575 . . . . 0.0 109.826 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.414 ' CE1' HG12 ' A' ' 10' ' ' ILE . 7.0 m80 -106.2 156.65 18.25 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.433 ' N ' ' CD2' ' B' ' 6' ' ' LEU . 2.0 mm? -109.12 101.14 10.22 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.248 -0.908 . . . . 0.0 109.997 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.61 120.61 0.05 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.82 -149.16 28.05 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.62 -15.72 63.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.539 -0.977 . . . . 0.0 110.047 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -60.86 -30.8 70.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.156 -0.965 . . . . 0.0 109.783 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 58.3 tp -70.89 -52.32 20.82 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.512 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 18.7 t -53.51 -49.43 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.506 -0.746 . . . . 0.0 110.401 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.02 -31.28 69.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.571 -0.705 . . . . 0.0 109.597 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.55 -34.16 75.35 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.403 ' CD2' ' CD2' ' A' ' 16' ' ' LEU . 23.9 mt -75.35 -25.51 57.82 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -74.34 -31.61 62.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 109.124 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.1 -33.99 38.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.639 -0.663 . . . . 0.0 109.538 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 39.1 t -81.28 -69.27 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.654 -0.654 . . . . 0.0 109.784 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 55.7 m -57.94 -66.52 0.46 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.357 -0.839 . . . . 0.0 109.786 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.25 -38.3 3.22 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.6 -173.44 1.16 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.51 -0.994 . . . . 0.0 109.486 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.86 -64.71 1.02 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.557 -0.714 . . . . 0.0 109.703 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.86 41.79 2.29 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.01 35.04 5.18 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -176.11 -172.02 0.47 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.57 -0.959 . . . . 0.0 109.738 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -52.04 110.51 0.49 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.378 -0.827 . . . . 0.0 109.909 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.12 94.16 41.05 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.602 -0.686 . . . . 0.0 109.672 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.484 0.933 0 C-N-CA 122.476 2.117 . . . . 0.0 110.05 179.854 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.65 -22.19 61.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.684 -0.635 . . . . 0.0 110.262 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -63.55 -42.48 98.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.463 -0.773 . . . . 0.0 110.372 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.6 m -119.76 27.44 8.72 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.59 -43.62 15.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.75 . . . . 0.0 109.437 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 t -84.76 -27.85 26.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.604 -0.685 . . . . 0.0 109.965 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -116.99 168.47 10.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.473 -0.767 . . . . 0.0 109.362 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.445 ' CG1' ' CE1' ' B' ' 5' ' ' HIS . 10.7 mt -107.66 90.02 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.502 -0.749 . . . . 0.0 109.162 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.5 m -60.19 -169.44 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.367 -0.833 . . . . 0.0 109.602 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.468 ' CB ' ' CE2' ' A' ' 14' ' ' TYR . 48.7 m -94.21 160.4 14.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.612 -0.68 . . . . 0.0 109.249 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.59 -26.6 62.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.627 -0.671 . . . . 0.0 109.904 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.468 ' CE2' ' CB ' ' A' ' 12' ' ' SER . 12.5 p90 -64.88 -18.16 64.94 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.495 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -78.77 -44.58 22.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.298 -0.876 . . . . 0.0 109.061 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mt -64.88 -19.69 66.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.584 -0.697 . . . . 0.0 109.643 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -55.8 -21.28 18.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 0.0 110.563 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -94.49 32.78 1.51 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.284 -0.885 . . . . 0.0 109.644 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -114.91 11.5 16.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.429 -0.795 . . . . 0.0 110.08 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.5 m -97.15 28.78 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.169 -0.957 . . . . 0.0 109.536 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 m120 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.548 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.433 ' CE2' HD21 ' B' ' 17' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -161.68 -43.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 109.062 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -156.98 29.16 0.31 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 109.159 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -143.42 131.8 22.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.534 -0.729 . . . . 0.0 109.568 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.445 ' CE1' ' CG1' ' A' ' 10' ' ' ILE . 79.3 m80 -81.51 164.04 22.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.649 -0.657 . . . . 0.0 109.476 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' B' ' 6' ' ' LEU . 1.5 mm? -109.56 82.09 1.54 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.527 -0.733 . . . . 0.0 109.404 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 74.3 m -130.91 121.52 25.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.506 -0.746 . . . . 0.0 109.828 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.71 -128.32 8.4 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 93.4 p -84.43 -9.72 58.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.689 -0.889 . . . . 0.0 110.396 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -61.32 -27.89 68.81 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.011 -1.055 . . . . 0.0 109.348 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 56.3 tp -70.47 -61.97 1.57 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.466 -0.771 . . . . 0.0 108.94 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 36.0 t -47.21 -49.74 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.724 -0.61 . . . . 0.0 111.454 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -56.53 -39.14 72.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.372 -0.83 . . . . 0.0 110.441 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.83 -28.88 64.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.441 -0.787 . . . . 0.0 109.886 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 50.8 mt -65.55 -38.5 89.77 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -66.01 -34.19 77.52 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.433 HD21 ' CE2' ' B' ' 1' ' ' PHE . 2.2 tp -61.39 -34.02 74.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.685 -0.634 . . . . 0.0 109.354 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 45.2 t -87.78 -75.19 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.527 -0.733 . . . . 0.0 109.951 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -75.74 -76.36 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.254 -0.904 . . . . 0.0 109.064 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.07 17.66 26.81 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.81 160.21 16.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.348 -1.089 . . . . 0.0 108.9 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -39.83 61.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.449 -0.782 . . . . 0.0 109.493 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.23 61.85 0.62 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.7 -41.0 0.36 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -102.87 -175.83 2.92 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.57 -0.959 . . . . 0.0 110.23 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -58.21 127.4 31.9 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.57 0.7 . . . . 0.0 110.326 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.73 94.77 31.02 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.483 0.857 0 C-N-CA 122.33 2.02 . . . . 0.0 110.244 -179.821 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.8 t . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 120.38 0.133 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -96.9 27.06 4.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.973 -1.079 . . . . 0.0 109.775 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.28 -30.66 7.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.0 9.36 6.3 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.548 -0.72 . . . . 0.0 110.505 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 46.6 t -82.01 84.82 6.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.087 -1.008 . . . . 0.0 108.964 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.7 m -160.95 -42.92 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.488 -0.758 . . . . 0.0 109.944 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.434 ' HA ' ' CE1' ' B' ' 5' ' ' HIS . 11.6 t -154.06 -125.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.731 . . . . 0.0 109.368 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.434 ' CD1' ' N ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -101.61 105.63 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.582 -1.324 . . . . 0.0 108.686 -179.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -82.13 155.72 24.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.673 -0.642 . . . . 0.0 109.512 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.2 p -95.65 151.78 19.04 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.455 ' CD2' ' CZ ' ' B' ' 1' ' ' PHE . 1.3 tm? -66.49 -26.72 67.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.647 -0.658 . . . . 0.0 109.437 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -51.94 -24.82 6.98 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.148 -0.97 . . . . 0.0 110.603 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -87.89 -44.23 11.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.348 -0.845 . . . . 0.0 109.966 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mt -65.01 -16.21 63.18 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.436 -0.79 . . . . 0.0 110.5 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.15 -23.56 35.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.177 -0.952 . . . . 0.0 110.307 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -96.64 37.92 1.25 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.479 -0.763 . . . . 0.0 109.802 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -115.99 -0.91 12.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.484 -0.76 . . . . 0.0 110.554 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.5 m -88.62 11.12 18.23 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.082 -1.011 . . . . 0.0 110.57 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.9 p30 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.098 -1.001 . . . . 0.0 109.581 179.879 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.455 ' CZ ' ' CD2' ' A' ' 13' ' ' LEU . 9.1 p90 . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 120.473 0.178 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 35.1 m -63.09 -29.67 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.167 -0.958 . . . . 0.0 109.254 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -142.97 30.09 1.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -130.52 -179.21 5.14 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.434 ' CE1' ' HA ' ' A' ' 9' ' ' SER . 12.3 m-70 -109.15 149.55 29.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.338 -0.851 . . . . 0.0 109.524 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.28 100.01 12.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.563 -0.71 . . . . 0.0 110.123 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.67 142.58 0.14 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.586 -0.696 . . . . 0.0 109.236 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.23 -115.33 4.08 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.38 -19.62 18.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.674 -0.898 . . . . 0.0 109.956 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -56.68 -28.18 60.27 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.012 -1.055 . . . . 0.0 109.445 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 0.6 OUTLIER -64.73 -60.03 3.56 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 25.2 t -52.62 -47.32 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.835 -0.541 . . . . 0.0 111.577 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -58.93 -30.77 68.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.292 -0.88 . . . . 0.0 110.353 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.417 ' HB3' ' CD2' ' B' ' 1' ' ' PHE . . . -77.92 -27.39 49.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.506 -0.747 . . . . 0.0 109.796 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' B' ' 11' ' ' LEU . 45.3 mt -70.49 -37.89 74.27 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.294 -0.879 . . . . 0.0 108.941 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -76.11 -34.55 59.48 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -30.01 69.71 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 33.0 t -86.82 -69.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.531 -0.73 . . . . 0.0 109.479 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 11.6 m -88.68 -70.16 0.66 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.557 -0.714 . . . . 0.0 109.335 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.44 36.97 22.14 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -86.51 177.29 7.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.53 -0.982 . . . . 0.0 109.119 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -82.74 80.27 8.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.524 -0.735 . . . . 0.0 109.204 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.81 63.27 2.91 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.83 22.13 5.8 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -151.1 -173.19 4.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.263 -1.139 . . . . 0.0 109.573 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.405 ' CE1' ' HD3' ' B' ' 28' ' ' PRO . 3.6 t80 -49.95 101.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.54 -0.725 . . . . 0.0 110.085 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.42 90.91 36.32 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . 0.405 ' HD3' ' CE1' ' B' ' 26' ' ' TYR . 4.9 Cg_exo . . . . . 0 N--CA 1.482 0.816 0 C-N-CA 122.625 2.217 . . . . 0.0 110.094 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -70.17 -10.08 57.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.622 -0.674 . . . . 0.0 110.037 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.52 -65.7 0.51 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.074 -1.016 . . . . 0.0 110.004 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.0 m -129.68 36.83 4.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.478 -0.764 . . . . 0.0 110.336 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.0 t -54.17 -55.46 27.65 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.187 -0.946 . . . . 0.0 109.335 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -92.64 49.74 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.528 -0.733 . . . . 0.0 109.454 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -176.56 163.2 2.37 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.423 HG12 ' CE1' ' B' ' 5' ' ' HIS . 16.8 mt -103.69 86.81 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.426 -0.797 . . . . 0.0 109.166 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -178.83 0.1 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.765 -0.584 . . . . 0.0 110.079 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -91.71 166.12 12.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.708 -0.62 . . . . 0.0 109.623 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -66.51 -32.11 73.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.669 -0.644 . . . . 0.0 109.679 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -27.14 63.99 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.335 -0.853 . . . . 0.0 109.694 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -67.39 -50.12 60.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.459 -0.776 . . . . 0.0 109.508 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' B' ' 15' ' ' LEU . 10.2 mt -65.43 -16.65 63.85 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.431 -0.793 . . . . 0.0 110.25 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.91 -19.41 42.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.249 -0.907 . . . . 0.0 110.354 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -96.27 30.63 2.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.264 -0.898 . . . . 0.0 109.801 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.455 ' CD2' HD23 ' B' ' 15' ' ' LEU . 6.4 m-85 -114.69 -14.91 11.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.6 -0.687 . . . . 0.0 110.026 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.9 m -73.56 -20.15 60.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.136 -0.978 . . . . 0.0 110.22 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.7 p30 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.415 179.78 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.44 ' CZ ' ' CD2' ' B' ' 17' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 18.4 t -83.48 -69.59 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.595 -1.316 . . . . 0.0 109.081 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -154.35 24.63 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.532 -0.73 . . . . 0.0 109.935 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -115.47 142.11 47.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.448 -0.782 . . . . 0.0 109.328 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.423 ' CE1' HG12 ' A' ' 10' ' ' ILE . 49.8 m80 -70.51 -178.47 1.78 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.63 -0.669 . . . . 0.0 109.866 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 38.0 mt -130.63 42.18 3.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.501 -0.749 . . . . 0.0 110.854 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.67 140.78 52.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.212 -0.93 . . . . 0.0 109.281 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.66 -144.61 21.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.3 -14.67 60.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.456 -1.026 . . . . 0.0 109.893 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -60.43 -37.86 82.26 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.082 -1.011 . . . . 0.0 109.126 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 2.5 tt -61.65 -58.5 7.81 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.806 -0.559 . . . . 0.0 109.696 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 t -49.56 -51.06 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.625 -0.672 . . . . 0.0 111.22 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -58.61 -33.65 70.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.368 -0.832 . . . . 0.0 110.092 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.45 -30.56 67.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.548 -0.72 . . . . 0.0 109.7 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.456 ' CB ' ' CD1' ' B' ' 25' ' ' PHE . 30.2 mt -69.25 -36.52 77.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.75 -29.94 66.31 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.44 ' CD2' ' CZ ' ' B' ' 1' ' ' PHE . 1.5 tp -68.66 -35.47 77.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.602 -0.686 . . . . 0.0 109.436 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 39.7 t -80.84 -69.81 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.543 -0.723 . . . . 0.0 109.726 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.56 -81.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.472 -0.768 . . . . 0.0 109.416 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 139.19 -52.05 0.73 Allowed Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.671 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -90.34 152.02 21.2 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.34 -1.094 . . . . 0.0 110.062 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 19.3 mtt180 -76.03 139.03 41.25 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.22 17.62 57.11 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.6 33.56 5.18 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.456 ' CD1' ' CB ' ' B' ' 15' ' ' LEU . 27.0 p90 -176.83 -169.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.717 -0.872 . . . . 0.0 109.016 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.402 ' CE1' ' HD3' ' B' ' 28' ' ' PRO . 3.8 t80 -51.52 99.93 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.294 -0.879 . . . . 0.0 109.82 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 19.5 p -132.61 89.88 34.55 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . 0.402 ' HD3' ' CE1' ' B' ' 26' ' ' TYR . 4.4 Cg_exo . . . . . 0 C--N 1.322 -0.866 0 C-N-CA 122.394 2.062 . . . . 0.0 110.159 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.6 t . . . . . 0 N--CA 1.494 1.738 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.25 -21.26 63.73 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.442 -0.786 . . . . 0.0 110.04 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -111.79 -3.52 14.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.383 -0.823 . . . . 0.0 110.951 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.4 m -121.26 18.78 11.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.983 -1.073 . . . . 0.0 110.529 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.02 21.68 13.57 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.164 -0.96 . . . . 0.0 109.828 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.6 m -129.73 -66.22 0.8 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 108.83 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.99 -164.88 1.21 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.432 ' CD1' ' CE1' ' B' ' 5' ' ' HIS . 4.5 mm -90.82 98.55 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.4 -0.813 . . . . 0.0 108.941 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -70.69 -167.76 0.21 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.671 -0.643 . . . . 0.0 109.747 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.406 ' OG ' ' CE1' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -129.02 156.12 44.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.509 -0.744 . . . . 0.0 109.604 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.448 ' CD2' ' CE1' ' B' ' 1' ' ' PHE . 3.2 tm? -66.78 -26.32 66.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.619 -0.676 . . . . 0.0 110.521 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.406 ' CE1' ' OG ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -54.89 -22.32 14.41 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.073 -1.017 . . . . 0.0 110.561 -179.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -86.39 -39.94 15.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.419 -0.801 . . . . 0.0 109.437 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.407 ' CD2' ' CD2' ' B' ' 15' ' ' LEU . 6.5 mt -68.64 -10.78 58.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.489 -0.757 . . . . 0.0 110.258 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -67.51 -28.43 67.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 109.412 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -71.01 -12.16 61.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.553 -0.717 . . . . 0.0 110.622 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -74.59 -7.8 54.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.32 -0.862 . . . . 0.0 110.47 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 27.9 m -97.64 33.44 2.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.132 -0.98 . . . . 0.0 109.596 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.533 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.448 ' CE1' ' CD2' ' A' ' 13' ' ' LEU . 8.5 p90 . . . . . 0 N--CA 1.5 2.036 0 CA-C-O 120.464 0.173 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.94 -33.16 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.056 -1.027 . . . . 0.0 108.734 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -144.27 30.04 1.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -126.65 -159.5 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.432 ' CE1' ' CD1' ' A' ' 10' ' ' ILE . 20.3 m80 -115.97 -172.82 2.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.349 -0.844 . . . . 0.0 109.829 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 tp -130.45 43.57 3.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.572 -0.705 . . . . 0.0 110.178 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 59.5 m -122.86 136.29 54.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.509 -0.744 . . . . 0.0 109.464 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.94 -132.94 11.43 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -81.53 2.86 27.11 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.646 -0.914 . . . . 0.0 110.33 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -77.13 -37.18 54.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.053 -1.03 . . . . 0.0 108.733 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 36.9 tp -68.17 -63.69 1.01 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -52.54 -49.77 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.658 -0.651 . . . . 0.0 110.641 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -59.54 -30.79 68.86 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.329 -0.857 . . . . 0.0 109.658 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.427 ' HB3' ' CD2' ' B' ' 1' ' ' PHE . . . -71.42 -32.13 68.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.636 -0.665 . . . . 0.0 109.764 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.423 ' HB3' ' CG ' ' B' ' 25' ' ' PHE . 38.2 mt -68.92 -39.66 79.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.471 -0.768 . . . . 0.0 109.162 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -67.49 -34.0 76.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.692 . . . . 0.0 109.522 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.33 -46.21 74.13 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.553 -0.717 . . . . 0.0 109.677 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 44.3 t -67.42 -69.81 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.506 -0.746 . . . . 0.0 109.355 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.88 -79.46 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.483 -0.76 . . . . 0.0 108.992 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.44 -28.02 14.92 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.93 170.12 4.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.423 -1.045 . . . . 0.0 109.764 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.74 138.87 31.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.546 -0.721 . . . . 0.0 109.395 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.56 29.6 69.97 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.78 27.7 10.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.423 ' CG ' ' HB3' ' B' ' 15' ' ' LEU . 12.5 p90 -177.72 -177.32 0.65 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -1.073 . . . . 0.0 110.177 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -57.49 125.97 25.24 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.6 -0.687 . . . . 0.0 109.893 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 8.8 p -117.63 96.36 49.28 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.574 -0.703 . . . . 0.0 109.257 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo . . . . . 0 N--CA 1.483 0.878 0 C-N-CA 122.487 2.124 . . . . 0.0 110.169 -179.755 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.4 t . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -60.28 -18.51 49.68 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.58 -0.7 . . . . 0.0 110.082 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -52.64 -59.32 4.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.249 -0.907 . . . . 0.0 110.309 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -124.23 36.02 4.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.524 -0.735 . . . . 0.0 109.515 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' B' ' 6' ' ' LEU . 0.1 OUTLIER -62.59 -43.16 99.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.625 -0.672 . . . . 0.0 109.555 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 m -87.41 -33.67 19.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.534 -0.729 . . . . 0.0 109.75 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -94.45 -177.63 4.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.457 -0.777 . . . . 0.0 109.449 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.44 ' CG1' ' CE1' ' B' ' 5' ' ' HIS . 19.5 mt -114.73 99.95 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.377 -0.827 . . . . 0.0 109.409 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.33 -177.87 6.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.567 -0.708 . . . . 0.0 109.304 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.12 153.95 19.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.507 -0.746 . . . . 0.0 109.424 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.5 tp -57.86 -20.32 35.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.597 -0.689 . . . . 0.0 110.826 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -53.24 -28.19 26.05 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.22 -0.925 . . . . 0.0 111.697 -178.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.443 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 14.3 pt20 -80.06 -44.37 20.18 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.104 -0.997 . . . . 0.0 109.66 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.401 ' CD2' ' CD2' ' B' ' 15' ' ' LEU . 9.9 mt -67.0 -16.43 64.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.51 -0.744 . . . . 0.0 109.649 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.62 -17.92 50.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.173 -0.954 . . . . 0.0 109.84 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -93.27 27.28 2.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 0.0 109.869 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.453 ' CD2' ' CD2' ' B' ' 15' ' ' LEU . 6.3 m-85 -107.16 -20.59 13.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.365 -0.834 . . . . 0.0 109.966 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.3 m -75.88 -4.2 39.51 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.275 -0.89 . . . . 0.0 110.287 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p30 . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.004 -1.06 . . . . 0.0 109.548 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.446 ' CZ ' ' CD2' ' B' ' 17' ' ' LEU . 3.3 t80 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 9.0 t -46.35 -64.65 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 O-C-N 121.65 -0.656 . . . . 0.0 110.52 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -174.4 36.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -122.26 148.81 44.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.609 -0.682 . . . . 0.0 109.258 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.44 ' CE1' ' CG1' ' A' ' 10' ' ' ILE . 51.1 m80 -78.38 -178.31 5.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.642 -0.661 . . . . 0.0 109.576 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -142.42 131.96 23.83 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.95 -76.71 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.146 -0.971 . . . . 0.0 109.595 178.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.08 -121.59 0.06 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 22.3 p -73.58 -8.54 56.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.47 -1.018 . . . . 0.0 109.445 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -61.28 -41.82 97.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.877 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 67.2 tp -60.46 -56.29 23.14 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.485 -0.76 . . . . 0.0 109.682 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.4 t -49.76 -53.77 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.567 -0.708 . . . . 0.0 111.081 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -58.07 -31.93 67.55 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.437 -0.789 . . . . 0.0 110.188 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.418 ' HA ' ' CE1' ' B' ' 1' ' ' PHE . . . -69.13 -34.11 74.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.482 -0.762 . . . . 0.0 109.654 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.453 ' CD2' ' CD2' ' A' ' 19' ' ' TYR . 25.8 mt -70.81 -32.94 70.19 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -68.29 -33.72 74.87 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.446 ' CD2' ' CZ ' ' B' ' 1' ' ' PHE . 0.5 OUTLIER -69.14 -39.22 78.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.689 -0.632 . . . . 0.0 109.745 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 30.8 t -72.84 -68.2 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.57 -0.706 . . . . 0.0 110.135 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 10.6 m -65.15 -69.19 0.31 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.417 -0.802 . . . . 0.0 109.195 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.0 -36.52 3.52 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.28 167.43 12.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.338 -1.095 . . . . 0.0 109.928 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.56 -63.56 1.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.81 86.26 0.97 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -161.5 -41.38 0.02 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.441 ' CG ' ' HB3' ' B' ' 15' ' ' LEU . 28.0 p90 -116.43 -174.49 2.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.409 -1.053 . . . . 0.0 110.446 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.423 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 2.9 t80 -54.5 100.0 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.428 HG21 ' CE1' ' B' ' 25' ' ' PHE . 40.4 p -113.1 92.46 21.74 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.653 -0.654 . . . . 0.0 109.57 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . 0.423 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 2.4 Cg_endo . . . . . 0 C--N 1.323 -0.808 0 C-N-CA 122.422 2.081 . . . . 0.0 109.776 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.0 t . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -74.81 -5.55 44.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.557 -0.715 . . . . 0.0 110.195 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -58.24 -63.21 1.35 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.196 -0.94 . . . . 0.0 110.013 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.5 p -120.48 27.32 8.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.477 -0.764 . . . . 0.0 110.279 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -32.09 54.36 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.217 -0.927 . . . . 0.0 109.389 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -113.42 -32.73 6.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.676 -0.64 . . . . 0.0 109.325 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.431 ' O ' ' CD2' ' B' ' 5' ' ' HIS . 0.4 OUTLIER -98.85 -171.41 2.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.449 -0.782 . . . . 0.0 108.926 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.408 HG21 HD11 ' A' ' 10' ' ' ILE . 1.7 mm -104.21 160.64 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.361 -0.837 . . . . 0.0 109.008 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.0 p -147.27 179.56 7.56 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.507 -0.746 . . . . 0.0 109.806 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.434 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -82.8 102.06 11.34 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -70.27 -14.61 62.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.545 -0.722 . . . . 0.0 110.859 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.434 ' CE2' ' HB2' ' A' ' 12' ' ' SER . 17.3 p90 -71.25 -18.92 62.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.088 -1.008 . . . . 0.0 109.779 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -84.18 -3.24 58.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.359 -0.838 . . . . 0.0 110.416 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.408 HD22 ' CG ' ' A' ' 19' ' ' TYR . 4.4 mt -65.7 -14.15 60.7 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.134 -0.979 . . . . 0.0 109.99 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -59.06 -19.65 46.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.164 -0.96 . . . . 0.0 110.002 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -96.89 31.95 2.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.296 -0.878 . . . . 0.0 109.438 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.408 ' CG ' HD22 ' A' ' 16' ' ' LEU . 6.4 m-85 -115.19 12.97 16.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.435 -0.79 . . . . 0.0 109.95 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.81 -56.11 5.12 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.231 -0.918 . . . . 0.0 109.571 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.297 -1.713 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.326 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 13.3 p90 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 120.613 0.244 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 24.5 t -51.89 -25.72 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 120.962 -1.087 . . . . 0.0 110.469 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -151.57 27.14 0.66 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 109.303 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' B' ' 5' ' ' HIS . 5.8 mp0 -107.24 -97.21 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.441 -0.787 . . . . 0.0 109.329 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.431 ' CD2' ' O ' ' A' ' 9' ' ' SER . 1.1 m80 -173.1 152.58 2.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.833 -1.167 . . . . 0.0 109.86 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 21.9 mt -115.11 86.15 2.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.635 -0.666 . . . . 0.0 109.511 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -150.2 129.95 13.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.48 -0.762 . . . . 0.0 109.481 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.29 -136.48 14.46 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.42 -6.81 57.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.494 -1.003 . . . . 0.0 110.364 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -66.57 -29.68 69.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 109.691 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 60.7 tp -71.25 -46.28 61.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.486 -0.759 . . . . 0.0 109.544 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 39.3 t -60.66 -43.79 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.672 -0.643 . . . . 0.0 109.952 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.77 -39.51 94.41 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.435 -0.791 . . . . 0.0 109.302 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.32 -30.39 70.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.607 -0.683 . . . . 0.0 109.769 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.448 ' CB ' ' CD1' ' B' ' 25' ' ' PHE . 1.2 mt -70.4 -36.18 73.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.507 -0.745 . . . . 0.0 109.416 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -70.3 -32.55 70.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.581 -0.699 . . . . 0.0 109.607 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.82 -24.67 41.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.477 -0.764 . . . . 0.0 110.086 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 41.9 t -89.48 -68.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.246 -0.909 . . . . 0.0 109.801 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 m -53.71 -78.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.39 -0.819 . . . . 0.0 110.269 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.33 -40.42 1.56 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.84 176.02 1.03 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.287 -1.125 . . . . 0.0 109.593 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.42 -44.35 6.55 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.75 42.97 1.68 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.28 38.16 3.21 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.448 ' CD1' ' CB ' ' B' ' 15' ' ' LEU . 52.5 p90 -178.4 -166.71 0.11 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.397 -1.061 . . . . 0.0 109.522 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.408 ' HB2' ' CD1' ' B' ' 15' ' ' LEU . 0.4 OUTLIER -47.29 94.38 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.868 -0.52 . . . . 0.0 110.188 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.33 98.86 28.58 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.484 0.956 0 C-N-CA 122.3 2.0 . . . . 0.0 110.047 -179.62 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -90.52 53.58 2.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.233 -0.917 . . . . 0.0 109.044 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -142.22 -46.32 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.539 -0.726 . . . . 0.0 109.368 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.0 m -115.6 15.87 16.55 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.539 -0.726 . . . . 0.0 109.952 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 45.3 t -72.93 -35.77 67.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.09 -1.006 . . . . 0.0 109.314 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 m -73.22 -58.14 3.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.487 -0.758 . . . . 0.0 109.797 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.4 p -119.62 -167.86 1.49 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.502 -0.749 . . . . 0.0 109.815 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.405 ' CG1' ' CE1' ' B' ' 5' ' ' HIS . 7.4 mt -101.82 130.16 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.0 p -106.23 -172.9 2.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.31 -0.869 . . . . 0.0 110.429 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.57 144.8 55.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.573 -0.705 . . . . 0.0 110.787 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.15 -30.25 68.44 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -22.29 22.09 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.489 -0.757 . . . . 0.0 109.94 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -72.45 -46.74 53.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.36 -0.838 . . . . 0.0 109.487 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.423 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 5.4 mt -65.4 -21.62 66.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.516 -0.74 . . . . 0.0 110.093 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.77 -26.92 58.69 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.226 -0.921 . . . . 0.0 110.308 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -97.74 35.88 1.61 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.377 -0.827 . . . . 0.0 109.672 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 7.1 m-85 -113.8 -0.98 14.04 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.501 -0.75 . . . . 0.0 110.383 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.2 m -81.15 1.77 30.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.145 -0.972 . . . . 0.0 110.469 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 120.999 -1.063 . . . . 0.0 109.571 -179.817 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 28.8 m -50.49 172.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.444 -0.785 . . . . 0.0 110.703 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -58.59 92.54 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.464 -0.772 . . . . 0.0 109.901 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -130.4 104.99 7.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.556 -0.715 . . . . 0.0 109.385 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.405 ' CE1' ' CG1' ' A' ' 10' ' ' ILE . 70.9 m80 -74.4 135.07 42.39 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.95 98.25 11.14 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.483 -0.761 . . . . 0.0 109.734 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -178.46 127.36 0.11 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.694 . . . . 0.0 109.422 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.83 -141.17 26.95 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p -69.23 -16.66 63.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.561 -0.964 . . . . 0.0 110.169 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -67.81 -38.76 83.68 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.176 -0.953 . . . . 0.0 109.575 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 66.7 tp -68.69 -46.19 69.68 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.654 -0.654 . . . . 0.0 109.379 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.7 t -55.97 -49.9 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.428 -0.795 . . . . 0.0 110.073 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -62.31 -26.33 68.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.556 -0.715 . . . . 0.0 109.578 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.85 -32.26 67.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.641 -0.662 . . . . 0.0 109.293 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.433 ' HB3' ' CG ' ' B' ' 25' ' ' PHE . 24.0 mt -79.33 -26.58 42.13 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.48 -29.79 61.58 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -83.35 -32.31 26.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.494 -0.754 . . . . 0.0 109.477 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 45.3 t -81.28 -68.88 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.528 -0.732 . . . . 0.0 109.506 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 60.5 m -54.33 -73.29 0.05 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.496 -0.753 . . . . 0.0 110.428 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.76 -45.88 1.1 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 174.12 8.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.377 -1.072 . . . . 0.0 109.688 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.67 31.44 5.46 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.18 37.15 0.09 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.91 46.75 1.06 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.433 ' CG ' ' HB3' ' B' ' 15' ' ' LEU . 14.5 p90 -179.33 -173.62 0.28 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.465 -1.021 . . . . 0.0 109.877 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -54.46 108.36 0.37 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.509 -0.744 . . . . 0.0 109.482 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.78 93.32 46.09 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.715 -0.615 . . . . 0.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.484 0.952 0 C-N-CA 122.529 2.153 . . . . 0.0 109.979 -179.91 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.401 ' CG2' ' CD2' ' B' ' 11' ' ' LEU . 3.7 t . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.074 0.464 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.37 -8.87 54.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.431 -0.793 . . . . 0.0 110.866 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.69 -14.56 8.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.154 -0.966 . . . . 0.0 110.883 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.9 m -120.19 24.44 10.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.027 -1.046 . . . . 0.0 110.12 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -84.84 -42.9 14.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.348 -0.845 . . . . 0.0 109.301 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.9 m -78.91 -48.13 15.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.548 -0.72 . . . . 0.0 109.654 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -110.0 -177.91 3.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.689 . . . . 0.0 109.543 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.439 ' CG1' ' CE1' ' B' ' 5' ' ' HIS . 32.0 mt -106.25 135.23 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.7 m -94.99 -174.69 3.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.726 . . . . 0.0 110.129 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.8 m -91.84 166.36 12.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.661 -0.649 . . . . 0.0 109.962 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.5 tp -67.47 -24.81 65.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.673 -0.642 . . . . 0.0 110.174 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -58.67 -19.35 38.67 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.456 -0.778 . . . . 0.0 110.954 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -77.64 -69.35 0.55 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.084 -1.01 . . . . 0.0 110.375 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 24.4 mt -60.16 -17.66 42.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.405 -0.809 . . . . 0.0 109.992 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -64.75 -44.09 91.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 108.577 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -71.52 -9.99 59.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.649 -0.657 . . . . 0.0 109.737 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -89.29 22.56 2.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.4 -0.812 . . . . 0.0 110.45 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.8 m -109.31 40.79 1.77 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.166 -0.959 . . . . 0.0 109.691 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.1 m120 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.1 -0.952 . . . . 0.0 109.475 179.938 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.422 ' CE2' ' CB ' ' B' ' 4' ' ' GLN . 10.0 t80 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . 0.444 ' O ' ' C ' ' B' ' 3' ' ' ASN . 10.7 t -42.96 113.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 122.017 -0.427 . . . . 0.0 110.792 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' B' ' 2' ' ' VAL . 2.7 p30 0.77 75.82 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.101 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . 0.422 ' CB ' ' CE2' ' B' ' 1' ' ' PHE . 0.0 OUTLIER -142.5 131.79 23.48 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.616 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.439 ' CE1' ' CG1' ' A' ' 10' ' ' ILE . 74.6 m80 -91.16 172.63 8.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.785 . . . . 0.0 109.381 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 28.6 mt -126.31 121.02 31.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.473 -0.767 . . . . 0.0 110.263 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 179.78 105.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.8 -144.76 17.49 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 60.3 p -64.36 -19.73 65.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.562 -0.963 . . . . 0.0 109.98 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -57.46 -30.66 65.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.17 -0.956 . . . . 0.0 109.769 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.401 ' CD2' ' CG2' ' A' ' 3' ' ' VAL . 66.8 tp -68.63 -56.46 8.13 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 t -50.07 -48.09 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.643 -0.66 . . . . 0.0 111.107 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -62.16 -33.43 74.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.496 -0.752 . . . . 0.0 109.696 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.53 -28.61 67.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.557 -0.714 . . . . 0.0 109.555 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 30.4 mt -78.09 -29.45 49.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.477 -0.765 . . . . 0.0 109.11 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -69.59 -35.2 75.12 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.31 -54.86 6.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.697 -0.627 . . . . 0.0 109.547 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 20.9 t -61.52 -66.51 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.539 -0.726 . . . . 0.0 109.805 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 45.4 m -59.61 -69.38 0.21 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.566 -0.709 . . . . 0.0 109.82 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.98 -27.34 18.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.77 142.77 40.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.467 -1.019 . . . . 0.0 109.608 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 117.26 20.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.581 -0.699 . . . . 0.0 109.272 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.5 31.78 49.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.94 32.17 5.76 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.417 ' CE1' HG21 ' B' ' 27' ' ' THR . 38.4 p90 -167.95 -171.38 1.55 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.965 . . . . 0.0 109.618 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.421 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 3.1 t80 -52.97 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.493 -0.754 . . . . 0.0 109.765 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.417 HG21 ' CE1' ' B' ' 25' ' ' PHE . 0.8 OUTLIER -121.8 92.47 48.76 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . 0.421 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 6.1 Cg_exo . . . . . 0 N--CA 1.482 0.839 0 C-N-CA 122.593 2.195 . . . . 0.0 110.059 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.403 ' CG1' ' HA ' ' B' ' 7' ' ' CYS . 18.0 t . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -57.56 -21.85 41.1 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.577 -0.702 . . . . 0.0 109.986 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -63.21 -41.8 99.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.448 -0.783 . . . . 0.0 110.098 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.1 m -113.53 20.85 15.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.429 -0.794 . . . . 0.0 111.072 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.7 t -93.29 43.74 1.13 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.04 -1.037 . . . . 0.0 109.611 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 t -138.92 -45.22 0.47 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.07 -170.95 2.62 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.436 HD11 ' CE1' ' B' ' 5' ' ' HIS . 1.0 OUTLIER -97.39 102.1 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.182 -0.949 . . . . 0.0 109.601 -178.615 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.1 m -62.46 -174.46 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.321 0.581 . . . . 0.0 110.188 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.6 m -105.58 163.64 12.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.744 -0.597 . . . . 0.0 109.501 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.428 HD11 ' CD1' ' B' ' 1' ' ' PHE . 42.2 tp -66.51 -28.25 68.41 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.572 -0.705 . . . . 0.0 109.918 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -58.34 -22.85 54.81 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.486 -0.759 . . . . 0.0 110.285 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -80.51 -47.91 13.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.291 -0.88 . . . . 0.0 109.702 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.4 mt -66.97 -20.27 65.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.515 -0.74 . . . . 0.0 110.315 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -62.0 -22.39 65.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.251 -0.905 . . . . 0.0 110.022 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -98.53 33.38 2.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.84 . . . . 0.0 109.648 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -112.28 7.2 19.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.646 -0.659 . . . . 0.0 110.346 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.47 35.51 1.48 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.047 -0.977 . . . . 0.0 109.544 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.43 ' CD1' HG22 ' B' ' 2' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . 0.43 HG22 ' CD1' ' B' ' 1' ' ' PHE . 15.6 t -86.22 -58.06 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.662 -1.274 . . . . 0.0 109.316 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.84 37.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.433 -0.792 . . . . 0.0 109.664 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -120.42 139.83 52.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.589 -0.694 . . . . 0.0 109.262 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.436 ' CE1' HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -77.78 164.68 25.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.471 -0.768 . . . . 0.0 109.602 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 18.8 mt -120.34 112.3 18.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.568 -0.707 . . . . 0.0 110.463 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.403 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 0.1 OUTLIER 179.71 120.25 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.425 -0.797 . . . . 0.0 109.153 178.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.39 -147.33 19.07 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.5 t -65.73 -14.67 61.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.349 -1.089 . . . . 0.0 109.92 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.96 -29.95 67.55 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.139 -0.976 . . . . 0.0 109.194 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.52 -52.89 49.33 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 18.1 t -56.07 -37.58 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.802 -0.562 . . . . 0.0 110.699 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -74.8 -26.33 59.66 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.455 -0.778 . . . . 0.0 110.212 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.19 -31.25 64.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 40.3 mt -74.02 -39.76 63.37 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -61.55 -33.04 73.17 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 tp -67.87 -40.74 83.54 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 35.8 t -86.49 -75.12 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.671 -0.643 . . . . 0.0 110.134 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 14.0 m -64.78 -62.72 1.4 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 109.599 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.16 15.73 78.66 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -90.48 158.11 17.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -1.178 . . . . 0.0 109.16 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.85 117.34 26.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.529 -0.732 . . . . 0.0 109.29 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.03 36.25 93.02 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.96 -19.86 6.64 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -127.42 -174.82 3.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.264 -1.139 . . . . 0.0 110.232 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.456 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 4.2 t80 -60.11 105.61 0.42 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.546 0.689 . . . . 0.0 109.47 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.75 90.82 21.93 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . 0.456 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 8.7 Cg_endo . . . . . 0 N--CA 1.486 1.064 0 C-N-CA 122.857 2.371 . . . . 0.0 110.826 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -89.68 59.15 4.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.393 -0.817 . . . . 0.0 109.699 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.5 -45.96 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.478 -0.764 . . . . 0.0 109.143 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 59.1 m -115.35 16.14 16.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.662 -0.649 . . . . 0.0 110.058 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.89 -29.37 62.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.282 -0.887 . . . . 0.0 109.159 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -84.08 -49.15 9.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.584 -0.698 . . . . 0.0 110.212 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p -122.83 166.92 14.2 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.532 -0.73 . . . . 0.0 110.061 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.433 HG13 ' CD2' ' B' ' 5' ' ' HIS . 0.1 OUTLIER -86.81 120.9 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 87.7 m -82.8 -89.0 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.605 -0.684 . . . . 0.0 110.016 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.6 t -179.45 168.83 1.44 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.993 -1.067 . . . . 0.0 109.466 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.24 -33.1 74.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.584 -0.698 . . . . 0.0 110.478 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -21.54 61.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.264 -0.898 . . . . 0.0 110.208 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -76.74 -50.95 12.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.324 -0.86 . . . . 0.0 110.123 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.423 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 10.4 mt -66.81 -21.14 66.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.448 -0.783 . . . . 0.0 110.162 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -55.46 -22.5 20.89 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.239 -0.913 . . . . 0.0 110.466 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -98.02 35.33 1.75 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.366 -0.834 . . . . 0.0 109.808 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 6.6 m-85 -111.57 0.61 16.49 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.468 -0.77 . . . . 0.0 110.373 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.97 36.43 1.56 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.097 -1.002 . . . . 0.0 109.436 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.128 -0.939 . . . . 0.0 109.501 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -36.07 -72.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.581 0 O-C-N 122.053 -0.404 . . . . 0.0 112.022 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -178.16 54.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.162 -0.961 . . . . 0.0 109.375 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -103.39 123.97 47.83 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.433 ' CD2' HG13 ' A' ' 10' ' ' ILE . 13.0 m80 -84.11 137.89 33.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.464 -0.773 . . . . 0.0 109.672 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.413 ' HB3' ' CD2' ' B' ' 11' ' ' LEU . 50.0 mt -81.78 95.52 7.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.875 -0.515 . . . . 0.0 110.413 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.05 120.41 0.44 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.666 -0.646 . . . . 0.0 109.35 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.21 -142.31 21.24 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 51.7 p -66.02 -23.83 66.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.942 . . . . 0.0 109.459 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -56.29 -29.9 61.81 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.241 -0.912 . . . . 0.0 109.112 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.413 ' CD2' ' HB3' ' B' ' 6' ' ' LEU . 0.4 OUTLIER -63.41 -60.35 3.48 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -51.12 -52.65 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.665 -0.647 . . . . 0.0 111.143 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -59.52 -29.25 67.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.37 -0.831 . . . . 0.0 110.346 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.85 63.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.485 -0.759 . . . . 0.0 109.742 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' B' ' 11' ' ' LEU . 31.3 mt -77.2 -30.57 54.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.435 -0.791 . . . . 0.0 109.541 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -75.99 -30.86 58.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.568 -0.708 . . . . 0.0 109.42 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tp -80.18 -30.62 38.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.595 -0.69 . . . . 0.0 109.631 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 43.3 t -82.66 -68.59 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.695 . . . . 0.0 109.195 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 33.8 m -67.74 -67.55 0.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.68 -0.638 . . . . 0.0 109.387 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.04 7.89 79.79 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -89.83 151.63 21.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.115 -1.227 . . . . 0.0 109.669 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.36 104.13 9.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.745 . . . . 0.0 108.99 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.81 42.51 30.91 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.07 -20.38 6.77 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -115.41 -170.49 1.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.404 -1.056 . . . . 0.0 109.566 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.416 ' O ' ' CG ' ' B' ' 26' ' ' TYR . 0.5 OUTLIER -55.44 93.52 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.613 -0.68 . . . . 0.0 109.645 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.5 p -124.13 97.07 41.1 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . 0.41 ' HD3' ' CE1' ' B' ' 26' ' ' TYR . 6.1 Cg_exo . . . . . 0 N--CA 1.485 1.019 0 C-N-CA 122.621 2.214 . . . . 0.0 110.692 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -89.55 54.51 2.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.321 -0.862 . . . . 0.0 109.721 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -141.2 -50.48 0.43 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.497 -0.752 . . . . 0.0 108.993 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.3 m -128.41 32.72 4.81 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -57.17 7.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.69 -0.631 . . . . 0.0 110.272 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 m -68.0 -28.21 67.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.505 -0.747 . . . . 0.0 110.899 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.433 ' HA ' ' CE1' ' B' ' 5' ' ' HIS . 1.2 m -116.98 -162.52 0.86 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.375 -0.828 . . . . 0.0 109.942 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.461 HG22 HD11 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -111.14 129.34 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.477 -0.764 . . . . 0.0 109.008 -179.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.91 -164.41 1.02 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.652 -0.655 . . . . 0.0 109.91 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.455 ' CB ' ' CE2' ' A' ' 14' ' ' TYR . 1.6 m -102.09 162.18 13.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.547 -0.721 . . . . 0.0 109.747 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.33 -35.4 80.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.624 -0.673 . . . . 0.0 110.387 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.455 ' CE2' ' CB ' ' A' ' 12' ' ' SER . 20.4 p90 -61.58 -23.33 65.92 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.389 -0.82 . . . . 0.0 110.058 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.404 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 5.8 tp60 -68.04 -57.11 6.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.419 -0.801 . . . . 0.0 109.494 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.432 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 23.0 mt -66.07 -14.24 61.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.576 -0.703 . . . . 0.0 110.222 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -62.23 -31.17 71.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.186 -0.946 . . . . 0.0 109.554 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -98.51 32.97 2.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.492 -0.755 . . . . 0.0 109.446 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.432 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 7.2 m-85 -113.42 -7.41 13.46 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.615 -0.678 . . . . 0.0 110.226 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.0 m -74.6 -22.07 59.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.081 -1.012 . . . . 0.0 110.357 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.54 -179.871 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.455 ' CE1' ' CB ' ' B' ' 4' ' ' GLN . 2.3 p90 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . 0.425 HG21 ' CD2' ' B' ' 1' ' ' PHE . 27.4 m -50.09 -26.16 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.354 -1.467 . . . . 0.0 110.977 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -171.08 40.85 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.574 -0.704 . . . . 0.0 109.189 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . 0.455 ' CB ' ' CE1' ' B' ' 1' ' ' PHE . 7.0 tp60 -136.38 108.04 7.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.583 -0.698 . . . . 0.0 109.912 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.444 ' CD2' HG21 ' A' ' 10' ' ' ILE . 14.3 m-70 -64.06 163.23 12.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.611 -0.681 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.426 ' N ' ' CD2' ' B' ' 6' ' ' LEU . 2.5 mm? -114.42 55.35 0.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.501 -0.749 . . . . 0.0 109.596 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.86 129.01 33.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.522 -0.736 . . . . 0.0 109.333 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.56 -147.53 35.71 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 16.2 p -67.84 -12.21 60.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.553 -0.969 . . . . 0.0 110.489 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -60.69 -33.4 72.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.067 -1.021 . . . . 0.0 109.706 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 62.4 tp -65.07 -55.89 16.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.614 -0.679 . . . . 0.0 109.218 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.2 t -52.08 -47.67 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.544 -0.723 . . . . 0.0 110.813 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -62.22 -32.26 72.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.441 -0.787 . . . . 0.0 109.729 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.09 -31.94 71.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.557 -0.715 . . . . 0.0 109.153 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 31.7 mt -74.88 -28.56 60.7 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -70.17 -34.33 72.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.504 -0.748 . . . . 0.0 108.992 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.428 HD21 ' CE2' ' B' ' 1' ' ' PHE . 0.5 OUTLIER -73.76 -42.37 61.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.721 -0.612 . . . . 0.0 109.6 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.0 -71.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -77.91 0.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.457 -0.777 . . . . 0.0 108.979 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.53 -27.92 9.5 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.27 176.32 0.35 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.423 -1.045 . . . . 0.0 109.759 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -76.38 -63.16 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.593 -0.692 . . . . 0.0 109.386 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -119.41 48.02 0.98 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.62 26.12 25.59 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -162.06 -176.92 5.44 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.498 -1.001 . . . . 0.0 109.798 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -56.45 123.81 15.99 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.548 -0.72 . . . . 0.0 110.157 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.31 96.82 43.63 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.483 0.866 0 C-N-CA 122.386 2.057 . . . . 0.0 110.21 -179.523 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.408 0.623 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.6 -30.79 67.49 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.651 -0.655 . . . . 0.0 110.274 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -76.16 -28.6 57.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.502 -0.749 . . . . 0.0 109.817 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.2 m -113.32 26.43 10.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.431 -0.793 . . . . 0.0 110.158 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -101.39 -32.09 10.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 0.0 109.197 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -85.79 -57.29 3.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.646 -0.658 . . . . 0.0 109.515 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.89 -160.67 0.82 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.631 -0.668 . . . . 0.0 109.358 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.406 HD11 HG22 ' A' ' 10' ' ' ILE . 1.2 mm -93.88 -168.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.54 168.28 7.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.414 -0.804 . . . . 0.0 109.106 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.405 ' OG ' ' CE1' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -100.48 162.13 13.14 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.456 ' CD2' ' CE1' ' B' ' 1' ' ' PHE . 3.4 tm? -66.98 -23.48 65.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.679 -0.638 . . . . 0.0 110.261 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.422 ' CE1' ' HG2' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -56.63 -20.74 22.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.128 -0.982 . . . . 0.0 110.803 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.422 ' HG2' ' CE1' ' A' ' 14' ' ' TYR . 5.3 mm100 -74.36 -46.27 41.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.41 -0.806 . . . . 0.0 109.843 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.9 mt -68.42 -10.0 52.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.436 -0.79 . . . . 0.0 110.722 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.94 -26.33 68.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.11 -0.994 . . . . 0.0 109.21 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -62.29 -32.74 73.51 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.747 0.784 . . . . 0.0 109.633 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.41 ' CD1' ' HB2' ' B' ' 26' ' ' TYR . 35.5 m-85 -81.66 -17.07 49.32 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.995 -0.441 . . . . 0.0 111.139 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -105.13 28.8 6.92 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.045 -1.034 . . . . 0.0 109.766 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.582 -179.871 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.456 ' CE1' ' CD2' ' A' ' 13' ' ' LEU . 3.0 p90 . . . . . 0 N--CA 1.5 2.033 0 CA-C-O 120.474 0.178 . . . . 0.0 110.771 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.22 -26.29 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.976 -1.078 . . . . 0.0 109.35 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -152.89 29.24 0.52 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . 0.428 ' HG2' ' CE1' ' B' ' 10' ' ' HIS . 0.3 OUTLIER -118.7 -178.89 3.65 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.401 ' NE2' HD12 ' A' ' 10' ' ' ILE . 5.8 m80 -103.4 125.41 49.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.347 -0.846 . . . . 0.0 109.855 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 tp -83.95 94.1 8.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.706 -0.621 . . . . 0.0 110.08 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.88 134.4 2.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.419 -0.801 . . . . 0.0 109.334 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.3 -145.72 21.43 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 53.7 p -70.79 -9.0 56.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.496 -1.002 . . . . 0.0 110.31 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . 0.428 ' CE1' ' HG2' ' B' ' 4' ' ' GLN . 28.3 t60 -65.37 -31.08 72.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.087 -1.008 . . . . 0.0 108.944 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.415 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 56.0 tp -63.69 -57.31 10.41 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.5 t -53.45 -51.82 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.64 -0.662 . . . . 0.0 110.955 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -56.21 -28.61 58.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.346 -0.846 . . . . 0.0 110.217 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.401 ' HB3' ' CD2' ' B' ' 1' ' ' PHE . . . -76.58 -35.0 58.42 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.442 ' HB3' ' CG ' ' B' ' 25' ' ' PHE . 49.3 mt -64.56 -28.22 69.49 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -80.82 -35.72 32.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.527 -0.733 . . . . 0.0 109.137 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -65.42 -32.61 74.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.658 -0.651 . . . . 0.0 109.804 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 35.9 t -82.22 -55.68 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.601 -0.687 . . . . 0.0 109.405 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 4.7 m -69.19 -80.24 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.54 -0.725 . . . . 0.0 109.528 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.95 -56.56 0.66 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.96 172.23 8.73 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.454 -1.027 . . . . 0.0 109.426 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.25 -47.77 33.0 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.44 94.54 1.4 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -177.93 -35.85 0.06 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.442 ' CG ' ' HB3' ' B' ' 15' ' ' LEU . 44.5 p90 -124.83 -174.64 3.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -1.088 . . . . 0.0 110.867 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.426 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 7.1 t80 -58.45 111.0 1.08 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.853 -0.529 . . . . 0.0 109.828 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.3 p -122.88 92.2 49.28 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.553 -0.717 . . . . 0.0 109.372 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . 0.426 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 1.5 Cg_endo . . . . . 0 N--CA 1.484 0.965 0 C-N-CA 122.526 2.151 . . . . 0.0 109.858 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.7 t . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.17 3.76 22.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 0.0 109.956 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -63.42 1.23 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.117 -0.989 . . . . 0.0 110.039 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 p -136.27 25.61 3.22 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.978 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.1 t -52.45 -23.78 6.75 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.11 -0.994 . . . . 0.0 110.011 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 m -65.7 -68.49 0.36 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.353 -0.842 . . . . 0.0 111.033 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.4 -153.56 0.53 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.328 -0.858 . . . . 0.0 110.356 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.484 ' CD1' ' CE1' ' B' ' 5' ' ' HIS . 10.1 mm -83.65 168.21 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.096 -1.002 . . . . 0.0 108.728 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.1 p -160.1 174.42 14.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.427 -0.796 . . . . 0.0 110.438 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -72.08 133.13 45.06 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.345 0.593 . . . . 0.0 109.747 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.412 ' HG ' ' CB ' ' B' ' 1' ' ' PHE . 4.6 mm? -68.43 -17.34 64.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.749 -0.594 . . . . 0.0 110.412 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -56.83 -22.46 36.74 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.139 -0.976 . . . . 0.0 109.86 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.26 -49.09 75.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.404 -0.81 . . . . 0.0 109.357 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.8 mt -68.9 -16.51 63.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.521 -0.737 . . . . 0.0 110.051 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.71 -26.75 65.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 109.174 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -89.25 13.12 14.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.379 -0.826 . . . . 0.0 110.078 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -97.77 20.62 11.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.102 -0.999 . . . . 0.0 109.179 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.3 m -109.97 23.88 13.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.328 -0.857 . . . . 0.0 109.987 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 117.903 -1.046 . . . . 0.0 109.427 -179.952 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.416 ' CE1' HD21 ' B' ' 17' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.27 172.23 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.924 -1.11 . . . . 0.0 108.163 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -59.44 92.98 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.317 -0.864 . . . . 0.0 109.376 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -142.03 174.4 10.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.502 -0.748 . . . . 0.0 110.203 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.484 ' CE1' ' CD1' ' A' ' 10' ' ' ILE . 3.6 m80 -119.12 146.45 45.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.613 -0.68 . . . . 0.0 109.248 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.77 90.44 4.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.504 -0.748 . . . . 0.0 109.439 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.3 154.23 10.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.625 -0.672 . . . . 0.0 109.719 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.03 -132.89 49.15 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.5 p -83.51 -13.8 53.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.947 . . . . 0.0 109.759 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -63.71 -33.09 74.87 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.132 -0.98 . . . . 0.0 108.944 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.433 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 2.6 tm? -68.87 -54.51 15.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.813 -0.554 . . . . 0.0 109.771 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 t -53.74 -47.77 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.501 -0.749 . . . . 0.0 110.677 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.7 -29.07 70.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.484 -0.76 . . . . 0.0 109.396 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.67 -26.4 62.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.57 -0.706 . . . . 0.0 109.529 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 11' ' ' LEU . 29.1 mt -78.85 -32.14 45.92 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.418 -0.801 . . . . 0.0 108.882 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.06 -32.99 67.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.595 -0.691 . . . . 0.0 110.012 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.416 HD21 ' CE1' ' B' ' 1' ' ' PHE . 0.1 OUTLIER -80.58 -46.71 15.27 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.413 -0.804 . . . . 0.0 109.937 -179.434 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 48.0 t -59.65 -56.93 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.419 -0.801 . . . . 0.0 109.386 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -74.89 0.1 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.21 -35.17 3.73 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -90.41 163.77 14.55 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.395 -1.062 . . . . 0.0 109.849 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.85 127.9 39.84 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.18 28.7 36.04 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.97 30.73 5.76 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.417 ' CD2' ' HB2' ' B' ' 15' ' ' LEU . 23.8 p90 -165.65 -173.2 2.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.454 -1.027 . . . . 0.0 109.512 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -54.33 109.58 0.51 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.574 -0.703 . . . . 0.0 109.562 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 2.0 p -122.88 91.86 49.49 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.483 0.91 0 C-N-CA 122.48 2.12 . . . . 0.0 110.143 -179.926 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.4 t . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 120.42 0.152 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -90.35 51.72 2.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.136 -0.978 . . . . 0.0 109.429 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -138.44 -43.79 0.5 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.498 -0.752 . . . . 0.0 109.379 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.1 m -118.59 15.57 13.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.543 -0.723 . . . . 0.0 110.399 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.61 -27.22 64.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.279 -0.888 . . . . 0.0 110.351 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 m -99.29 -67.83 0.83 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.351 -0.843 . . . . 0.0 110.907 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.2 p -74.99 171.81 13.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.279 -0.888 . . . . 0.0 110.229 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.448 ' CG1' ' CE1' ' B' ' 5' ' ' HIS . 56.6 mt -102.52 91.16 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.6 m -61.74 -178.91 0.16 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.613 -0.68 . . . . 0.0 110.268 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.465 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 22.2 t -106.71 172.47 6.8 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.453 ' CD1' ' CE1' ' B' ' 1' ' ' PHE . 0.6 OUTLIER -67.36 -26.14 66.33 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.403 -0.811 . . . . 0.0 111.415 -178.699 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.465 ' CE2' ' HB3' ' A' ' 12' ' ' SER . 8.9 p90 -59.51 -20.51 55.95 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.997 -1.064 . . . . 0.0 110.042 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.93 -49.91 12.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.388 -0.82 . . . . 0.0 109.428 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.411 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 11.3 mt -67.45 -16.78 64.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.531 -0.731 . . . . 0.0 109.991 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -57.91 -20.72 39.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.187 -0.945 . . . . 0.0 110.219 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -96.95 33.21 1.94 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.84 . . . . 0.0 109.488 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.411 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 7.5 m-85 -113.27 -0.43 14.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.518 -0.739 . . . . 0.0 110.361 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.6 m -96.83 40.49 1.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.122 -0.986 . . . . 0.0 109.562 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.444 179.957 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.453 ' CE1' ' CD1' ' A' ' 13' ' ' LEU . 1.1 p90 . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 15.5 t -54.66 -26.7 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -160.69 31.62 0.15 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -127.48 168.67 14.59 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.638 -0.664 . . . . 0.0 109.857 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.448 ' CE1' ' CG1' ' A' ' 10' ' ' ILE . 18.1 m80 -96.61 161.53 13.85 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 43.7 mt -109.44 -11.11 14.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.478 -0.764 . . . . 0.0 110.82 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.77 138.96 56.87 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.955 -1.091 . . . . 0.0 110.344 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.47 -159.33 33.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.0 p -64.7 -14.66 59.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.435 -1.038 . . . . 0.0 110.04 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -52.14 -27.98 16.26 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.891 -1.131 . . . . 0.0 110.323 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.5 -62.91 1.27 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.614 -0.679 . . . . 0.0 109.199 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 39.4 t -47.16 -52.64 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.839 -0.538 . . . . 0.0 111.445 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -57.53 -36.66 71.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.386 -0.821 . . . . 0.0 110.224 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.1 -31.63 72.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.346 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.412 ' CB ' ' CD1' ' B' ' 25' ' ' PHE . 40.6 mt -64.47 -40.64 96.07 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -63.66 -34.04 76.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.23 -37.3 86.85 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.12 -71.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.586 -0.696 . . . . 0.0 109.613 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 m -90.75 -58.25 2.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.455 -0.778 . . . . 0.0 109.408 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.37 32.78 68.23 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -88.62 -177.55 5.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.613 -0.933 . . . . 0.0 109.409 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.406 ' HG2' ' NH1' ' B' ' 22' ' ' ARG . 2.7 tpt180 -91.93 52.7 2.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.624 -0.672 . . . . 0.0 109.432 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.95 40.68 1.05 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.07 -28.21 6.62 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' CB ' ' B' ' 15' ' ' LEU . 29.2 p90 -105.36 -175.8 2.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.57 -0.959 . . . . 0.0 109.408 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -58.89 118.41 5.73 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.474 -0.766 . . . . 0.0 109.423 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 23.8 p -127.14 94.65 38.5 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.482 0.838 0 C-N-CA 122.343 2.029 . . . . 0.0 110.165 -179.592 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 120.672 0.272 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -105.24 31.51 4.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.179 -0.951 . . . . 0.0 108.928 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -118.77 -33.76 4.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.674 -0.641 . . . . 0.0 109.985 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.0 m -130.33 19.13 5.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.471 -0.768 . . . . 0.0 110.459 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.7 t -91.29 -26.81 18.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 109.565 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -75.35 -27.69 59.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.474 -0.766 . . . . 0.0 110.182 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.4 p -134.64 -171.6 2.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 109.936 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.454 ' CG1' ' CE1' ' B' ' 5' ' ' HIS . 18.3 mt -102.31 95.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.27 -172.82 0.35 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.573 -0.704 . . . . 0.0 109.687 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.427 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 1.4 m -108.64 162.82 13.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.644 -0.66 . . . . 0.0 109.689 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.43 HD11 ' CD2' ' B' ' 1' ' ' PHE . 20.0 tp -71.11 -17.69 62.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.805 -0.559 . . . . 0.0 110.223 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.427 ' CE2' ' HB3' ' A' ' 12' ' ' SER . 10.8 p90 -87.54 11.29 15.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.088 -1.007 . . . . 0.0 110.422 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -105.5 -32.28 8.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.072 -1.017 . . . . 0.0 109.434 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.9 mt -66.16 -13.03 59.53 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.565 -0.71 . . . . 0.0 110.558 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.81 -19.19 39.0 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.08 -1.013 . . . . 0.0 110.124 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -93.53 28.79 2.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.204 -0.935 . . . . 0.0 110.191 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -115.08 10.89 16.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.173 -0.954 . . . . 0.0 110.456 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.31 33.12 2.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.273 -0.892 . . . . 0.0 109.343 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.389 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.448 ' CZ ' HD21 ' B' ' 17' ' ' LEU . 34.3 t80 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 17.5 m -140.63 -162.43 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -52.75 -25.04 9.97 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.956 -1.09 . . . . 0.0 110.022 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -71.87 144.11 49.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.519 -0.738 . . . . 0.0 109.109 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.454 ' CE1' ' CG1' ' A' ' 10' ' ' ILE . 13.0 m80 -68.25 160.6 28.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.552 -0.718 . . . . 0.0 109.493 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 19.7 tp -107.41 98.43 8.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.611 -0.681 . . . . 0.0 109.732 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.7 173.15 2.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.637 -0.664 . . . . 0.0 109.895 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.7 -154.02 39.78 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.1 p -63.8 -21.5 66.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.576 -0.955 . . . . 0.0 109.507 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -60.52 -34.13 73.65 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.869 . . . . 0.0 109.075 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 2.5 tt -61.86 -55.05 33.86 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -53.74 -49.97 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.748 -0.595 . . . . 0.0 111.05 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -59.76 -27.48 66.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.446 -0.784 . . . . 0.0 110.631 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.421 ' HB3' ' CD2' ' B' ' 1' ' ' PHE . . . -80.11 -31.37 39.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 110.301 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 11' ' ' LEU . 50.5 mt -66.72 -41.28 88.18 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -70.94 -31.38 67.95 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.448 HD21 ' CZ ' ' B' ' 1' ' ' PHE . 1.1 mp -63.24 -34.46 77.71 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -84.77 -73.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.626 -0.671 . . . . 0.0 109.359 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 90.8 m -64.49 -82.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 108.852 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.16 23.26 9.84 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 120.136 -1.031 . . . . 0.0 111.533 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.26 -173.68 3.9 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 118.784 1.292 . . . . 0.0 109.165 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -93.44 50.74 1.52 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.532 -0.73 . . . . 0.0 109.51 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.73 71.99 0.63 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.28 35.49 2.17 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.419 ' CE1' HG21 ' B' ' 27' ' ' THR . 36.8 p90 -167.08 -171.91 1.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.959 . . . . 0.0 109.607 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.424 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 3.8 t80 -57.69 98.85 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.582 -0.699 . . . . 0.0 109.167 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.419 HG21 ' CE1' ' B' ' 25' ' ' PHE . 2.2 p -114.33 91.87 25.51 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.591 -0.693 . . . . 0.0 109.666 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . 0.424 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 4.0 Cg_exo . . . . . 0 N--CA 1.482 0.843 0 C-N-CA 122.453 2.102 . . . . 0.0 110.074 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.423 HG23 ' CE1' ' A' ' 19' ' ' TYR . 4.0 mp -123.8 -50.61 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.554 -0.968 . . . . 0.0 109.758 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.4 t -74.21 -56.78 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.531 -0.731 . . . . 0.0 109.093 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.49 -18.3 58.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.652 -0.655 . . . . 0.0 110.049 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -42.1 82.38 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.253 -0.905 . . . . 0.0 109.987 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -146.53 43.49 1.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.45 -0.781 . . . . 0.0 109.897 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -63.3 -43.02 99.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.398 -0.814 . . . . 0.0 109.157 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -97.24 29.51 3.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.714 -0.616 . . . . 0.0 109.552 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p -161.07 -174.17 4.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.556 -0.715 . . . . 0.0 109.263 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.16 98.62 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 m -84.41 -85.76 0.13 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.587 -0.696 . . . . 0.0 110.423 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -173.97 151.43 1.76 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.068 -1.02 . . . . 0.0 109.975 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -67.18 -21.51 65.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.648 -0.658 . . . . 0.0 110.106 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -24.78 34.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.064 -1.023 . . . . 0.0 109.91 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -79.02 -47.28 16.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.384 -0.822 . . . . 0.0 109.218 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 mt -65.78 -15.14 62.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.632 -0.667 . . . . 0.0 110.129 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.38 -18.8 41.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.261 -0.899 . . . . 0.0 110.288 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -94.32 28.35 2.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.924 . . . . 0.0 109.988 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.423 ' CE1' HG23 ' A' ' 2' ' ' ILE . 6.4 m-85 -115.99 18.55 15.48 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.377 -0.827 . . . . 0.0 110.211 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.1 m -109.62 30.11 6.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m120 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.469 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.409 ' CD2' HG13 ' B' ' 2' ' ' VAL . 66.5 t80 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.409 HG13 ' CD2' ' B' ' 1' ' ' PHE . 13.3 p -165.34 -33.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.192 -0.942 . . . . 0.0 110.488 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -157.88 -42.26 0.06 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.012 -1.055 . . . . 0.0 109.587 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -76.06 159.91 30.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.473 -0.767 . . . . 0.0 109.012 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -83.26 -178.61 7.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.615 -0.678 . . . . 0.0 109.518 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 33.7 mt -127.4 53.53 1.73 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.546 -0.722 . . . . 0.0 110.422 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -135.53 132.16 36.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.407 -0.808 . . . . 0.0 109.181 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.28 -137.4 13.71 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 53.9 p -85.47 3.76 38.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.499 -1.0 . . . . 0.0 110.101 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -76.36 -34.23 58.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.101 -1.0 . . . . 0.0 109.211 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -66.53 -51.38 57.23 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.6 t -55.32 -48.31 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.587 -0.695 . . . . 0.0 110.17 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -60.55 -29.89 69.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.434 -0.791 . . . . 0.0 109.51 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.78 -32.08 67.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.518 -0.739 . . . . 0.0 109.453 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.444 ' CB ' ' CD1' ' B' ' 25' ' ' PHE . 41.4 mt -65.69 -41.27 92.58 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.47 -37.85 88.86 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.406 ' CD2' ' CZ ' ' B' ' 1' ' ' PHE . 2.7 tp -64.71 -28.72 69.78 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 42.0 t -73.22 -69.38 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 109.792 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -94.91 -76.37 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.478 -0.764 . . . . 0.0 109.288 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.87 -13.03 10.71 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.787 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -87.33 145.15 26.46 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.151 -1.205 . . . . 0.0 109.489 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -76.48 152.14 36.2 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.76 25.63 63.94 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.52 -28.11 4.15 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.444 ' CD1' ' CB ' ' B' ' 15' ' ' LEU . 30.5 p90 -131.48 -173.94 3.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.621 -0.929 . . . . 0.0 109.569 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.424 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 9.5 t80 -61.73 108.61 1.03 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 109.491 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 45.6 p -123.48 87.98 51.82 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.424 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 1.6 Cg_endo -62.85 86.88 0.11 Allowed 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.709 2.272 . . . . 0.0 110.217 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.299 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.7 tt -137.6 -56.39 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.604 -0.939 . . . . 0.0 109.361 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.0 t -92.83 -27.35 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.054 -1.029 . . . . 0.0 109.688 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.02 42.16 1.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 109.677 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.14 -46.99 2.17 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.2 m -125.97 25.39 6.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.675 -0.641 . . . . 0.0 109.621 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.0 -58.55 6.37 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.39 -0.819 . . . . 0.0 109.472 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.401 HG21 ' N ' ' A' ' 9' ' ' SER . 3.5 t -72.08 -33.75 68.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.483 -0.761 . . . . 0.0 110.043 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.401 ' N ' HG21 ' A' ' 8' ' ' THR . 3.6 m -86.11 165.48 16.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.433 -0.792 . . . . 0.0 108.884 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.99 69.81 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.286 -0.884 . . . . 0.0 109.043 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.7 m -64.98 178.74 0.78 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.53 -0.731 . . . . 0.0 109.753 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.428 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 50.1 m -72.9 115.0 11.67 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.405 ' CD1' ' CD1' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -69.25 -8.18 43.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.667 -0.646 . . . . 0.0 110.975 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.428 ' CD1' ' HB3' ' A' ' 12' ' ' SER . 0.1 OUTLIER -67.28 -18.73 65.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.967 -1.083 . . . . 0.0 109.934 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.409 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 0.8 OUTLIER -69.35 -10.64 58.82 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.258 -0.901 . . . . 0.0 110.764 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.406 ' CD2' ' CD2' ' B' ' 15' ' ' LEU . 5.8 mt -65.47 -12.06 49.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.164 -0.96 . . . . 0.0 110.656 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -59.51 -19.53 48.8 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.105 -0.997 . . . . 0.0 110.196 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -97.13 29.61 3.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.288 -0.883 . . . . 0.0 109.775 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -118.38 19.78 13.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.645 -0.659 . . . . 0.0 109.632 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.7 m -103.59 27.27 7.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.247 -0.908 . . . . 0.0 110.026 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.911 -1.042 . . . . 0.0 109.484 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.421 ' CZ ' ' CB ' ' B' ' 17' ' ' LEU . 34.8 p90 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 120.613 0.244 . . . . 0.0 110.51 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 40.4 t -51.31 -38.86 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.005 -1.06 . . . . 0.0 110.55 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -134.03 30.01 3.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.439 -0.788 . . . . 0.0 109.668 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' B' ' 5' ' ' HIS . 18.6 mt-30 -117.66 -84.5 0.64 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.66 -0.65 . . . . 0.0 109.394 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.433 ' CG ' ' O ' ' B' ' 4' ' ' GLN . 0.6 OUTLIER -178.99 -172.53 0.25 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.449 -0.782 . . . . 0.0 109.059 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 40.3 mt -133.77 43.34 2.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.594 -0.691 . . . . 0.0 109.448 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 58.6 m -114.68 137.17 52.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.524 -0.735 . . . . 0.0 109.596 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.46 -140.58 23.75 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.3 -0.67 29.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.567 -0.961 . . . . 0.0 110.652 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -66.94 -31.18 71.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.013 -1.054 . . . . 0.0 109.271 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 63.4 tp -68.52 -57.43 5.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.576 -0.702 . . . . 0.0 109.182 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 24.7 t -51.65 -44.48 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.657 -0.652 . . . . 0.0 110.843 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -63.78 -34.45 77.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.449 -0.782 . . . . 0.0 109.646 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.419 ' HB3' ' CD2' ' B' ' 1' ' ' PHE . . . -68.9 -29.74 68.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.53 -0.731 . . . . 0.0 109.4 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.406 ' CD2' ' CD2' ' A' ' 16' ' ' LEU . 40.4 mt -70.71 -37.51 73.55 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -63.49 -41.62 98.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.66 -0.65 . . . . 0.0 109.505 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.421 ' CB ' ' CZ ' ' B' ' 1' ' ' PHE . 0.2 OUTLIER -63.31 -55.67 22.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.68 . . . . 0.0 109.603 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 43.6 t -55.59 -72.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.652 -0.655 . . . . 0.0 110.238 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.68 -74.28 0.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.835 . . . . 0.0 109.277 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.62 -16.11 61.87 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -60.42 160.95 7.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.171 -1.193 . . . . 0.0 109.841 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.53 108.65 17.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.642 -0.661 . . . . 0.0 109.512 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.2 40.19 61.62 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.1 -24.27 6.06 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -112.56 -175.63 2.72 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.437 -1.037 . . . . 0.0 109.964 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -52.02 138.84 24.17 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.481 -0.762 . . . . 0.0 110.138 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.11 93.15 31.16 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -58.48 -178.75 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.831 0 C-N-CA 122.264 1.976 . . . . 0.0 109.913 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.683 -179.869 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.2 tt -163.28 -44.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.678 -0.895 . . . . 0.0 109.319 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -90.37 -26.72 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.467 -0.77 . . . . 0.0 109.43 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -61.09 -17.64 53.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.514 -0.741 . . . . 0.0 110.117 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -48.24 -60.57 2.54 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.233 -0.917 . . . . 0.0 111.294 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.1 m -111.56 7.48 20.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.393 -0.817 . . . . 0.0 110.477 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -71.61 -28.98 64.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.003 -1.061 . . . . 0.0 109.408 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 m -80.79 -52.96 6.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.474 -0.766 . . . . 0.0 109.802 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.18 -177.36 4.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.0 109.883 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.496 HG12 ' CD2' ' B' ' 5' ' ' HIS . 0.4 OUTLIER -84.78 136.46 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.4 p -122.58 -160.23 0.87 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.373 -0.829 . . . . 0.0 110.085 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.07 139.69 46.22 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.439 ' CD2' ' CD1' ' B' ' 1' ' ' PHE . 0.1 OUTLIER -66.05 -13.18 59.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.457 -0.777 . . . . 0.0 110.527 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -60.03 -20.22 56.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.846 -1.159 . . . . 0.0 109.979 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -88.8 -41.45 12.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.372 -0.83 . . . . 0.0 109.892 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mt -66.15 -22.13 66.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.509 -0.744 . . . . 0.0 110.038 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.07 -19.18 41.81 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.189 -0.944 . . . . 0.0 110.378 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -94.98 29.66 2.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.242 -0.911 . . . . 0.0 109.688 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -106.62 10.72 31.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.481 -0.762 . . . . 0.0 109.922 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.9 m -95.21 36.15 1.25 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.176 -0.952 . . . . 0.0 109.823 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.6 -179.917 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.439 ' CD1' ' CD2' ' A' ' 13' ' ' LEU . 3.3 p90 . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 120.38 0.133 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.64 -35.08 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.792 -1.192 . . . . 0.0 108.496 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -150.35 22.35 0.83 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.473 ' O ' ' CG ' ' B' ' 5' ' ' HIS . 57.8 mt-30 -101.03 -94.54 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.496 ' CD2' HG12 ' A' ' 10' ' ' ILE . 0.9 OUTLIER 178.12 168.27 0.77 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.267 -0.895 . . . . 0.0 109.029 178.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.425 ' N ' ' CD2' ' B' ' 6' ' ' LEU . 0.4 OUTLIER -129.66 85.89 2.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.536 -0.728 . . . . 0.0 109.574 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.22 141.07 17.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.572 -0.705 . . . . 0.0 109.623 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.62 -106.01 2.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.6 p -109.25 -13.66 14.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.519 -0.989 . . . . 0.0 110.066 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -64.5 -34.24 77.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.111 -0.993 . . . . 0.0 109.34 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.412 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 58.4 tp -63.93 -54.83 28.48 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 17.2 t -52.72 -50.16 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.607 -0.683 . . . . 0.0 110.745 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -30.66 68.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.476 -0.765 . . . . 0.0 109.801 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.428 ' HB3' ' CD2' ' B' ' 1' ' ' PHE . . . -73.27 -30.85 63.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.539 -0.726 . . . . 0.0 109.691 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' B' ' 11' ' ' LEU . 39.4 mt -69.37 -39.17 78.2 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.357 -0.839 . . . . 0.0 109.291 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -73.22 -29.62 62.93 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.682 -0.636 . . . . 0.0 109.99 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.3 -28.32 53.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.516 -0.74 . . . . 0.0 109.794 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -79.46 -67.1 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.417 -0.802 . . . . 0.0 109.404 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -86.95 -60.05 2.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.586 -0.696 . . . . 0.0 109.352 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.72 30.21 40.38 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -86.36 160.52 19.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.646 -0.914 . . . . 0.0 109.079 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -83.59 82.3 8.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.568 -0.708 . . . . 0.0 109.116 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.52 53.27 3.28 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.81 27.78 5.35 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -165.03 -175.15 3.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.344 -1.092 . . . . 0.0 109.984 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -52.47 108.54 0.31 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.582 -0.698 . . . . 0.0 109.81 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.8 p -121.42 92.15 48.53 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -57.87 121.88 10.78 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 122.611 2.207 . . . . 0.0 110.288 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 mttt . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.921 179.741 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.2 tp -115.47 -43.79 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.617 -0.931 . . . . 0.0 109.466 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.3 t -90.96 -44.19 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.395 -0.816 . . . . 0.0 109.6 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -59.39 -27.14 65.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.6 -0.688 . . . . 0.0 109.846 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -77.32 -31.13 54.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.421 -0.8 . . . . 0.0 109.336 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.6 m -108.65 30.65 6.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.483 -0.76 . . . . 0.0 109.877 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 46.0 t -114.27 -45.32 3.05 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.407 -0.808 . . . . 0.0 109.755 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 93.2 m -58.66 -82.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.414 -0.804 . . . . 0.0 110.289 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.7 m -84.87 -172.04 3.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.118 -0.989 . . . . 0.0 109.575 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.488 ' CD1' ' CE1' ' B' ' 5' ' ' HIS . 4.4 mm -84.35 101.36 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.55 -162.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.635 -0.665 . . . . 0.0 109.552 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.9 m -116.71 155.92 28.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.39 -0.818 . . . . 0.0 109.334 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.88 -30.23 70.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.448 -0.782 . . . . 0.0 109.703 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -61.84 -27.74 68.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.529 -0.732 . . . . 0.0 109.684 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -67.99 -46.82 70.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.632 -0.667 . . . . 0.0 110.202 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.424 ' CD2' ' CD2' ' B' ' 15' ' ' LEU . 5.5 mt -66.38 -16.16 63.85 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.355 -0.841 . . . . 0.0 109.778 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.26 -19.02 42.4 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.226 -0.921 . . . . 0.0 110.101 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -94.31 29.98 2.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.189 -0.944 . . . . 0.0 109.909 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.437 ' CD2' HD23 ' B' ' 15' ' ' LEU . 5.6 m-85 -115.01 9.31 16.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.445 -0.784 . . . . 0.0 110.359 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.0 m -108.15 34.45 3.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.04 -1.038 . . . . 0.0 109.153 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.232 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 8.8 p -46.56 -33.0 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.46 -0.775 . . . . 0.0 110.631 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -160.45 135.21 7.62 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.33 43.53 1.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.131 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.488 ' CE1' ' CD1' ' A' ' 10' ' ' ILE . 3.0 m170 -106.8 129.76 54.61 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 mt -126.8 120.81 30.22 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.566 -0.709 . . . . 0.0 109.859 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.66 142.91 0.15 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.525 -0.734 . . . . 0.0 109.421 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.75 -111.24 4.02 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.64 -22.22 16.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.99 . . . . 0.0 109.529 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -58.11 -34.24 69.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.321 -0.862 . . . . 0.0 109.697 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 62.4 tp -63.67 -53.77 46.1 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -53.31 -55.47 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.564 -0.71 . . . . 0.0 110.657 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.4 -26.13 64.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.32 -0.863 . . . . 0.0 109.902 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.01 -34.94 69.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.479 -0.763 . . . . 0.0 109.524 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.437 HD23 ' CD2' ' A' ' 19' ' ' TYR . 24.8 mt -70.78 -34.91 72.29 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -73.02 -28.39 62.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.61 -0.682 . . . . 0.0 109.34 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.53 -29.89 52.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.681 . . . . 0.0 109.608 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 61.1 t -85.12 -72.03 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.526 -0.734 . . . . 0.0 109.432 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.16 -56.61 3.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.382 -0.824 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.49 28.15 55.95 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -83.66 150.06 26.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.454 -1.027 . . . . 0.0 109.326 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.415 ' NH1' ' HG3' ' B' ' 22' ' ' ARG . 1.3 mmm-85 -80.21 89.55 5.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.452 -0.78 . . . . 0.0 109.007 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.35 32.22 28.84 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.49 2.9 46.28 Favored Glycine 0 N--CA 1.492 2.396 0 O-C-N 121.512 -0.993 . . . . 0.0 110.985 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.429 ' CG ' ' HB3' ' B' ' 15' ' ' LEU . 5.1 p90 -143.7 -178.88 6.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.945 -1.326 . . . . 0.0 110.259 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.467 ' CE1' ' HD3' ' B' ' 28' ' ' PRO . 8.2 t80 -58.38 109.13 0.72 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.693 0.759 . . . . 0.0 110.429 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.84 91.43 6.64 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.467 ' HD3' ' CE1' ' B' ' 26' ' ' TYR . 3.3 Cg_exo -52.69 83.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 123.526 2.817 . . . . 0.0 111.433 -177.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.076 179.634 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 tt -167.53 -55.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.34 -1.094 . . . . 0.0 109.444 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.3 t -93.28 -31.25 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.12 -0.987 . . . . 0.0 110.007 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -74.83 -3.1 29.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.747 . . . . 0.0 111.026 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -90.59 -17.44 26.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.008 -1.058 . . . . 0.0 110.685 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.5 m -135.87 19.23 3.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.121 -0.987 . . . . 0.0 110.666 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.0 t -83.58 -32.31 25.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.216 -0.927 . . . . 0.0 109.508 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -73.35 -52.67 13.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.364 -0.835 . . . . 0.0 109.647 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.9 p -109.89 -169.38 1.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.629 -0.669 . . . . 0.0 109.721 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.414 HG12 ' CE1' ' B' ' 5' ' ' HIS . 58.3 mt -110.0 99.95 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.696 -0.628 . . . . 0.0 109.766 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.1 m -61.95 -174.24 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.544 -0.723 . . . . 0.0 109.386 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.446 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -107.55 175.61 5.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.595 -0.691 . . . . 0.0 109.216 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.63 -12.13 59.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.728 -0.608 . . . . 0.0 110.792 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 12' ' ' SER . 15.4 p90 -68.07 -22.34 64.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.127 -0.983 . . . . 0.0 110.412 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.06 -58.68 2.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.323 -0.861 . . . . 0.0 110.106 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.403 ' CD2' ' CD2' ' B' ' 15' ' ' LEU . 32.6 mt -64.31 -14.22 54.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.526 -0.734 . . . . 0.0 110.875 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -30.34 71.41 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.104 -0.997 . . . . 0.0 109.4 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -97.8 29.53 3.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.547 -0.721 . . . . 0.0 109.771 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -110.5 8.77 23.17 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.53 -0.731 . . . . 0.0 110.138 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.5 m -97.49 29.26 3.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.205 -0.934 . . . . 0.0 109.56 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.27 -179.958 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.463 ' N ' ' CD1' ' B' ' 1' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.426 HG23 ' CD2' ' B' ' 1' ' ' PHE . 17.3 m -88.98 -34.39 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.412 ' N ' HG21 ' B' ' 2' ' ' VAL . 17.3 p30 -156.76 34.2 0.3 Allowed 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.69 155.85 37.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.779 -0.575 . . . . 0.0 109.826 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.414 ' CE1' HG12 ' A' ' 10' ' ' ILE . 7.0 m80 -106.2 156.65 18.25 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.433 ' N ' ' CD2' ' B' ' 6' ' ' LEU . 2.0 mm? -109.12 101.14 10.22 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.248 -0.908 . . . . 0.0 109.997 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.61 120.61 0.05 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.82 -149.16 28.05 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.62 -15.72 63.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.539 -0.977 . . . . 0.0 110.047 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -60.86 -30.8 70.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.156 -0.965 . . . . 0.0 109.783 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 58.3 tp -70.89 -52.32 20.82 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.512 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 18.7 t -53.51 -49.43 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.506 -0.746 . . . . 0.0 110.401 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.02 -31.28 69.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.571 -0.705 . . . . 0.0 109.597 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.55 -34.16 75.35 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.403 ' CD2' ' CD2' ' A' ' 16' ' ' LEU . 23.9 mt -75.35 -25.51 57.82 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -74.34 -31.61 62.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 109.124 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.1 -33.99 38.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.639 -0.663 . . . . 0.0 109.538 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 39.1 t -81.28 -69.27 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.654 -0.654 . . . . 0.0 109.784 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 55.7 m -57.94 -66.52 0.46 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.357 -0.839 . . . . 0.0 109.786 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.25 -38.3 3.22 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.6 -173.44 1.16 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.51 -0.994 . . . . 0.0 109.486 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.86 -64.71 1.02 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.557 -0.714 . . . . 0.0 109.703 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.86 41.79 2.29 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.01 35.04 5.18 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -176.11 -172.02 0.47 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.57 -0.959 . . . . 0.0 109.738 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -52.04 110.51 0.49 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.378 -0.827 . . . . 0.0 109.909 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.12 94.16 41.05 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.602 -0.686 . . . . 0.0 109.672 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.33 109.94 0.54 Allowed 'Trans proline' 0 N--CA 1.484 0.933 0 C-N-CA 122.476 2.117 . . . . 0.0 110.05 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.988 179.92 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.3 tt -141.37 -44.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.513 -0.992 . . . . 0.0 109.439 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.9 t -90.48 -46.36 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.534 -0.729 . . . . 0.0 109.118 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.65 -22.19 61.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.684 -0.635 . . . . 0.0 110.262 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -63.55 -42.48 98.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.463 -0.773 . . . . 0.0 110.372 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.6 m -119.76 27.44 8.72 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.59 -43.62 15.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.75 . . . . 0.0 109.437 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 t -84.76 -27.85 26.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.604 -0.685 . . . . 0.0 109.965 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -116.99 168.47 10.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.473 -0.767 . . . . 0.0 109.362 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.445 ' CG1' ' CE1' ' B' ' 5' ' ' HIS . 10.7 mt -107.66 90.02 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.502 -0.749 . . . . 0.0 109.162 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.5 m -60.19 -169.44 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.367 -0.833 . . . . 0.0 109.602 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.468 ' CB ' ' CE2' ' A' ' 14' ' ' TYR . 48.7 m -94.21 160.4 14.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.612 -0.68 . . . . 0.0 109.249 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.59 -26.6 62.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.627 -0.671 . . . . 0.0 109.904 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.468 ' CE2' ' CB ' ' A' ' 12' ' ' SER . 12.5 p90 -64.88 -18.16 64.94 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.495 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -78.77 -44.58 22.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.298 -0.876 . . . . 0.0 109.061 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mt -64.88 -19.69 66.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.584 -0.697 . . . . 0.0 109.643 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -55.8 -21.28 18.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 0.0 110.563 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -94.49 32.78 1.51 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.284 -0.885 . . . . 0.0 109.644 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -114.91 11.5 16.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.429 -0.795 . . . . 0.0 110.08 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.5 m -97.15 28.78 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.169 -0.957 . . . . 0.0 109.536 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 m120 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.548 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.433 ' CE2' HD21 ' B' ' 17' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -161.68 -43.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 109.062 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -156.98 29.16 0.31 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 109.159 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -143.42 131.8 22.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.534 -0.729 . . . . 0.0 109.568 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.445 ' CE1' ' CG1' ' A' ' 10' ' ' ILE . 79.3 m80 -81.51 164.04 22.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.649 -0.657 . . . . 0.0 109.476 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' B' ' 6' ' ' LEU . 1.5 mm? -109.56 82.09 1.54 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.527 -0.733 . . . . 0.0 109.404 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 74.3 m -130.91 121.52 25.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.506 -0.746 . . . . 0.0 109.828 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.71 -128.32 8.4 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 93.4 p -84.43 -9.72 58.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.689 -0.889 . . . . 0.0 110.396 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -61.32 -27.89 68.81 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.011 -1.055 . . . . 0.0 109.348 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 56.3 tp -70.47 -61.97 1.57 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.466 -0.771 . . . . 0.0 108.94 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 36.0 t -47.21 -49.74 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.724 -0.61 . . . . 0.0 111.454 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -56.53 -39.14 72.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.372 -0.83 . . . . 0.0 110.441 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.83 -28.88 64.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.441 -0.787 . . . . 0.0 109.886 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 50.8 mt -65.55 -38.5 89.77 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -66.01 -34.19 77.52 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.433 HD21 ' CE2' ' B' ' 1' ' ' PHE . 2.2 tp -61.39 -34.02 74.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.685 -0.634 . . . . 0.0 109.354 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 45.2 t -87.78 -75.19 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.527 -0.733 . . . . 0.0 109.951 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -75.74 -76.36 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.254 -0.904 . . . . 0.0 109.064 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.07 17.66 26.81 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.81 160.21 16.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.348 -1.089 . . . . 0.0 108.9 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -39.83 61.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.449 -0.782 . . . . 0.0 109.493 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.23 61.85 0.62 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.7 -41.0 0.36 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -102.87 -175.83 2.92 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.57 -0.959 . . . . 0.0 110.23 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -58.21 127.4 31.9 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.57 0.7 . . . . 0.0 110.326 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.73 94.77 31.02 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -56.52 155.25 26.67 Favored 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 122.33 2.02 . . . . 0.0 110.244 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.514 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.2 tp -67.55 -43.73 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.655 -0.909 . . . . 0.0 109.574 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.8 t -90.24 0.03 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.465 -0.772 . . . . 0.0 110.772 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -96.9 27.06 4.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.973 -1.079 . . . . 0.0 109.775 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.28 -30.66 7.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.0 9.36 6.3 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.548 -0.72 . . . . 0.0 110.505 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 46.6 t -82.01 84.82 6.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.087 -1.008 . . . . 0.0 108.964 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.7 m -160.95 -42.92 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.488 -0.758 . . . . 0.0 109.944 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.434 ' HA ' ' CE1' ' B' ' 5' ' ' HIS . 11.6 t -154.06 -125.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.731 . . . . 0.0 109.368 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.434 ' CD1' ' N ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -101.61 105.63 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.582 -1.324 . . . . 0.0 108.686 -179.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -82.13 155.72 24.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.673 -0.642 . . . . 0.0 109.512 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.2 p -95.65 151.78 19.04 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.455 ' CD2' ' CZ ' ' B' ' 1' ' ' PHE . 1.3 tm? -66.49 -26.72 67.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.647 -0.658 . . . . 0.0 109.437 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -51.94 -24.82 6.98 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.148 -0.97 . . . . 0.0 110.603 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -87.89 -44.23 11.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.348 -0.845 . . . . 0.0 109.966 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mt -65.01 -16.21 63.18 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.436 -0.79 . . . . 0.0 110.5 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.15 -23.56 35.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.177 -0.952 . . . . 0.0 110.307 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -96.64 37.92 1.25 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.479 -0.763 . . . . 0.0 109.802 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -115.99 -0.91 12.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.484 -0.76 . . . . 0.0 110.554 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.5 m -88.62 11.12 18.23 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.082 -1.011 . . . . 0.0 110.57 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.9 p30 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.098 -1.001 . . . . 0.0 109.581 179.879 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.455 ' CZ ' ' CD2' ' A' ' 13' ' ' LEU . 9.1 p90 . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 120.473 0.178 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 35.1 m -63.09 -29.67 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.167 -0.958 . . . . 0.0 109.254 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -142.97 30.09 1.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -130.52 -179.21 5.14 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.434 ' CE1' ' HA ' ' A' ' 9' ' ' SER . 12.3 m-70 -109.15 149.55 29.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.338 -0.851 . . . . 0.0 109.524 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.28 100.01 12.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.563 -0.71 . . . . 0.0 110.123 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.67 142.58 0.14 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.586 -0.696 . . . . 0.0 109.236 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.23 -115.33 4.08 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.38 -19.62 18.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.674 -0.898 . . . . 0.0 109.956 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -56.68 -28.18 60.27 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.012 -1.055 . . . . 0.0 109.445 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 0.6 OUTLIER -64.73 -60.03 3.56 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 25.2 t -52.62 -47.32 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.835 -0.541 . . . . 0.0 111.577 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -58.93 -30.77 68.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.292 -0.88 . . . . 0.0 110.353 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.417 ' HB3' ' CD2' ' B' ' 1' ' ' PHE . . . -77.92 -27.39 49.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.506 -0.747 . . . . 0.0 109.796 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' B' ' 11' ' ' LEU . 45.3 mt -70.49 -37.89 74.27 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.294 -0.879 . . . . 0.0 108.941 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -76.11 -34.55 59.48 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -30.01 69.71 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 33.0 t -86.82 -69.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.531 -0.73 . . . . 0.0 109.479 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 11.6 m -88.68 -70.16 0.66 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.557 -0.714 . . . . 0.0 109.335 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.44 36.97 22.14 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -86.51 177.29 7.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.53 -0.982 . . . . 0.0 109.119 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -82.74 80.27 8.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.524 -0.735 . . . . 0.0 109.204 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.81 63.27 2.91 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.83 22.13 5.8 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -151.1 -173.19 4.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.263 -1.139 . . . . 0.0 109.573 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.405 ' CE1' ' HD3' ' B' ' 28' ' ' PRO . 3.6 t80 -49.95 101.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.54 -0.725 . . . . 0.0 110.085 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.42 90.91 36.32 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.405 ' HD3' ' CE1' ' B' ' 26' ' ' TYR . 4.9 Cg_exo -56.81 105.53 0.18 Allowed 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 122.625 2.217 . . . . 0.0 110.094 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.384 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.396 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 tt -62.63 -41.78 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.997 . . . . 0.0 109.022 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.5 -30.76 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.518 -0.739 . . . . 0.0 109.03 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -70.17 -10.08 57.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.622 -0.674 . . . . 0.0 110.037 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.52 -65.7 0.51 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.074 -1.016 . . . . 0.0 110.004 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.0 m -129.68 36.83 4.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.478 -0.764 . . . . 0.0 110.336 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.0 t -54.17 -55.46 27.65 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.187 -0.946 . . . . 0.0 109.335 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -92.64 49.74 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.528 -0.733 . . . . 0.0 109.454 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -176.56 163.2 2.37 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.423 HG12 ' CE1' ' B' ' 5' ' ' HIS . 16.8 mt -103.69 86.81 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.426 -0.797 . . . . 0.0 109.166 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -178.83 0.1 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.765 -0.584 . . . . 0.0 110.079 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -91.71 166.12 12.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.708 -0.62 . . . . 0.0 109.623 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -66.51 -32.11 73.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.669 -0.644 . . . . 0.0 109.679 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -27.14 63.99 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.335 -0.853 . . . . 0.0 109.694 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -67.39 -50.12 60.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.459 -0.776 . . . . 0.0 109.508 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' B' ' 15' ' ' LEU . 10.2 mt -65.43 -16.65 63.85 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.431 -0.793 . . . . 0.0 110.25 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.91 -19.41 42.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.249 -0.907 . . . . 0.0 110.354 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -96.27 30.63 2.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.264 -0.898 . . . . 0.0 109.801 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.455 ' CD2' HD23 ' B' ' 15' ' ' LEU . 6.4 m-85 -114.69 -14.91 11.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.6 -0.687 . . . . 0.0 110.026 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.9 m -73.56 -20.15 60.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.136 -0.978 . . . . 0.0 110.22 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.7 p30 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.415 179.78 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.44 ' CZ ' ' CD2' ' B' ' 17' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 18.4 t -83.48 -69.59 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.595 -1.316 . . . . 0.0 109.081 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -154.35 24.63 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.532 -0.73 . . . . 0.0 109.935 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -115.47 142.11 47.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.448 -0.782 . . . . 0.0 109.328 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.423 ' CE1' HG12 ' A' ' 10' ' ' ILE . 49.8 m80 -70.51 -178.47 1.78 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.63 -0.669 . . . . 0.0 109.866 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 38.0 mt -130.63 42.18 3.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.501 -0.749 . . . . 0.0 110.854 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.67 140.78 52.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.212 -0.93 . . . . 0.0 109.281 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.66 -144.61 21.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.3 -14.67 60.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.456 -1.026 . . . . 0.0 109.893 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -60.43 -37.86 82.26 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.082 -1.011 . . . . 0.0 109.126 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 2.5 tt -61.65 -58.5 7.81 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.806 -0.559 . . . . 0.0 109.696 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 t -49.56 -51.06 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.625 -0.672 . . . . 0.0 111.22 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -58.61 -33.65 70.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.368 -0.832 . . . . 0.0 110.092 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.45 -30.56 67.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.548 -0.72 . . . . 0.0 109.7 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.456 ' CB ' ' CD1' ' B' ' 25' ' ' PHE . 30.2 mt -69.25 -36.52 77.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.75 -29.94 66.31 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.44 ' CD2' ' CZ ' ' B' ' 1' ' ' PHE . 1.5 tp -68.66 -35.47 77.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.602 -0.686 . . . . 0.0 109.436 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 39.7 t -80.84 -69.81 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.543 -0.723 . . . . 0.0 109.726 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.56 -81.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.472 -0.768 . . . . 0.0 109.416 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 139.19 -52.05 0.73 Allowed Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.671 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -90.34 152.02 21.2 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.34 -1.094 . . . . 0.0 110.062 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 19.3 mtt180 -76.03 139.03 41.25 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.22 17.62 57.11 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.6 33.56 5.18 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.456 ' CD1' ' CB ' ' B' ' 15' ' ' LEU . 27.0 p90 -176.83 -169.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.717 -0.872 . . . . 0.0 109.016 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.402 ' CE1' ' HD3' ' B' ' 28' ' ' PRO . 3.8 t80 -51.52 99.93 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.294 -0.879 . . . . 0.0 109.82 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 19.5 p -132.61 89.88 34.55 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.402 ' HD3' ' CE1' ' B' ' 26' ' ' TYR . 4.4 Cg_exo -58.8 146.66 91.98 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 122.394 2.062 . . . . 0.0 110.159 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.6 mttt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.527 -179.949 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.42 -55.81 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.585 -0.95 . . . . 0.0 109.735 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.6 t -65.99 -34.81 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.544 -0.723 . . . . 0.0 109.403 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.25 -21.26 63.73 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.442 -0.786 . . . . 0.0 110.04 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -111.79 -3.52 14.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.383 -0.823 . . . . 0.0 110.951 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.4 m -121.26 18.78 11.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.983 -1.073 . . . . 0.0 110.529 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.02 21.68 13.57 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.164 -0.96 . . . . 0.0 109.828 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.6 m -129.73 -66.22 0.8 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 108.83 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.99 -164.88 1.21 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.432 ' CD1' ' CE1' ' B' ' 5' ' ' HIS . 4.5 mm -90.82 98.55 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.4 -0.813 . . . . 0.0 108.941 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -70.69 -167.76 0.21 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.671 -0.643 . . . . 0.0 109.747 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.406 ' OG ' ' CE1' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -129.02 156.12 44.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.509 -0.744 . . . . 0.0 109.604 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.448 ' CD2' ' CE1' ' B' ' 1' ' ' PHE . 3.2 tm? -66.78 -26.32 66.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.619 -0.676 . . . . 0.0 110.521 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.406 ' CE1' ' OG ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -54.89 -22.32 14.41 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.073 -1.017 . . . . 0.0 110.561 -179.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -86.39 -39.94 15.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.419 -0.801 . . . . 0.0 109.437 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.407 ' CD2' ' CD2' ' B' ' 15' ' ' LEU . 6.5 mt -68.64 -10.78 58.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.489 -0.757 . . . . 0.0 110.258 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -67.51 -28.43 67.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 109.412 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -71.01 -12.16 61.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.553 -0.717 . . . . 0.0 110.622 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -74.59 -7.8 54.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.32 -0.862 . . . . 0.0 110.47 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 27.9 m -97.64 33.44 2.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.132 -0.98 . . . . 0.0 109.596 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.533 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.448 ' CE1' ' CD2' ' A' ' 13' ' ' LEU . 8.5 p90 . . . . . 0 N--CA 1.5 2.036 0 CA-C-O 120.464 0.173 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.94 -33.16 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.056 -1.027 . . . . 0.0 108.734 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -144.27 30.04 1.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -126.65 -159.5 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.432 ' CE1' ' CD1' ' A' ' 10' ' ' ILE . 20.3 m80 -115.97 -172.82 2.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.349 -0.844 . . . . 0.0 109.829 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 tp -130.45 43.57 3.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.572 -0.705 . . . . 0.0 110.178 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 59.5 m -122.86 136.29 54.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.509 -0.744 . . . . 0.0 109.464 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.94 -132.94 11.43 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -81.53 2.86 27.11 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.646 -0.914 . . . . 0.0 110.33 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -77.13 -37.18 54.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.053 -1.03 . . . . 0.0 108.733 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 36.9 tp -68.17 -63.69 1.01 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -52.54 -49.77 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.658 -0.651 . . . . 0.0 110.641 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -59.54 -30.79 68.86 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.329 -0.857 . . . . 0.0 109.658 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.427 ' HB3' ' CD2' ' B' ' 1' ' ' PHE . . . -71.42 -32.13 68.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.636 -0.665 . . . . 0.0 109.764 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.423 ' HB3' ' CG ' ' B' ' 25' ' ' PHE . 38.2 mt -68.92 -39.66 79.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.471 -0.768 . . . . 0.0 109.162 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -67.49 -34.0 76.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.692 . . . . 0.0 109.522 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.33 -46.21 74.13 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.553 -0.717 . . . . 0.0 109.677 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 44.3 t -67.42 -69.81 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.506 -0.746 . . . . 0.0 109.355 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.88 -79.46 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.483 -0.76 . . . . 0.0 108.992 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.44 -28.02 14.92 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.93 170.12 4.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.423 -1.045 . . . . 0.0 109.764 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.74 138.87 31.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.546 -0.721 . . . . 0.0 109.395 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.56 29.6 69.97 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.78 27.7 10.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.423 ' CG ' ' HB3' ' B' ' 15' ' ' LEU . 12.5 p90 -177.72 -177.32 0.65 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -1.073 . . . . 0.0 110.177 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -57.49 125.97 25.24 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.6 -0.687 . . . . 0.0 109.893 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 8.8 p -117.63 96.36 49.28 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.574 -0.703 . . . . 0.0 109.257 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -57.79 162.46 10.82 Favored 'Trans proline' 0 N--CA 1.483 0.878 0 C-N-CA 122.487 2.124 . . . . 0.0 110.169 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.443 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.432 HD12 ' CE1' ' A' ' 19' ' ' TYR . 8.2 tt -171.99 -50.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.658 -0.907 . . . . 0.0 109.138 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.413 ' N ' ' CG2' ' A' ' 2' ' ' ILE . 31.4 t -92.54 -61.38 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.365 -0.834 . . . . 0.0 109.122 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -60.28 -18.51 49.68 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.58 -0.7 . . . . 0.0 110.082 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -52.64 -59.32 4.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.249 -0.907 . . . . 0.0 110.309 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -124.23 36.02 4.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.524 -0.735 . . . . 0.0 109.515 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' B' ' 6' ' ' LEU . 0.1 OUTLIER -62.59 -43.16 99.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.625 -0.672 . . . . 0.0 109.555 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 m -87.41 -33.67 19.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.534 -0.729 . . . . 0.0 109.75 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -94.45 -177.63 4.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.457 -0.777 . . . . 0.0 109.449 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.44 ' CG1' ' CE1' ' B' ' 5' ' ' HIS . 19.5 mt -114.73 99.95 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.377 -0.827 . . . . 0.0 109.409 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.33 -177.87 6.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.567 -0.708 . . . . 0.0 109.304 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.12 153.95 19.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.507 -0.746 . . . . 0.0 109.424 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.5 tp -57.86 -20.32 35.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.597 -0.689 . . . . 0.0 110.826 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -53.24 -28.19 26.05 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.22 -0.925 . . . . 0.0 111.697 -178.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.443 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 14.3 pt20 -80.06 -44.37 20.18 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.104 -0.997 . . . . 0.0 109.66 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.401 ' CD2' ' CD2' ' B' ' 15' ' ' LEU . 9.9 mt -67.0 -16.43 64.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.51 -0.744 . . . . 0.0 109.649 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.62 -17.92 50.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.173 -0.954 . . . . 0.0 109.84 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -93.27 27.28 2.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 0.0 109.869 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.453 ' CD2' ' CD2' ' B' ' 15' ' ' LEU . 6.3 m-85 -107.16 -20.59 13.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.365 -0.834 . . . . 0.0 109.966 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.3 m -75.88 -4.2 39.51 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.275 -0.89 . . . . 0.0 110.287 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p30 . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.004 -1.06 . . . . 0.0 109.548 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.446 ' CZ ' ' CD2' ' B' ' 17' ' ' LEU . 3.3 t80 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 9.0 t -46.35 -64.65 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 O-C-N 121.65 -0.656 . . . . 0.0 110.52 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -174.4 36.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -122.26 148.81 44.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.609 -0.682 . . . . 0.0 109.258 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.44 ' CE1' ' CG1' ' A' ' 10' ' ' ILE . 51.1 m80 -78.38 -178.31 5.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.642 -0.661 . . . . 0.0 109.576 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -142.42 131.96 23.83 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.95 -76.71 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.146 -0.971 . . . . 0.0 109.595 178.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.08 -121.59 0.06 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 22.3 p -73.58 -8.54 56.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.47 -1.018 . . . . 0.0 109.445 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -61.28 -41.82 97.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.877 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 67.2 tp -60.46 -56.29 23.14 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.485 -0.76 . . . . 0.0 109.682 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.4 t -49.76 -53.77 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.567 -0.708 . . . . 0.0 111.081 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -58.07 -31.93 67.55 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.437 -0.789 . . . . 0.0 110.188 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.418 ' HA ' ' CE1' ' B' ' 1' ' ' PHE . . . -69.13 -34.11 74.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.482 -0.762 . . . . 0.0 109.654 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.453 ' CD2' ' CD2' ' A' ' 19' ' ' TYR . 25.8 mt -70.81 -32.94 70.19 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -68.29 -33.72 74.87 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.446 ' CD2' ' CZ ' ' B' ' 1' ' ' PHE . 0.5 OUTLIER -69.14 -39.22 78.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.689 -0.632 . . . . 0.0 109.745 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 30.8 t -72.84 -68.2 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.57 -0.706 . . . . 0.0 110.135 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 10.6 m -65.15 -69.19 0.31 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.417 -0.802 . . . . 0.0 109.195 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.0 -36.52 3.52 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.28 167.43 12.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.338 -1.095 . . . . 0.0 109.928 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.56 -63.56 1.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.81 86.26 0.97 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -161.5 -41.38 0.02 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.441 ' CG ' ' HB3' ' B' ' 15' ' ' LEU . 28.0 p90 -116.43 -174.49 2.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.409 -1.053 . . . . 0.0 110.446 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.423 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 2.9 t80 -54.5 100.0 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.428 HG21 ' CE1' ' B' ' 25' ' ' PHE . 40.4 p -113.1 92.46 21.74 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.653 -0.654 . . . . 0.0 109.57 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.423 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 2.4 Cg_endo -60.49 89.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 122.422 2.081 . . . . 0.0 109.776 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.518 -179.821 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.469 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.435 ' CD1' ' CZ ' ' A' ' 19' ' ' TYR . 1.1 tp -128.21 -44.21 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.495 -1.003 . . . . 0.0 109.321 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.0 t -90.96 -28.83 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.645 -0.659 . . . . 0.0 109.406 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -74.81 -5.55 44.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.557 -0.715 . . . . 0.0 110.195 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -58.24 -63.21 1.35 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.196 -0.94 . . . . 0.0 110.013 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.5 p -120.48 27.32 8.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.477 -0.764 . . . . 0.0 110.279 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -32.09 54.36 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.217 -0.927 . . . . 0.0 109.389 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -113.42 -32.73 6.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.676 -0.64 . . . . 0.0 109.325 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.431 ' O ' ' CD2' ' B' ' 5' ' ' HIS . 0.4 OUTLIER -98.85 -171.41 2.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.449 -0.782 . . . . 0.0 108.926 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.408 HG21 HD11 ' A' ' 10' ' ' ILE . 1.7 mm -104.21 160.64 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.361 -0.837 . . . . 0.0 109.008 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.0 p -147.27 179.56 7.56 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.507 -0.746 . . . . 0.0 109.806 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.434 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -82.8 102.06 11.34 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -70.27 -14.61 62.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.545 -0.722 . . . . 0.0 110.859 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.434 ' CE2' ' HB2' ' A' ' 12' ' ' SER . 17.3 p90 -71.25 -18.92 62.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.088 -1.008 . . . . 0.0 109.779 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -84.18 -3.24 58.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.359 -0.838 . . . . 0.0 110.416 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.408 HD22 ' CG ' ' A' ' 19' ' ' TYR . 4.4 mt -65.7 -14.15 60.7 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.134 -0.979 . . . . 0.0 109.99 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -59.06 -19.65 46.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.164 -0.96 . . . . 0.0 110.002 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -96.89 31.95 2.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.296 -0.878 . . . . 0.0 109.438 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.435 ' CZ ' ' CD1' ' A' ' 2' ' ' ILE . 6.4 m-85 -115.19 12.97 16.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.435 -0.79 . . . . 0.0 109.95 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.81 -56.11 5.12 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.231 -0.918 . . . . 0.0 109.571 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.297 -1.713 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.326 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 13.3 p90 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 120.613 0.244 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 24.5 t -51.89 -25.72 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 120.962 -1.087 . . . . 0.0 110.469 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -151.57 27.14 0.66 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 109.303 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' B' ' 5' ' ' HIS . 5.8 mp0 -107.24 -97.21 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.441 -0.787 . . . . 0.0 109.329 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.431 ' CD2' ' O ' ' A' ' 9' ' ' SER . 1.1 m80 -173.1 152.58 2.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.833 -1.167 . . . . 0.0 109.86 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 21.9 mt -115.11 86.15 2.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.635 -0.666 . . . . 0.0 109.511 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -150.2 129.95 13.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.48 -0.762 . . . . 0.0 109.481 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.29 -136.48 14.46 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.42 -6.81 57.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.494 -1.003 . . . . 0.0 110.364 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -66.57 -29.68 69.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 109.691 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 60.7 tp -71.25 -46.28 61.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.486 -0.759 . . . . 0.0 109.544 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 39.3 t -60.66 -43.79 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.672 -0.643 . . . . 0.0 109.952 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.77 -39.51 94.41 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.435 -0.791 . . . . 0.0 109.302 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.32 -30.39 70.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.607 -0.683 . . . . 0.0 109.769 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.448 ' CB ' ' CD1' ' B' ' 25' ' ' PHE . 1.2 mt -70.4 -36.18 73.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.507 -0.745 . . . . 0.0 109.416 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -70.3 -32.55 70.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.581 -0.699 . . . . 0.0 109.607 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.82 -24.67 41.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.477 -0.764 . . . . 0.0 110.086 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 41.9 t -89.48 -68.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.246 -0.909 . . . . 0.0 109.801 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 m -53.71 -78.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.39 -0.819 . . . . 0.0 110.269 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.33 -40.42 1.56 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.84 176.02 1.03 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.287 -1.125 . . . . 0.0 109.593 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.42 -44.35 6.55 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.75 42.97 1.68 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.28 38.16 3.21 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.448 ' CD1' ' CB ' ' B' ' 15' ' ' LEU . 52.5 p90 -178.4 -166.71 0.11 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.397 -1.061 . . . . 0.0 109.522 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.408 ' HB2' ' CD1' ' B' ' 15' ' ' LEU . 0.4 OUTLIER -47.29 94.38 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.868 -0.52 . . . . 0.0 110.188 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.33 98.86 28.58 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -56.95 142.14 93.61 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.3 2.0 . . . . 0.0 110.047 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.453 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.4 tt -67.04 -44.56 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.678 -0.895 . . . . 0.0 109.669 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 t -90.76 -13.23 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.445 -0.785 . . . . 0.0 110.221 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -90.52 53.58 2.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.233 -0.917 . . . . 0.0 109.044 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -142.22 -46.32 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.539 -0.726 . . . . 0.0 109.368 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.0 m -115.6 15.87 16.55 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.539 -0.726 . . . . 0.0 109.952 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 45.3 t -72.93 -35.77 67.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.09 -1.006 . . . . 0.0 109.314 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 m -73.22 -58.14 3.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.487 -0.758 . . . . 0.0 109.797 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.4 p -119.62 -167.86 1.49 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.502 -0.749 . . . . 0.0 109.815 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.405 ' CG1' ' CE1' ' B' ' 5' ' ' HIS . 7.4 mt -101.82 130.16 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.0 p -106.23 -172.9 2.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.31 -0.869 . . . . 0.0 110.429 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.57 144.8 55.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.573 -0.705 . . . . 0.0 110.787 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.15 -30.25 68.44 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -22.29 22.09 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.489 -0.757 . . . . 0.0 109.94 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -72.45 -46.74 53.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.36 -0.838 . . . . 0.0 109.487 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.423 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 5.4 mt -65.4 -21.62 66.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.516 -0.74 . . . . 0.0 110.093 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.77 -26.92 58.69 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.226 -0.921 . . . . 0.0 110.308 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -97.74 35.88 1.61 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.377 -0.827 . . . . 0.0 109.672 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 7.1 m-85 -113.8 -0.98 14.04 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.501 -0.75 . . . . 0.0 110.383 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.2 m -81.15 1.77 30.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.145 -0.972 . . . . 0.0 110.469 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 120.999 -1.063 . . . . 0.0 109.571 -179.817 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 28.8 m -50.49 172.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.444 -0.785 . . . . 0.0 110.703 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -58.59 92.54 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.464 -0.772 . . . . 0.0 109.901 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -130.4 104.99 7.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.556 -0.715 . . . . 0.0 109.385 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.405 ' CE1' ' CG1' ' A' ' 10' ' ' ILE . 70.9 m80 -74.4 135.07 42.39 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.95 98.25 11.14 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.483 -0.761 . . . . 0.0 109.734 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -178.46 127.36 0.11 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.694 . . . . 0.0 109.422 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.83 -141.17 26.95 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p -69.23 -16.66 63.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.561 -0.964 . . . . 0.0 110.169 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -67.81 -38.76 83.68 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.176 -0.953 . . . . 0.0 109.575 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 66.7 tp -68.69 -46.19 69.68 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.654 -0.654 . . . . 0.0 109.379 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.7 t -55.97 -49.9 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.428 -0.795 . . . . 0.0 110.073 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -62.31 -26.33 68.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.556 -0.715 . . . . 0.0 109.578 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.85 -32.26 67.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.641 -0.662 . . . . 0.0 109.293 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.433 ' HB3' ' CG ' ' B' ' 25' ' ' PHE . 24.0 mt -79.33 -26.58 42.13 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.48 -29.79 61.58 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -83.35 -32.31 26.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.494 -0.754 . . . . 0.0 109.477 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 45.3 t -81.28 -68.88 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.528 -0.732 . . . . 0.0 109.506 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 60.5 m -54.33 -73.29 0.05 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.496 -0.753 . . . . 0.0 110.428 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.76 -45.88 1.1 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 174.12 8.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.377 -1.072 . . . . 0.0 109.688 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.67 31.44 5.46 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.18 37.15 0.09 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.91 46.75 1.06 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.433 ' CG ' ' HB3' ' B' ' 15' ' ' LEU . 14.5 p90 -179.33 -173.62 0.28 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.465 -1.021 . . . . 0.0 109.877 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -54.46 108.36 0.37 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.509 -0.744 . . . . 0.0 109.482 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.78 93.32 46.09 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.715 -0.615 . . . . 0.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -58.24 110.75 0.69 Allowed 'Trans proline' 0 N--CA 1.484 0.952 0 C-N-CA 122.529 2.153 . . . . 0.0 109.979 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 tptt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.393 179.943 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.413 HG13 ' CE2' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -109.62 -48.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.561 -0.964 . . . . 0.0 108.881 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.401 ' CG2' ' CD2' ' B' ' 11' ' ' LEU . 3.7 t -83.68 -48.35 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.684 -0.635 . . . . 0.0 110.016 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.37 -8.87 54.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.431 -0.793 . . . . 0.0 110.866 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.69 -14.56 8.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.154 -0.966 . . . . 0.0 110.883 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.9 m -120.19 24.44 10.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.027 -1.046 . . . . 0.0 110.12 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -84.84 -42.9 14.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.348 -0.845 . . . . 0.0 109.301 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.9 m -78.91 -48.13 15.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.548 -0.72 . . . . 0.0 109.654 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -110.0 -177.91 3.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.689 . . . . 0.0 109.543 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.439 ' CG1' ' CE1' ' B' ' 5' ' ' HIS . 32.0 mt -106.25 135.23 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.7 m -94.99 -174.69 3.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.726 . . . . 0.0 110.129 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.8 m -91.84 166.36 12.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.661 -0.649 . . . . 0.0 109.962 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.5 tp -67.47 -24.81 65.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.673 -0.642 . . . . 0.0 110.174 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -58.67 -19.35 38.67 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.456 -0.778 . . . . 0.0 110.954 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -77.64 -69.35 0.55 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.084 -1.01 . . . . 0.0 110.375 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 24.4 mt -60.16 -17.66 42.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.405 -0.809 . . . . 0.0 109.992 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -64.75 -44.09 91.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 108.577 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -71.52 -9.99 59.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.649 -0.657 . . . . 0.0 109.737 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.413 ' CE2' HG13 ' A' ' 2' ' ' ILE . 6.9 m-30 -89.29 22.56 2.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.4 -0.812 . . . . 0.0 110.45 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.8 m -109.31 40.79 1.77 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.166 -0.959 . . . . 0.0 109.691 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.1 m120 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.1 -0.952 . . . . 0.0 109.475 179.938 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.422 ' CE2' ' CB ' ' B' ' 4' ' ' GLN . 10.0 t80 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.444 ' O ' ' C ' ' B' ' 3' ' ' ASN . 10.7 t -42.96 113.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 122.017 -0.427 . . . . 0.0 110.792 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' B' ' 2' ' ' VAL . 2.7 p30 0.77 75.82 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.101 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.422 ' CB ' ' CE2' ' B' ' 1' ' ' PHE . 0.0 OUTLIER -142.5 131.79 23.48 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.616 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.439 ' CE1' ' CG1' ' A' ' 10' ' ' ILE . 74.6 m80 -91.16 172.63 8.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.785 . . . . 0.0 109.381 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 28.6 mt -126.31 121.02 31.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.473 -0.767 . . . . 0.0 110.263 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 179.78 105.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.8 -144.76 17.49 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 60.3 p -64.36 -19.73 65.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.562 -0.963 . . . . 0.0 109.98 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -57.46 -30.66 65.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.17 -0.956 . . . . 0.0 109.769 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.401 ' CD2' ' CG2' ' A' ' 3' ' ' VAL . 66.8 tp -68.63 -56.46 8.13 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 t -50.07 -48.09 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.643 -0.66 . . . . 0.0 111.107 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -62.16 -33.43 74.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.496 -0.752 . . . . 0.0 109.696 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.53 -28.61 67.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.557 -0.714 . . . . 0.0 109.555 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 30.4 mt -78.09 -29.45 49.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.477 -0.765 . . . . 0.0 109.11 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -69.59 -35.2 75.12 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.31 -54.86 6.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.697 -0.627 . . . . 0.0 109.547 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 20.9 t -61.52 -66.51 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.539 -0.726 . . . . 0.0 109.805 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 45.4 m -59.61 -69.38 0.21 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.566 -0.709 . . . . 0.0 109.82 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.98 -27.34 18.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.77 142.77 40.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.467 -1.019 . . . . 0.0 109.608 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 117.26 20.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.581 -0.699 . . . . 0.0 109.272 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.5 31.78 49.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.94 32.17 5.76 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.417 ' CE1' HG21 ' B' ' 27' ' ' THR . 38.4 p90 -167.95 -171.38 1.55 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.965 . . . . 0.0 109.618 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.421 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 3.1 t80 -52.97 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.493 -0.754 . . . . 0.0 109.765 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.417 HG21 ' CE1' ' B' ' 25' ' ' PHE . 0.8 OUTLIER -121.8 92.47 48.76 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.421 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 6.1 Cg_exo -58.05 161.89 12.49 Favored 'Trans proline' 0 N--CA 1.482 0.839 0 C-N-CA 122.593 2.195 . . . . 0.0 110.059 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 tttp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.427 -179.892 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.6 tt -146.7 -45.27 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.598 -0.942 . . . . 0.0 109.461 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.403 ' CG1' ' HA ' ' B' ' 7' ' ' CYS . 18.0 t -90.92 -34.28 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.396 -0.815 . . . . 0.0 109.399 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -57.56 -21.85 41.1 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.577 -0.702 . . . . 0.0 109.986 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -63.21 -41.8 99.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.448 -0.783 . . . . 0.0 110.098 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.1 m -113.53 20.85 15.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.429 -0.794 . . . . 0.0 111.072 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.7 t -93.29 43.74 1.13 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.04 -1.037 . . . . 0.0 109.611 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 t -138.92 -45.22 0.47 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.07 -170.95 2.62 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.436 HD11 ' CE1' ' B' ' 5' ' ' HIS . 1.0 OUTLIER -97.39 102.1 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.182 -0.949 . . . . 0.0 109.601 -178.615 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.1 m -62.46 -174.46 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.321 0.581 . . . . 0.0 110.188 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.6 m -105.58 163.64 12.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.744 -0.597 . . . . 0.0 109.501 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.428 HD11 ' CD1' ' B' ' 1' ' ' PHE . 42.2 tp -66.51 -28.25 68.41 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.572 -0.705 . . . . 0.0 109.918 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -58.34 -22.85 54.81 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.486 -0.759 . . . . 0.0 110.285 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -80.51 -47.91 13.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.291 -0.88 . . . . 0.0 109.702 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.4 mt -66.97 -20.27 65.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.515 -0.74 . . . . 0.0 110.315 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -62.0 -22.39 65.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.251 -0.905 . . . . 0.0 110.022 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -98.53 33.38 2.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.84 . . . . 0.0 109.648 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -112.28 7.2 19.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.646 -0.659 . . . . 0.0 110.346 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.47 35.51 1.48 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.047 -0.977 . . . . 0.0 109.544 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.43 ' CD1' HG22 ' B' ' 2' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.43 HG22 ' CD1' ' B' ' 1' ' ' PHE . 15.6 t -86.22 -58.06 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.662 -1.274 . . . . 0.0 109.316 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.84 37.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.433 -0.792 . . . . 0.0 109.664 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -120.42 139.83 52.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.589 -0.694 . . . . 0.0 109.262 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.436 ' CE1' HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -77.78 164.68 25.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.471 -0.768 . . . . 0.0 109.602 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 18.8 mt -120.34 112.3 18.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.568 -0.707 . . . . 0.0 110.463 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.403 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 0.1 OUTLIER 179.71 120.25 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.425 -0.797 . . . . 0.0 109.153 178.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.39 -147.33 19.07 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.5 t -65.73 -14.67 61.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.349 -1.089 . . . . 0.0 109.92 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.96 -29.95 67.55 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.139 -0.976 . . . . 0.0 109.194 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.52 -52.89 49.33 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 18.1 t -56.07 -37.58 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.802 -0.562 . . . . 0.0 110.699 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -74.8 -26.33 59.66 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.455 -0.778 . . . . 0.0 110.212 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.19 -31.25 64.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 40.3 mt -74.02 -39.76 63.37 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -61.55 -33.04 73.17 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 tp -67.87 -40.74 83.54 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 35.8 t -86.49 -75.12 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.671 -0.643 . . . . 0.0 110.134 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 14.0 m -64.78 -62.72 1.4 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 109.599 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.16 15.73 78.66 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -90.48 158.11 17.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -1.178 . . . . 0.0 109.16 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.85 117.34 26.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.529 -0.732 . . . . 0.0 109.29 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.03 36.25 93.02 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.96 -19.86 6.64 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -127.42 -174.82 3.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.264 -1.139 . . . . 0.0 110.232 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.456 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 4.2 t80 -60.11 105.61 0.42 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.546 0.689 . . . . 0.0 109.47 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.75 90.82 21.93 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.456 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 8.7 Cg_endo -68.35 83.15 0.49 Allowed 'Trans proline' 0 N--CA 1.486 1.064 0 C-N-CA 122.857 2.371 . . . . 0.0 110.826 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.052 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.152 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.8 tt -136.9 -48.26 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.582 -0.951 . . . . 0.0 109.793 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.6 t -92.05 -21.82 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.25 -0.906 . . . . 0.0 109.955 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -89.68 59.15 4.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.393 -0.817 . . . . 0.0 109.699 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.5 -45.96 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.478 -0.764 . . . . 0.0 109.143 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 59.1 m -115.35 16.14 16.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.662 -0.649 . . . . 0.0 110.058 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.89 -29.37 62.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.282 -0.887 . . . . 0.0 109.159 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -84.08 -49.15 9.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.584 -0.698 . . . . 0.0 110.212 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p -122.83 166.92 14.2 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.532 -0.73 . . . . 0.0 110.061 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.433 HG13 ' CD2' ' B' ' 5' ' ' HIS . 0.1 OUTLIER -86.81 120.9 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 87.7 m -82.8 -89.0 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.605 -0.684 . . . . 0.0 110.016 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.6 t -179.45 168.83 1.44 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.993 -1.067 . . . . 0.0 109.466 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.24 -33.1 74.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.584 -0.698 . . . . 0.0 110.478 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -21.54 61.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.264 -0.898 . . . . 0.0 110.208 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -76.74 -50.95 12.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.324 -0.86 . . . . 0.0 110.123 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.423 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 10.4 mt -66.81 -21.14 66.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.448 -0.783 . . . . 0.0 110.162 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -55.46 -22.5 20.89 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.239 -0.913 . . . . 0.0 110.466 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -98.02 35.33 1.75 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.366 -0.834 . . . . 0.0 109.808 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 6.6 m-85 -111.57 0.61 16.49 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.468 -0.77 . . . . 0.0 110.373 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.97 36.43 1.56 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.097 -1.002 . . . . 0.0 109.436 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.128 -0.939 . . . . 0.0 109.501 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -36.07 -72.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.581 0 O-C-N 122.053 -0.404 . . . . 0.0 112.022 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -178.16 54.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.162 -0.961 . . . . 0.0 109.375 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -103.39 123.97 47.83 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.433 ' CD2' HG13 ' A' ' 10' ' ' ILE . 13.0 m80 -84.11 137.89 33.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.464 -0.773 . . . . 0.0 109.672 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.413 ' HB3' ' CD2' ' B' ' 11' ' ' LEU . 50.0 mt -81.78 95.52 7.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.875 -0.515 . . . . 0.0 110.413 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.05 120.41 0.44 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.666 -0.646 . . . . 0.0 109.35 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.21 -142.31 21.24 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 51.7 p -66.02 -23.83 66.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.942 . . . . 0.0 109.459 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -56.29 -29.9 61.81 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.241 -0.912 . . . . 0.0 109.112 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.413 ' CD2' ' HB3' ' B' ' 6' ' ' LEU . 0.4 OUTLIER -63.41 -60.35 3.48 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -51.12 -52.65 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.665 -0.647 . . . . 0.0 111.143 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -59.52 -29.25 67.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.37 -0.831 . . . . 0.0 110.346 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.85 63.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.485 -0.759 . . . . 0.0 109.742 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' B' ' 11' ' ' LEU . 31.3 mt -77.2 -30.57 54.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.435 -0.791 . . . . 0.0 109.541 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -75.99 -30.86 58.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.568 -0.708 . . . . 0.0 109.42 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tp -80.18 -30.62 38.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.595 -0.69 . . . . 0.0 109.631 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 43.3 t -82.66 -68.59 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.695 . . . . 0.0 109.195 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 33.8 m -67.74 -67.55 0.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.68 -0.638 . . . . 0.0 109.387 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.04 7.89 79.79 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -89.83 151.63 21.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.115 -1.227 . . . . 0.0 109.669 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.36 104.13 9.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.745 . . . . 0.0 108.99 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.81 42.51 30.91 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.07 -20.38 6.77 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -115.41 -170.49 1.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.404 -1.056 . . . . 0.0 109.566 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.416 ' O ' ' CG ' ' B' ' 26' ' ' TYR . 0.5 OUTLIER -55.44 93.52 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.613 -0.68 . . . . 0.0 109.645 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.5 p -124.13 97.07 41.1 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.41 ' HD3' ' CE1' ' B' ' 26' ' ' TYR . 6.1 Cg_exo -57.64 -172.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.019 0 C-N-CA 122.621 2.214 . . . . 0.0 110.692 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.442 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 tt -143.42 -47.4 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.518 -0.989 . . . . 0.0 109.385 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.5 t -92.93 -18.41 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.437 -0.789 . . . . 0.0 110.075 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -89.55 54.51 2.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.321 -0.862 . . . . 0.0 109.721 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -141.2 -50.48 0.43 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.497 -0.752 . . . . 0.0 108.993 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.3 m -128.41 32.72 4.81 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -57.17 7.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.69 -0.631 . . . . 0.0 110.272 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 m -68.0 -28.21 67.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.505 -0.747 . . . . 0.0 110.899 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.433 ' HA ' ' CE1' ' B' ' 5' ' ' HIS . 1.2 m -116.98 -162.52 0.86 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.375 -0.828 . . . . 0.0 109.942 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.461 HG22 HD11 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -111.14 129.34 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.477 -0.764 . . . . 0.0 109.008 -179.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.91 -164.41 1.02 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.652 -0.655 . . . . 0.0 109.91 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.455 ' CB ' ' CE2' ' A' ' 14' ' ' TYR . 1.6 m -102.09 162.18 13.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.547 -0.721 . . . . 0.0 109.747 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.33 -35.4 80.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.624 -0.673 . . . . 0.0 110.387 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.455 ' CE2' ' CB ' ' A' ' 12' ' ' SER . 20.4 p90 -61.58 -23.33 65.92 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.389 -0.82 . . . . 0.0 110.058 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.404 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 5.8 tp60 -68.04 -57.11 6.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.419 -0.801 . . . . 0.0 109.494 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.432 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 23.0 mt -66.07 -14.24 61.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.576 -0.703 . . . . 0.0 110.222 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -62.23 -31.17 71.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.186 -0.946 . . . . 0.0 109.554 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -98.51 32.97 2.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.492 -0.755 . . . . 0.0 109.446 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.432 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 7.2 m-85 -113.42 -7.41 13.46 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.615 -0.678 . . . . 0.0 110.226 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.0 m -74.6 -22.07 59.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.081 -1.012 . . . . 0.0 110.357 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.54 -179.871 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.455 ' CE1' ' CB ' ' B' ' 4' ' ' GLN . 2.3 p90 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.425 HG21 ' CD2' ' B' ' 1' ' ' PHE . 27.4 m -50.09 -26.16 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.354 -1.467 . . . . 0.0 110.977 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -171.08 40.85 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.574 -0.704 . . . . 0.0 109.189 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.455 ' CB ' ' CE1' ' B' ' 1' ' ' PHE . 7.0 tp60 -136.38 108.04 7.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.583 -0.698 . . . . 0.0 109.912 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.444 ' CD2' HG21 ' A' ' 10' ' ' ILE . 14.3 m-70 -64.06 163.23 12.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.611 -0.681 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.426 ' N ' ' CD2' ' B' ' 6' ' ' LEU . 2.5 mm? -114.42 55.35 0.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.501 -0.749 . . . . 0.0 109.596 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.86 129.01 33.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.522 -0.736 . . . . 0.0 109.333 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.56 -147.53 35.71 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 16.2 p -67.84 -12.21 60.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.553 -0.969 . . . . 0.0 110.489 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -60.69 -33.4 72.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.067 -1.021 . . . . 0.0 109.706 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 62.4 tp -65.07 -55.89 16.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.614 -0.679 . . . . 0.0 109.218 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.2 t -52.08 -47.67 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.544 -0.723 . . . . 0.0 110.813 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -62.22 -32.26 72.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.441 -0.787 . . . . 0.0 109.729 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.09 -31.94 71.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.557 -0.715 . . . . 0.0 109.153 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 31.7 mt -74.88 -28.56 60.7 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -70.17 -34.33 72.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.504 -0.748 . . . . 0.0 108.992 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.428 HD21 ' CE2' ' B' ' 1' ' ' PHE . 0.5 OUTLIER -73.76 -42.37 61.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.721 -0.612 . . . . 0.0 109.6 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.0 -71.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -77.91 0.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.457 -0.777 . . . . 0.0 108.979 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.53 -27.92 9.5 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.27 176.32 0.35 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.423 -1.045 . . . . 0.0 109.759 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -76.38 -63.16 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.593 -0.692 . . . . 0.0 109.386 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -119.41 48.02 0.98 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.62 26.12 25.59 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -162.06 -176.92 5.44 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.498 -1.001 . . . . 0.0 109.798 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -56.45 123.81 15.99 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.548 -0.72 . . . . 0.0 110.157 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.31 96.82 43.63 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.78 165.04 5.21 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 122.386 2.057 . . . . 0.0 110.21 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 2.5 pttt . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.708 -179.895 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.433 ' CG2' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -170.73 -53.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.608 -0.936 . . . . 0.0 109.195 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.433 ' N ' ' CG2' ' A' ' 2' ' ' ILE . 32.2 t -92.36 -53.51 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.344 -0.848 . . . . 0.0 109.672 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.6 -30.79 67.49 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.651 -0.655 . . . . 0.0 110.274 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -76.16 -28.6 57.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.502 -0.749 . . . . 0.0 109.817 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.2 m -113.32 26.43 10.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.431 -0.793 . . . . 0.0 110.158 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -101.39 -32.09 10.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 0.0 109.197 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -85.79 -57.29 3.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.646 -0.658 . . . . 0.0 109.515 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.89 -160.67 0.82 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.631 -0.668 . . . . 0.0 109.358 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.406 HD11 HG22 ' A' ' 10' ' ' ILE . 1.2 mm -93.88 -168.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.54 168.28 7.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.414 -0.804 . . . . 0.0 109.106 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.405 ' OG ' ' CE1' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -100.48 162.13 13.14 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.456 ' CD2' ' CE1' ' B' ' 1' ' ' PHE . 3.4 tm? -66.98 -23.48 65.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.679 -0.638 . . . . 0.0 110.261 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.422 ' CE1' ' HG2' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -56.63 -20.74 22.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.128 -0.982 . . . . 0.0 110.803 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.422 ' HG2' ' CE1' ' A' ' 14' ' ' TYR . 5.3 mm100 -74.36 -46.27 41.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.41 -0.806 . . . . 0.0 109.843 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.9 mt -68.42 -10.0 52.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.436 -0.79 . . . . 0.0 110.722 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.94 -26.33 68.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.11 -0.994 . . . . 0.0 109.21 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -62.29 -32.74 73.51 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.747 0.784 . . . . 0.0 109.633 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.419 ' OH ' HG22 ' A' ' 2' ' ' ILE . 35.5 m-85 -81.66 -17.07 49.32 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.995 -0.441 . . . . 0.0 111.139 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -105.13 28.8 6.92 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.045 -1.034 . . . . 0.0 109.766 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.582 -179.871 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.456 ' CE1' ' CD2' ' A' ' 13' ' ' LEU . 3.0 p90 . . . . . 0 N--CA 1.5 2.033 0 CA-C-O 120.474 0.178 . . . . 0.0 110.771 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.22 -26.29 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.976 -1.078 . . . . 0.0 109.35 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -152.89 29.24 0.52 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.428 ' HG2' ' CE1' ' B' ' 10' ' ' HIS . 0.3 OUTLIER -118.7 -178.89 3.65 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.401 ' NE2' HD12 ' A' ' 10' ' ' ILE . 5.8 m80 -103.4 125.41 49.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.347 -0.846 . . . . 0.0 109.855 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 tp -83.95 94.1 8.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.706 -0.621 . . . . 0.0 110.08 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.88 134.4 2.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.419 -0.801 . . . . 0.0 109.334 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.3 -145.72 21.43 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 53.7 p -70.79 -9.0 56.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.496 -1.002 . . . . 0.0 110.31 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . 0.428 ' CE1' ' HG2' ' B' ' 4' ' ' GLN . 28.3 t60 -65.37 -31.08 72.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.087 -1.008 . . . . 0.0 108.944 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.415 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 56.0 tp -63.69 -57.31 10.41 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.5 t -53.45 -51.82 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.64 -0.662 . . . . 0.0 110.955 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -56.21 -28.61 58.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.346 -0.846 . . . . 0.0 110.217 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.401 ' HB3' ' CD2' ' B' ' 1' ' ' PHE . . . -76.58 -35.0 58.42 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.442 ' HB3' ' CG ' ' B' ' 25' ' ' PHE . 49.3 mt -64.56 -28.22 69.49 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -80.82 -35.72 32.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.527 -0.733 . . . . 0.0 109.137 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -65.42 -32.61 74.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.658 -0.651 . . . . 0.0 109.804 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 35.9 t -82.22 -55.68 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.601 -0.687 . . . . 0.0 109.405 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 4.7 m -69.19 -80.24 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.54 -0.725 . . . . 0.0 109.528 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.95 -56.56 0.66 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.96 172.23 8.73 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.454 -1.027 . . . . 0.0 109.426 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.25 -47.77 33.0 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.44 94.54 1.4 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -177.93 -35.85 0.06 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.442 ' CG ' ' HB3' ' B' ' 15' ' ' LEU . 44.5 p90 -124.83 -174.64 3.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -1.088 . . . . 0.0 110.867 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.426 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 7.1 t80 -58.45 111.0 1.08 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.853 -0.529 . . . . 0.0 109.828 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.3 p -122.88 92.2 49.28 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.553 -0.717 . . . . 0.0 109.372 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.426 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 1.5 Cg_endo -61.87 129.0 25.96 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 C-N-CA 122.526 2.151 . . . . 0.0 109.858 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 22.4 mttp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.53 179.938 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.5 tt -172.89 -44.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.588 -0.948 . . . . 0.0 109.248 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.7 t -91.58 -9.51 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.576 -0.702 . . . . 0.0 110.358 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.17 3.76 22.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 0.0 109.956 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -63.42 1.23 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.117 -0.989 . . . . 0.0 110.039 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 p -136.27 25.61 3.22 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.978 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.1 t -52.45 -23.78 6.75 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.11 -0.994 . . . . 0.0 110.011 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 m -65.7 -68.49 0.36 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.353 -0.842 . . . . 0.0 111.033 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.4 -153.56 0.53 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.328 -0.858 . . . . 0.0 110.356 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.484 ' CD1' ' CE1' ' B' ' 5' ' ' HIS . 10.1 mm -83.65 168.21 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.096 -1.002 . . . . 0.0 108.728 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.1 p -160.1 174.42 14.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.427 -0.796 . . . . 0.0 110.438 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -72.08 133.13 45.06 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.345 0.593 . . . . 0.0 109.747 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.412 ' HG ' ' CB ' ' B' ' 1' ' ' PHE . 4.6 mm? -68.43 -17.34 64.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.749 -0.594 . . . . 0.0 110.412 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -56.83 -22.46 36.74 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.139 -0.976 . . . . 0.0 109.86 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.26 -49.09 75.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.404 -0.81 . . . . 0.0 109.357 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.8 mt -68.9 -16.51 63.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.521 -0.737 . . . . 0.0 110.051 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.71 -26.75 65.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 109.174 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -89.25 13.12 14.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.379 -0.826 . . . . 0.0 110.078 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -97.77 20.62 11.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.102 -0.999 . . . . 0.0 109.179 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.3 m -109.97 23.88 13.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.328 -0.857 . . . . 0.0 109.987 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 117.903 -1.046 . . . . 0.0 109.427 -179.952 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.416 ' CE1' HD21 ' B' ' 17' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.27 172.23 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.924 -1.11 . . . . 0.0 108.163 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -59.44 92.98 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.317 -0.864 . . . . 0.0 109.376 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -142.03 174.4 10.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.502 -0.748 . . . . 0.0 110.203 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.484 ' CE1' ' CD1' ' A' ' 10' ' ' ILE . 3.6 m80 -119.12 146.45 45.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.613 -0.68 . . . . 0.0 109.248 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.77 90.44 4.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.504 -0.748 . . . . 0.0 109.439 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.3 154.23 10.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.625 -0.672 . . . . 0.0 109.719 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.03 -132.89 49.15 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.5 p -83.51 -13.8 53.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.947 . . . . 0.0 109.759 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -63.71 -33.09 74.87 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.132 -0.98 . . . . 0.0 108.944 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.433 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 2.6 tm? -68.87 -54.51 15.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.813 -0.554 . . . . 0.0 109.771 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 t -53.74 -47.77 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.501 -0.749 . . . . 0.0 110.677 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.7 -29.07 70.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.484 -0.76 . . . . 0.0 109.396 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.67 -26.4 62.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.57 -0.706 . . . . 0.0 109.529 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 11' ' ' LEU . 29.1 mt -78.85 -32.14 45.92 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.418 -0.801 . . . . 0.0 108.882 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.06 -32.99 67.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.595 -0.691 . . . . 0.0 110.012 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.416 HD21 ' CE1' ' B' ' 1' ' ' PHE . 0.1 OUTLIER -80.58 -46.71 15.27 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.413 -0.804 . . . . 0.0 109.937 -179.434 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 48.0 t -59.65 -56.93 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.419 -0.801 . . . . 0.0 109.386 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -74.89 0.1 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.21 -35.17 3.73 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -90.41 163.77 14.55 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.395 -1.062 . . . . 0.0 109.849 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.85 127.9 39.84 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.18 28.7 36.04 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.97 30.73 5.76 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.417 ' CD2' ' HB2' ' B' ' 15' ' ' LEU . 23.8 p90 -165.65 -173.2 2.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.454 -1.027 . . . . 0.0 109.512 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -54.33 109.58 0.51 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.574 -0.703 . . . . 0.0 109.562 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 2.0 p -122.88 91.86 49.49 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -57.31 142.21 94.8 Favored 'Trans proline' 0 N--CA 1.483 0.91 0 C-N-CA 122.48 2.12 . . . . 0.0 110.143 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.455 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.0 tt -172.26 -44.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.667 -0.902 . . . . 0.0 109.583 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.4 t -91.32 -9.24 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.342 -0.849 . . . . 0.0 110.685 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -90.35 51.72 2.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.136 -0.978 . . . . 0.0 109.429 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -138.44 -43.79 0.5 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.498 -0.752 . . . . 0.0 109.379 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.1 m -118.59 15.57 13.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.543 -0.723 . . . . 0.0 110.399 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.61 -27.22 64.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.279 -0.888 . . . . 0.0 110.351 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 m -99.29 -67.83 0.83 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.351 -0.843 . . . . 0.0 110.907 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.2 p -74.99 171.81 13.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.279 -0.888 . . . . 0.0 110.229 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.448 ' CG1' ' CE1' ' B' ' 5' ' ' HIS . 56.6 mt -102.52 91.16 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.6 m -61.74 -178.91 0.16 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.613 -0.68 . . . . 0.0 110.268 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.465 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 22.2 t -106.71 172.47 6.8 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.453 ' CD1' ' CE1' ' B' ' 1' ' ' PHE . 0.6 OUTLIER -67.36 -26.14 66.33 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.403 -0.811 . . . . 0.0 111.415 -178.699 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.465 ' CE2' ' HB3' ' A' ' 12' ' ' SER . 8.9 p90 -59.51 -20.51 55.95 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.997 -1.064 . . . . 0.0 110.042 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.93 -49.91 12.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.388 -0.82 . . . . 0.0 109.428 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.411 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 11.3 mt -67.45 -16.78 64.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.531 -0.731 . . . . 0.0 109.991 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -57.91 -20.72 39.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.187 -0.945 . . . . 0.0 110.219 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -96.95 33.21 1.94 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.84 . . . . 0.0 109.488 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.411 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 7.5 m-85 -113.27 -0.43 14.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.518 -0.739 . . . . 0.0 110.361 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.6 m -96.83 40.49 1.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.122 -0.986 . . . . 0.0 109.562 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.444 179.957 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.453 ' CE1' ' CD1' ' A' ' 13' ' ' LEU . 1.1 p90 . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 15.5 t -54.66 -26.7 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -160.69 31.62 0.15 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -127.48 168.67 14.59 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.638 -0.664 . . . . 0.0 109.857 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.448 ' CE1' ' CG1' ' A' ' 10' ' ' ILE . 18.1 m80 -96.61 161.53 13.85 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 43.7 mt -109.44 -11.11 14.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.478 -0.764 . . . . 0.0 110.82 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.77 138.96 56.87 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.955 -1.091 . . . . 0.0 110.344 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.47 -159.33 33.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.0 p -64.7 -14.66 59.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.435 -1.038 . . . . 0.0 110.04 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -52.14 -27.98 16.26 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.891 -1.131 . . . . 0.0 110.323 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.5 -62.91 1.27 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.614 -0.679 . . . . 0.0 109.199 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 39.4 t -47.16 -52.64 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.839 -0.538 . . . . 0.0 111.445 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -57.53 -36.66 71.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.386 -0.821 . . . . 0.0 110.224 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.1 -31.63 72.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.346 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.412 ' CB ' ' CD1' ' B' ' 25' ' ' PHE . 40.6 mt -64.47 -40.64 96.07 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -63.66 -34.04 76.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.23 -37.3 86.85 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.12 -71.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.586 -0.696 . . . . 0.0 109.613 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 m -90.75 -58.25 2.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.455 -0.778 . . . . 0.0 109.408 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.37 32.78 68.23 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -88.62 -177.55 5.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.613 -0.933 . . . . 0.0 109.409 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.406 ' HG2' ' NH1' ' B' ' 22' ' ' ARG . 2.7 tpt180 -91.93 52.7 2.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.624 -0.672 . . . . 0.0 109.432 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.95 40.68 1.05 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.07 -28.21 6.62 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' CB ' ' B' ' 15' ' ' LEU . 29.2 p90 -105.36 -175.8 2.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.57 -0.959 . . . . 0.0 109.408 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -58.89 118.41 5.73 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.474 -0.766 . . . . 0.0 109.423 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 23.8 p -127.14 94.65 38.5 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.72 118.87 5.83 Favored 'Trans proline' 0 N--CA 1.482 0.838 0 C-N-CA 122.343 2.029 . . . . 0.0 110.165 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 mtpp . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.91 179.88 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.3 tp -73.89 -32.56 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.577 -0.955 . . . . 0.0 109.378 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.0 t -90.32 12.44 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.642 -0.661 . . . . 0.0 110.377 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -105.24 31.51 4.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.179 -0.951 . . . . 0.0 108.928 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -118.77 -33.76 4.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.674 -0.641 . . . . 0.0 109.985 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.0 m -130.33 19.13 5.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.471 -0.768 . . . . 0.0 110.459 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.7 t -91.29 -26.81 18.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 109.565 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -75.35 -27.69 59.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.474 -0.766 . . . . 0.0 110.182 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.4 p -134.64 -171.6 2.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 109.936 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.454 ' CG1' ' CE1' ' B' ' 5' ' ' HIS . 18.3 mt -102.31 95.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.27 -172.82 0.35 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.573 -0.704 . . . . 0.0 109.687 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.427 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 1.4 m -108.64 162.82 13.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.644 -0.66 . . . . 0.0 109.689 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.43 HD11 ' CD2' ' B' ' 1' ' ' PHE . 20.0 tp -71.11 -17.69 62.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.805 -0.559 . . . . 0.0 110.223 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.427 ' CE2' ' HB3' ' A' ' 12' ' ' SER . 10.8 p90 -87.54 11.29 15.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.088 -1.007 . . . . 0.0 110.422 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -105.5 -32.28 8.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.072 -1.017 . . . . 0.0 109.434 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.9 mt -66.16 -13.03 59.53 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.565 -0.71 . . . . 0.0 110.558 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.81 -19.19 39.0 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.08 -1.013 . . . . 0.0 110.124 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -93.53 28.79 2.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.204 -0.935 . . . . 0.0 110.191 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -115.08 10.89 16.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.173 -0.954 . . . . 0.0 110.456 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.31 33.12 2.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.273 -0.892 . . . . 0.0 109.343 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.389 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.448 ' CZ ' HD21 ' B' ' 17' ' ' LEU . 34.3 t80 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 17.5 m -140.63 -162.43 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -52.75 -25.04 9.97 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.956 -1.09 . . . . 0.0 110.022 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -71.87 144.11 49.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.519 -0.738 . . . . 0.0 109.109 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.454 ' CE1' ' CG1' ' A' ' 10' ' ' ILE . 13.0 m80 -68.25 160.6 28.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.552 -0.718 . . . . 0.0 109.493 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 19.7 tp -107.41 98.43 8.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.611 -0.681 . . . . 0.0 109.732 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.7 173.15 2.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.637 -0.664 . . . . 0.0 109.895 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.7 -154.02 39.78 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.1 p -63.8 -21.5 66.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.576 -0.955 . . . . 0.0 109.507 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -60.52 -34.13 73.65 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.869 . . . . 0.0 109.075 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 2.5 tt -61.86 -55.05 33.86 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -53.74 -49.97 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.748 -0.595 . . . . 0.0 111.05 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -59.76 -27.48 66.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.446 -0.784 . . . . 0.0 110.631 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.421 ' HB3' ' CD2' ' B' ' 1' ' ' PHE . . . -80.11 -31.37 39.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 110.301 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 11' ' ' LEU . 50.5 mt -66.72 -41.28 88.18 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -70.94 -31.38 67.95 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.448 HD21 ' CZ ' ' B' ' 1' ' ' PHE . 1.1 mp -63.24 -34.46 77.71 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -84.77 -73.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.626 -0.671 . . . . 0.0 109.359 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 90.8 m -64.49 -82.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 108.852 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.16 23.26 9.84 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 120.136 -1.031 . . . . 0.0 111.533 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.26 -173.68 3.9 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 118.784 1.292 . . . . 0.0 109.165 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -93.44 50.74 1.52 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.532 -0.73 . . . . 0.0 109.51 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.73 71.99 0.63 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.28 35.49 2.17 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.419 ' CE1' HG21 ' B' ' 27' ' ' THR . 36.8 p90 -167.08 -171.91 1.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.959 . . . . 0.0 109.607 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.424 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 3.8 t80 -57.69 98.85 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.582 -0.699 . . . . 0.0 109.167 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.419 HG21 ' CE1' ' B' ' 25' ' ' PHE . 2.2 p -114.33 91.87 25.51 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.591 -0.693 . . . . 0.0 109.666 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.424 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 4.0 Cg_exo -59.24 -171.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.482 0.843 0 C-N-CA 122.453 2.102 . . . . 0.0 110.074 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.571 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.49 -18.3 58.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.652 -0.655 . . . . 0.0 110.049 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -42.1 82.38 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.253 -0.905 . . . . 0.0 109.987 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -146.53 43.49 1.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.45 -0.781 . . . . 0.0 109.897 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -63.3 -43.02 99.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.398 -0.814 . . . . 0.0 109.157 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -97.24 29.51 3.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.714 -0.616 . . . . 0.0 109.552 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p -161.07 -174.17 4.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.556 -0.715 . . . . 0.0 109.263 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.16 98.62 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 m -84.41 -85.76 0.13 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.587 -0.696 . . . . 0.0 110.423 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -173.97 151.43 1.76 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.068 -1.02 . . . . 0.0 109.975 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.747 HD13 ' O ' ' A' ' 13' ' ' LEU . 2.6 tm? -67.18 -21.51 65.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.648 -0.658 . . . . 0.0 110.106 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -24.78 34.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.064 -1.023 . . . . 0.0 109.91 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -79.02 -47.28 16.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.384 -0.822 . . . . 0.0 109.218 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.699 HD22 ' CD2' ' B' ' 15' ' ' LEU . 9.0 mt -65.78 -15.14 62.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.632 -0.667 . . . . 0.0 110.129 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.38 -18.8 41.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.261 -0.899 . . . . 0.0 110.288 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -94.32 28.35 2.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.924 . . . . 0.0 109.988 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -115.99 18.55 15.48 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.377 -0.827 . . . . 0.0 110.211 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.1 m -109.62 30.11 6.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m120 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.469 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.88 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 66.5 t80 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.814 HG12 ' HD2' ' B' ' 1' ' ' PHE . 13.3 p -165.34 -33.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.192 -0.942 . . . . 0.0 110.488 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.621 ' ND2' HG13 ' B' ' 2' ' ' VAL . 16.0 p30 -157.88 -42.26 0.06 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.012 -1.055 . . . . 0.0 109.587 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -76.06 159.91 30.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.473 -0.767 . . . . 0.0 109.012 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -83.26 -178.61 7.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.615 -0.678 . . . . 0.0 109.518 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.594 ' HB3' HD23 ' B' ' 11' ' ' LEU . 33.7 mt -127.4 53.53 1.73 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.546 -0.722 . . . . 0.0 110.422 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -135.53 132.16 36.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.407 -0.808 . . . . 0.0 109.181 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.28 -137.4 13.71 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 53.9 p -85.47 3.76 38.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.499 -1.0 . . . . 0.0 110.101 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -76.36 -34.23 58.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.101 -1.0 . . . . 0.0 109.211 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.611 HD21 HD21 ' A' ' 16' ' ' LEU . 3.5 tm? -66.53 -51.38 57.23 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.6 t -55.32 -48.31 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.587 -0.695 . . . . 0.0 110.17 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -60.55 -29.89 69.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.434 -0.791 . . . . 0.0 109.51 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.717 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -71.78 -32.08 67.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.518 -0.739 . . . . 0.0 109.453 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.699 ' CD2' HD22 ' A' ' 16' ' ' LEU . 41.4 mt -65.69 -41.27 92.58 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.47 -37.85 88.86 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.88 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 2.7 tp -64.71 -28.72 69.78 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.717 HG23 ' O ' ' B' ' 14' ' ' ALA . 42.0 t -73.22 -69.38 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 109.792 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -94.91 -76.37 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.478 -0.764 . . . . 0.0 109.288 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.87 -13.03 10.71 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.787 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -87.33 145.15 26.46 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.151 -1.205 . . . . 0.0 109.489 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -76.48 152.14 36.2 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.76 25.63 63.94 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.52 -28.11 4.15 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.582 ' CE1' HG22 ' B' ' 27' ' ' THR . 30.5 p90 -131.48 -173.94 3.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.621 -0.929 . . . . 0.0 109.569 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.413 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 9.5 t80 -61.73 108.61 1.03 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 109.491 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.582 HG22 ' CE1' ' B' ' 25' ' ' PHE . 45.6 p -123.48 87.98 51.82 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' PRO . . . . . 0.413 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 1.6 Cg_endo . . . . . 0 N--CA 1.483 0.906 0 C-N-CA 122.709 2.272 . . . . 0.0 110.217 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.508 HG22 HD22 ' B' ' 11' ' ' LEU . 30.0 t . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.02 42.16 1.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 109.677 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.14 -46.99 2.17 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.2 m -125.97 25.39 6.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.675 -0.641 . . . . 0.0 109.621 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.0 -58.55 6.37 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.39 -0.819 . . . . 0.0 109.472 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 t -72.08 -33.75 68.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.483 -0.761 . . . . 0.0 110.043 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -86.11 165.48 16.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.433 -0.792 . . . . 0.0 108.884 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.4 HG12 ' NE2' ' B' ' 5' ' ' HIS . 1.0 OUTLIER -110.99 69.81 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.286 -0.884 . . . . 0.0 109.043 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.7 m -64.98 178.74 0.78 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.53 -0.731 . . . . 0.0 109.753 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 50.1 m -72.9 115.0 11.67 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.918 HD11 HD21 ' B' ' 6' ' ' LEU . 0.3 OUTLIER -69.25 -8.18 43.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.667 -0.646 . . . . 0.0 110.975 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.445 ' CD1' ' HB3' ' A' ' 12' ' ' SER . 0.1 OUTLIER -67.28 -18.73 65.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.967 -1.083 . . . . 0.0 109.934 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.409 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 0.8 OUTLIER -69.35 -10.64 58.82 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.258 -0.901 . . . . 0.0 110.764 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.734 HD12 ' CD1' ' A' ' 13' ' ' LEU . 5.8 mt -65.47 -12.06 49.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.164 -0.96 . . . . 0.0 110.656 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -59.51 -19.53 48.8 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.105 -0.997 . . . . 0.0 110.196 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -97.13 29.61 3.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.288 -0.883 . . . . 0.0 109.775 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.454 ' CG ' HD23 ' A' ' 16' ' ' LEU . 9.0 m-85 -118.38 19.78 13.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.645 -0.659 . . . . 0.0 109.632 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.7 m -103.59 27.27 7.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.247 -0.908 . . . . 0.0 110.026 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.911 -1.042 . . . . 0.0 109.484 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.457 ' CB ' ' HB2' ' B' ' 14' ' ' ALA . 34.8 p90 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 120.613 0.244 . . . . 0.0 110.51 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 40.4 t -51.31 -38.86 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.005 -1.06 . . . . 0.0 110.55 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -134.03 30.01 3.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.439 -0.788 . . . . 0.0 109.668 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' B' ' 5' ' ' HIS . 18.6 mt-30 -117.66 -84.5 0.64 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.66 -0.65 . . . . 0.0 109.394 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.433 ' CG ' ' O ' ' B' ' 4' ' ' GLN . 0.6 OUTLIER -178.99 -172.53 0.25 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.449 -0.782 . . . . 0.0 109.059 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.918 HD21 HD11 ' A' ' 13' ' ' LEU . 40.3 mt -133.77 43.34 2.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.594 -0.691 . . . . 0.0 109.448 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 58.6 m -114.68 137.17 52.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.524 -0.735 . . . . 0.0 109.596 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.46 -140.58 23.75 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.3 -0.67 29.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.567 -0.961 . . . . 0.0 110.652 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -66.94 -31.18 71.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.013 -1.054 . . . . 0.0 109.271 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.508 HD22 HG22 ' A' ' 3' ' ' VAL . 63.4 tp -68.52 -57.43 5.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.576 -0.702 . . . . 0.0 109.182 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 24.7 t -51.65 -44.48 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.657 -0.652 . . . . 0.0 110.843 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -63.78 -34.45 77.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.449 -0.782 . . . . 0.0 109.646 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.457 ' HB2' ' CB ' ' B' ' 1' ' ' PHE . . . -68.9 -29.74 68.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.53 -0.731 . . . . 0.0 109.4 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.666 ' CD2' HD22 ' A' ' 16' ' ' LEU . 40.4 mt -70.71 -37.51 73.55 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -63.49 -41.62 98.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.66 -0.65 . . . . 0.0 109.505 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -63.31 -55.67 22.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.68 . . . . 0.0 109.603 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.642 HG21 ' HB3' ' A' ' 16' ' ' LEU . 43.6 t -55.59 -72.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.652 -0.655 . . . . 0.0 110.238 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.68 -74.28 0.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.835 . . . . 0.0 109.277 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.62 -16.11 61.87 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -60.42 160.95 7.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.171 -1.193 . . . . 0.0 109.841 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.53 108.65 17.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.642 -0.661 . . . . 0.0 109.512 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.2 40.19 61.62 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.1 -24.27 6.06 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -112.56 -175.63 2.72 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.437 -1.037 . . . . 0.0 109.964 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -52.02 138.84 24.17 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.481 -0.762 . . . . 0.0 110.138 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.11 93.15 31.16 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 N--CA 1.482 0.831 0 C-N-CA 122.264 1.976 . . . . 0.0 109.913 -179.798 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.726 HG13 HD22 ' B' ' 11' ' ' LEU . 40.2 t . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -61.09 -17.64 53.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.514 -0.741 . . . . 0.0 110.117 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -48.24 -60.57 2.54 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.233 -0.917 . . . . 0.0 111.294 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.929 ' CB ' HD23 ' B' ' 6' ' ' LEU . 4.1 m -111.56 7.48 20.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.393 -0.817 . . . . 0.0 110.477 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.663 ' SG ' HG12 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -71.61 -28.98 64.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.003 -1.061 . . . . 0.0 109.408 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 m -80.79 -52.96 6.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.474 -0.766 . . . . 0.0 109.802 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.18 -177.36 4.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.0 109.883 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.503 HG12 ' CD2' ' B' ' 5' ' ' HIS . 0.4 OUTLIER -84.78 136.46 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.4 p -122.58 -160.23 0.87 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.373 -0.829 . . . . 0.0 110.085 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.07 139.69 46.22 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.571 HD11 HG21 ' B' ' 18' ' ' VAL . 0.1 OUTLIER -66.05 -13.18 59.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.457 -0.777 . . . . 0.0 110.527 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -60.03 -20.22 56.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.846 -1.159 . . . . 0.0 109.979 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -88.8 -41.45 12.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.372 -0.83 . . . . 0.0 109.892 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.463 HD22 ' CD2' ' B' ' 15' ' ' LEU . 3.9 mt -66.15 -22.13 66.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.509 -0.744 . . . . 0.0 110.038 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.07 -19.18 41.81 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.189 -0.944 . . . . 0.0 110.378 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -94.98 29.66 2.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.242 -0.911 . . . . 0.0 109.688 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -106.62 10.72 31.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.481 -0.762 . . . . 0.0 109.922 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.9 m -95.21 36.15 1.25 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.176 -0.952 . . . . 0.0 109.823 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.6 -179.917 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.494 ' CB ' HD11 ' B' ' 6' ' ' LEU . 3.3 p90 . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 120.38 0.133 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.64 -35.08 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.792 -1.192 . . . . 0.0 108.496 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -150.35 22.35 0.83 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.473 ' O ' ' CG ' ' B' ' 5' ' ' HIS . 57.8 mt-30 -101.03 -94.54 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.902 ' O ' HD13 ' B' ' 6' ' ' LEU . 0.9 OUTLIER 178.12 168.27 0.77 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.267 -0.895 . . . . 0.0 109.029 178.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.929 HD23 ' CB ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -129.66 85.89 2.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.536 -0.728 . . . . 0.0 109.574 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.22 141.07 17.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.572 -0.705 . . . . 0.0 109.623 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.62 -106.01 2.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.6 p -109.25 -13.66 14.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.519 -0.989 . . . . 0.0 110.066 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -64.5 -34.24 77.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.111 -0.993 . . . . 0.0 109.34 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.726 HD22 HG13 ' A' ' 3' ' ' VAL . 58.4 tp -63.93 -54.83 28.48 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.402 HG23 ' H ' ' B' ' 12' ' ' VAL . 17.2 t -52.72 -50.16 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.607 -0.683 . . . . 0.0 110.745 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -30.66 68.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.476 -0.765 . . . . 0.0 109.801 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.814 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -73.27 -30.85 63.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.539 -0.726 . . . . 0.0 109.691 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.463 ' CD2' HD22 ' A' ' 16' ' ' LEU . 39.4 mt -69.37 -39.17 78.2 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.357 -0.839 . . . . 0.0 109.291 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -73.22 -29.62 62.93 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.682 -0.636 . . . . 0.0 109.99 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.3 -28.32 53.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.516 -0.74 . . . . 0.0 109.794 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.814 HG23 ' O ' ' B' ' 14' ' ' ALA . 41.3 t -79.46 -67.1 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.417 -0.802 . . . . 0.0 109.404 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -86.95 -60.05 2.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.586 -0.696 . . . . 0.0 109.352 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.72 30.21 40.38 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -86.36 160.52 19.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.646 -0.914 . . . . 0.0 109.079 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -83.59 82.3 8.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.568 -0.708 . . . . 0.0 109.116 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.52 53.27 3.28 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.81 27.78 5.35 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -165.03 -175.15 3.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.344 -1.092 . . . . 0.0 109.984 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -52.47 108.54 0.31 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.582 -0.698 . . . . 0.0 109.81 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.8 p -121.42 92.15 48.53 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.483 0.905 0 C-N-CA 122.611 2.207 . . . . 0.0 110.288 -179.679 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -59.39 -27.14 65.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.6 -0.688 . . . . 0.0 109.846 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -77.32 -31.13 54.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.421 -0.8 . . . . 0.0 109.336 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.6 m -108.65 30.65 6.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.483 -0.76 . . . . 0.0 109.877 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 46.0 t -114.27 -45.32 3.05 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.407 -0.808 . . . . 0.0 109.755 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 93.2 m -58.66 -82.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.414 -0.804 . . . . 0.0 110.289 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.7 m -84.87 -172.04 3.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.118 -0.989 . . . . 0.0 109.575 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.489 HD13 ' CE1' ' B' ' 5' ' ' HIS . 4.4 mm -84.35 101.36 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.55 -162.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.635 -0.665 . . . . 0.0 109.552 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.9 m -116.71 155.92 28.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.39 -0.818 . . . . 0.0 109.334 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.618 HD21 HG22 ' B' ' 18' ' ' VAL . 0.8 OUTLIER -66.88 -30.23 70.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.448 -0.782 . . . . 0.0 109.703 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -61.84 -27.74 68.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.529 -0.732 . . . . 0.0 109.684 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -67.99 -46.82 70.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.632 -0.667 . . . . 0.0 110.202 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.714 HD11 HD22 ' B' ' 6' ' ' LEU . 5.5 mt -66.38 -16.16 63.85 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.355 -0.841 . . . . 0.0 109.778 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.26 -19.02 42.4 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.226 -0.921 . . . . 0.0 110.101 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -94.31 29.98 2.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.189 -0.944 . . . . 0.0 109.909 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -115.01 9.31 16.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.445 -0.784 . . . . 0.0 110.359 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.0 m -108.15 34.45 3.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.04 -1.038 . . . . 0.0 109.153 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.232 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 8.8 p -46.56 -33.0 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.46 -0.775 . . . . 0.0 110.631 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -160.45 135.21 7.62 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.416 ' CB ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -99.33 43.53 1.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.131 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.489 ' CE1' HD13 ' A' ' 10' ' ' ILE . 3.0 m170 -106.8 129.76 54.61 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.714 HD22 HD11 ' A' ' 16' ' ' LEU . 3.3 mt -126.8 120.81 30.22 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.566 -0.709 . . . . 0.0 109.859 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.66 142.91 0.15 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.525 -0.734 . . . . 0.0 109.421 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.75 -111.24 4.02 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.64 -22.22 16.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.99 . . . . 0.0 109.529 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -58.11 -34.24 69.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.321 -0.862 . . . . 0.0 109.697 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' B' ' 6' ' ' LEU . 62.4 tp -63.67 -53.77 46.1 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -53.31 -55.47 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.564 -0.71 . . . . 0.0 110.657 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.4 -26.13 64.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.32 -0.863 . . . . 0.0 109.902 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.609 ' HB1' ' CD1' ' A' ' 16' ' ' LEU . . . -72.01 -34.94 69.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.479 -0.763 . . . . 0.0 109.524 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.665 HD23 HD22 ' A' ' 16' ' ' LEU . 24.8 mt -70.78 -34.91 72.29 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -73.02 -28.39 62.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.61 -0.682 . . . . 0.0 109.34 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -77.53 -29.89 52.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.681 . . . . 0.0 109.608 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.618 HG22 HD21 ' A' ' 13' ' ' LEU . 61.1 t -85.12 -72.03 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.526 -0.734 . . . . 0.0 109.432 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.16 -56.61 3.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.382 -0.824 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.49 28.15 55.95 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -83.66 150.06 26.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.454 -1.027 . . . . 0.0 109.326 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.425 ' NH1' ' HG3' ' B' ' 22' ' ' ARG . 1.3 mmm-85 -80.21 89.55 5.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.452 -0.78 . . . . 0.0 109.007 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.35 32.22 28.84 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.49 2.9 46.28 Favored Glycine 0 N--CA 1.492 2.396 0 O-C-N 121.512 -0.993 . . . . 0.0 110.985 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.649 ' HB2' HD13 ' B' ' 15' ' ' LEU . 5.1 p90 -143.7 -178.88 6.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.945 -1.326 . . . . 0.0 110.259 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.461 ' CE1' ' HD3' ' B' ' 28' ' ' PRO . 8.2 t80 -58.38 109.13 0.72 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.693 0.759 . . . . 0.0 110.429 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.84 91.43 6.64 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' PRO . . . . . 0.461 ' HD3' ' CE1' ' B' ' 26' ' ' TYR . 3.3 Cg_exo . . . . . 0 N--CA 1.49 1.267 0 C-N-CA 123.526 2.817 . . . . 0.0 111.433 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.615 HG22 HD22 ' B' ' 11' ' ' LEU . 26.3 t . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.211 0.529 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -74.83 -3.1 29.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.747 . . . . 0.0 111.026 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -90.59 -17.44 26.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.008 -1.058 . . . . 0.0 110.685 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.668 ' CB ' HD23 ' B' ' 6' ' ' LEU . 63.5 m -135.87 19.23 3.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.121 -0.987 . . . . 0.0 110.666 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.0 t -83.58 -32.31 25.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.216 -0.927 . . . . 0.0 109.508 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -73.35 -52.67 13.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.364 -0.835 . . . . 0.0 109.647 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.9 p -109.89 -169.38 1.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.629 -0.669 . . . . 0.0 109.721 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.651 HG23 ' O ' ' B' ' 4' ' ' GLN . 58.3 mt -110.0 99.95 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.696 -0.628 . . . . 0.0 109.766 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.1 m -61.95 -174.24 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.544 -0.723 . . . . 0.0 109.386 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.474 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -107.55 175.61 5.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.595 -0.691 . . . . 0.0 109.216 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -67.63 -12.13 59.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.728 -0.608 . . . . 0.0 110.792 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.474 ' CE2' ' HB2' ' A' ' 12' ' ' SER . 15.4 p90 -68.07 -22.34 64.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.127 -0.983 . . . . 0.0 110.412 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.06 -58.68 2.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.323 -0.861 . . . . 0.0 110.106 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.773 HD22 HD23 ' B' ' 15' ' ' LEU . 32.6 mt -64.31 -14.22 54.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.526 -0.734 . . . . 0.0 110.875 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -30.34 71.41 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.104 -0.997 . . . . 0.0 109.4 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -97.8 29.53 3.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.547 -0.721 . . . . 0.0 109.771 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -110.5 8.77 23.17 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.53 -0.731 . . . . 0.0 110.138 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.5 m -97.49 29.26 3.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.205 -0.934 . . . . 0.0 109.56 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.27 -179.958 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.587 ' CZ ' HD22 ' B' ' 17' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.422 HG22 ' CD2' ' B' ' 1' ' ' PHE . 17.3 m -88.98 -34.39 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.76 34.2 0.3 Allowed 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.651 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -123.69 155.85 37.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.779 -0.575 . . . . 0.0 109.826 -178.716 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.433 ' CE1' HG12 ' A' ' 10' ' ' ILE . 7.0 m80 -106.2 156.65 18.25 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 16' ' ' LEU . 2.0 mm? -109.12 101.14 10.22 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.248 -0.908 . . . . 0.0 109.997 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.61 120.61 0.05 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.82 -149.16 28.05 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.62 -15.72 63.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.539 -0.977 . . . . 0.0 110.047 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -60.86 -30.8 70.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.156 -0.965 . . . . 0.0 109.783 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.615 HD22 HG22 ' A' ' 3' ' ' VAL . 58.3 tp -70.89 -52.32 20.82 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.512 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 18.7 t -53.51 -49.43 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.506 -0.746 . . . . 0.0 110.401 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.02 -31.28 69.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.571 -0.705 . . . . 0.0 109.597 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.754 ' HB1' HD13 ' A' ' 16' ' ' LEU . . . -68.55 -34.16 75.35 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.773 HD23 HD22 ' A' ' 16' ' ' LEU . 23.9 mt -75.35 -25.51 57.82 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -74.34 -31.61 62.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 109.124 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.587 HD22 ' CZ ' ' B' ' 1' ' ' PHE . 0.2 OUTLIER -80.1 -33.99 38.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.639 -0.663 . . . . 0.0 109.538 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.576 HG23 ' O ' ' B' ' 14' ' ' ALA . 39.1 t -81.28 -69.27 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.654 -0.654 . . . . 0.0 109.784 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 55.7 m -57.94 -66.52 0.46 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.357 -0.839 . . . . 0.0 109.786 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.25 -38.3 3.22 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.6 -173.44 1.16 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.51 -0.994 . . . . 0.0 109.486 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.86 -64.71 1.02 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.557 -0.714 . . . . 0.0 109.703 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.86 41.79 2.29 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.01 35.04 5.18 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -176.11 -172.02 0.47 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.57 -0.959 . . . . 0.0 109.738 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -52.04 110.51 0.49 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.378 -0.827 . . . . 0.0 109.909 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.12 94.16 41.05 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.602 -0.686 . . . . 0.0 109.672 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.484 0.933 0 C-N-CA 122.476 2.117 . . . . 0.0 110.05 179.854 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.475 HG22 HD22 ' B' ' 11' ' ' LEU . 42.9 t . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.65 -22.19 61.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.684 -0.635 . . . . 0.0 110.262 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -63.55 -42.48 98.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.463 -0.773 . . . . 0.0 110.372 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.476 ' HB2' HD23 ' B' ' 6' ' ' LEU . 57.6 m -119.76 27.44 8.72 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.59 -43.62 15.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.75 . . . . 0.0 109.437 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 t -84.76 -27.85 26.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.604 -0.685 . . . . 0.0 109.965 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -116.99 168.47 10.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.473 -0.767 . . . . 0.0 109.362 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.457 HG12 ' CE1' ' B' ' 5' ' ' HIS . 10.7 mt -107.66 90.02 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.502 -0.749 . . . . 0.0 109.162 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.5 m -60.19 -169.44 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.367 -0.833 . . . . 0.0 109.602 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.468 ' CB ' ' CE2' ' A' ' 14' ' ' TYR . 48.7 m -94.21 160.4 14.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.612 -0.68 . . . . 0.0 109.249 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 13' ' ' LEU . 3.4 tm? -71.59 -26.6 62.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.627 -0.671 . . . . 0.0 109.904 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.468 ' CE2' ' CB ' ' A' ' 12' ' ' SER . 12.5 p90 -64.88 -18.16 64.94 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.495 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -78.77 -44.58 22.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.298 -0.876 . . . . 0.0 109.061 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.58 HD22 ' CD2' ' B' ' 15' ' ' LEU . 1.5 mt -64.88 -19.69 66.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.584 -0.697 . . . . 0.0 109.643 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -55.8 -21.28 18.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 0.0 110.563 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -94.49 32.78 1.51 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.284 -0.885 . . . . 0.0 109.644 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.462 ' CG ' HD23 ' A' ' 16' ' ' LEU . 8.3 m-85 -114.91 11.5 16.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.429 -0.795 . . . . 0.0 110.08 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' B' ' 25' ' ' PHE . 84.5 m -97.15 28.78 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.169 -0.957 . . . . 0.0 109.536 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 m120 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.548 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.808 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.711 HG12 ' CD1' ' B' ' 1' ' ' PHE . 7.5 p -161.68 -43.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 109.062 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.445 ' N ' HG13 ' B' ' 2' ' ' VAL . 17.4 m120 -156.98 29.16 0.31 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 109.159 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -143.42 131.8 22.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.534 -0.729 . . . . 0.0 109.568 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.457 ' CE1' HG12 ' A' ' 10' ' ' ILE . 79.3 m80 -81.51 164.04 22.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.649 -0.657 . . . . 0.0 109.476 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.701 HD22 ' N ' ' B' ' 6' ' ' LEU . 1.5 mm? -109.56 82.09 1.54 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.527 -0.733 . . . . 0.0 109.404 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 74.3 m -130.91 121.52 25.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.506 -0.746 . . . . 0.0 109.828 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.71 -128.32 8.4 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 93.4 p -84.43 -9.72 58.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.689 -0.889 . . . . 0.0 110.396 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -61.32 -27.89 68.81 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.011 -1.055 . . . . 0.0 109.348 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' B' ' 6' ' ' LEU . 56.3 tp -70.47 -61.97 1.57 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.466 -0.771 . . . . 0.0 108.94 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.402 ' H ' HG23 ' B' ' 12' ' ' VAL . 36.0 t -47.21 -49.74 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.724 -0.61 . . . . 0.0 111.454 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -56.53 -39.14 72.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.372 -0.83 . . . . 0.0 110.441 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.83 -28.88 64.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.441 -0.787 . . . . 0.0 109.886 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.58 ' CD2' HD22 ' A' ' 16' ' ' LEU . 50.8 mt -65.55 -38.5 89.77 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -66.01 -34.19 77.52 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.808 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 2.2 tp -61.39 -34.02 74.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.685 -0.634 . . . . 0.0 109.354 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.523 ' CG2' HD21 ' A' ' 13' ' ' LEU . 45.2 t -87.78 -75.19 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.527 -0.733 . . . . 0.0 109.951 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -75.74 -76.36 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.254 -0.904 . . . . 0.0 109.064 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.07 17.66 26.81 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.81 160.21 16.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.348 -1.089 . . . . 0.0 108.9 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -39.83 61.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.449 -0.782 . . . . 0.0 109.493 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.23 61.85 0.62 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.7 -41.0 0.36 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 21.3 p90 -102.87 -175.83 2.92 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.57 -0.959 . . . . 0.0 110.23 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -58.21 127.4 31.9 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.57 0.7 . . . . 0.0 110.326 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.73 94.77 31.02 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.483 0.857 0 C-N-CA 122.33 2.02 . . . . 0.0 110.244 -179.821 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 3' ' ' VAL . 23.8 t . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 120.38 0.133 . . . . 0.0 110.772 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -96.9 27.06 4.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.973 -1.079 . . . . 0.0 109.775 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.28 -30.66 7.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.0 9.36 6.3 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.548 -0.72 . . . . 0.0 110.505 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 46.6 t -82.01 84.82 6.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.087 -1.008 . . . . 0.0 108.964 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.7 m -160.95 -42.92 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.488 -0.758 . . . . 0.0 109.944 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.464 ' HA ' ' CE1' ' B' ' 5' ' ' HIS . 11.6 t -154.06 -125.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.731 . . . . 0.0 109.368 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.624 HD13 ' N ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -101.61 105.63 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.582 -1.324 . . . . 0.0 108.686 -179.193 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -82.13 155.72 24.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.673 -0.642 . . . . 0.0 109.512 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.2 p -95.65 151.78 19.04 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.853 HD13 ' O ' ' A' ' 13' ' ' LEU . 1.3 tm? -66.49 -26.72 67.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.647 -0.658 . . . . 0.0 109.437 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -51.94 -24.82 6.98 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.148 -0.97 . . . . 0.0 110.603 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -87.89 -44.23 11.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.348 -0.845 . . . . 0.0 109.966 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.717 HD11 HD21 ' B' ' 6' ' ' LEU . 4.2 mt -65.01 -16.21 63.18 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.436 -0.79 . . . . 0.0 110.5 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.15 -23.56 35.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.177 -0.952 . . . . 0.0 110.307 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -96.64 37.92 1.25 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.479 -0.763 . . . . 0.0 109.802 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.603 ' CG ' HD23 ' A' ' 16' ' ' LEU . 7.2 m-85 -115.99 -0.91 12.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.484 -0.76 . . . . 0.0 110.554 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.5 m -88.62 11.12 18.23 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.082 -1.011 . . . . 0.0 110.57 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.9 p30 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.098 -1.001 . . . . 0.0 109.581 179.879 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.631 ' CE1' HD23 ' A' ' 13' ' ' LEU . 9.1 p90 . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 120.473 0.178 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 35.1 m -63.09 -29.67 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.167 -0.958 . . . . 0.0 109.254 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -142.97 30.09 1.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -130.52 -179.21 5.14 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.464 ' CE1' ' HA ' ' A' ' 9' ' ' SER . 12.3 m-70 -109.15 149.55 29.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.338 -0.851 . . . . 0.0 109.524 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.717 HD21 HD11 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -93.28 100.01 12.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.563 -0.71 . . . . 0.0 110.123 -179.058 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.67 142.58 0.14 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.586 -0.696 . . . . 0.0 109.236 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.23 -115.33 4.08 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.38 -19.62 18.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.674 -0.898 . . . . 0.0 109.956 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -56.68 -28.18 60.27 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.012 -1.055 . . . . 0.0 109.445 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.524 HD22 ' HG ' ' B' ' 6' ' ' LEU . 0.6 OUTLIER -64.73 -60.03 3.56 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 25.2 t -52.62 -47.32 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.835 -0.541 . . . . 0.0 111.577 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -58.93 -30.77 68.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.292 -0.88 . . . . 0.0 110.353 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.805 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -77.92 -27.39 49.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.506 -0.747 . . . . 0.0 109.796 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.586 HD23 HD22 ' A' ' 16' ' ' LEU . 45.3 mt -70.49 -37.89 74.27 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.294 -0.879 . . . . 0.0 108.941 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -76.11 -34.55 59.48 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -30.01 69.71 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.805 HG23 ' O ' ' B' ' 14' ' ' ALA . 33.0 t -86.82 -69.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.531 -0.73 . . . . 0.0 109.479 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 11.6 m -88.68 -70.16 0.66 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.557 -0.714 . . . . 0.0 109.335 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.44 36.97 22.14 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -86.51 177.29 7.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.53 -0.982 . . . . 0.0 109.119 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -82.74 80.27 8.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.524 -0.735 . . . . 0.0 109.204 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.81 63.27 2.91 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.83 22.13 5.8 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -151.1 -173.19 4.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.263 -1.139 . . . . 0.0 109.573 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.404 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 3.6 t80 -49.95 101.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.54 -0.725 . . . . 0.0 110.085 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.42 90.91 36.32 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' PRO . . . . . 0.404 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 4.9 Cg_exo . . . . . 0 N--CA 1.482 0.816 0 C-N-CA 122.625 2.217 . . . . 0.0 110.094 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -70.17 -10.08 57.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.622 -0.674 . . . . 0.0 110.037 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.52 -65.7 0.51 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.074 -1.016 . . . . 0.0 110.004 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.0 m -129.68 36.83 4.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.478 -0.764 . . . . 0.0 110.336 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.0 t -54.17 -55.46 27.65 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.187 -0.946 . . . . 0.0 109.335 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -92.64 49.74 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.528 -0.733 . . . . 0.0 109.454 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -176.56 163.2 2.37 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.44 HG12 ' CE1' ' B' ' 5' ' ' HIS . 16.8 mt -103.69 86.81 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.426 -0.797 . . . . 0.0 109.166 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -178.83 0.1 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.765 -0.584 . . . . 0.0 110.079 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -91.71 166.12 12.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.708 -0.62 . . . . 0.0 109.623 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.737 HD13 ' O ' ' A' ' 13' ' ' LEU . 3.5 tm? -66.51 -32.11 73.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.669 -0.644 . . . . 0.0 109.679 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -27.14 63.99 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.335 -0.853 . . . . 0.0 109.694 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -67.39 -50.12 60.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.459 -0.776 . . . . 0.0 109.508 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.864 HD11 HD22 ' B' ' 6' ' ' LEU . 10.2 mt -65.43 -16.65 63.85 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.431 -0.793 . . . . 0.0 110.25 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.91 -19.41 42.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.249 -0.907 . . . . 0.0 110.354 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -96.27 30.63 2.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.264 -0.898 . . . . 0.0 109.801 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.486 ' HB3' HD22 ' B' ' 15' ' ' LEU . 6.4 m-85 -114.69 -14.91 11.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.6 -0.687 . . . . 0.0 110.026 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.9 m -73.56 -20.15 60.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.136 -0.978 . . . . 0.0 110.22 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.7 p30 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.415 179.78 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.919 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.574 HG23 ' CD1' ' B' ' 1' ' ' PHE . 18.4 t -83.48 -69.59 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.595 -1.316 . . . . 0.0 109.081 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.508 ' OD1' HG12 ' B' ' 2' ' ' VAL . 34.4 m120 -154.35 24.63 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.532 -0.73 . . . . 0.0 109.935 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -115.47 142.11 47.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.448 -0.782 . . . . 0.0 109.328 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.44 ' CE1' HG12 ' A' ' 10' ' ' ILE . 49.8 m80 -70.51 -178.47 1.78 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.63 -0.669 . . . . 0.0 109.866 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.864 HD22 HD11 ' A' ' 16' ' ' LEU . 38.0 mt -130.63 42.18 3.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.501 -0.749 . . . . 0.0 110.854 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.67 140.78 52.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.212 -0.93 . . . . 0.0 109.281 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.66 -144.61 21.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.3 -14.67 60.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.456 -1.026 . . . . 0.0 109.893 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -60.43 -37.86 82.26 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.082 -1.011 . . . . 0.0 109.126 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.457 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 2.5 tt -61.65 -58.5 7.81 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.806 -0.559 . . . . 0.0 109.696 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 t -49.56 -51.06 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.625 -0.672 . . . . 0.0 111.22 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -58.61 -33.65 70.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.368 -0.832 . . . . 0.0 110.092 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.447 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -70.45 -30.56 67.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.548 -0.72 . . . . 0.0 109.7 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.751 ' CD2' HD22 ' A' ' 16' ' ' LEU . 30.2 mt -69.25 -36.52 77.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.75 -29.94 66.31 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.919 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 1.5 tp -68.66 -35.47 77.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.602 -0.686 . . . . 0.0 109.436 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 14' ' ' ALA . 39.7 t -80.84 -69.81 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.543 -0.723 . . . . 0.0 109.726 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.56 -81.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.472 -0.768 . . . . 0.0 109.416 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 139.19 -52.05 0.73 Allowed Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.671 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -90.34 152.02 21.2 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.34 -1.094 . . . . 0.0 110.062 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 19.3 mtt180 -76.03 139.03 41.25 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.22 17.62 57.11 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.6 33.56 5.18 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.456 ' CD1' ' CB ' ' B' ' 15' ' ' LEU . 27.0 p90 -176.83 -169.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.717 -0.872 . . . . 0.0 109.016 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -51.52 99.93 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.294 -0.879 . . . . 0.0 109.82 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 19.5 p -132.61 89.88 34.55 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo . . . . . 0 C--N 1.322 -0.866 0 C-N-CA 122.394 2.062 . . . . 0.0 110.159 -179.78 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.504 HG23 ' OH ' ' A' ' 19' ' ' TYR . 23.6 t . . . . . 0 N--CA 1.494 1.738 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.25 -21.26 63.73 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.442 -0.786 . . . . 0.0 110.04 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -111.79 -3.52 14.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.383 -0.823 . . . . 0.0 110.951 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.4 m -121.26 18.78 11.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.983 -1.073 . . . . 0.0 110.529 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.02 21.68 13.57 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.164 -0.96 . . . . 0.0 109.828 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.6 m -129.73 -66.22 0.8 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 108.83 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.99 -164.88 1.21 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.585 HD13 ' NE2' ' B' ' 5' ' ' HIS . 4.5 mm -90.82 98.55 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.4 -0.813 . . . . 0.0 108.941 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -70.69 -167.76 0.21 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.671 -0.643 . . . . 0.0 109.747 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.02 156.12 44.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.509 -0.744 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.863 HD13 ' O ' ' A' ' 13' ' ' LEU . 3.2 tm? -66.78 -26.32 66.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.619 -0.676 . . . . 0.0 110.521 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.89 -22.32 14.41 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.073 -1.017 . . . . 0.0 110.561 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -86.39 -39.94 15.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.419 -0.801 . . . . 0.0 109.437 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.665 HD11 HD11 ' B' ' 6' ' ' LEU . 6.5 mt -68.64 -10.78 58.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.489 -0.757 . . . . 0.0 110.258 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -67.51 -28.43 67.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 109.412 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -71.01 -12.16 61.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.553 -0.717 . . . . 0.0 110.622 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.504 ' OH ' HG23 ' A' ' 3' ' ' VAL . 5.3 m-85 -74.59 -7.8 54.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.32 -0.862 . . . . 0.0 110.47 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 27.9 m -97.64 33.44 2.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.132 -0.98 . . . . 0.0 109.596 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.533 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.7 ' CD1' HD23 ' A' ' 13' ' ' LEU . 8.5 p90 . . . . . 0 N--CA 1.5 2.036 0 CA-C-O 120.464 0.173 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.94 -33.16 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.056 -1.027 . . . . 0.0 108.734 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -144.27 30.04 1.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -126.65 -159.5 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.585 ' NE2' HD13 ' A' ' 10' ' ' ILE . 20.3 m80 -115.97 -172.82 2.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.349 -0.844 . . . . 0.0 109.829 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.665 HD11 HD11 ' A' ' 16' ' ' LEU . 4.4 tp -130.45 43.57 3.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.572 -0.705 . . . . 0.0 110.178 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 59.5 m -122.86 136.29 54.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.509 -0.744 . . . . 0.0 109.464 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.94 -132.94 11.43 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -81.53 2.86 27.11 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.646 -0.914 . . . . 0.0 110.33 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -77.13 -37.18 54.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.053 -1.03 . . . . 0.0 108.733 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 36.9 tp -68.17 -63.69 1.01 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -52.54 -49.77 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.658 -0.651 . . . . 0.0 110.641 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -59.54 -30.79 68.86 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.329 -0.857 . . . . 0.0 109.658 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.42 -32.13 68.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.636 -0.665 . . . . 0.0 109.764 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.65 ' CD2' HD22 ' A' ' 16' ' ' LEU . 38.2 mt -68.92 -39.66 79.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.471 -0.768 . . . . 0.0 109.162 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -67.49 -34.0 76.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.692 . . . . 0.0 109.522 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.33 -46.21 74.13 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.553 -0.717 . . . . 0.0 109.677 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.629 ' CG2' HD21 ' A' ' 13' ' ' LEU . 44.3 t -67.42 -69.81 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.506 -0.746 . . . . 0.0 109.355 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.88 -79.46 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.483 -0.76 . . . . 0.0 108.992 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.44 -28.02 14.92 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.93 170.12 4.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.423 -1.045 . . . . 0.0 109.764 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.74 138.87 31.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.546 -0.721 . . . . 0.0 109.395 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.56 29.6 69.97 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.78 27.7 10.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.473 ' HB2' HD13 ' B' ' 15' ' ' LEU . 12.5 p90 -177.72 -177.32 0.65 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -1.073 . . . . 0.0 110.177 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -57.49 125.97 25.24 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.6 -0.687 . . . . 0.0 109.893 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 8.8 p -117.63 96.36 49.28 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.574 -0.703 . . . . 0.0 109.257 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo . . . . . 0 N--CA 1.483 0.878 0 C-N-CA 122.487 2.124 . . . . 0.0 110.169 -179.755 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.412 HG12 ' SG ' ' A' ' 7' ' ' CYS . 31.4 t . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -60.28 -18.51 49.68 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.58 -0.7 . . . . 0.0 110.082 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -52.64 -59.32 4.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.249 -0.907 . . . . 0.0 110.309 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -124.23 36.02 4.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.524 -0.735 . . . . 0.0 109.515 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' B' ' 6' ' ' LEU . 0.1 OUTLIER -62.59 -43.16 99.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.625 -0.672 . . . . 0.0 109.555 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 m -87.41 -33.67 19.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.534 -0.729 . . . . 0.0 109.75 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -94.45 -177.63 4.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.457 -0.777 . . . . 0.0 109.449 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.593 ' CG1' ' CE1' ' B' ' 5' ' ' HIS . 19.5 mt -114.73 99.95 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.377 -0.827 . . . . 0.0 109.409 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.33 -177.87 6.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.567 -0.708 . . . . 0.0 109.304 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.12 153.95 19.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.507 -0.746 . . . . 0.0 109.424 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.685 HD11 HG22 ' B' ' 18' ' ' VAL . 59.5 tp -57.86 -20.32 35.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.597 -0.689 . . . . 0.0 110.826 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -53.24 -28.19 26.05 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.22 -0.925 . . . . 0.0 111.697 -178.424 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.443 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 14.3 pt20 -80.06 -44.37 20.18 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.104 -0.997 . . . . 0.0 109.66 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.641 HD22 HD23 ' B' ' 15' ' ' LEU . 9.9 mt -67.0 -16.43 64.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.51 -0.744 . . . . 0.0 109.649 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.62 -17.92 50.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.173 -0.954 . . . . 0.0 109.84 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -93.27 27.28 2.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 0.0 109.869 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.493 ' CD2' HD22 ' B' ' 15' ' ' LEU . 6.3 m-85 -107.16 -20.59 13.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.365 -0.834 . . . . 0.0 109.966 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.3 m -75.88 -4.2 39.51 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.275 -0.89 . . . . 0.0 110.287 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p30 . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.004 -1.06 . . . . 0.0 109.548 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.859 ' CZ ' HD22 ' B' ' 17' ' ' LEU . 3.3 t80 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.532 HG12 ' OD1' ' B' ' 3' ' ' ASN . 9.0 t -46.35 -64.65 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 O-C-N 121.65 -0.656 . . . . 0.0 110.52 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.532 ' OD1' HG12 ' B' ' 2' ' ' VAL . 0.9 OUTLIER -174.4 36.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -122.26 148.81 44.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.609 -0.682 . . . . 0.0 109.258 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.593 ' CE1' ' CG1' ' A' ' 10' ' ' ILE . 46.6 m-70 -78.38 -178.31 5.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.642 -0.661 . . . . 0.0 109.576 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -142.42 131.96 23.83 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.481 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.95 -76.71 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.146 -0.971 . . . . 0.0 109.595 178.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.08 -121.59 0.06 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 22.3 p -73.58 -8.54 56.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.47 -1.018 . . . . 0.0 109.445 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -61.28 -41.82 97.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.877 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.473 ' CD1' HD21 ' A' ' 16' ' ' LEU . 67.2 tp -60.46 -56.29 23.14 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.485 -0.76 . . . . 0.0 109.682 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.4 t -49.76 -53.77 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.567 -0.708 . . . . 0.0 111.081 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -58.07 -31.93 67.55 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.437 -0.789 . . . . 0.0 110.188 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.424 ' HA ' ' CE1' ' B' ' 1' ' ' PHE . . . -69.13 -34.11 74.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.482 -0.762 . . . . 0.0 109.654 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.641 HD23 HD22 ' A' ' 16' ' ' LEU . 25.8 mt -70.81 -32.94 70.19 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -68.29 -33.72 74.87 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.859 HD22 ' CZ ' ' B' ' 1' ' ' PHE . 0.5 OUTLIER -69.14 -39.22 78.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.689 -0.632 . . . . 0.0 109.745 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.685 HG22 HD11 ' A' ' 13' ' ' LEU . 30.8 t -72.84 -68.2 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.57 -0.706 . . . . 0.0 110.135 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 10.6 m -65.15 -69.19 0.31 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.417 -0.802 . . . . 0.0 109.195 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.0 -36.52 3.52 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.28 167.43 12.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.338 -1.095 . . . . 0.0 109.928 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.56 -63.56 1.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.81 86.26 0.97 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -161.5 -41.38 0.02 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.531 ' O ' HG23 ' B' ' 27' ' ' THR . 28.0 p90 -116.43 -174.49 2.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.409 -1.053 . . . . 0.0 110.446 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.412 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 2.9 t80 -54.5 100.0 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.531 HG23 ' O ' ' B' ' 25' ' ' PHE . 40.4 p -113.1 92.46 21.74 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.653 -0.654 . . . . 0.0 109.57 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' PRO . . . . . 0.412 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 2.4 Cg_endo . . . . . 0 C--N 1.323 -0.808 0 C-N-CA 122.422 2.081 . . . . 0.0 109.776 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.808 HG22 ' CD2' ' B' ' 11' ' ' LEU . 19.0 t . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -74.81 -5.55 44.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.557 -0.715 . . . . 0.0 110.195 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -58.24 -63.21 1.35 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.196 -0.94 . . . . 0.0 110.013 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.553 ' SG ' HD12 ' B' ' 6' ' ' LEU . 4.5 p -120.48 27.32 8.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.477 -0.764 . . . . 0.0 110.279 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -32.09 54.36 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.217 -0.927 . . . . 0.0 109.389 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -113.42 -32.73 6.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.676 -0.64 . . . . 0.0 109.325 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.431 ' O ' ' CD2' ' B' ' 5' ' ' HIS . 0.4 OUTLIER -98.85 -171.41 2.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.449 -0.782 . . . . 0.0 108.926 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.482 HD13 ' NE2' ' B' ' 5' ' ' HIS . 1.7 mm -104.21 160.64 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.361 -0.837 . . . . 0.0 109.008 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.406 ' SG ' HD12 ' B' ' 6' ' ' LEU . 4.0 p -147.27 179.56 7.56 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.507 -0.746 . . . . 0.0 109.806 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.467 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -82.8 102.06 11.34 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.87 HD11 HD21 ' B' ' 6' ' ' LEU . 3.1 mm? -70.27 -14.61 62.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.545 -0.722 . . . . 0.0 110.859 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' A' ' 12' ' ' SER . 17.3 p90 -71.25 -18.92 62.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.088 -1.008 . . . . 0.0 109.779 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -84.18 -3.24 58.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.359 -0.838 . . . . 0.0 110.416 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.745 HD12 ' CD1' ' A' ' 13' ' ' LEU . 4.4 mt -65.7 -14.15 60.7 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.134 -0.979 . . . . 0.0 109.99 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -59.06 -19.65 46.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.164 -0.96 . . . . 0.0 110.002 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -96.89 31.95 2.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.296 -0.878 . . . . 0.0 109.438 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.598 ' CG ' HD23 ' A' ' 16' ' ' LEU . 6.4 m-85 -115.19 12.97 16.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.435 -0.79 . . . . 0.0 109.95 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.81 -56.11 5.12 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.231 -0.918 . . . . 0.0 109.571 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.297 -1.713 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.326 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.427 ' HE2' HD22 ' B' ' 17' ' ' LEU . 13.3 p90 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 120.613 0.244 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 24.5 t -51.89 -25.72 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 120.962 -1.087 . . . . 0.0 110.469 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -151.57 27.14 0.66 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 109.303 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' B' ' 5' ' ' HIS . 5.8 mp0 -107.24 -97.21 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.441 -0.787 . . . . 0.0 109.329 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.482 ' NE2' HD13 ' A' ' 10' ' ' ILE . 1.1 m80 -173.1 152.58 2.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.833 -1.167 . . . . 0.0 109.86 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.87 HD21 HD11 ' A' ' 13' ' ' LEU . 21.9 mt -115.11 86.15 2.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.635 -0.666 . . . . 0.0 109.511 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -150.2 129.95 13.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.48 -0.762 . . . . 0.0 109.481 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.29 -136.48 14.46 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.42 -6.81 57.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.494 -1.003 . . . . 0.0 110.364 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -66.57 -29.68 69.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 109.691 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.808 ' CD2' HG22 ' A' ' 3' ' ' VAL . 60.7 tp -71.25 -46.28 61.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.486 -0.759 . . . . 0.0 109.544 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.411 HG13 ' O ' ' B' ' 26' ' ' TYR . 39.3 t -60.66 -43.79 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.672 -0.643 . . . . 0.0 109.952 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.77 -39.51 94.41 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.435 -0.791 . . . . 0.0 109.302 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.768 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -66.32 -30.39 70.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.607 -0.683 . . . . 0.0 109.769 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.691 HD22 HD22 ' A' ' 16' ' ' LEU . 1.2 mt -70.4 -36.18 73.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.507 -0.745 . . . . 0.0 109.416 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -70.3 -32.55 70.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.581 -0.699 . . . . 0.0 109.607 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.427 HD22 ' HE2' ' B' ' 1' ' ' PHE . 0.3 OUTLIER -79.82 -24.67 41.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.477 -0.764 . . . . 0.0 110.086 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.768 HG23 ' O ' ' B' ' 14' ' ' ALA . 41.9 t -89.48 -68.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.246 -0.909 . . . . 0.0 109.801 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 m -53.71 -78.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.39 -0.819 . . . . 0.0 110.269 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.33 -40.42 1.56 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.84 176.02 1.03 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.287 -1.125 . . . . 0.0 109.593 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.42 -44.35 6.55 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.53 ' HA2' HG21 ' B' ' 27' ' ' THR . . . -118.75 42.97 1.68 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.28 38.16 3.21 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.477 ' CD1' ' HB2' ' B' ' 15' ' ' LEU . 52.5 p90 -178.4 -166.71 0.11 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.397 -1.061 . . . . 0.0 109.522 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.519 ' CB ' HD12 ' B' ' 15' ' ' LEU . 0.4 OUTLIER -47.29 94.38 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.868 -0.52 . . . . 0.0 110.188 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.53 HG21 ' HA2' ' B' ' 23' ' ' GLY . 0.8 OUTLIER -127.33 98.86 28.58 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.484 0.956 0 C-N-CA 122.3 2.0 . . . . 0.0 110.047 -179.62 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -90.52 53.58 2.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.233 -0.917 . . . . 0.0 109.044 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -142.22 -46.32 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.539 -0.726 . . . . 0.0 109.368 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.592 ' CB ' HD23 ' B' ' 6' ' ' LEU . 8.0 m -115.6 15.87 16.55 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.539 -0.726 . . . . 0.0 109.952 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 45.3 t -72.93 -35.77 67.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.09 -1.006 . . . . 0.0 109.314 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 m -73.22 -58.14 3.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.487 -0.758 . . . . 0.0 109.797 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.4 p -119.62 -167.86 1.49 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.502 -0.749 . . . . 0.0 109.815 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.423 HG12 ' CE1' ' B' ' 5' ' ' HIS . 7.4 mt -101.82 130.16 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.0 p -106.23 -172.9 2.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.31 -0.869 . . . . 0.0 110.429 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.57 144.8 55.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.573 -0.705 . . . . 0.0 110.787 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.825 HD13 ' O ' ' A' ' 13' ' ' LEU . 3.4 tm? -69.15 -30.25 68.44 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -22.29 22.09 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.489 -0.757 . . . . 0.0 109.94 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -72.45 -46.74 53.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.36 -0.838 . . . . 0.0 109.487 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.701 HD11 ' HG ' ' B' ' 6' ' ' LEU . 5.4 mt -65.4 -21.62 66.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.516 -0.74 . . . . 0.0 110.093 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.77 -26.92 58.69 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.226 -0.921 . . . . 0.0 110.308 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -97.74 35.88 1.61 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.377 -0.827 . . . . 0.0 109.672 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.453 ' HB3' HD22 ' B' ' 15' ' ' LEU . 7.1 m-85 -113.8 -0.98 14.04 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.501 -0.75 . . . . 0.0 110.383 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.2 m -81.15 1.77 30.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.145 -0.972 . . . . 0.0 110.469 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 120.999 -1.063 . . . . 0.0 109.571 -179.817 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.445 ' CD2' HD23 ' A' ' 13' ' ' LEU . 1.2 t80 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 28.8 m -50.49 172.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.444 -0.785 . . . . 0.0 110.703 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -58.59 92.54 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.464 -0.772 . . . . 0.0 109.901 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -130.4 104.99 7.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.556 -0.715 . . . . 0.0 109.385 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.423 ' CE1' HG12 ' A' ' 10' ' ' ILE . 70.9 m80 -74.4 135.07 42.39 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.835 ' HB3' HD13 ' B' ' 11' ' ' LEU . 0.2 OUTLIER -86.95 98.25 11.14 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.483 -0.761 . . . . 0.0 109.734 -179.274 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -178.46 127.36 0.11 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.694 . . . . 0.0 109.422 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.83 -141.17 26.95 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p -69.23 -16.66 63.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.561 -0.964 . . . . 0.0 110.169 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -67.81 -38.76 83.68 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.176 -0.953 . . . . 0.0 109.575 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.835 HD13 ' HB3' ' B' ' 6' ' ' LEU . 66.7 tp -68.69 -46.19 69.68 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.654 -0.654 . . . . 0.0 109.379 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.411 HG23 ' H ' ' B' ' 12' ' ' VAL . 8.7 t -55.97 -49.9 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.428 -0.795 . . . . 0.0 110.073 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -62.31 -26.33 68.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.556 -0.715 . . . . 0.0 109.578 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.745 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -71.85 -32.26 67.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.641 -0.662 . . . . 0.0 109.293 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.578 HD23 HD22 ' A' ' 16' ' ' LEU . 24.0 mt -79.33 -26.58 42.13 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.48 -29.79 61.58 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -83.35 -32.31 26.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.494 -0.754 . . . . 0.0 109.477 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.745 HG23 ' O ' ' B' ' 14' ' ' ALA . 45.3 t -81.28 -68.88 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.528 -0.732 . . . . 0.0 109.506 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 60.5 m -54.33 -73.29 0.05 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.496 -0.753 . . . . 0.0 110.428 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.76 -45.88 1.1 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 174.12 8.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.377 -1.072 . . . . 0.0 109.688 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.67 31.44 5.46 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.18 37.15 0.09 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.91 46.75 1.06 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.459 ' CG ' ' HB3' ' B' ' 15' ' ' LEU . 14.5 p90 -179.33 -173.62 0.28 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.465 -1.021 . . . . 0.0 109.877 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.4 ' HB3' ' CD1' ' B' ' 15' ' ' LEU . 4.8 t80 -54.46 108.36 0.37 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.509 -0.744 . . . . 0.0 109.482 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.78 93.32 46.09 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.715 -0.615 . . . . 0.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.484 0.952 0 C-N-CA 122.529 2.153 . . . . 0.0 109.979 -179.91 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.889 ' CG2' HD22 ' B' ' 11' ' ' LEU . 3.7 t . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.074 0.464 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.37 -8.87 54.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.431 -0.793 . . . . 0.0 110.866 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.69 -14.56 8.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.154 -0.966 . . . . 0.0 110.883 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.483 ' HB2' HD12 ' B' ' 6' ' ' LEU . 11.9 m -120.19 24.44 10.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.027 -1.046 . . . . 0.0 110.12 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -84.84 -42.9 14.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.348 -0.845 . . . . 0.0 109.301 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.9 m -78.91 -48.13 15.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.548 -0.72 . . . . 0.0 109.654 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -110.0 -177.91 3.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.689 . . . . 0.0 109.543 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.44 HG12 ' CE1' ' B' ' 5' ' ' HIS . 32.0 mt -106.25 135.23 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.7 m -94.99 -174.69 3.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.726 . . . . 0.0 110.129 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.8 m -91.84 166.36 12.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.661 -0.649 . . . . 0.0 109.962 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.474 HD11 HG13 ' B' ' 18' ' ' VAL . 45.5 tp -67.47 -24.81 65.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.673 -0.642 . . . . 0.0 110.174 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -58.67 -19.35 38.67 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.456 -0.778 . . . . 0.0 110.954 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -77.64 -69.35 0.55 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.084 -1.01 . . . . 0.0 110.375 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.677 HD22 ' CD2' ' B' ' 15' ' ' LEU . 24.4 mt -60.16 -17.66 42.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.405 -0.809 . . . . 0.0 109.992 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -64.75 -44.09 91.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 108.577 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -71.52 -9.99 59.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.649 -0.657 . . . . 0.0 109.737 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -89.29 22.56 2.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.4 -0.812 . . . . 0.0 110.45 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.8 m -109.31 40.79 1.77 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.166 -0.959 . . . . 0.0 109.691 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.1 m120 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.1 -0.952 . . . . 0.0 109.475 179.938 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.422 ' CE2' ' CB ' ' B' ' 4' ' ' GLN . 10.0 t80 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.472 HG12 ' OD1' ' B' ' 3' ' ' ASN . 10.7 t -42.96 113.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 122.017 -0.427 . . . . 0.0 110.792 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.472 ' OD1' HG12 ' B' ' 2' ' ' VAL . 6.4 p-10 0.77 75.82 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.101 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.422 ' CB ' ' CE2' ' B' ' 1' ' ' PHE . 0.0 OUTLIER -142.5 131.79 23.48 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.616 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.44 ' CE1' HG12 ' A' ' 10' ' ' ILE . 74.6 m80 -91.16 172.63 8.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.785 . . . . 0.0 109.381 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.483 HD12 ' HB2' ' A' ' 6' ' ' CYS . 28.6 mt -126.31 121.02 31.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.473 -0.767 . . . . 0.0 110.263 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 179.78 105.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.8 -144.76 17.49 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 60.3 p -64.36 -19.73 65.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.562 -0.963 . . . . 0.0 109.98 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -57.46 -30.66 65.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.17 -0.956 . . . . 0.0 109.769 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.889 HD22 ' CG2' ' A' ' 3' ' ' VAL . 66.8 tp -68.63 -56.46 8.13 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 t -50.07 -48.09 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.643 -0.66 . . . . 0.0 111.107 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -62.16 -33.43 74.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.496 -0.752 . . . . 0.0 109.696 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.553 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -68.53 -28.61 67.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.557 -0.714 . . . . 0.0 109.555 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.677 ' CD2' HD22 ' A' ' 16' ' ' LEU . 30.4 mt -78.09 -29.45 49.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.477 -0.765 . . . . 0.0 109.11 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -69.59 -35.2 75.12 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.31 -54.86 6.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.697 -0.627 . . . . 0.0 109.547 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.553 HG23 ' O ' ' B' ' 14' ' ' ALA . 20.9 t -61.52 -66.51 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.539 -0.726 . . . . 0.0 109.805 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 45.4 m -59.61 -69.38 0.21 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.566 -0.709 . . . . 0.0 109.82 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.98 -27.34 18.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.77 142.77 40.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.467 -1.019 . . . . 0.0 109.608 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 117.26 20.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.581 -0.699 . . . . 0.0 109.272 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.5 31.78 49.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.94 32.17 5.76 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -167.95 -171.38 1.55 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.965 . . . . 0.0 109.618 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.425 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 3.1 t80 -52.97 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.493 -0.754 . . . . 0.0 109.765 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.8 92.47 48.76 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' PRO . . . . . 0.425 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 6.1 Cg_exo . . . . . 0 N--CA 1.482 0.839 0 C-N-CA 122.593 2.195 . . . . 0.0 110.059 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.666 HG22 ' HG ' ' B' ' 11' ' ' LEU . 18.0 t . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -57.56 -21.85 41.1 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.577 -0.702 . . . . 0.0 109.986 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -63.21 -41.8 99.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.448 -0.783 . . . . 0.0 110.098 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.448 ' HB3' HD12 ' B' ' 6' ' ' LEU . 85.1 m -113.53 20.85 15.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.429 -0.794 . . . . 0.0 111.072 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.7 t -93.29 43.74 1.13 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.04 -1.037 . . . . 0.0 109.611 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.485 HG23 ' N ' ' A' ' 9' ' ' SER . 3.2 t -138.92 -45.22 0.47 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.485 ' N ' HG23 ' A' ' 8' ' ' THR . 0.2 OUTLIER -134.07 -170.95 2.62 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.398 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.599 ' CD1' ' CE1' ' B' ' 5' ' ' HIS . 1.0 OUTLIER -97.39 102.1 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.182 -0.949 . . . . 0.0 109.601 -178.615 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.1 m -62.46 -174.46 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.321 0.581 . . . . 0.0 110.188 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.6 m -105.58 163.64 12.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.744 -0.597 . . . . 0.0 109.501 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.674 HD11 HG22 ' B' ' 18' ' ' VAL . 42.2 tp -66.51 -28.25 68.41 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.572 -0.705 . . . . 0.0 109.918 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -58.34 -22.85 54.81 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.486 -0.759 . . . . 0.0 110.285 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -80.51 -47.91 13.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.291 -0.88 . . . . 0.0 109.702 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.605 HD22 HD23 ' B' ' 15' ' ' LEU . 14.4 mt -66.97 -20.27 65.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.515 -0.74 . . . . 0.0 110.315 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -62.0 -22.39 65.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.251 -0.905 . . . . 0.0 110.022 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -98.53 33.38 2.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.84 . . . . 0.0 109.648 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -112.28 7.2 19.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.646 -0.659 . . . . 0.0 110.346 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.47 35.51 1.48 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.047 -0.977 . . . . 0.0 109.544 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.711 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.618 HG12 ' OD1' ' B' ' 3' ' ' ASN . 15.6 t -86.22 -58.06 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.662 -1.274 . . . . 0.0 109.316 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.618 ' OD1' HG12 ' B' ' 2' ' ' VAL . 0.6 OUTLIER -178.84 37.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.433 -0.792 . . . . 0.0 109.664 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -120.42 139.83 52.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.589 -0.694 . . . . 0.0 109.262 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.599 ' CE1' ' CD1' ' A' ' 10' ' ' ILE . 0.1 OUTLIER -77.78 164.68 25.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.471 -0.768 . . . . 0.0 109.602 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.448 HD12 ' HB3' ' A' ' 6' ' ' CYS . 18.8 mt -120.34 112.3 18.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.568 -0.707 . . . . 0.0 110.463 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.461 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.1 OUTLIER 179.71 120.25 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.425 -0.797 . . . . 0.0 109.153 178.564 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.39 -147.33 19.07 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.5 t -65.73 -14.67 61.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.349 -1.089 . . . . 0.0 109.92 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.96 -29.95 67.55 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.139 -0.976 . . . . 0.0 109.194 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.666 ' HG ' HG22 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -65.52 -52.89 49.33 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.072 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 18.1 t -56.07 -37.58 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.802 -0.562 . . . . 0.0 110.699 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -74.8 -26.33 59.66 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.455 -0.778 . . . . 0.0 110.212 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.19 -31.25 64.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.605 HD23 HD22 ' A' ' 16' ' ' LEU . 40.3 mt -74.02 -39.76 63.37 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -61.55 -33.04 73.17 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.711 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 1.7 tp -67.87 -40.74 83.54 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.674 HG22 HD11 ' A' ' 13' ' ' LEU . 35.8 t -86.49 -75.12 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.671 -0.643 . . . . 0.0 110.134 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 14.0 m -64.78 -62.72 1.4 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 109.599 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.16 15.73 78.66 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -90.48 158.11 17.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -1.178 . . . . 0.0 109.16 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.85 117.34 26.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.529 -0.732 . . . . 0.0 109.29 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.03 36.25 93.02 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.96 -19.86 6.64 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.661 ' CE1' HG23 ' B' ' 27' ' ' THR . 34.5 p90 -127.42 -174.82 3.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.264 -1.139 . . . . 0.0 110.232 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.46 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 4.2 t80 -60.11 105.61 0.42 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.546 0.689 . . . . 0.0 109.47 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.661 HG23 ' CE1' ' B' ' 25' ' ' PHE . 0.0 OUTLIER -134.75 90.82 21.93 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 28' ' ' PRO . . . . . 0.46 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 8.7 Cg_endo . . . . . 0 N--CA 1.486 1.064 0 C-N-CA 122.857 2.371 . . . . 0.0 110.826 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.419 HG12 ' SG ' ' A' ' 7' ' ' CYS . 43.6 t . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -89.68 59.15 4.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.393 -0.817 . . . . 0.0 109.699 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.5 -45.96 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.478 -0.764 . . . . 0.0 109.143 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.467 ' HB2' HD12 ' B' ' 6' ' ' LEU . 59.1 m -115.35 16.14 16.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.662 -0.649 . . . . 0.0 110.058 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' HG12 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -73.89 -29.37 62.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.282 -0.887 . . . . 0.0 109.159 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -84.08 -49.15 9.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.584 -0.698 . . . . 0.0 110.212 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p -122.83 166.92 14.2 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.532 -0.73 . . . . 0.0 110.061 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.437 ' HB ' ' CE1' ' B' ' 5' ' ' HIS . 0.1 OUTLIER -86.81 120.9 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 87.7 m -82.8 -89.0 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.605 -0.684 . . . . 0.0 110.016 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.6 t -179.45 168.83 1.44 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.993 -1.067 . . . . 0.0 109.466 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.509 HD21 HG22 ' B' ' 18' ' ' VAL . 0.7 OUTLIER -67.24 -33.1 74.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.584 -0.698 . . . . 0.0 110.478 -179.289 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -21.54 61.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.264 -0.898 . . . . 0.0 110.208 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -76.74 -50.95 12.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.324 -0.86 . . . . 0.0 110.123 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.687 HD22 ' CD2' ' B' ' 15' ' ' LEU . 10.4 mt -66.81 -21.14 66.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.448 -0.783 . . . . 0.0 110.162 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -55.46 -22.5 20.89 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.239 -0.913 . . . . 0.0 110.466 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -98.02 35.33 1.75 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.366 -0.834 . . . . 0.0 109.808 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.428 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 6.6 m-85 -111.57 0.61 16.49 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.468 -0.77 . . . . 0.0 110.373 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.97 36.43 1.56 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.097 -1.002 . . . . 0.0 109.436 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.128 -0.939 . . . . 0.0 109.501 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.523 HG23 ' H ' ' B' ' 3' ' ' ASN . 0.2 OUTLIER -36.07 -72.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.581 0 O-C-N 122.053 -0.404 . . . . 0.0 112.022 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.523 ' H ' HG23 ' B' ' 2' ' ' VAL . 2.8 p-10 -178.16 54.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.162 -0.961 . . . . 0.0 109.375 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -103.39 123.97 47.83 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.437 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 31.0 m-70 -84.11 137.89 33.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.464 -0.773 . . . . 0.0 109.672 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.63 ' CD2' HD11 ' A' ' 16' ' ' LEU . 50.0 mt -81.78 95.52 7.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.875 -0.515 . . . . 0.0 110.413 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.05 120.41 0.44 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.666 -0.646 . . . . 0.0 109.35 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.21 -142.31 21.24 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 51.7 p -66.02 -23.83 66.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.942 . . . . 0.0 109.459 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -56.29 -29.9 61.81 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.241 -0.912 . . . . 0.0 109.112 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.431 ' CD1' HD11 ' B' ' 15' ' ' LEU . 0.4 OUTLIER -63.41 -60.35 3.48 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.938 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -51.12 -52.65 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.665 -0.647 . . . . 0.0 111.143 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -59.52 -29.25 67.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.37 -0.831 . . . . 0.0 110.346 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.76 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -73.08 -30.85 63.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.485 -0.759 . . . . 0.0 109.742 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.687 ' CD2' HD22 ' A' ' 16' ' ' LEU . 31.3 mt -77.2 -30.57 54.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.435 -0.791 . . . . 0.0 109.541 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -75.99 -30.86 58.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.568 -0.708 . . . . 0.0 109.42 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tp -80.18 -30.62 38.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.595 -0.69 . . . . 0.0 109.631 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.76 HG23 ' O ' ' B' ' 14' ' ' ALA . 43.3 t -82.66 -68.59 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.695 . . . . 0.0 109.195 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 33.8 m -67.74 -67.55 0.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.68 -0.638 . . . . 0.0 109.387 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.04 7.89 79.79 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -89.83 151.63 21.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.115 -1.227 . . . . 0.0 109.669 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.36 104.13 9.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.745 . . . . 0.0 108.99 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.81 42.51 30.91 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.07 -20.38 6.77 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.446 ' CE1' HG23 ' B' ' 27' ' ' THR . 37.2 p90 -115.41 -170.49 1.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.404 -1.056 . . . . 0.0 109.566 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.416 ' O ' ' CG ' ' B' ' 26' ' ' TYR . 0.5 OUTLIER -55.44 93.52 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.613 -0.68 . . . . 0.0 109.645 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.446 HG23 ' CE1' ' B' ' 25' ' ' PHE . 1.5 p -124.13 97.07 41.1 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' PRO . . . . . 0.405 ' HD3' ' CE1' ' B' ' 26' ' ' TYR . 6.1 Cg_exo . . . . . 0 N--CA 1.485 1.019 0 C-N-CA 122.621 2.214 . . . . 0.0 110.692 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.538 HG12 ' SG ' ' A' ' 7' ' ' CYS . 47.5 t . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -89.55 54.51 2.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.321 -0.862 . . . . 0.0 109.721 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -141.2 -50.48 0.43 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.497 -0.752 . . . . 0.0 108.993 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.3 m -128.41 32.72 4.81 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.538 ' SG ' HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -67.43 -57.17 7.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.69 -0.631 . . . . 0.0 110.272 -179.688 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 m -68.0 -28.21 67.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.505 -0.747 . . . . 0.0 110.899 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.44 ' HA ' ' CE1' ' B' ' 5' ' ' HIS . 1.2 m -116.98 -162.52 0.86 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.375 -0.828 . . . . 0.0 109.942 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.476 HG23 ' CD2' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -111.14 129.34 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.477 -0.764 . . . . 0.0 109.008 -179.373 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.91 -164.41 1.02 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.652 -0.655 . . . . 0.0 109.91 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.455 ' CB ' ' CE2' ' A' ' 14' ' ' TYR . 1.6 m -102.09 162.18 13.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.547 -0.721 . . . . 0.0 109.747 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.33 -35.4 80.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.624 -0.673 . . . . 0.0 110.387 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.455 ' CE2' ' CB ' ' A' ' 12' ' ' SER . 20.4 p90 -61.58 -23.33 65.92 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.389 -0.82 . . . . 0.0 110.058 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.404 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 1.0 OUTLIER -68.04 -57.11 6.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.419 -0.801 . . . . 0.0 109.494 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.693 HD22 HD23 ' B' ' 15' ' ' LEU . 23.0 mt -66.07 -14.24 61.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.576 -0.703 . . . . 0.0 110.222 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -62.23 -31.17 71.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.186 -0.946 . . . . 0.0 109.554 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -98.51 32.97 2.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.492 -0.755 . . . . 0.0 109.446 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 7.2 m-85 -113.42 -7.41 13.46 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.615 -0.678 . . . . 0.0 110.226 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.0 m -74.6 -22.07 59.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.081 -1.012 . . . . 0.0 110.357 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.54 -179.871 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.708 ' CD2' HG22 ' B' ' 2' ' ' VAL . 2.3 p90 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.708 HG22 ' CD2' ' B' ' 1' ' ' PHE . 27.4 m -50.09 -26.16 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.354 -1.467 . . . . 0.0 110.977 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -171.08 40.85 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.574 -0.704 . . . . 0.0 109.189 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.455 ' CB ' ' CE1' ' B' ' 1' ' ' PHE . 7.0 tp60 -136.38 108.04 7.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.583 -0.698 . . . . 0.0 109.912 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.476 ' CD2' HG23 ' A' ' 10' ' ' ILE . 14.3 m-70 -64.06 163.23 12.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.611 -0.681 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.689 HD11 HD11 ' A' ' 16' ' ' LEU . 2.5 mm? -114.42 55.35 0.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.501 -0.749 . . . . 0.0 109.596 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.86 129.01 33.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.522 -0.736 . . . . 0.0 109.333 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.56 -147.53 35.71 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 16.2 p -67.84 -12.21 60.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.553 -0.969 . . . . 0.0 110.489 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -60.69 -33.4 72.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.067 -1.021 . . . . 0.0 109.706 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.528 HD12 HD12 ' B' ' 6' ' ' LEU . 62.4 tp -65.07 -55.89 16.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.614 -0.679 . . . . 0.0 109.218 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.2 t -52.08 -47.67 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.544 -0.723 . . . . 0.0 110.813 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -62.22 -32.26 72.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.441 -0.787 . . . . 0.0 109.729 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.493 ' HB1' HD13 ' A' ' 16' ' ' LEU . . . -68.09 -31.94 71.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.557 -0.715 . . . . 0.0 109.153 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.693 HD23 HD22 ' A' ' 16' ' ' LEU . 31.7 mt -74.88 -28.56 60.7 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -70.17 -34.33 72.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.504 -0.748 . . . . 0.0 108.992 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.679 HD22 ' HZ ' ' B' ' 1' ' ' PHE . 0.5 OUTLIER -73.76 -42.37 61.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.721 -0.612 . . . . 0.0 109.6 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.426 HG23 ' O ' ' B' ' 14' ' ' ALA . 47.3 t -71.0 -71.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -77.91 0.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.457 -0.777 . . . . 0.0 108.979 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.53 -27.92 9.5 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.27 176.32 0.35 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.423 -1.045 . . . . 0.0 109.759 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -76.38 -63.16 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.593 -0.692 . . . . 0.0 109.386 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -119.41 48.02 0.98 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.62 26.12 25.59 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -162.06 -176.92 5.44 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.498 -1.001 . . . . 0.0 109.798 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -56.45 123.81 15.99 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.548 -0.72 . . . . 0.0 110.157 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.31 96.82 43.63 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.483 0.866 0 C-N-CA 122.386 2.057 . . . . 0.0 110.21 -179.523 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.656 HG22 HD22 ' B' ' 11' ' ' LEU . 32.2 t . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.408 0.623 . . . . 0.0 109.672 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.6 -30.79 67.49 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.651 -0.655 . . . . 0.0 110.274 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -76.16 -28.6 57.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.502 -0.749 . . . . 0.0 109.817 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.2 m -113.32 26.43 10.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.431 -0.793 . . . . 0.0 110.158 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.425 ' SG ' HG12 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -101.39 -32.09 10.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 0.0 109.197 179.672 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -85.79 -57.29 3.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.646 -0.658 . . . . 0.0 109.515 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.89 -160.67 0.82 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.631 -0.668 . . . . 0.0 109.358 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 11' ' ' CYS . 1.2 mm -93.88 -168.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.502 ' H ' HG22 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -170.54 168.28 7.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.414 -0.804 . . . . 0.0 109.106 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.48 162.13 13.14 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.872 HD13 ' O ' ' A' ' 13' ' ' LEU . 3.4 tm? -66.98 -23.48 65.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.679 -0.638 . . . . 0.0 110.261 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CE1' ' HG2' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -56.63 -20.74 22.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.128 -0.982 . . . . 0.0 110.803 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.443 ' HG2' ' CE1' ' A' ' 14' ' ' TYR . 5.3 mm100 -74.36 -46.27 41.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.41 -0.806 . . . . 0.0 109.843 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.654 HD22 ' CD2' ' B' ' 15' ' ' LEU . 68.9 mt -68.42 -10.0 52.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.436 -0.79 . . . . 0.0 110.722 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.94 -26.33 68.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.11 -0.994 . . . . 0.0 109.21 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -62.29 -32.74 73.51 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.747 0.784 . . . . 0.0 109.633 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.433 ' CD1' ' HB2' ' B' ' 26' ' ' TYR . 35.5 m-85 -81.66 -17.07 49.32 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.995 -0.441 . . . . 0.0 111.139 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -105.13 28.8 6.92 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.045 -1.034 . . . . 0.0 109.766 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.582 -179.871 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.741 ' CE1' HD23 ' A' ' 13' ' ' LEU . 3.0 p90 . . . . . 0 N--CA 1.5 2.033 0 CA-C-O 120.474 0.178 . . . . 0.0 110.771 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.22 -26.29 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.976 -1.078 . . . . 0.0 109.35 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -152.89 29.24 0.52 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.428 ' HG2' ' CE1' ' B' ' 10' ' ' HIS . 0.3 OUTLIER -118.7 -178.89 3.65 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -103.4 125.41 49.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.347 -0.846 . . . . 0.0 109.855 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.618 HD21 HD13 ' B' ' 11' ' ' LEU . 6.4 tp -83.95 94.1 8.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.706 -0.621 . . . . 0.0 110.08 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.88 134.4 2.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.419 -0.801 . . . . 0.0 109.334 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.3 -145.72 21.43 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 53.7 p -70.79 -9.0 56.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.496 -1.002 . . . . 0.0 110.31 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' HIS . . . . . 0.428 ' CE1' ' HG2' ' B' ' 4' ' ' GLN . 28.3 t60 -65.37 -31.08 72.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.087 -1.008 . . . . 0.0 108.944 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.656 HD22 HG22 ' A' ' 3' ' ' VAL . 56.0 tp -63.69 -57.31 10.41 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.5 t -53.45 -51.82 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.64 -0.662 . . . . 0.0 110.955 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -56.21 -28.61 58.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.346 -0.846 . . . . 0.0 110.217 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.588 ' HB1' HD13 ' A' ' 16' ' ' LEU . . . -76.58 -35.0 58.42 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.654 ' CD2' HD22 ' A' ' 16' ' ' LEU . 49.3 mt -64.56 -28.22 69.49 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -80.82 -35.72 32.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.527 -0.733 . . . . 0.0 109.137 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -65.42 -32.61 74.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.658 -0.651 . . . . 0.0 109.804 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.814 ' CG2' HD21 ' A' ' 13' ' ' LEU . 35.9 t -82.22 -55.68 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.601 -0.687 . . . . 0.0 109.405 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 4.7 m -69.19 -80.24 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.54 -0.725 . . . . 0.0 109.528 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.95 -56.56 0.66 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.96 172.23 8.73 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.454 -1.027 . . . . 0.0 109.426 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.25 -47.77 33.0 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.44 94.54 1.4 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -177.93 -35.85 0.06 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.473 ' CG ' ' HB3' ' B' ' 15' ' ' LEU . 44.5 p90 -124.83 -174.64 3.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -1.088 . . . . 0.0 110.867 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.433 ' HB2' ' CD1' ' A' ' 19' ' ' TYR . 7.1 t80 -58.45 111.0 1.08 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.853 -0.529 . . . . 0.0 109.828 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.3 p -122.88 92.2 49.28 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.553 -0.717 . . . . 0.0 109.372 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' PRO . . . . . 0.413 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 1.5 Cg_endo . . . . . 0 N--CA 1.484 0.965 0 C-N-CA 122.526 2.151 . . . . 0.0 109.858 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.53 HG22 ' HG ' ' B' ' 11' ' ' LEU . 44.7 t . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.17 3.76 22.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 0.0 109.956 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -63.42 1.23 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.117 -0.989 . . . . 0.0 110.039 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.498 ' SG ' HD23 ' B' ' 6' ' ' LEU . 12.6 p -136.27 25.61 3.22 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.978 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.1 t -52.45 -23.78 6.75 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.11 -0.994 . . . . 0.0 110.011 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 m -65.7 -68.49 0.36 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.353 -0.842 . . . . 0.0 111.033 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.4 -153.56 0.53 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.328 -0.858 . . . . 0.0 110.356 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.665 HD13 ' CE1' ' B' ' 5' ' ' HIS . 10.1 mm -83.65 168.21 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.096 -1.002 . . . . 0.0 108.728 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.479 ' H ' HG22 ' A' ' 10' ' ' ILE . 2.1 p -160.1 174.42 14.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.427 -0.796 . . . . 0.0 110.438 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -72.08 133.13 45.06 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.345 0.593 . . . . 0.0 109.747 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.478 HD12 ' HB2' ' B' ' 1' ' ' PHE . 4.6 mm? -68.43 -17.34 64.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.749 -0.594 . . . . 0.0 110.412 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -56.83 -22.46 36.74 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.139 -0.976 . . . . 0.0 109.86 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.26 -49.09 75.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.404 -0.81 . . . . 0.0 109.357 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.725 HD22 HD23 ' B' ' 15' ' ' LEU . 15.8 mt -68.9 -16.51 63.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.521 -0.737 . . . . 0.0 110.051 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.71 -26.75 65.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 109.174 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.25 13.12 14.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.379 -0.826 . . . . 0.0 110.078 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -97.77 20.62 11.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.102 -0.999 . . . . 0.0 109.179 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.3 m -109.97 23.88 13.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.328 -0.857 . . . . 0.0 109.987 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.9 m120 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 117.903 -1.046 . . . . 0.0 109.427 -179.952 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.718 ' CZ ' HD22 ' B' ' 17' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.524 HG23 ' CD1' ' B' ' 1' ' ' PHE . 0.2 OUTLIER -118.27 172.23 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.924 -1.11 . . . . 0.0 108.163 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -59.44 92.98 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.317 -0.864 . . . . 0.0 109.376 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -142.03 174.4 10.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.502 -0.748 . . . . 0.0 110.203 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.665 ' CE1' HD13 ' A' ' 10' ' ' ILE . 3.6 m80 -119.12 146.45 45.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.613 -0.68 . . . . 0.0 109.248 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.683 HD12 HD11 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -100.77 90.44 4.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.504 -0.748 . . . . 0.0 109.439 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.3 154.23 10.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.625 -0.672 . . . . 0.0 109.719 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.03 -132.89 49.15 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.5 p -83.51 -13.8 53.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.947 . . . . 0.0 109.759 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -63.71 -33.09 74.87 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.132 -0.98 . . . . 0.0 108.944 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.612 ' C ' HD13 ' B' ' 11' ' ' LEU . 2.6 tm? -68.87 -54.51 15.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.813 -0.554 . . . . 0.0 109.771 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 t -53.74 -47.77 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.501 -0.749 . . . . 0.0 110.677 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.7 -29.07 70.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.484 -0.76 . . . . 0.0 109.396 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.72 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -71.67 -26.4 62.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.57 -0.706 . . . . 0.0 109.529 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.725 HD23 HD22 ' A' ' 16' ' ' LEU . 29.1 mt -78.85 -32.14 45.92 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.418 -0.801 . . . . 0.0 108.882 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.06 -32.99 67.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.595 -0.691 . . . . 0.0 110.012 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.718 HD22 ' CZ ' ' B' ' 1' ' ' PHE . 0.1 OUTLIER -80.58 -46.71 15.27 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.413 -0.804 . . . . 0.0 109.937 -179.434 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.72 HG23 ' O ' ' B' ' 14' ' ' ALA . 48.0 t -59.65 -56.93 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.419 -0.801 . . . . 0.0 109.386 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -74.89 0.1 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.21 -35.17 3.73 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -90.41 163.77 14.55 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.395 -1.062 . . . . 0.0 109.849 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.85 127.9 39.84 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.18 28.7 36.04 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.97 30.73 5.76 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.445 ' CD2' ' HB2' ' B' ' 15' ' ' LEU . 23.8 p90 -165.65 -173.2 2.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.454 -1.027 . . . . 0.0 109.512 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.454 ' HB3' HD13 ' B' ' 15' ' ' LEU . 7.5 t80 -54.33 109.58 0.51 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.574 -0.703 . . . . 0.0 109.562 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 2.0 p -122.88 91.86 49.49 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.483 0.91 0 C-N-CA 122.48 2.12 . . . . 0.0 110.143 -179.926 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 3' ' ' VAL . 30.4 t . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 120.42 0.152 . . . . 0.0 110.685 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -90.35 51.72 2.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.136 -0.978 . . . . 0.0 109.429 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -138.44 -43.79 0.5 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.498 -0.752 . . . . 0.0 109.379 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.1 m -118.59 15.57 13.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.543 -0.723 . . . . 0.0 110.399 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.61 -27.22 64.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.279 -0.888 . . . . 0.0 110.351 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 m -99.29 -67.83 0.83 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.351 -0.843 . . . . 0.0 110.907 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.2 p -74.99 171.81 13.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.279 -0.888 . . . . 0.0 110.229 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.858 HG23 ' O ' ' B' ' 4' ' ' GLN . 56.6 mt -102.52 91.16 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.6 m -61.74 -178.91 0.16 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.613 -0.68 . . . . 0.0 110.268 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.483 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 22.2 t -106.71 172.47 6.8 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.507 HD23 ' O ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -67.36 -26.14 66.33 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.403 -0.811 . . . . 0.0 111.415 -178.699 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 12' ' ' SER . 8.9 p90 -59.51 -20.51 55.95 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.997 -1.064 . . . . 0.0 110.042 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.93 -49.91 12.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.388 -0.82 . . . . 0.0 109.428 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.711 HD21 ' CD2' ' B' ' 11' ' ' LEU . 11.3 mt -67.45 -16.78 64.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.531 -0.731 . . . . 0.0 109.991 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -57.91 -20.72 39.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.187 -0.945 . . . . 0.0 110.219 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -96.95 33.21 1.94 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.84 . . . . 0.0 109.488 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.42 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 7.5 m-85 -113.27 -0.43 14.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.518 -0.739 . . . . 0.0 110.361 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.6 m -96.83 40.49 1.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.122 -0.986 . . . . 0.0 109.562 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.444 179.957 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.543 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 1.1 p90 . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 15.5 t -54.66 -26.7 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -160.69 31.62 0.15 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.858 ' O ' HG23 ' A' ' 10' ' ' ILE . 13.3 mt-30 -127.48 168.67 14.59 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.638 -0.664 . . . . 0.0 109.857 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.458 ' CE1' HG12 ' A' ' 10' ' ' ILE . 18.1 m80 -96.61 161.53 13.85 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.531 HD22 HD11 ' A' ' 16' ' ' LEU . 43.7 mt -109.44 -11.11 14.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.478 -0.764 . . . . 0.0 110.82 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.77 138.96 56.87 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.955 -1.091 . . . . 0.0 110.344 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.47 -159.33 33.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.0 p -64.7 -14.66 59.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.435 -1.038 . . . . 0.0 110.04 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -52.14 -27.98 16.26 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.891 -1.131 . . . . 0.0 110.323 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.711 ' CD2' HD21 ' A' ' 16' ' ' LEU . 3.2 tm? -72.5 -62.91 1.27 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.614 -0.679 . . . . 0.0 109.199 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 39.4 t -47.16 -52.64 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.839 -0.538 . . . . 0.0 111.445 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -57.53 -36.66 71.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.386 -0.821 . . . . 0.0 110.224 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.5 ' HB1' ' HD2' ' B' ' 1' ' ' PHE . . . -67.1 -31.63 72.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.346 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.644 HD23 HD22 ' A' ' 16' ' ' LEU . 40.6 mt -64.47 -40.64 96.07 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -63.66 -34.04 76.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.543 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 0.8 OUTLIER -65.23 -37.3 86.85 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.5 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 14' ' ' ALA . 40.5 t -74.12 -71.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.586 -0.696 . . . . 0.0 109.613 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 m -90.75 -58.25 2.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.455 -0.778 . . . . 0.0 109.408 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.37 32.78 68.23 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -88.62 -177.55 5.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.613 -0.933 . . . . 0.0 109.409 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.409 ' NH1' ' HG2' ' B' ' 22' ' ' ARG . 2.7 tpt180 -91.93 52.7 2.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.624 -0.672 . . . . 0.0 109.432 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.95 40.68 1.05 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.07 -28.21 6.62 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' CB ' ' B' ' 15' ' ' LEU . 29.2 p90 -105.36 -175.8 2.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.57 -0.959 . . . . 0.0 109.408 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -58.89 118.41 5.73 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.474 -0.766 . . . . 0.0 109.423 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 23.8 p -127.14 94.65 38.5 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.482 0.838 0 C-N-CA 122.343 2.029 . . . . 0.0 110.165 -179.592 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.792 HG13 HD12 ' B' ' 11' ' ' LEU . 25.0 t . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 120.672 0.272 . . . . 0.0 110.377 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -105.24 31.51 4.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.179 -0.951 . . . . 0.0 108.928 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -118.77 -33.76 4.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.674 -0.641 . . . . 0.0 109.985 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.0 m -130.33 19.13 5.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.471 -0.768 . . . . 0.0 110.459 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.7 t -91.29 -26.81 18.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 109.565 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -75.35 -27.69 59.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.474 -0.766 . . . . 0.0 110.182 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.4 p -134.64 -171.6 2.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 109.936 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.454 ' CG1' ' CE1' ' B' ' 5' ' ' HIS . 18.3 mt -102.31 95.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.406 ' SG ' ' NE2' ' A' ' 15' ' ' GLN . 1.3 m -68.27 -172.82 0.35 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.573 -0.704 . . . . 0.0 109.687 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.447 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 1.4 m -108.64 162.82 13.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.644 -0.66 . . . . 0.0 109.689 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.749 HD13 ' CD2' ' B' ' 1' ' ' PHE . 20.0 tp -71.11 -17.69 62.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.805 -0.559 . . . . 0.0 110.223 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.447 ' CE2' ' HB3' ' A' ' 12' ' ' SER . 10.8 p90 -87.54 11.29 15.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.088 -1.007 . . . . 0.0 110.422 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.406 ' NE2' ' SG ' ' A' ' 11' ' ' CYS . 4.7 tt0 -105.5 -32.28 8.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.072 -1.017 . . . . 0.0 109.434 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.811 HD22 ' CD2' ' B' ' 15' ' ' LEU . 9.9 mt -66.16 -13.03 59.53 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.565 -0.71 . . . . 0.0 110.558 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.81 -19.19 39.0 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.08 -1.013 . . . . 0.0 110.124 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -93.53 28.79 2.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.204 -0.935 . . . . 0.0 110.191 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -115.08 10.89 16.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.173 -0.954 . . . . 0.0 110.456 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.31 33.12 2.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.273 -0.892 . . . . 0.0 109.343 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.389 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.906 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 34.3 t80 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.709 HG13 ' CD1' ' B' ' 1' ' ' PHE . 17.5 m -140.63 -162.43 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -52.75 -25.04 9.97 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.956 -1.09 . . . . 0.0 110.022 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.568 ' H ' HG23 ' B' ' 2' ' ' VAL . 12.3 mm-40 -71.87 144.11 49.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.519 -0.738 . . . . 0.0 109.109 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.454 ' CE1' ' CG1' ' A' ' 10' ' ' ILE . 13.0 m80 -68.25 160.6 28.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.552 -0.718 . . . . 0.0 109.493 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.415 HD11 HD11 ' A' ' 16' ' ' LEU . 19.7 tp -107.41 98.43 8.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.611 -0.681 . . . . 0.0 109.732 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.7 173.15 2.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.637 -0.664 . . . . 0.0 109.895 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.7 -154.02 39.78 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.1 p -63.8 -21.5 66.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.576 -0.955 . . . . 0.0 109.507 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -60.52 -34.13 73.65 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.869 . . . . 0.0 109.075 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.792 HD12 HG13 ' A' ' 3' ' ' VAL . 2.5 tt -61.86 -55.05 33.86 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.404 ' H ' HG23 ' B' ' 12' ' ' VAL . 21.2 t -53.74 -49.97 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.748 -0.595 . . . . 0.0 111.05 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -59.76 -27.48 66.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.446 -0.784 . . . . 0.0 110.631 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.11 -31.37 39.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 110.301 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.811 ' CD2' HD22 ' A' ' 16' ' ' LEU . 50.5 mt -66.72 -41.28 88.18 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -70.94 -31.38 67.95 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.906 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 1.1 mp -63.24 -34.46 77.71 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -84.77 -73.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.626 -0.671 . . . . 0.0 109.359 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 90.8 m -64.49 -82.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 108.852 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.16 23.26 9.84 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 120.136 -1.031 . . . . 0.0 111.533 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.26 -173.68 3.9 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 118.784 1.292 . . . . 0.0 109.165 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -93.44 50.74 1.52 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.532 -0.73 . . . . 0.0 109.51 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.73 71.99 0.63 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.28 35.49 2.17 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -167.08 -171.91 1.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.959 . . . . 0.0 109.607 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.415 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 3.8 t80 -57.69 98.85 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.582 -0.699 . . . . 0.0 109.167 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 2.2 p -114.33 91.87 25.51 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.591 -0.693 . . . . 0.0 109.666 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' PRO . . . . . 0.415 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 4.0 Cg_exo . . . . . 0 N--CA 1.482 0.843 0 C-N-CA 122.453 2.102 . . . . 0.0 110.074 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.749 HG23 ' CG ' ' A' ' 15' ' ' GLN . 4.0 mp -123.8 -50.61 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.554 -0.968 . . . . 0.0 109.758 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.4 t -74.21 -56.78 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.531 -0.731 . . . . 0.0 109.093 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.49 -18.3 58.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.652 -0.655 . . . . 0.0 110.049 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -42.1 82.38 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.253 -0.905 . . . . 0.0 109.987 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -146.53 43.49 1.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.45 -0.781 . . . . 0.0 109.897 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -63.3 -43.02 99.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.398 -0.814 . . . . 0.0 109.157 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -97.24 29.51 3.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.714 -0.616 . . . . 0.0 109.552 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p -161.07 -174.17 4.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.556 -0.715 . . . . 0.0 109.263 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.16 98.62 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 m -84.41 -85.76 0.13 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.587 -0.696 . . . . 0.0 110.423 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -173.97 151.43 1.76 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.068 -1.02 . . . . 0.0 109.975 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.747 HD13 ' O ' ' A' ' 13' ' ' LEU . 2.6 tm? -67.18 -21.51 65.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.648 -0.658 . . . . 0.0 110.106 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -24.78 34.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.064 -1.023 . . . . 0.0 109.91 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.749 ' CG ' HG23 ' A' ' 2' ' ' ILE . 3.5 tp60 -79.02 -47.28 16.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.384 -0.822 . . . . 0.0 109.218 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.699 HD22 ' CD2' ' B' ' 15' ' ' LEU . 9.0 mt -65.78 -15.14 62.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.632 -0.667 . . . . 0.0 110.129 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.38 -18.8 41.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.261 -0.899 . . . . 0.0 110.288 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -94.32 28.35 2.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.924 . . . . 0.0 109.988 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.539 ' CE1' HG21 ' A' ' 2' ' ' ILE . 6.4 m-85 -115.99 18.55 15.48 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.377 -0.827 . . . . 0.0 110.211 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.1 m -109.62 30.11 6.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m120 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.469 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.88 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 66.5 t80 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.814 HG12 ' HD2' ' B' ' 1' ' ' PHE . 13.3 p -165.34 -33.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.192 -0.942 . . . . 0.0 110.488 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.621 ' ND2' HG13 ' B' ' 2' ' ' VAL . 16.0 p30 -157.88 -42.26 0.06 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.012 -1.055 . . . . 0.0 109.587 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -76.06 159.91 30.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.473 -0.767 . . . . 0.0 109.012 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -83.26 -178.61 7.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.615 -0.678 . . . . 0.0 109.518 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.594 ' HB3' HD23 ' B' ' 11' ' ' LEU . 33.7 mt -127.4 53.53 1.73 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.546 -0.722 . . . . 0.0 110.422 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -135.53 132.16 36.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.407 -0.808 . . . . 0.0 109.181 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.28 -137.4 13.71 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 53.9 p -85.47 3.76 38.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.499 -1.0 . . . . 0.0 110.101 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -76.36 -34.23 58.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.101 -1.0 . . . . 0.0 109.211 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.611 HD21 HD21 ' A' ' 16' ' ' LEU . 3.5 tm? -66.53 -51.38 57.23 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.6 t -55.32 -48.31 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.587 -0.695 . . . . 0.0 110.17 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -60.55 -29.89 69.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.434 -0.791 . . . . 0.0 109.51 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.717 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -71.78 -32.08 67.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.518 -0.739 . . . . 0.0 109.453 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.699 ' CD2' HD22 ' A' ' 16' ' ' LEU . 41.4 mt -65.69 -41.27 92.58 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.47 -37.85 88.86 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.88 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 2.7 tp -64.71 -28.72 69.78 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.717 HG23 ' O ' ' B' ' 14' ' ' ALA . 42.0 t -73.22 -69.38 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 109.792 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -94.91 -76.37 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.478 -0.764 . . . . 0.0 109.288 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.87 -13.03 10.71 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.787 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -87.33 145.15 26.46 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.151 -1.205 . . . . 0.0 109.489 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -76.48 152.14 36.2 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.76 25.63 63.94 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.52 -28.11 4.15 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.582 ' CE1' HG22 ' B' ' 27' ' ' THR . 30.5 p90 -131.48 -173.94 3.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.621 -0.929 . . . . 0.0 109.569 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.413 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 9.5 t80 -61.73 108.61 1.03 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 109.491 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.582 HG22 ' CE1' ' B' ' 25' ' ' PHE . 45.6 p -123.48 87.98 51.82 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.413 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 1.6 Cg_endo -62.85 86.88 0.11 Allowed 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.709 2.272 . . . . 0.0 110.217 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.299 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.519 HG23 ' H ' ' A' ' 3' ' ' VAL . 7.7 tt -137.6 -56.39 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.604 -0.939 . . . . 0.0 109.361 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.519 ' H ' HG23 ' A' ' 2' ' ' ILE . 30.0 t -92.83 -27.35 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.054 -1.029 . . . . 0.0 109.688 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.02 42.16 1.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 109.677 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.14 -46.99 2.17 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.2 m -125.97 25.39 6.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.675 -0.641 . . . . 0.0 109.621 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.0 -58.55 6.37 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.39 -0.819 . . . . 0.0 109.472 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 t -72.08 -33.75 68.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.483 -0.761 . . . . 0.0 110.043 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -86.11 165.48 16.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.433 -0.792 . . . . 0.0 108.884 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.4 HG12 ' NE2' ' B' ' 5' ' ' HIS . 1.0 OUTLIER -110.99 69.81 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.286 -0.884 . . . . 0.0 109.043 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.7 m -64.98 178.74 0.78 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.53 -0.731 . . . . 0.0 109.753 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 50.1 m -72.9 115.0 11.67 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.918 HD11 HD21 ' B' ' 6' ' ' LEU . 0.3 OUTLIER -69.25 -8.18 43.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.667 -0.646 . . . . 0.0 110.975 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.445 ' CD1' ' HB3' ' A' ' 12' ' ' SER . 0.1 OUTLIER -67.28 -18.73 65.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.967 -1.083 . . . . 0.0 109.934 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.409 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 0.8 OUTLIER -69.35 -10.64 58.82 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.258 -0.901 . . . . 0.0 110.764 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.734 HD12 ' CD1' ' A' ' 13' ' ' LEU . 5.8 mt -65.47 -12.06 49.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.164 -0.96 . . . . 0.0 110.656 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -59.51 -19.53 48.8 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.105 -0.997 . . . . 0.0 110.196 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -97.13 29.61 3.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.288 -0.883 . . . . 0.0 109.775 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.502 ' CE2' HD11 ' A' ' 2' ' ' ILE . 9.0 m-85 -118.38 19.78 13.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.645 -0.659 . . . . 0.0 109.632 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.7 m -103.59 27.27 7.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.247 -0.908 . . . . 0.0 110.026 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.911 -1.042 . . . . 0.0 109.484 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.457 ' CB ' ' HB2' ' B' ' 14' ' ' ALA . 34.8 p90 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 120.613 0.244 . . . . 0.0 110.51 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 40.4 t -51.31 -38.86 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.005 -1.06 . . . . 0.0 110.55 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -134.03 30.01 3.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.439 -0.788 . . . . 0.0 109.668 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' B' ' 5' ' ' HIS . 18.6 mt-30 -117.66 -84.5 0.64 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.66 -0.65 . . . . 0.0 109.394 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.433 ' CG ' ' O ' ' B' ' 4' ' ' GLN . 0.6 OUTLIER -178.99 -172.53 0.25 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.449 -0.782 . . . . 0.0 109.059 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.918 HD21 HD11 ' A' ' 13' ' ' LEU . 40.3 mt -133.77 43.34 2.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.594 -0.691 . . . . 0.0 109.448 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 58.6 m -114.68 137.17 52.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.524 -0.735 . . . . 0.0 109.596 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.46 -140.58 23.75 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.3 -0.67 29.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.567 -0.961 . . . . 0.0 110.652 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -66.94 -31.18 71.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.013 -1.054 . . . . 0.0 109.271 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.508 HD22 HG22 ' A' ' 3' ' ' VAL . 63.4 tp -68.52 -57.43 5.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.576 -0.702 . . . . 0.0 109.182 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 24.7 t -51.65 -44.48 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.657 -0.652 . . . . 0.0 110.843 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -63.78 -34.45 77.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.449 -0.782 . . . . 0.0 109.646 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.457 ' HB2' ' CB ' ' B' ' 1' ' ' PHE . . . -68.9 -29.74 68.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.53 -0.731 . . . . 0.0 109.4 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.666 ' CD2' HD22 ' A' ' 16' ' ' LEU . 40.4 mt -70.71 -37.51 73.55 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -63.49 -41.62 98.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.66 -0.65 . . . . 0.0 109.505 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -63.31 -55.67 22.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.68 . . . . 0.0 109.603 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.642 HG21 ' HB3' ' A' ' 16' ' ' LEU . 43.6 t -55.59 -72.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.652 -0.655 . . . . 0.0 110.238 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.68 -74.28 0.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.835 . . . . 0.0 109.277 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.62 -16.11 61.87 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -60.42 160.95 7.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.171 -1.193 . . . . 0.0 109.841 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.53 108.65 17.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.642 -0.661 . . . . 0.0 109.512 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.2 40.19 61.62 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.1 -24.27 6.06 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -112.56 -175.63 2.72 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.437 -1.037 . . . . 0.0 109.964 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -52.02 138.84 24.17 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.481 -0.762 . . . . 0.0 110.138 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.11 93.15 31.16 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -58.48 -178.75 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.831 0 C-N-CA 122.264 1.976 . . . . 0.0 109.913 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.683 -179.869 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.775 HG23 HG23 ' A' ' 3' ' ' VAL . 15.2 tt -163.28 -44.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.678 -0.895 . . . . 0.0 109.319 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.775 HG23 HG23 ' A' ' 2' ' ' ILE . 40.2 t -90.37 -26.72 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.467 -0.77 . . . . 0.0 109.43 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -61.09 -17.64 53.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.514 -0.741 . . . . 0.0 110.117 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -48.24 -60.57 2.54 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.233 -0.917 . . . . 0.0 111.294 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.929 ' CB ' HD23 ' B' ' 6' ' ' LEU . 4.1 m -111.56 7.48 20.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.393 -0.817 . . . . 0.0 110.477 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.663 ' SG ' HG12 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -71.61 -28.98 64.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.003 -1.061 . . . . 0.0 109.408 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 m -80.79 -52.96 6.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.474 -0.766 . . . . 0.0 109.802 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.18 -177.36 4.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.0 109.883 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.503 HG12 ' CD2' ' B' ' 5' ' ' HIS . 0.4 OUTLIER -84.78 136.46 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.4 p -122.58 -160.23 0.87 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.373 -0.829 . . . . 0.0 110.085 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.07 139.69 46.22 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.571 HD11 HG21 ' B' ' 18' ' ' VAL . 0.1 OUTLIER -66.05 -13.18 59.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.457 -0.777 . . . . 0.0 110.527 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -60.03 -20.22 56.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.846 -1.159 . . . . 0.0 109.979 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -88.8 -41.45 12.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.372 -0.83 . . . . 0.0 109.892 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.463 HD22 ' CD2' ' B' ' 15' ' ' LEU . 3.9 mt -66.15 -22.13 66.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.509 -0.744 . . . . 0.0 110.038 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.07 -19.18 41.81 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.189 -0.944 . . . . 0.0 110.378 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -94.98 29.66 2.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.242 -0.911 . . . . 0.0 109.688 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -106.62 10.72 31.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.481 -0.762 . . . . 0.0 109.922 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.9 m -95.21 36.15 1.25 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.176 -0.952 . . . . 0.0 109.823 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.6 -179.917 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.494 ' CB ' HD11 ' B' ' 6' ' ' LEU . 3.3 p90 . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 120.38 0.133 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.64 -35.08 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.792 -1.192 . . . . 0.0 108.496 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -150.35 22.35 0.83 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.473 ' O ' ' CG ' ' B' ' 5' ' ' HIS . 57.8 mt-30 -101.03 -94.54 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.902 ' O ' HD13 ' B' ' 6' ' ' LEU . 0.9 OUTLIER 178.12 168.27 0.77 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.267 -0.895 . . . . 0.0 109.029 178.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.929 HD23 ' CB ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -129.66 85.89 2.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.536 -0.728 . . . . 0.0 109.574 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.22 141.07 17.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.572 -0.705 . . . . 0.0 109.623 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.62 -106.01 2.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.6 p -109.25 -13.66 14.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.519 -0.989 . . . . 0.0 110.066 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -64.5 -34.24 77.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.111 -0.993 . . . . 0.0 109.34 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.726 HD22 HG13 ' A' ' 3' ' ' VAL . 58.4 tp -63.93 -54.83 28.48 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.402 HG23 ' H ' ' B' ' 12' ' ' VAL . 17.2 t -52.72 -50.16 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.607 -0.683 . . . . 0.0 110.745 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -30.66 68.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.476 -0.765 . . . . 0.0 109.801 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.814 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -73.27 -30.85 63.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.539 -0.726 . . . . 0.0 109.691 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.463 ' CD2' HD22 ' A' ' 16' ' ' LEU . 39.4 mt -69.37 -39.17 78.2 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.357 -0.839 . . . . 0.0 109.291 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -73.22 -29.62 62.93 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.682 -0.636 . . . . 0.0 109.99 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.3 -28.32 53.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.516 -0.74 . . . . 0.0 109.794 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.814 HG23 ' O ' ' B' ' 14' ' ' ALA . 41.3 t -79.46 -67.1 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.417 -0.802 . . . . 0.0 109.404 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -86.95 -60.05 2.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.586 -0.696 . . . . 0.0 109.352 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.72 30.21 40.38 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -86.36 160.52 19.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.646 -0.914 . . . . 0.0 109.079 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -83.59 82.3 8.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.568 -0.708 . . . . 0.0 109.116 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.52 53.27 3.28 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.81 27.78 5.35 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -165.03 -175.15 3.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.344 -1.092 . . . . 0.0 109.984 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -52.47 108.54 0.31 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.582 -0.698 . . . . 0.0 109.81 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.8 p -121.42 92.15 48.53 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -57.87 121.88 10.78 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 122.611 2.207 . . . . 0.0 110.288 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 mttt . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.921 179.741 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.697 HG23 HG23 ' A' ' 3' ' ' VAL . 3.2 tp -115.47 -43.79 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.617 -0.931 . . . . 0.0 109.466 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.697 HG23 HG23 ' A' ' 2' ' ' ILE . 24.3 t -90.96 -44.19 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.395 -0.816 . . . . 0.0 109.6 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -59.39 -27.14 65.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.6 -0.688 . . . . 0.0 109.846 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -77.32 -31.13 54.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.421 -0.8 . . . . 0.0 109.336 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.6 m -108.65 30.65 6.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.483 -0.76 . . . . 0.0 109.877 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 46.0 t -114.27 -45.32 3.05 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.407 -0.808 . . . . 0.0 109.755 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 93.2 m -58.66 -82.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.414 -0.804 . . . . 0.0 110.289 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.7 m -84.87 -172.04 3.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.118 -0.989 . . . . 0.0 109.575 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.489 HD13 ' CE1' ' B' ' 5' ' ' HIS . 4.4 mm -84.35 101.36 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.55 -162.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.635 -0.665 . . . . 0.0 109.552 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.9 m -116.71 155.92 28.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.39 -0.818 . . . . 0.0 109.334 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.618 HD21 HG22 ' B' ' 18' ' ' VAL . 0.8 OUTLIER -66.88 -30.23 70.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.448 -0.782 . . . . 0.0 109.703 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -61.84 -27.74 68.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.529 -0.732 . . . . 0.0 109.684 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -67.99 -46.82 70.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.632 -0.667 . . . . 0.0 110.202 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.714 HD11 HD22 ' B' ' 6' ' ' LEU . 5.5 mt -66.38 -16.16 63.85 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.355 -0.841 . . . . 0.0 109.778 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.26 -19.02 42.4 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.226 -0.921 . . . . 0.0 110.101 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -94.31 29.98 2.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.189 -0.944 . . . . 0.0 109.909 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -115.01 9.31 16.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.445 -0.784 . . . . 0.0 110.359 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.0 m -108.15 34.45 3.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.04 -1.038 . . . . 0.0 109.153 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.232 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 8.8 p -46.56 -33.0 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.46 -0.775 . . . . 0.0 110.631 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -160.45 135.21 7.62 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.416 ' CB ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -99.33 43.53 1.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.131 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.489 ' CE1' HD13 ' A' ' 10' ' ' ILE . 3.0 m170 -106.8 129.76 54.61 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.714 HD22 HD11 ' A' ' 16' ' ' LEU . 3.3 mt -126.8 120.81 30.22 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.566 -0.709 . . . . 0.0 109.859 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.66 142.91 0.15 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.525 -0.734 . . . . 0.0 109.421 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.75 -111.24 4.02 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.64 -22.22 16.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.99 . . . . 0.0 109.529 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -58.11 -34.24 69.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.321 -0.862 . . . . 0.0 109.697 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.412 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 62.4 tp -63.67 -53.77 46.1 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -53.31 -55.47 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.564 -0.71 . . . . 0.0 110.657 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.4 -26.13 64.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.32 -0.863 . . . . 0.0 109.902 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.609 ' HB1' ' CD1' ' A' ' 16' ' ' LEU . . . -72.01 -34.94 69.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.479 -0.763 . . . . 0.0 109.524 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.665 HD23 HD22 ' A' ' 16' ' ' LEU . 24.8 mt -70.78 -34.91 72.29 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -73.02 -28.39 62.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.61 -0.682 . . . . 0.0 109.34 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -77.53 -29.89 52.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.681 . . . . 0.0 109.608 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.618 HG22 HD21 ' A' ' 13' ' ' LEU . 61.1 t -85.12 -72.03 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.526 -0.734 . . . . 0.0 109.432 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.16 -56.61 3.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.382 -0.824 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.49 28.15 55.95 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -83.66 150.06 26.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.454 -1.027 . . . . 0.0 109.326 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.425 ' NH1' ' HG3' ' B' ' 22' ' ' ARG . 1.3 mmm-85 -80.21 89.55 5.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.452 -0.78 . . . . 0.0 109.007 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.35 32.22 28.84 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.49 2.9 46.28 Favored Glycine 0 N--CA 1.492 2.396 0 O-C-N 121.512 -0.993 . . . . 0.0 110.985 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.649 ' HB2' HD13 ' B' ' 15' ' ' LEU . 5.1 p90 -143.7 -178.88 6.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.945 -1.326 . . . . 0.0 110.259 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.461 ' CE1' ' HD3' ' B' ' 28' ' ' PRO . 8.2 t80 -58.38 109.13 0.72 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.693 0.759 . . . . 0.0 110.429 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.84 91.43 6.64 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.461 ' HD3' ' CE1' ' B' ' 26' ' ' TYR . 3.3 Cg_exo -52.69 83.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 123.526 2.817 . . . . 0.0 111.433 -177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.076 179.634 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.51 HG23 ' H ' ' A' ' 3' ' ' VAL . 7.2 tt -167.53 -55.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.34 -1.094 . . . . 0.0 109.444 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.615 HG22 HD22 ' B' ' 11' ' ' LEU . 26.3 t -93.28 -31.25 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.12 -0.987 . . . . 0.0 110.007 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -74.83 -3.1 29.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.747 . . . . 0.0 111.026 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -90.59 -17.44 26.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.008 -1.058 . . . . 0.0 110.685 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.668 ' CB ' HD23 ' B' ' 6' ' ' LEU . 63.5 m -135.87 19.23 3.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.121 -0.987 . . . . 0.0 110.666 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.0 t -83.58 -32.31 25.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.216 -0.927 . . . . 0.0 109.508 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -73.35 -52.67 13.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.364 -0.835 . . . . 0.0 109.647 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.9 p -109.89 -169.38 1.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.629 -0.669 . . . . 0.0 109.721 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.651 HG23 ' O ' ' B' ' 4' ' ' GLN . 58.3 mt -110.0 99.95 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.696 -0.628 . . . . 0.0 109.766 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.1 m -61.95 -174.24 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.544 -0.723 . . . . 0.0 109.386 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.474 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -107.55 175.61 5.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.595 -0.691 . . . . 0.0 109.216 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -67.63 -12.13 59.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.728 -0.608 . . . . 0.0 110.792 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.474 ' CE2' ' HB2' ' A' ' 12' ' ' SER . 15.4 p90 -68.07 -22.34 64.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.127 -0.983 . . . . 0.0 110.412 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.06 -58.68 2.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.323 -0.861 . . . . 0.0 110.106 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.773 HD22 HD23 ' B' ' 15' ' ' LEU . 32.6 mt -64.31 -14.22 54.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.526 -0.734 . . . . 0.0 110.875 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -30.34 71.41 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.104 -0.997 . . . . 0.0 109.4 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -97.8 29.53 3.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.547 -0.721 . . . . 0.0 109.771 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -110.5 8.77 23.17 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.53 -0.731 . . . . 0.0 110.138 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.5 m -97.49 29.26 3.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.205 -0.934 . . . . 0.0 109.56 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.27 -179.958 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.587 ' CZ ' HD22 ' B' ' 17' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.422 HG22 ' CD2' ' B' ' 1' ' ' PHE . 17.3 m -88.98 -34.39 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.76 34.2 0.3 Allowed 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.651 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -123.69 155.85 37.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.779 -0.575 . . . . 0.0 109.826 -178.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.433 ' CE1' HG12 ' A' ' 10' ' ' ILE . 7.0 m80 -106.2 156.65 18.25 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 16' ' ' LEU . 2.0 mm? -109.12 101.14 10.22 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.248 -0.908 . . . . 0.0 109.997 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.61 120.61 0.05 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.82 -149.16 28.05 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.62 -15.72 63.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.539 -0.977 . . . . 0.0 110.047 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -60.86 -30.8 70.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.156 -0.965 . . . . 0.0 109.783 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.615 HD22 HG22 ' A' ' 3' ' ' VAL . 58.3 tp -70.89 -52.32 20.82 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.512 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 18.7 t -53.51 -49.43 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.506 -0.746 . . . . 0.0 110.401 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.02 -31.28 69.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.571 -0.705 . . . . 0.0 109.597 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.754 ' HB1' HD13 ' A' ' 16' ' ' LEU . . . -68.55 -34.16 75.35 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.773 HD23 HD22 ' A' ' 16' ' ' LEU . 23.9 mt -75.35 -25.51 57.82 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -74.34 -31.61 62.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 109.124 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.587 HD22 ' CZ ' ' B' ' 1' ' ' PHE . 0.2 OUTLIER -80.1 -33.99 38.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.639 -0.663 . . . . 0.0 109.538 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.576 HG23 ' O ' ' B' ' 14' ' ' ALA . 39.1 t -81.28 -69.27 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.654 -0.654 . . . . 0.0 109.784 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 55.7 m -57.94 -66.52 0.46 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.357 -0.839 . . . . 0.0 109.786 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.25 -38.3 3.22 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.6 -173.44 1.16 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.51 -0.994 . . . . 0.0 109.486 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.86 -64.71 1.02 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.557 -0.714 . . . . 0.0 109.703 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.86 41.79 2.29 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.01 35.04 5.18 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -176.11 -172.02 0.47 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.57 -0.959 . . . . 0.0 109.738 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -52.04 110.51 0.49 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.378 -0.827 . . . . 0.0 109.909 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.12 94.16 41.05 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.602 -0.686 . . . . 0.0 109.672 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.33 109.94 0.54 Allowed 'Trans proline' 0 N--CA 1.484 0.933 0 C-N-CA 122.476 2.117 . . . . 0.0 110.05 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.988 179.92 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.749 HG23 HG23 ' A' ' 3' ' ' VAL . 9.3 tt -141.37 -44.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.513 -0.992 . . . . 0.0 109.439 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.749 HG23 HG23 ' A' ' 2' ' ' ILE . 42.9 t -90.48 -46.36 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.534 -0.729 . . . . 0.0 109.118 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.65 -22.19 61.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.684 -0.635 . . . . 0.0 110.262 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -63.55 -42.48 98.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.463 -0.773 . . . . 0.0 110.372 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.476 ' HB2' HD23 ' B' ' 6' ' ' LEU . 57.6 m -119.76 27.44 8.72 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.59 -43.62 15.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.75 . . . . 0.0 109.437 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 t -84.76 -27.85 26.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.604 -0.685 . . . . 0.0 109.965 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -116.99 168.47 10.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.473 -0.767 . . . . 0.0 109.362 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.457 HG12 ' CE1' ' B' ' 5' ' ' HIS . 10.7 mt -107.66 90.02 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.502 -0.749 . . . . 0.0 109.162 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.5 m -60.19 -169.44 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.367 -0.833 . . . . 0.0 109.602 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.468 ' CB ' ' CE2' ' A' ' 14' ' ' TYR . 48.7 m -94.21 160.4 14.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.612 -0.68 . . . . 0.0 109.249 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 13' ' ' LEU . 3.4 tm? -71.59 -26.6 62.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.627 -0.671 . . . . 0.0 109.904 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.468 ' CE2' ' CB ' ' A' ' 12' ' ' SER . 12.5 p90 -64.88 -18.16 64.94 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.495 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -78.77 -44.58 22.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.298 -0.876 . . . . 0.0 109.061 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.58 HD22 ' CD2' ' B' ' 15' ' ' LEU . 1.5 mt -64.88 -19.69 66.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.584 -0.697 . . . . 0.0 109.643 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -55.8 -21.28 18.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 0.0 110.563 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -94.49 32.78 1.51 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.284 -0.885 . . . . 0.0 109.644 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.462 ' CG ' HD23 ' A' ' 16' ' ' LEU . 8.3 m-85 -114.91 11.5 16.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.429 -0.795 . . . . 0.0 110.08 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' B' ' 25' ' ' PHE . 84.5 m -97.15 28.78 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.169 -0.957 . . . . 0.0 109.536 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 m120 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.548 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.808 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.711 HG12 ' CD1' ' B' ' 1' ' ' PHE . 7.5 p -161.68 -43.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 109.062 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.445 ' N ' HG13 ' B' ' 2' ' ' VAL . 17.4 m120 -156.98 29.16 0.31 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 109.159 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -143.42 131.8 22.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.534 -0.729 . . . . 0.0 109.568 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.457 ' CE1' HG12 ' A' ' 10' ' ' ILE . 79.3 m80 -81.51 164.04 22.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.649 -0.657 . . . . 0.0 109.476 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.701 HD22 ' N ' ' B' ' 6' ' ' LEU . 1.5 mm? -109.56 82.09 1.54 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.527 -0.733 . . . . 0.0 109.404 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 74.3 m -130.91 121.52 25.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.506 -0.746 . . . . 0.0 109.828 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.71 -128.32 8.4 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 93.4 p -84.43 -9.72 58.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.689 -0.889 . . . . 0.0 110.396 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -61.32 -27.89 68.81 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.011 -1.055 . . . . 0.0 109.348 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' B' ' 6' ' ' LEU . 56.3 tp -70.47 -61.97 1.57 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.466 -0.771 . . . . 0.0 108.94 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.402 ' H ' HG23 ' B' ' 12' ' ' VAL . 36.0 t -47.21 -49.74 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.724 -0.61 . . . . 0.0 111.454 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -56.53 -39.14 72.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.372 -0.83 . . . . 0.0 110.441 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.83 -28.88 64.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.441 -0.787 . . . . 0.0 109.886 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.58 ' CD2' HD22 ' A' ' 16' ' ' LEU . 50.8 mt -65.55 -38.5 89.77 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -66.01 -34.19 77.52 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.808 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 2.2 tp -61.39 -34.02 74.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.685 -0.634 . . . . 0.0 109.354 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.523 ' CG2' HD21 ' A' ' 13' ' ' LEU . 45.2 t -87.78 -75.19 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.527 -0.733 . . . . 0.0 109.951 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -75.74 -76.36 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.254 -0.904 . . . . 0.0 109.064 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.07 17.66 26.81 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.81 160.21 16.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.348 -1.089 . . . . 0.0 108.9 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -39.83 61.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.449 -0.782 . . . . 0.0 109.493 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.23 61.85 0.62 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.7 -41.0 0.36 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 21.3 p90 -102.87 -175.83 2.92 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.57 -0.959 . . . . 0.0 110.23 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -58.21 127.4 31.9 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.57 0.7 . . . . 0.0 110.326 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.73 94.77 31.02 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -56.52 155.25 26.67 Favored 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 122.33 2.02 . . . . 0.0 110.244 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.514 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.761 HG23 HG23 ' A' ' 3' ' ' VAL . 3.2 tp -67.55 -43.73 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.655 -0.909 . . . . 0.0 109.574 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.761 HG23 HG23 ' A' ' 2' ' ' ILE . 23.8 t -90.24 0.03 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.465 -0.772 . . . . 0.0 110.772 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -96.9 27.06 4.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.973 -1.079 . . . . 0.0 109.775 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.28 -30.66 7.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.0 9.36 6.3 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.548 -0.72 . . . . 0.0 110.505 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 46.6 t -82.01 84.82 6.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.087 -1.008 . . . . 0.0 108.964 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.7 m -160.95 -42.92 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.488 -0.758 . . . . 0.0 109.944 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.464 ' HA ' ' CE1' ' B' ' 5' ' ' HIS . 11.6 t -154.06 -125.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.731 . . . . 0.0 109.368 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.624 HD13 ' N ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -101.61 105.63 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.582 -1.324 . . . . 0.0 108.686 -179.193 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -82.13 155.72 24.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.673 -0.642 . . . . 0.0 109.512 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.2 p -95.65 151.78 19.04 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.853 HD13 ' O ' ' A' ' 13' ' ' LEU . 1.3 tm? -66.49 -26.72 67.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.647 -0.658 . . . . 0.0 109.437 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -51.94 -24.82 6.98 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.148 -0.97 . . . . 0.0 110.603 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -87.89 -44.23 11.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.348 -0.845 . . . . 0.0 109.966 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.717 HD11 HD21 ' B' ' 6' ' ' LEU . 4.2 mt -65.01 -16.21 63.18 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.436 -0.79 . . . . 0.0 110.5 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.15 -23.56 35.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.177 -0.952 . . . . 0.0 110.307 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -96.64 37.92 1.25 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.479 -0.763 . . . . 0.0 109.802 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.603 ' CG ' HD23 ' A' ' 16' ' ' LEU . 7.2 m-85 -115.99 -0.91 12.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.484 -0.76 . . . . 0.0 110.554 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.5 m -88.62 11.12 18.23 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.082 -1.011 . . . . 0.0 110.57 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.9 p30 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.098 -1.001 . . . . 0.0 109.581 179.879 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.631 ' CE1' HD23 ' A' ' 13' ' ' LEU . 9.1 p90 . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 120.473 0.178 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 35.1 m -63.09 -29.67 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.167 -0.958 . . . . 0.0 109.254 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -142.97 30.09 1.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -130.52 -179.21 5.14 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.464 ' CE1' ' HA ' ' A' ' 9' ' ' SER . 12.3 m-70 -109.15 149.55 29.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.338 -0.851 . . . . 0.0 109.524 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.717 HD21 HD11 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -93.28 100.01 12.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.563 -0.71 . . . . 0.0 110.123 -179.058 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.67 142.58 0.14 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.586 -0.696 . . . . 0.0 109.236 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.23 -115.33 4.08 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.38 -19.62 18.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.674 -0.898 . . . . 0.0 109.956 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -56.68 -28.18 60.27 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.012 -1.055 . . . . 0.0 109.445 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.524 HD22 ' HG ' ' B' ' 6' ' ' LEU . 0.6 OUTLIER -64.73 -60.03 3.56 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 25.2 t -52.62 -47.32 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.835 -0.541 . . . . 0.0 111.577 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -58.93 -30.77 68.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.292 -0.88 . . . . 0.0 110.353 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.805 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -77.92 -27.39 49.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.506 -0.747 . . . . 0.0 109.796 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.586 HD23 HD22 ' A' ' 16' ' ' LEU . 45.3 mt -70.49 -37.89 74.27 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.294 -0.879 . . . . 0.0 108.941 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -76.11 -34.55 59.48 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -30.01 69.71 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.805 HG23 ' O ' ' B' ' 14' ' ' ALA . 33.0 t -86.82 -69.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.531 -0.73 . . . . 0.0 109.479 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 11.6 m -88.68 -70.16 0.66 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.557 -0.714 . . . . 0.0 109.335 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.44 36.97 22.14 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -86.51 177.29 7.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.53 -0.982 . . . . 0.0 109.119 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -82.74 80.27 8.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.524 -0.735 . . . . 0.0 109.204 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.81 63.27 2.91 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.83 22.13 5.8 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -151.1 -173.19 4.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.263 -1.139 . . . . 0.0 109.573 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.404 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 3.6 t80 -49.95 101.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.54 -0.725 . . . . 0.0 110.085 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.42 90.91 36.32 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.404 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 4.9 Cg_exo -56.81 105.53 0.18 Allowed 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 122.625 2.217 . . . . 0.0 110.094 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.384 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.396 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.537 HG23 HG23 ' A' ' 3' ' ' VAL . 1.9 tt -62.63 -41.78 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.997 . . . . 0.0 109.022 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.537 HG23 HG23 ' A' ' 2' ' ' ILE . 21.3 t -87.5 -30.76 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.518 -0.739 . . . . 0.0 109.03 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -70.17 -10.08 57.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.622 -0.674 . . . . 0.0 110.037 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.52 -65.7 0.51 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.074 -1.016 . . . . 0.0 110.004 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.0 m -129.68 36.83 4.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.478 -0.764 . . . . 0.0 110.336 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.0 t -54.17 -55.46 27.65 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.187 -0.946 . . . . 0.0 109.335 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -92.64 49.74 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.528 -0.733 . . . . 0.0 109.454 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -176.56 163.2 2.37 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.44 HG12 ' CE1' ' B' ' 5' ' ' HIS . 16.8 mt -103.69 86.81 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.426 -0.797 . . . . 0.0 109.166 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -178.83 0.1 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.765 -0.584 . . . . 0.0 110.079 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -91.71 166.12 12.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.708 -0.62 . . . . 0.0 109.623 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.737 HD13 ' O ' ' A' ' 13' ' ' LEU . 3.5 tm? -66.51 -32.11 73.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.669 -0.644 . . . . 0.0 109.679 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -27.14 63.99 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.335 -0.853 . . . . 0.0 109.694 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -67.39 -50.12 60.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.459 -0.776 . . . . 0.0 109.508 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.864 HD11 HD22 ' B' ' 6' ' ' LEU . 10.2 mt -65.43 -16.65 63.85 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.431 -0.793 . . . . 0.0 110.25 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.91 -19.41 42.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.249 -0.907 . . . . 0.0 110.354 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -96.27 30.63 2.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.264 -0.898 . . . . 0.0 109.801 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.486 ' HB3' HD22 ' B' ' 15' ' ' LEU . 6.4 m-85 -114.69 -14.91 11.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.6 -0.687 . . . . 0.0 110.026 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.9 m -73.56 -20.15 60.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.136 -0.978 . . . . 0.0 110.22 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.7 p30 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.415 179.78 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.919 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.574 HG23 ' CD1' ' B' ' 1' ' ' PHE . 18.4 t -83.48 -69.59 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.595 -1.316 . . . . 0.0 109.081 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.508 ' OD1' HG12 ' B' ' 2' ' ' VAL . 34.4 m120 -154.35 24.63 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.532 -0.73 . . . . 0.0 109.935 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -115.47 142.11 47.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.448 -0.782 . . . . 0.0 109.328 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.44 ' CE1' HG12 ' A' ' 10' ' ' ILE . 49.8 m80 -70.51 -178.47 1.78 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.63 -0.669 . . . . 0.0 109.866 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.864 HD22 HD11 ' A' ' 16' ' ' LEU . 38.0 mt -130.63 42.18 3.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.501 -0.749 . . . . 0.0 110.854 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.67 140.78 52.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.212 -0.93 . . . . 0.0 109.281 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.66 -144.61 21.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.3 -14.67 60.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.456 -1.026 . . . . 0.0 109.893 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -60.43 -37.86 82.26 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.082 -1.011 . . . . 0.0 109.126 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.457 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 2.5 tt -61.65 -58.5 7.81 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.806 -0.559 . . . . 0.0 109.696 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 t -49.56 -51.06 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.625 -0.672 . . . . 0.0 111.22 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -58.61 -33.65 70.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.368 -0.832 . . . . 0.0 110.092 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.447 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -70.45 -30.56 67.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.548 -0.72 . . . . 0.0 109.7 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.751 ' CD2' HD22 ' A' ' 16' ' ' LEU . 30.2 mt -69.25 -36.52 77.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.75 -29.94 66.31 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.919 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 1.5 tp -68.66 -35.47 77.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.602 -0.686 . . . . 0.0 109.436 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 14' ' ' ALA . 39.7 t -80.84 -69.81 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.543 -0.723 . . . . 0.0 109.726 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.56 -81.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.472 -0.768 . . . . 0.0 109.416 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 139.19 -52.05 0.73 Allowed Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.671 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -90.34 152.02 21.2 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.34 -1.094 . . . . 0.0 110.062 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 19.3 mtt180 -76.03 139.03 41.25 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.22 17.62 57.11 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.6 33.56 5.18 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.456 ' CD1' ' CB ' ' B' ' 15' ' ' LEU . 27.0 p90 -176.83 -169.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.717 -0.872 . . . . 0.0 109.016 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -51.52 99.93 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.294 -0.879 . . . . 0.0 109.82 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 19.5 p -132.61 89.88 34.55 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.8 146.66 91.98 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 122.394 2.062 . . . . 0.0 110.159 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.6 mttt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.527 -179.949 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.424 HG21 ' CE1' ' A' ' 19' ' ' TYR . 4.3 mp -113.42 -55.81 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.585 -0.95 . . . . 0.0 109.735 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.504 HG23 ' OH ' ' A' ' 19' ' ' TYR . 23.6 t -65.99 -34.81 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.544 -0.723 . . . . 0.0 109.403 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.25 -21.26 63.73 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.442 -0.786 . . . . 0.0 110.04 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -111.79 -3.52 14.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.383 -0.823 . . . . 0.0 110.951 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.4 m -121.26 18.78 11.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.983 -1.073 . . . . 0.0 110.529 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.02 21.68 13.57 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.164 -0.96 . . . . 0.0 109.828 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.6 m -129.73 -66.22 0.8 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 108.83 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.99 -164.88 1.21 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.585 HD13 ' NE2' ' B' ' 5' ' ' HIS . 4.5 mm -90.82 98.55 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.4 -0.813 . . . . 0.0 108.941 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -70.69 -167.76 0.21 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.671 -0.643 . . . . 0.0 109.747 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.02 156.12 44.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.509 -0.744 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.863 HD13 ' O ' ' A' ' 13' ' ' LEU . 3.2 tm? -66.78 -26.32 66.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.619 -0.676 . . . . 0.0 110.521 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.89 -22.32 14.41 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.073 -1.017 . . . . 0.0 110.561 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -86.39 -39.94 15.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.419 -0.801 . . . . 0.0 109.437 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.665 HD11 HD11 ' B' ' 6' ' ' LEU . 6.5 mt -68.64 -10.78 58.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.489 -0.757 . . . . 0.0 110.258 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -67.51 -28.43 67.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 109.412 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -71.01 -12.16 61.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.553 -0.717 . . . . 0.0 110.622 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.504 ' OH ' HG23 ' A' ' 3' ' ' VAL . 5.3 m-85 -74.59 -7.8 54.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.32 -0.862 . . . . 0.0 110.47 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 27.9 m -97.64 33.44 2.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.132 -0.98 . . . . 0.0 109.596 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.533 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.7 ' CD1' HD23 ' A' ' 13' ' ' LEU . 8.5 p90 . . . . . 0 N--CA 1.5 2.036 0 CA-C-O 120.464 0.173 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.94 -33.16 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.056 -1.027 . . . . 0.0 108.734 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -144.27 30.04 1.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -126.65 -159.5 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.585 ' NE2' HD13 ' A' ' 10' ' ' ILE . 20.3 m80 -115.97 -172.82 2.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.349 -0.844 . . . . 0.0 109.829 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.665 HD11 HD11 ' A' ' 16' ' ' LEU . 4.4 tp -130.45 43.57 3.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.572 -0.705 . . . . 0.0 110.178 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 59.5 m -122.86 136.29 54.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.509 -0.744 . . . . 0.0 109.464 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.94 -132.94 11.43 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -81.53 2.86 27.11 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.646 -0.914 . . . . 0.0 110.33 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -77.13 -37.18 54.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.053 -1.03 . . . . 0.0 108.733 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 36.9 tp -68.17 -63.69 1.01 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -52.54 -49.77 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.658 -0.651 . . . . 0.0 110.641 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -59.54 -30.79 68.86 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.329 -0.857 . . . . 0.0 109.658 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.42 -32.13 68.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.636 -0.665 . . . . 0.0 109.764 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.65 ' CD2' HD22 ' A' ' 16' ' ' LEU . 38.2 mt -68.92 -39.66 79.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.471 -0.768 . . . . 0.0 109.162 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -67.49 -34.0 76.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.692 . . . . 0.0 109.522 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.33 -46.21 74.13 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.553 -0.717 . . . . 0.0 109.677 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.629 ' CG2' HD21 ' A' ' 13' ' ' LEU . 44.3 t -67.42 -69.81 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.506 -0.746 . . . . 0.0 109.355 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.88 -79.46 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.483 -0.76 . . . . 0.0 108.992 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.44 -28.02 14.92 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.93 170.12 4.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.423 -1.045 . . . . 0.0 109.764 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.74 138.87 31.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.546 -0.721 . . . . 0.0 109.395 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.56 29.6 69.97 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.78 27.7 10.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.473 ' HB2' HD13 ' B' ' 15' ' ' LEU . 12.5 p90 -177.72 -177.32 0.65 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -1.073 . . . . 0.0 110.177 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -57.49 125.97 25.24 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.6 -0.687 . . . . 0.0 109.893 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 8.8 p -117.63 96.36 49.28 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.574 -0.703 . . . . 0.0 109.257 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -57.79 162.46 10.82 Favored 'Trans proline' 0 N--CA 1.483 0.878 0 C-N-CA 122.487 2.124 . . . . 0.0 110.169 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.443 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.646 HG23 HG23 ' A' ' 3' ' ' VAL . 8.2 tt -171.99 -50.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.658 -0.907 . . . . 0.0 109.138 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.646 HG23 HG23 ' A' ' 2' ' ' ILE . 31.4 t -92.54 -61.38 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.365 -0.834 . . . . 0.0 109.122 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -60.28 -18.51 49.68 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.58 -0.7 . . . . 0.0 110.082 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -52.64 -59.32 4.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.249 -0.907 . . . . 0.0 110.309 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -124.23 36.02 4.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.524 -0.735 . . . . 0.0 109.515 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' B' ' 6' ' ' LEU . 0.1 OUTLIER -62.59 -43.16 99.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.625 -0.672 . . . . 0.0 109.555 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 m -87.41 -33.67 19.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.534 -0.729 . . . . 0.0 109.75 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -94.45 -177.63 4.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.457 -0.777 . . . . 0.0 109.449 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.593 ' CG1' ' CE1' ' B' ' 5' ' ' HIS . 19.5 mt -114.73 99.95 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.377 -0.827 . . . . 0.0 109.409 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.33 -177.87 6.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.567 -0.708 . . . . 0.0 109.304 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.12 153.95 19.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.507 -0.746 . . . . 0.0 109.424 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.685 HD11 HG22 ' B' ' 18' ' ' VAL . 59.5 tp -57.86 -20.32 35.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.597 -0.689 . . . . 0.0 110.826 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -53.24 -28.19 26.05 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.22 -0.925 . . . . 0.0 111.697 -178.424 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.443 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 14.3 pt20 -80.06 -44.37 20.18 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.104 -0.997 . . . . 0.0 109.66 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.641 HD22 HD23 ' B' ' 15' ' ' LEU . 9.9 mt -67.0 -16.43 64.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.51 -0.744 . . . . 0.0 109.649 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.62 -17.92 50.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.173 -0.954 . . . . 0.0 109.84 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -93.27 27.28 2.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 0.0 109.869 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.493 ' CD2' HD22 ' B' ' 15' ' ' LEU . 6.3 m-85 -107.16 -20.59 13.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.365 -0.834 . . . . 0.0 109.966 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.3 m -75.88 -4.2 39.51 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.275 -0.89 . . . . 0.0 110.287 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p30 . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.004 -1.06 . . . . 0.0 109.548 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.859 ' CZ ' HD22 ' B' ' 17' ' ' LEU . 3.3 t80 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.532 HG12 ' OD1' ' B' ' 3' ' ' ASN . 9.0 t -46.35 -64.65 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 O-C-N 121.65 -0.656 . . . . 0.0 110.52 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.532 ' OD1' HG12 ' B' ' 2' ' ' VAL . 0.9 OUTLIER -174.4 36.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -122.26 148.81 44.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.609 -0.682 . . . . 0.0 109.258 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.593 ' CE1' ' CG1' ' A' ' 10' ' ' ILE . 46.6 m-70 -78.38 -178.31 5.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.642 -0.661 . . . . 0.0 109.576 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -142.42 131.96 23.83 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.481 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.95 -76.71 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.146 -0.971 . . . . 0.0 109.595 178.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.08 -121.59 0.06 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 22.3 p -73.58 -8.54 56.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.47 -1.018 . . . . 0.0 109.445 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -61.28 -41.82 97.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.877 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.473 ' CD1' HD21 ' A' ' 16' ' ' LEU . 67.2 tp -60.46 -56.29 23.14 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.485 -0.76 . . . . 0.0 109.682 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.4 t -49.76 -53.77 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.567 -0.708 . . . . 0.0 111.081 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -58.07 -31.93 67.55 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.437 -0.789 . . . . 0.0 110.188 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.424 ' HA ' ' CE1' ' B' ' 1' ' ' PHE . . . -69.13 -34.11 74.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.482 -0.762 . . . . 0.0 109.654 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.641 HD23 HD22 ' A' ' 16' ' ' LEU . 25.8 mt -70.81 -32.94 70.19 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -68.29 -33.72 74.87 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.859 HD22 ' CZ ' ' B' ' 1' ' ' PHE . 0.5 OUTLIER -69.14 -39.22 78.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.689 -0.632 . . . . 0.0 109.745 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.685 HG22 HD11 ' A' ' 13' ' ' LEU . 30.8 t -72.84 -68.2 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.57 -0.706 . . . . 0.0 110.135 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 10.6 m -65.15 -69.19 0.31 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.417 -0.802 . . . . 0.0 109.195 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.0 -36.52 3.52 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.28 167.43 12.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.338 -1.095 . . . . 0.0 109.928 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.56 -63.56 1.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.81 86.26 0.97 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -161.5 -41.38 0.02 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.531 ' O ' HG23 ' B' ' 27' ' ' THR . 28.0 p90 -116.43 -174.49 2.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.409 -1.053 . . . . 0.0 110.446 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.412 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 2.9 t80 -54.5 100.0 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.531 HG23 ' O ' ' B' ' 25' ' ' PHE . 40.4 p -113.1 92.46 21.74 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.653 -0.654 . . . . 0.0 109.57 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.412 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 2.4 Cg_endo -60.49 89.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 122.422 2.081 . . . . 0.0 109.776 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.518 -179.821 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.469 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.811 HG23 HG23 ' A' ' 3' ' ' VAL . 1.1 tp -128.21 -44.21 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.495 -1.003 . . . . 0.0 109.321 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.811 HG23 HG23 ' A' ' 2' ' ' ILE . 19.0 t -90.96 -28.83 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.645 -0.659 . . . . 0.0 109.406 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -74.81 -5.55 44.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.557 -0.715 . . . . 0.0 110.195 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -58.24 -63.21 1.35 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.196 -0.94 . . . . 0.0 110.013 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.553 ' SG ' HD12 ' B' ' 6' ' ' LEU . 4.5 p -120.48 27.32 8.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.477 -0.764 . . . . 0.0 110.279 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -32.09 54.36 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.217 -0.927 . . . . 0.0 109.389 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -113.42 -32.73 6.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.676 -0.64 . . . . 0.0 109.325 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.431 ' O ' ' CD2' ' B' ' 5' ' ' HIS . 0.4 OUTLIER -98.85 -171.41 2.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.449 -0.782 . . . . 0.0 108.926 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.482 HD13 ' NE2' ' B' ' 5' ' ' HIS . 1.7 mm -104.21 160.64 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.361 -0.837 . . . . 0.0 109.008 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.406 ' SG ' HD12 ' B' ' 6' ' ' LEU . 4.0 p -147.27 179.56 7.56 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.507 -0.746 . . . . 0.0 109.806 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.467 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -82.8 102.06 11.34 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.87 HD11 HD21 ' B' ' 6' ' ' LEU . 3.1 mm? -70.27 -14.61 62.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.545 -0.722 . . . . 0.0 110.859 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' A' ' 12' ' ' SER . 17.3 p90 -71.25 -18.92 62.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.088 -1.008 . . . . 0.0 109.779 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -84.18 -3.24 58.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.359 -0.838 . . . . 0.0 110.416 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.745 HD12 ' CD1' ' A' ' 13' ' ' LEU . 4.4 mt -65.7 -14.15 60.7 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.134 -0.979 . . . . 0.0 109.99 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -59.06 -19.65 46.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.164 -0.96 . . . . 0.0 110.002 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -96.89 31.95 2.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.296 -0.878 . . . . 0.0 109.438 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.77 ' CZ ' HD11 ' A' ' 2' ' ' ILE . 6.4 m-85 -115.19 12.97 16.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.435 -0.79 . . . . 0.0 109.95 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.81 -56.11 5.12 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.231 -0.918 . . . . 0.0 109.571 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.297 -1.713 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.326 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.427 ' HE2' HD22 ' B' ' 17' ' ' LEU . 13.3 p90 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 120.613 0.244 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 24.5 t -51.89 -25.72 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 120.962 -1.087 . . . . 0.0 110.469 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -151.57 27.14 0.66 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 109.303 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' B' ' 5' ' ' HIS . 5.8 mp0 -107.24 -97.21 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.441 -0.787 . . . . 0.0 109.329 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.482 ' NE2' HD13 ' A' ' 10' ' ' ILE . 1.1 m80 -173.1 152.58 2.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.833 -1.167 . . . . 0.0 109.86 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.87 HD21 HD11 ' A' ' 13' ' ' LEU . 21.9 mt -115.11 86.15 2.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.635 -0.666 . . . . 0.0 109.511 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -150.2 129.95 13.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.48 -0.762 . . . . 0.0 109.481 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.29 -136.48 14.46 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.42 -6.81 57.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.494 -1.003 . . . . 0.0 110.364 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -66.57 -29.68 69.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 109.691 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.808 ' CD2' HG22 ' A' ' 3' ' ' VAL . 60.7 tp -71.25 -46.28 61.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.486 -0.759 . . . . 0.0 109.544 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.411 HG13 ' O ' ' B' ' 26' ' ' TYR . 39.3 t -60.66 -43.79 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.672 -0.643 . . . . 0.0 109.952 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.77 -39.51 94.41 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.435 -0.791 . . . . 0.0 109.302 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.768 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -66.32 -30.39 70.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.607 -0.683 . . . . 0.0 109.769 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.691 HD22 HD22 ' A' ' 16' ' ' LEU . 1.2 mt -70.4 -36.18 73.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.507 -0.745 . . . . 0.0 109.416 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -70.3 -32.55 70.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.581 -0.699 . . . . 0.0 109.607 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.427 HD22 ' HE2' ' B' ' 1' ' ' PHE . 0.3 OUTLIER -79.82 -24.67 41.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.477 -0.764 . . . . 0.0 110.086 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.768 HG23 ' O ' ' B' ' 14' ' ' ALA . 41.9 t -89.48 -68.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.246 -0.909 . . . . 0.0 109.801 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 m -53.71 -78.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.39 -0.819 . . . . 0.0 110.269 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.33 -40.42 1.56 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.84 176.02 1.03 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.287 -1.125 . . . . 0.0 109.593 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.42 -44.35 6.55 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.53 ' HA2' HG21 ' B' ' 27' ' ' THR . . . -118.75 42.97 1.68 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.28 38.16 3.21 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.477 ' CD1' ' HB2' ' B' ' 15' ' ' LEU . 52.5 p90 -178.4 -166.71 0.11 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.397 -1.061 . . . . 0.0 109.522 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.519 ' CB ' HD12 ' B' ' 15' ' ' LEU . 0.4 OUTLIER -47.29 94.38 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.868 -0.52 . . . . 0.0 110.188 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.53 HG21 ' HA2' ' B' ' 23' ' ' GLY . 0.8 OUTLIER -127.33 98.86 28.58 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -56.95 142.14 93.61 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.3 2.0 . . . . 0.0 110.047 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.453 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.782 HG23 HG23 ' A' ' 3' ' ' VAL . 4.4 tt -67.04 -44.56 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.678 -0.895 . . . . 0.0 109.669 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.782 HG23 HG23 ' A' ' 2' ' ' ILE . 21.0 t -90.76 -13.23 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.445 -0.785 . . . . 0.0 110.221 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -90.52 53.58 2.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.233 -0.917 . . . . 0.0 109.044 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -142.22 -46.32 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.539 -0.726 . . . . 0.0 109.368 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.592 ' CB ' HD23 ' B' ' 6' ' ' LEU . 8.0 m -115.6 15.87 16.55 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.539 -0.726 . . . . 0.0 109.952 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 45.3 t -72.93 -35.77 67.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.09 -1.006 . . . . 0.0 109.314 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 m -73.22 -58.14 3.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.487 -0.758 . . . . 0.0 109.797 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.4 p -119.62 -167.86 1.49 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.502 -0.749 . . . . 0.0 109.815 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.423 HG12 ' CE1' ' B' ' 5' ' ' HIS . 7.4 mt -101.82 130.16 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.0 p -106.23 -172.9 2.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.31 -0.869 . . . . 0.0 110.429 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.57 144.8 55.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.573 -0.705 . . . . 0.0 110.787 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.825 HD13 ' O ' ' A' ' 13' ' ' LEU . 3.4 tm? -69.15 -30.25 68.44 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -22.29 22.09 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.489 -0.757 . . . . 0.0 109.94 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -72.45 -46.74 53.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.36 -0.838 . . . . 0.0 109.487 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.701 HD11 ' HG ' ' B' ' 6' ' ' LEU . 5.4 mt -65.4 -21.62 66.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.516 -0.74 . . . . 0.0 110.093 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.77 -26.92 58.69 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.226 -0.921 . . . . 0.0 110.308 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -97.74 35.88 1.61 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.377 -0.827 . . . . 0.0 109.672 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.453 ' HB3' HD22 ' B' ' 15' ' ' LEU . 7.1 m-85 -113.8 -0.98 14.04 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.501 -0.75 . . . . 0.0 110.383 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.2 m -81.15 1.77 30.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.145 -0.972 . . . . 0.0 110.469 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 120.999 -1.063 . . . . 0.0 109.571 -179.817 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.445 ' CD2' HD23 ' A' ' 13' ' ' LEU . 1.2 t80 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 28.8 m -50.49 172.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.444 -0.785 . . . . 0.0 110.703 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -58.59 92.54 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.464 -0.772 . . . . 0.0 109.901 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -130.4 104.99 7.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.556 -0.715 . . . . 0.0 109.385 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.423 ' CE1' HG12 ' A' ' 10' ' ' ILE . 70.9 m80 -74.4 135.07 42.39 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.835 ' HB3' HD13 ' B' ' 11' ' ' LEU . 0.2 OUTLIER -86.95 98.25 11.14 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.483 -0.761 . . . . 0.0 109.734 -179.274 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -178.46 127.36 0.11 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.694 . . . . 0.0 109.422 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.83 -141.17 26.95 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p -69.23 -16.66 63.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.561 -0.964 . . . . 0.0 110.169 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -67.81 -38.76 83.68 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.176 -0.953 . . . . 0.0 109.575 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.835 HD13 ' HB3' ' B' ' 6' ' ' LEU . 66.7 tp -68.69 -46.19 69.68 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.654 -0.654 . . . . 0.0 109.379 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.411 HG23 ' H ' ' B' ' 12' ' ' VAL . 8.7 t -55.97 -49.9 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.428 -0.795 . . . . 0.0 110.073 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -62.31 -26.33 68.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.556 -0.715 . . . . 0.0 109.578 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.745 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -71.85 -32.26 67.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.641 -0.662 . . . . 0.0 109.293 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.578 HD23 HD22 ' A' ' 16' ' ' LEU . 24.0 mt -79.33 -26.58 42.13 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.48 -29.79 61.58 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -83.35 -32.31 26.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.494 -0.754 . . . . 0.0 109.477 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.745 HG23 ' O ' ' B' ' 14' ' ' ALA . 45.3 t -81.28 -68.88 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.528 -0.732 . . . . 0.0 109.506 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 60.5 m -54.33 -73.29 0.05 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.496 -0.753 . . . . 0.0 110.428 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.76 -45.88 1.1 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 174.12 8.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.377 -1.072 . . . . 0.0 109.688 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.67 31.44 5.46 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.18 37.15 0.09 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.91 46.75 1.06 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.459 ' CG ' ' HB3' ' B' ' 15' ' ' LEU . 14.5 p90 -179.33 -173.62 0.28 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.465 -1.021 . . . . 0.0 109.877 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.4 ' HB3' ' CD1' ' B' ' 15' ' ' LEU . 4.8 t80 -54.46 108.36 0.37 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.509 -0.744 . . . . 0.0 109.482 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.78 93.32 46.09 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.715 -0.615 . . . . 0.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -58.24 110.75 0.69 Allowed 'Trans proline' 0 N--CA 1.484 0.952 0 C-N-CA 122.529 2.153 . . . . 0.0 109.979 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 tptt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.393 179.943 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.559 HG23 HD13 ' B' ' 6' ' ' LEU . 0.3 OUTLIER -109.62 -48.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.561 -0.964 . . . . 0.0 108.881 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.889 ' CG2' HD22 ' B' ' 11' ' ' LEU . 3.7 t -83.68 -48.35 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.684 -0.635 . . . . 0.0 110.016 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.37 -8.87 54.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.431 -0.793 . . . . 0.0 110.866 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.69 -14.56 8.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.154 -0.966 . . . . 0.0 110.883 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.483 ' HB2' HD12 ' B' ' 6' ' ' LEU . 11.9 m -120.19 24.44 10.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.027 -1.046 . . . . 0.0 110.12 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -84.84 -42.9 14.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.348 -0.845 . . . . 0.0 109.301 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.9 m -78.91 -48.13 15.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.548 -0.72 . . . . 0.0 109.654 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -110.0 -177.91 3.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.689 . . . . 0.0 109.543 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.44 HG12 ' CE1' ' B' ' 5' ' ' HIS . 32.0 mt -106.25 135.23 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.7 m -94.99 -174.69 3.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.726 . . . . 0.0 110.129 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.8 m -91.84 166.36 12.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.661 -0.649 . . . . 0.0 109.962 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.474 HD11 HG13 ' B' ' 18' ' ' VAL . 45.5 tp -67.47 -24.81 65.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.673 -0.642 . . . . 0.0 110.174 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -58.67 -19.35 38.67 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.456 -0.778 . . . . 0.0 110.954 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -77.64 -69.35 0.55 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.084 -1.01 . . . . 0.0 110.375 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.677 HD22 ' CD2' ' B' ' 15' ' ' LEU . 24.4 mt -60.16 -17.66 42.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.405 -0.809 . . . . 0.0 109.992 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -64.75 -44.09 91.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 108.577 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -71.52 -9.99 59.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.649 -0.657 . . . . 0.0 109.737 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.419 ' CE2' HG13 ' A' ' 2' ' ' ILE . 6.9 m-30 -89.29 22.56 2.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.4 -0.812 . . . . 0.0 110.45 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.8 m -109.31 40.79 1.77 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.166 -0.959 . . . . 0.0 109.691 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.1 m120 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.1 -0.952 . . . . 0.0 109.475 179.938 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.422 ' CE2' ' CB ' ' B' ' 4' ' ' GLN . 10.0 t80 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.472 HG12 ' OD1' ' B' ' 3' ' ' ASN . 10.7 t -42.96 113.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 122.017 -0.427 . . . . 0.0 110.792 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.472 ' OD1' HG12 ' B' ' 2' ' ' VAL . 6.4 p-10 0.77 75.82 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.101 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.422 ' CB ' ' CE2' ' B' ' 1' ' ' PHE . 0.0 OUTLIER -142.5 131.79 23.48 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.616 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.44 ' CE1' HG12 ' A' ' 10' ' ' ILE . 74.6 m80 -91.16 172.63 8.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.785 . . . . 0.0 109.381 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.559 HD13 HG23 ' A' ' 2' ' ' ILE . 28.6 mt -126.31 121.02 31.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.473 -0.767 . . . . 0.0 110.263 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 179.78 105.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.8 -144.76 17.49 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 60.3 p -64.36 -19.73 65.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.562 -0.963 . . . . 0.0 109.98 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -57.46 -30.66 65.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.17 -0.956 . . . . 0.0 109.769 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.889 HD22 ' CG2' ' A' ' 3' ' ' VAL . 66.8 tp -68.63 -56.46 8.13 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 t -50.07 -48.09 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.643 -0.66 . . . . 0.0 111.107 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -62.16 -33.43 74.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.496 -0.752 . . . . 0.0 109.696 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.553 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -68.53 -28.61 67.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.557 -0.714 . . . . 0.0 109.555 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.677 ' CD2' HD22 ' A' ' 16' ' ' LEU . 30.4 mt -78.09 -29.45 49.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.477 -0.765 . . . . 0.0 109.11 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -69.59 -35.2 75.12 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.31 -54.86 6.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.697 -0.627 . . . . 0.0 109.547 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.553 HG23 ' O ' ' B' ' 14' ' ' ALA . 20.9 t -61.52 -66.51 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.539 -0.726 . . . . 0.0 109.805 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 45.4 m -59.61 -69.38 0.21 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.566 -0.709 . . . . 0.0 109.82 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.98 -27.34 18.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.77 142.77 40.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.467 -1.019 . . . . 0.0 109.608 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 117.26 20.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.581 -0.699 . . . . 0.0 109.272 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.5 31.78 49.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.94 32.17 5.76 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -167.95 -171.38 1.55 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.965 . . . . 0.0 109.618 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.425 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 3.1 t80 -52.97 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.493 -0.754 . . . . 0.0 109.765 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.8 92.47 48.76 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.425 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 6.1 Cg_exo -58.05 161.89 12.49 Favored 'Trans proline' 0 N--CA 1.482 0.839 0 C-N-CA 122.593 2.195 . . . . 0.0 110.059 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 tttp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.427 -179.892 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.768 HG23 HG23 ' A' ' 3' ' ' VAL . 4.6 tt -146.7 -45.27 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.598 -0.942 . . . . 0.0 109.461 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.768 HG23 HG23 ' A' ' 2' ' ' ILE . 18.0 t -90.92 -34.28 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.396 -0.815 . . . . 0.0 109.399 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -57.56 -21.85 41.1 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.577 -0.702 . . . . 0.0 109.986 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -63.21 -41.8 99.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.448 -0.783 . . . . 0.0 110.098 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.448 ' HB3' HD12 ' B' ' 6' ' ' LEU . 85.1 m -113.53 20.85 15.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.429 -0.794 . . . . 0.0 111.072 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.7 t -93.29 43.74 1.13 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.04 -1.037 . . . . 0.0 109.611 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.485 HG23 ' N ' ' A' ' 9' ' ' SER . 3.2 t -138.92 -45.22 0.47 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.485 ' N ' HG23 ' A' ' 8' ' ' THR . 0.2 OUTLIER -134.07 -170.95 2.62 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.398 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.599 ' CD1' ' CE1' ' B' ' 5' ' ' HIS . 1.0 OUTLIER -97.39 102.1 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.182 -0.949 . . . . 0.0 109.601 -178.615 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.1 m -62.46 -174.46 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.321 0.581 . . . . 0.0 110.188 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.6 m -105.58 163.64 12.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.744 -0.597 . . . . 0.0 109.501 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.674 HD11 HG22 ' B' ' 18' ' ' VAL . 42.2 tp -66.51 -28.25 68.41 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.572 -0.705 . . . . 0.0 109.918 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -58.34 -22.85 54.81 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.486 -0.759 . . . . 0.0 110.285 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -80.51 -47.91 13.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.291 -0.88 . . . . 0.0 109.702 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.605 HD22 HD23 ' B' ' 15' ' ' LEU . 14.4 mt -66.97 -20.27 65.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.515 -0.74 . . . . 0.0 110.315 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -62.0 -22.39 65.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.251 -0.905 . . . . 0.0 110.022 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -98.53 33.38 2.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.84 . . . . 0.0 109.648 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -112.28 7.2 19.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.646 -0.659 . . . . 0.0 110.346 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.47 35.51 1.48 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.047 -0.977 . . . . 0.0 109.544 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.711 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.618 HG12 ' OD1' ' B' ' 3' ' ' ASN . 15.6 t -86.22 -58.06 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.662 -1.274 . . . . 0.0 109.316 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.618 ' OD1' HG12 ' B' ' 2' ' ' VAL . 0.6 OUTLIER -178.84 37.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.433 -0.792 . . . . 0.0 109.664 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -120.42 139.83 52.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.589 -0.694 . . . . 0.0 109.262 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.599 ' CE1' ' CD1' ' A' ' 10' ' ' ILE . 0.1 OUTLIER -77.78 164.68 25.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.471 -0.768 . . . . 0.0 109.602 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.448 HD12 ' HB3' ' A' ' 6' ' ' CYS . 18.8 mt -120.34 112.3 18.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.568 -0.707 . . . . 0.0 110.463 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.461 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.1 OUTLIER 179.71 120.25 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.425 -0.797 . . . . 0.0 109.153 178.564 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.39 -147.33 19.07 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.5 t -65.73 -14.67 61.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.349 -1.089 . . . . 0.0 109.92 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.96 -29.95 67.55 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.139 -0.976 . . . . 0.0 109.194 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.666 ' HG ' HG22 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -65.52 -52.89 49.33 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.072 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 18.1 t -56.07 -37.58 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.802 -0.562 . . . . 0.0 110.699 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -74.8 -26.33 59.66 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.455 -0.778 . . . . 0.0 110.212 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.19 -31.25 64.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.605 HD23 HD22 ' A' ' 16' ' ' LEU . 40.3 mt -74.02 -39.76 63.37 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -61.55 -33.04 73.17 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.711 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 1.7 tp -67.87 -40.74 83.54 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.674 HG22 HD11 ' A' ' 13' ' ' LEU . 35.8 t -86.49 -75.12 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.671 -0.643 . . . . 0.0 110.134 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 14.0 m -64.78 -62.72 1.4 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 109.599 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.16 15.73 78.66 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -90.48 158.11 17.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -1.178 . . . . 0.0 109.16 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.85 117.34 26.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.529 -0.732 . . . . 0.0 109.29 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.03 36.25 93.02 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.96 -19.86 6.64 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.661 ' CE1' HG23 ' B' ' 27' ' ' THR . 34.5 p90 -127.42 -174.82 3.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.264 -1.139 . . . . 0.0 110.232 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.46 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 4.2 t80 -60.11 105.61 0.42 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.546 0.689 . . . . 0.0 109.47 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.661 HG23 ' CE1' ' B' ' 25' ' ' PHE . 0.0 OUTLIER -134.75 90.82 21.93 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.46 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 8.7 Cg_endo -68.35 83.15 0.49 Allowed 'Trans proline' 0 N--CA 1.486 1.064 0 C-N-CA 122.857 2.371 . . . . 0.0 110.826 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.052 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.152 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.712 HG23 HG23 ' A' ' 3' ' ' VAL . 14.8 tt -136.9 -48.26 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.582 -0.951 . . . . 0.0 109.793 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.712 HG23 HG23 ' A' ' 2' ' ' ILE . 43.6 t -92.05 -21.82 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.25 -0.906 . . . . 0.0 109.955 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -89.68 59.15 4.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.393 -0.817 . . . . 0.0 109.699 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.5 -45.96 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.478 -0.764 . . . . 0.0 109.143 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.467 ' HB2' HD12 ' B' ' 6' ' ' LEU . 59.1 m -115.35 16.14 16.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.662 -0.649 . . . . 0.0 110.058 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' HG12 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -73.89 -29.37 62.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.282 -0.887 . . . . 0.0 109.159 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -84.08 -49.15 9.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.584 -0.698 . . . . 0.0 110.212 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p -122.83 166.92 14.2 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.532 -0.73 . . . . 0.0 110.061 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.437 ' HB ' ' CE1' ' B' ' 5' ' ' HIS . 0.1 OUTLIER -86.81 120.9 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 87.7 m -82.8 -89.0 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.605 -0.684 . . . . 0.0 110.016 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.6 t -179.45 168.83 1.44 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.993 -1.067 . . . . 0.0 109.466 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.509 HD21 HG22 ' B' ' 18' ' ' VAL . 0.7 OUTLIER -67.24 -33.1 74.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.584 -0.698 . . . . 0.0 110.478 -179.289 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -21.54 61.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.264 -0.898 . . . . 0.0 110.208 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -76.74 -50.95 12.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.324 -0.86 . . . . 0.0 110.123 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.687 HD22 ' CD2' ' B' ' 15' ' ' LEU . 10.4 mt -66.81 -21.14 66.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.448 -0.783 . . . . 0.0 110.162 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -55.46 -22.5 20.89 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.239 -0.913 . . . . 0.0 110.466 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -98.02 35.33 1.75 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.366 -0.834 . . . . 0.0 109.808 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.428 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 6.6 m-85 -111.57 0.61 16.49 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.468 -0.77 . . . . 0.0 110.373 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.97 36.43 1.56 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.097 -1.002 . . . . 0.0 109.436 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.128 -0.939 . . . . 0.0 109.501 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.523 HG23 ' H ' ' B' ' 3' ' ' ASN . 0.2 OUTLIER -36.07 -72.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.581 0 O-C-N 122.053 -0.404 . . . . 0.0 112.022 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.523 ' H ' HG23 ' B' ' 2' ' ' VAL . 2.8 p-10 -178.16 54.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.162 -0.961 . . . . 0.0 109.375 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -103.39 123.97 47.83 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.437 ' CE1' ' HB ' ' A' ' 10' ' ' ILE . 31.0 m-70 -84.11 137.89 33.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.464 -0.773 . . . . 0.0 109.672 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.63 ' CD2' HD11 ' A' ' 16' ' ' LEU . 50.0 mt -81.78 95.52 7.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.875 -0.515 . . . . 0.0 110.413 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.05 120.41 0.44 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.666 -0.646 . . . . 0.0 109.35 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.21 -142.31 21.24 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 51.7 p -66.02 -23.83 66.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.942 . . . . 0.0 109.459 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -56.29 -29.9 61.81 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.241 -0.912 . . . . 0.0 109.112 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.431 ' CD1' HD11 ' B' ' 15' ' ' LEU . 0.4 OUTLIER -63.41 -60.35 3.48 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -51.12 -52.65 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.665 -0.647 . . . . 0.0 111.143 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -59.52 -29.25 67.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.37 -0.831 . . . . 0.0 110.346 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.76 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -73.08 -30.85 63.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.485 -0.759 . . . . 0.0 109.742 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.687 ' CD2' HD22 ' A' ' 16' ' ' LEU . 31.3 mt -77.2 -30.57 54.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.435 -0.791 . . . . 0.0 109.541 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -75.99 -30.86 58.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.568 -0.708 . . . . 0.0 109.42 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tp -80.18 -30.62 38.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.595 -0.69 . . . . 0.0 109.631 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.76 HG23 ' O ' ' B' ' 14' ' ' ALA . 43.3 t -82.66 -68.59 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.695 . . . . 0.0 109.195 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 33.8 m -67.74 -67.55 0.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.68 -0.638 . . . . 0.0 109.387 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.04 7.89 79.79 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -89.83 151.63 21.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.115 -1.227 . . . . 0.0 109.669 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.36 104.13 9.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.745 . . . . 0.0 108.99 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.81 42.51 30.91 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.07 -20.38 6.77 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.446 ' CE1' HG23 ' B' ' 27' ' ' THR . 37.2 p90 -115.41 -170.49 1.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.404 -1.056 . . . . 0.0 109.566 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.416 ' O ' ' CG ' ' B' ' 26' ' ' TYR . 0.5 OUTLIER -55.44 93.52 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.613 -0.68 . . . . 0.0 109.645 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.446 HG23 ' CE1' ' B' ' 25' ' ' PHE . 1.5 p -124.13 97.07 41.1 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.405 ' HD3' ' CE1' ' B' ' 26' ' ' TYR . 6.1 Cg_exo -57.64 -172.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.019 0 C-N-CA 122.621 2.214 . . . . 0.0 110.692 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.442 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.779 HG23 HG23 ' A' ' 3' ' ' VAL . 16.1 tt -143.42 -47.4 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.518 -0.989 . . . . 0.0 109.385 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.779 HG23 HG23 ' A' ' 2' ' ' ILE . 47.5 t -92.93 -18.41 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.437 -0.789 . . . . 0.0 110.075 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -89.55 54.51 2.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.321 -0.862 . . . . 0.0 109.721 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -141.2 -50.48 0.43 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.497 -0.752 . . . . 0.0 108.993 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.3 m -128.41 32.72 4.81 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.538 ' SG ' HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -67.43 -57.17 7.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.69 -0.631 . . . . 0.0 110.272 -179.688 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 m -68.0 -28.21 67.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.505 -0.747 . . . . 0.0 110.899 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.44 ' HA ' ' CE1' ' B' ' 5' ' ' HIS . 1.2 m -116.98 -162.52 0.86 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.375 -0.828 . . . . 0.0 109.942 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.476 HG23 ' CD2' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -111.14 129.34 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.477 -0.764 . . . . 0.0 109.008 -179.373 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.91 -164.41 1.02 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.652 -0.655 . . . . 0.0 109.91 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.455 ' CB ' ' CE2' ' A' ' 14' ' ' TYR . 1.6 m -102.09 162.18 13.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.547 -0.721 . . . . 0.0 109.747 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.33 -35.4 80.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.624 -0.673 . . . . 0.0 110.387 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.455 ' CE2' ' CB ' ' A' ' 12' ' ' SER . 20.4 p90 -61.58 -23.33 65.92 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.389 -0.82 . . . . 0.0 110.058 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.404 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 1.0 OUTLIER -68.04 -57.11 6.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.419 -0.801 . . . . 0.0 109.494 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.693 HD22 HD23 ' B' ' 15' ' ' LEU . 23.0 mt -66.07 -14.24 61.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.576 -0.703 . . . . 0.0 110.222 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -62.23 -31.17 71.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.186 -0.946 . . . . 0.0 109.554 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -98.51 32.97 2.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.492 -0.755 . . . . 0.0 109.446 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.471 ' CE2' HD11 ' A' ' 2' ' ' ILE . 7.2 m-85 -113.42 -7.41 13.46 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.615 -0.678 . . . . 0.0 110.226 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.0 m -74.6 -22.07 59.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.081 -1.012 . . . . 0.0 110.357 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.54 -179.871 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.708 ' CD2' HG22 ' B' ' 2' ' ' VAL . 2.3 p90 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.708 HG22 ' CD2' ' B' ' 1' ' ' PHE . 27.4 m -50.09 -26.16 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.354 -1.467 . . . . 0.0 110.977 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -171.08 40.85 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.574 -0.704 . . . . 0.0 109.189 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.455 ' CB ' ' CE1' ' B' ' 1' ' ' PHE . 7.0 tp60 -136.38 108.04 7.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.583 -0.698 . . . . 0.0 109.912 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.476 ' CD2' HG23 ' A' ' 10' ' ' ILE . 14.3 m-70 -64.06 163.23 12.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.611 -0.681 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.689 HD11 HD11 ' A' ' 16' ' ' LEU . 2.5 mm? -114.42 55.35 0.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.501 -0.749 . . . . 0.0 109.596 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.86 129.01 33.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.522 -0.736 . . . . 0.0 109.333 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.56 -147.53 35.71 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 16.2 p -67.84 -12.21 60.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.553 -0.969 . . . . 0.0 110.489 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -60.69 -33.4 72.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.067 -1.021 . . . . 0.0 109.706 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.528 HD12 HD12 ' B' ' 6' ' ' LEU . 62.4 tp -65.07 -55.89 16.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.614 -0.679 . . . . 0.0 109.218 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.2 t -52.08 -47.67 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.544 -0.723 . . . . 0.0 110.813 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -62.22 -32.26 72.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.441 -0.787 . . . . 0.0 109.729 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.493 ' HB1' HD13 ' A' ' 16' ' ' LEU . . . -68.09 -31.94 71.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.557 -0.715 . . . . 0.0 109.153 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.693 HD23 HD22 ' A' ' 16' ' ' LEU . 31.7 mt -74.88 -28.56 60.7 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -70.17 -34.33 72.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.504 -0.748 . . . . 0.0 108.992 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.679 HD22 ' HZ ' ' B' ' 1' ' ' PHE . 0.5 OUTLIER -73.76 -42.37 61.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.721 -0.612 . . . . 0.0 109.6 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.426 HG23 ' O ' ' B' ' 14' ' ' ALA . 47.3 t -71.0 -71.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -77.91 0.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.457 -0.777 . . . . 0.0 108.979 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.53 -27.92 9.5 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.27 176.32 0.35 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.423 -1.045 . . . . 0.0 109.759 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -76.38 -63.16 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.593 -0.692 . . . . 0.0 109.386 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -119.41 48.02 0.98 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.62 26.12 25.59 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -162.06 -176.92 5.44 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.498 -1.001 . . . . 0.0 109.798 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -56.45 123.81 15.99 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.548 -0.72 . . . . 0.0 110.157 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.31 96.82 43.63 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.78 165.04 5.21 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 122.386 2.057 . . . . 0.0 110.21 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 2.5 pttt . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.708 -179.895 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.522 ' CG2' HG23 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -170.73 -53.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.608 -0.936 . . . . 0.0 109.195 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.656 HG22 HD22 ' B' ' 11' ' ' LEU . 32.2 t -92.36 -53.51 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.344 -0.848 . . . . 0.0 109.672 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.6 -30.79 67.49 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.651 -0.655 . . . . 0.0 110.274 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -76.16 -28.6 57.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.502 -0.749 . . . . 0.0 109.817 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.2 m -113.32 26.43 10.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.431 -0.793 . . . . 0.0 110.158 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.425 ' SG ' HG12 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -101.39 -32.09 10.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 0.0 109.197 179.672 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -85.79 -57.29 3.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.646 -0.658 . . . . 0.0 109.515 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.89 -160.67 0.82 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.631 -0.668 . . . . 0.0 109.358 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 11' ' ' CYS . 1.2 mm -93.88 -168.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.502 ' H ' HG22 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -170.54 168.28 7.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.414 -0.804 . . . . 0.0 109.106 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.48 162.13 13.14 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.872 HD13 ' O ' ' A' ' 13' ' ' LEU . 3.4 tm? -66.98 -23.48 65.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.679 -0.638 . . . . 0.0 110.261 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CE1' ' HG2' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -56.63 -20.74 22.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.128 -0.982 . . . . 0.0 110.803 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.443 ' HG2' ' CE1' ' A' ' 14' ' ' TYR . 5.3 mm100 -74.36 -46.27 41.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.41 -0.806 . . . . 0.0 109.843 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.654 HD22 ' CD2' ' B' ' 15' ' ' LEU . 68.9 mt -68.42 -10.0 52.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.436 -0.79 . . . . 0.0 110.722 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.94 -26.33 68.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.11 -0.994 . . . . 0.0 109.21 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -62.29 -32.74 73.51 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.747 0.784 . . . . 0.0 109.633 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.433 ' OH ' HG21 ' A' ' 2' ' ' ILE . 35.5 m-85 -81.66 -17.07 49.32 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.995 -0.441 . . . . 0.0 111.139 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -105.13 28.8 6.92 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.045 -1.034 . . . . 0.0 109.766 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.582 -179.871 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.741 ' CE1' HD23 ' A' ' 13' ' ' LEU . 3.0 p90 . . . . . 0 N--CA 1.5 2.033 0 CA-C-O 120.474 0.178 . . . . 0.0 110.771 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.22 -26.29 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.976 -1.078 . . . . 0.0 109.35 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -152.89 29.24 0.52 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.428 ' HG2' ' CE1' ' B' ' 10' ' ' HIS . 0.3 OUTLIER -118.7 -178.89 3.65 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -103.4 125.41 49.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.347 -0.846 . . . . 0.0 109.855 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.618 HD21 HD13 ' B' ' 11' ' ' LEU . 6.4 tp -83.95 94.1 8.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.706 -0.621 . . . . 0.0 110.08 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.88 134.4 2.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.419 -0.801 . . . . 0.0 109.334 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.3 -145.72 21.43 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 53.7 p -70.79 -9.0 56.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.496 -1.002 . . . . 0.0 110.31 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' HIS . . . . . 0.428 ' CE1' ' HG2' ' B' ' 4' ' ' GLN . 28.3 t60 -65.37 -31.08 72.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.087 -1.008 . . . . 0.0 108.944 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.656 HD22 HG22 ' A' ' 3' ' ' VAL . 56.0 tp -63.69 -57.31 10.41 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.5 t -53.45 -51.82 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.64 -0.662 . . . . 0.0 110.955 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -56.21 -28.61 58.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.346 -0.846 . . . . 0.0 110.217 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.588 ' HB1' HD13 ' A' ' 16' ' ' LEU . . . -76.58 -35.0 58.42 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.654 ' CD2' HD22 ' A' ' 16' ' ' LEU . 49.3 mt -64.56 -28.22 69.49 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -80.82 -35.72 32.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.527 -0.733 . . . . 0.0 109.137 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -65.42 -32.61 74.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.658 -0.651 . . . . 0.0 109.804 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.814 ' CG2' HD21 ' A' ' 13' ' ' LEU . 35.9 t -82.22 -55.68 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.601 -0.687 . . . . 0.0 109.405 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 4.7 m -69.19 -80.24 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.54 -0.725 . . . . 0.0 109.528 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.95 -56.56 0.66 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.96 172.23 8.73 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.454 -1.027 . . . . 0.0 109.426 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.25 -47.77 33.0 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.44 94.54 1.4 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -177.93 -35.85 0.06 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.473 ' CG ' ' HB3' ' B' ' 15' ' ' LEU . 44.5 p90 -124.83 -174.64 3.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -1.088 . . . . 0.0 110.867 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.433 ' HB2' ' CD1' ' A' ' 19' ' ' TYR . 7.1 t80 -58.45 111.0 1.08 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.853 -0.529 . . . . 0.0 109.828 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.3 p -122.88 92.2 49.28 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.553 -0.717 . . . . 0.0 109.372 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.413 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 1.5 Cg_endo -61.87 129.0 25.96 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 C-N-CA 122.526 2.151 . . . . 0.0 109.858 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 22.4 mttp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.53 179.938 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.806 HG23 HG23 ' A' ' 3' ' ' VAL . 4.5 tt -172.89 -44.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.588 -0.948 . . . . 0.0 109.248 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.806 HG23 HG23 ' A' ' 2' ' ' ILE . 44.7 t -91.58 -9.51 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.576 -0.702 . . . . 0.0 110.358 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.17 3.76 22.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 0.0 109.956 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -63.42 1.23 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.117 -0.989 . . . . 0.0 110.039 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.498 ' SG ' HD23 ' B' ' 6' ' ' LEU . 12.6 p -136.27 25.61 3.22 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.978 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.1 t -52.45 -23.78 6.75 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.11 -0.994 . . . . 0.0 110.011 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 m -65.7 -68.49 0.36 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.353 -0.842 . . . . 0.0 111.033 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.4 -153.56 0.53 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.328 -0.858 . . . . 0.0 110.356 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.665 HD13 ' CE1' ' B' ' 5' ' ' HIS . 10.1 mm -83.65 168.21 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.096 -1.002 . . . . 0.0 108.728 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.479 ' H ' HG22 ' A' ' 10' ' ' ILE . 2.1 p -160.1 174.42 14.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.427 -0.796 . . . . 0.0 110.438 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -72.08 133.13 45.06 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.345 0.593 . . . . 0.0 109.747 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.478 HD12 ' HB2' ' B' ' 1' ' ' PHE . 4.6 mm? -68.43 -17.34 64.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.749 -0.594 . . . . 0.0 110.412 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -56.83 -22.46 36.74 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.139 -0.976 . . . . 0.0 109.86 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.26 -49.09 75.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.404 -0.81 . . . . 0.0 109.357 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.725 HD22 HD23 ' B' ' 15' ' ' LEU . 15.8 mt -68.9 -16.51 63.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.521 -0.737 . . . . 0.0 110.051 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.71 -26.75 65.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 109.174 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.25 13.12 14.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.379 -0.826 . . . . 0.0 110.078 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -97.77 20.62 11.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.102 -0.999 . . . . 0.0 109.179 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.3 m -109.97 23.88 13.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.328 -0.857 . . . . 0.0 109.987 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.9 m120 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 117.903 -1.046 . . . . 0.0 109.427 -179.952 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.718 ' CZ ' HD22 ' B' ' 17' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.524 HG23 ' CD1' ' B' ' 1' ' ' PHE . 0.2 OUTLIER -118.27 172.23 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.924 -1.11 . . . . 0.0 108.163 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -59.44 92.98 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.317 -0.864 . . . . 0.0 109.376 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -142.03 174.4 10.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.502 -0.748 . . . . 0.0 110.203 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.665 ' CE1' HD13 ' A' ' 10' ' ' ILE . 3.6 m80 -119.12 146.45 45.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.613 -0.68 . . . . 0.0 109.248 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.683 HD12 HD11 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -100.77 90.44 4.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.504 -0.748 . . . . 0.0 109.439 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.3 154.23 10.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.625 -0.672 . . . . 0.0 109.719 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.03 -132.89 49.15 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.5 p -83.51 -13.8 53.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.947 . . . . 0.0 109.759 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -63.71 -33.09 74.87 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.132 -0.98 . . . . 0.0 108.944 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.612 ' C ' HD13 ' B' ' 11' ' ' LEU . 2.6 tm? -68.87 -54.51 15.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.813 -0.554 . . . . 0.0 109.771 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 t -53.74 -47.77 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.501 -0.749 . . . . 0.0 110.677 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.7 -29.07 70.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.484 -0.76 . . . . 0.0 109.396 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.72 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -71.67 -26.4 62.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.57 -0.706 . . . . 0.0 109.529 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.725 HD23 HD22 ' A' ' 16' ' ' LEU . 29.1 mt -78.85 -32.14 45.92 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.418 -0.801 . . . . 0.0 108.882 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.06 -32.99 67.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.595 -0.691 . . . . 0.0 110.012 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.718 HD22 ' CZ ' ' B' ' 1' ' ' PHE . 0.1 OUTLIER -80.58 -46.71 15.27 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.413 -0.804 . . . . 0.0 109.937 -179.434 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.72 HG23 ' O ' ' B' ' 14' ' ' ALA . 48.0 t -59.65 -56.93 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.419 -0.801 . . . . 0.0 109.386 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -74.89 0.1 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.21 -35.17 3.73 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -90.41 163.77 14.55 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.395 -1.062 . . . . 0.0 109.849 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.85 127.9 39.84 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.18 28.7 36.04 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.97 30.73 5.76 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.445 ' CD2' ' HB2' ' B' ' 15' ' ' LEU . 23.8 p90 -165.65 -173.2 2.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.454 -1.027 . . . . 0.0 109.512 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.454 ' HB3' HD13 ' B' ' 15' ' ' LEU . 7.5 t80 -54.33 109.58 0.51 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.574 -0.703 . . . . 0.0 109.562 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 2.0 p -122.88 91.86 49.49 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -57.31 142.21 94.8 Favored 'Trans proline' 0 N--CA 1.483 0.91 0 C-N-CA 122.48 2.12 . . . . 0.0 110.143 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.455 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.808 HG23 HG23 ' A' ' 3' ' ' VAL . 5.0 tt -172.26 -44.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.667 -0.902 . . . . 0.0 109.583 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.808 HG23 HG23 ' A' ' 2' ' ' ILE . 30.4 t -91.32 -9.24 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.342 -0.849 . . . . 0.0 110.685 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -90.35 51.72 2.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.136 -0.978 . . . . 0.0 109.429 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -138.44 -43.79 0.5 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.498 -0.752 . . . . 0.0 109.379 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.1 m -118.59 15.57 13.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.543 -0.723 . . . . 0.0 110.399 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.61 -27.22 64.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.279 -0.888 . . . . 0.0 110.351 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 m -99.29 -67.83 0.83 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.351 -0.843 . . . . 0.0 110.907 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.2 p -74.99 171.81 13.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.279 -0.888 . . . . 0.0 110.229 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.858 HG23 ' O ' ' B' ' 4' ' ' GLN . 56.6 mt -102.52 91.16 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.6 m -61.74 -178.91 0.16 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.613 -0.68 . . . . 0.0 110.268 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.483 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 22.2 t -106.71 172.47 6.8 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.507 HD23 ' O ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -67.36 -26.14 66.33 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.403 -0.811 . . . . 0.0 111.415 -178.699 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 12' ' ' SER . 8.9 p90 -59.51 -20.51 55.95 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.997 -1.064 . . . . 0.0 110.042 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.93 -49.91 12.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.388 -0.82 . . . . 0.0 109.428 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.711 HD21 ' CD2' ' B' ' 11' ' ' LEU . 11.3 mt -67.45 -16.78 64.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.531 -0.731 . . . . 0.0 109.991 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -57.91 -20.72 39.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.187 -0.945 . . . . 0.0 110.219 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -96.95 33.21 1.94 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.84 . . . . 0.0 109.488 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.426 ' CE2' HD11 ' A' ' 2' ' ' ILE . 7.5 m-85 -113.27 -0.43 14.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.518 -0.739 . . . . 0.0 110.361 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.6 m -96.83 40.49 1.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.122 -0.986 . . . . 0.0 109.562 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.444 179.957 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.543 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 1.1 p90 . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 15.5 t -54.66 -26.7 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -160.69 31.62 0.15 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.858 ' O ' HG23 ' A' ' 10' ' ' ILE . 13.3 mt-30 -127.48 168.67 14.59 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.638 -0.664 . . . . 0.0 109.857 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.458 ' CE1' HG12 ' A' ' 10' ' ' ILE . 18.1 m80 -96.61 161.53 13.85 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.531 HD22 HD11 ' A' ' 16' ' ' LEU . 43.7 mt -109.44 -11.11 14.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.478 -0.764 . . . . 0.0 110.82 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.77 138.96 56.87 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.955 -1.091 . . . . 0.0 110.344 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.47 -159.33 33.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.0 p -64.7 -14.66 59.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.435 -1.038 . . . . 0.0 110.04 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -52.14 -27.98 16.26 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.891 -1.131 . . . . 0.0 110.323 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.711 ' CD2' HD21 ' A' ' 16' ' ' LEU . 3.2 tm? -72.5 -62.91 1.27 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.614 -0.679 . . . . 0.0 109.199 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 39.4 t -47.16 -52.64 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.839 -0.538 . . . . 0.0 111.445 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -57.53 -36.66 71.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.386 -0.821 . . . . 0.0 110.224 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.5 ' HB1' ' HD2' ' B' ' 1' ' ' PHE . . . -67.1 -31.63 72.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.346 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.644 HD23 HD22 ' A' ' 16' ' ' LEU . 40.6 mt -64.47 -40.64 96.07 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -63.66 -34.04 76.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.543 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 0.8 OUTLIER -65.23 -37.3 86.85 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.5 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 14' ' ' ALA . 40.5 t -74.12 -71.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.586 -0.696 . . . . 0.0 109.613 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 m -90.75 -58.25 2.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.455 -0.778 . . . . 0.0 109.408 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.37 32.78 68.23 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -88.62 -177.55 5.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.613 -0.933 . . . . 0.0 109.409 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.409 ' NH1' ' HG2' ' B' ' 22' ' ' ARG . 2.7 tpt180 -91.93 52.7 2.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.624 -0.672 . . . . 0.0 109.432 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.95 40.68 1.05 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.07 -28.21 6.62 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' CB ' ' B' ' 15' ' ' LEU . 29.2 p90 -105.36 -175.8 2.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.57 -0.959 . . . . 0.0 109.408 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -58.89 118.41 5.73 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.474 -0.766 . . . . 0.0 109.423 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 23.8 p -127.14 94.65 38.5 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.72 118.87 5.83 Favored 'Trans proline' 0 N--CA 1.482 0.838 0 C-N-CA 122.343 2.029 . . . . 0.0 110.165 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 mtpp . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.91 179.88 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.535 HG23 HG23 ' A' ' 3' ' ' VAL . 1.3 tp -73.89 -32.56 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.577 -0.955 . . . . 0.0 109.378 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.792 HG13 HD12 ' B' ' 11' ' ' LEU . 25.0 t -90.32 12.44 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.642 -0.661 . . . . 0.0 110.377 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -105.24 31.51 4.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.179 -0.951 . . . . 0.0 108.928 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -118.77 -33.76 4.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.674 -0.641 . . . . 0.0 109.985 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.0 m -130.33 19.13 5.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.471 -0.768 . . . . 0.0 110.459 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.7 t -91.29 -26.81 18.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 109.565 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -75.35 -27.69 59.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.474 -0.766 . . . . 0.0 110.182 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.4 p -134.64 -171.6 2.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 109.936 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.454 ' CG1' ' CE1' ' B' ' 5' ' ' HIS . 18.3 mt -102.31 95.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.406 ' SG ' ' NE2' ' A' ' 15' ' ' GLN . 1.3 m -68.27 -172.82 0.35 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.573 -0.704 . . . . 0.0 109.687 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.447 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 1.4 m -108.64 162.82 13.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.644 -0.66 . . . . 0.0 109.689 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.749 HD13 ' CD2' ' B' ' 1' ' ' PHE . 20.0 tp -71.11 -17.69 62.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.805 -0.559 . . . . 0.0 110.223 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.447 ' CE2' ' HB3' ' A' ' 12' ' ' SER . 10.8 p90 -87.54 11.29 15.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.088 -1.007 . . . . 0.0 110.422 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.406 ' NE2' ' SG ' ' A' ' 11' ' ' CYS . 4.7 tt0 -105.5 -32.28 8.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.072 -1.017 . . . . 0.0 109.434 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.811 HD22 ' CD2' ' B' ' 15' ' ' LEU . 9.9 mt -66.16 -13.03 59.53 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.565 -0.71 . . . . 0.0 110.558 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.81 -19.19 39.0 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.08 -1.013 . . . . 0.0 110.124 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -93.53 28.79 2.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.204 -0.935 . . . . 0.0 110.191 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -115.08 10.89 16.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.173 -0.954 . . . . 0.0 110.456 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.31 33.12 2.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.273 -0.892 . . . . 0.0 109.343 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.389 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.906 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 34.3 t80 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.709 HG13 ' CD1' ' B' ' 1' ' ' PHE . 17.5 m -140.63 -162.43 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -52.75 -25.04 9.97 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.956 -1.09 . . . . 0.0 110.022 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.568 ' H ' HG23 ' B' ' 2' ' ' VAL . 12.3 mm-40 -71.87 144.11 49.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.519 -0.738 . . . . 0.0 109.109 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.454 ' CE1' ' CG1' ' A' ' 10' ' ' ILE . 13.0 m80 -68.25 160.6 28.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.552 -0.718 . . . . 0.0 109.493 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.415 HD11 HD11 ' A' ' 16' ' ' LEU . 19.7 tp -107.41 98.43 8.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.611 -0.681 . . . . 0.0 109.732 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.7 173.15 2.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.637 -0.664 . . . . 0.0 109.895 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.7 -154.02 39.78 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.1 p -63.8 -21.5 66.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.576 -0.955 . . . . 0.0 109.507 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -60.52 -34.13 73.65 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.869 . . . . 0.0 109.075 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.792 HD12 HG13 ' A' ' 3' ' ' VAL . 2.5 tt -61.86 -55.05 33.86 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.404 ' H ' HG23 ' B' ' 12' ' ' VAL . 21.2 t -53.74 -49.97 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.748 -0.595 . . . . 0.0 111.05 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -59.76 -27.48 66.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.446 -0.784 . . . . 0.0 110.631 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.11 -31.37 39.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 110.301 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.811 ' CD2' HD22 ' A' ' 16' ' ' LEU . 50.5 mt -66.72 -41.28 88.18 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -70.94 -31.38 67.95 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.906 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 1.1 mp -63.24 -34.46 77.71 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -84.77 -73.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.626 -0.671 . . . . 0.0 109.359 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 90.8 m -64.49 -82.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 108.852 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.16 23.26 9.84 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 120.136 -1.031 . . . . 0.0 111.533 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.26 -173.68 3.9 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 118.784 1.292 . . . . 0.0 109.165 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -93.44 50.74 1.52 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.532 -0.73 . . . . 0.0 109.51 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.73 71.99 0.63 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.28 35.49 2.17 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -167.08 -171.91 1.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.959 . . . . 0.0 109.607 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.415 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 3.8 t80 -57.69 98.85 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.582 -0.699 . . . . 0.0 109.167 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 2.2 p -114.33 91.87 25.51 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.591 -0.693 . . . . 0.0 109.666 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.415 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 4.0 Cg_exo -59.24 -171.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.482 0.843 0 C-N-CA 122.453 2.102 . . . . 0.0 110.074 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.571 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.49 -18.3 58.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.652 -0.655 . . . . 0.0 110.049 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -42.1 82.38 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.253 -0.905 . . . . 0.0 109.987 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -146.53 43.49 1.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.45 -0.781 . . . . 0.0 109.897 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -63.3 -43.02 99.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.398 -0.814 . . . . 0.0 109.157 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -97.24 29.51 3.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.714 -0.616 . . . . 0.0 109.552 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p -161.07 -174.17 4.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.556 -0.715 . . . . 0.0 109.263 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.16 98.62 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 m -84.41 -85.76 0.13 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.587 -0.696 . . . . 0.0 110.423 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -173.97 151.43 1.76 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.068 -1.02 . . . . 0.0 109.975 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.747 HD13 ' O ' ' A' ' 13' ' ' LEU . 2.6 tm? -67.18 -21.51 65.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.648 -0.658 . . . . 0.0 110.106 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -24.78 34.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.064 -1.023 . . . . 0.0 109.91 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -79.02 -47.28 16.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.384 -0.822 . . . . 0.0 109.218 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.699 HD22 ' CD2' ' B' ' 15' ' ' LEU . 9.0 mt -65.78 -15.14 62.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.632 -0.667 . . . . 0.0 110.129 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.38 -18.8 41.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.261 -0.899 . . . . 0.0 110.288 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -94.32 28.35 2.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.924 . . . . 0.0 109.988 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -115.99 18.55 15.48 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.377 -0.827 . . . . 0.0 110.211 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.1 m -109.62 30.11 6.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m120 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.469 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.88 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 66.5 t80 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.814 HG12 ' HD2' ' B' ' 1' ' ' PHE . 13.3 p -165.34 -33.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.192 -0.942 . . . . 0.0 110.488 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.621 ' ND2' HG13 ' B' ' 2' ' ' VAL . 16.0 p30 -157.88 -42.26 0.06 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.012 -1.055 . . . . 0.0 109.587 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -76.06 159.91 30.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.473 -0.767 . . . . 0.0 109.012 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -83.26 -178.61 7.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.615 -0.678 . . . . 0.0 109.518 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.594 ' HB3' HD23 ' B' ' 11' ' ' LEU . 33.7 mt -127.4 53.53 1.73 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.546 -0.722 . . . . 0.0 110.422 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -135.53 132.16 36.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.407 -0.808 . . . . 0.0 109.181 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.28 -137.4 13.71 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 53.9 p -85.47 3.76 38.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.499 -1.0 . . . . 0.0 110.101 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -76.36 -34.23 58.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.101 -1.0 . . . . 0.0 109.211 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.611 HD21 HD21 ' A' ' 16' ' ' LEU . 3.5 tm? -66.53 -51.38 57.23 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.6 t -55.32 -48.31 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.587 -0.695 . . . . 0.0 110.17 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -60.55 -29.89 69.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.434 -0.791 . . . . 0.0 109.51 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.717 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -71.78 -32.08 67.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.518 -0.739 . . . . 0.0 109.453 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.699 ' CD2' HD22 ' A' ' 16' ' ' LEU . 41.4 mt -65.69 -41.27 92.58 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.47 -37.85 88.86 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.88 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 2.7 tp -64.71 -28.72 69.78 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.717 HG23 ' O ' ' B' ' 14' ' ' ALA . 42.0 t -73.22 -69.38 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 109.792 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -94.91 -76.37 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.478 -0.764 . . . . 0.0 109.288 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.87 -13.03 10.71 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.787 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -87.33 145.15 26.46 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.151 -1.205 . . . . 0.0 109.489 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -76.48 152.14 36.2 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.76 25.63 63.94 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.52 -28.11 4.15 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.582 ' CE1' HG22 ' B' ' 27' ' ' THR . 30.5 p90 -131.48 -173.94 3.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.621 -0.929 . . . . 0.0 109.569 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.413 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 9.5 t80 -61.73 108.61 1.03 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 109.491 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.582 HG22 ' CE1' ' B' ' 25' ' ' PHE . 45.6 p -123.48 87.98 51.82 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . 0.413 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 1.6 Cg_endo . . . . . 0 N--CA 1.483 0.906 0 C-N-CA 122.709 2.272 . . . . 0.0 110.217 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.508 HG22 HD22 ' B' ' 11' ' ' LEU . 30.0 t . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.02 42.16 1.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 109.677 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.14 -46.99 2.17 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.2 m -125.97 25.39 6.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.675 -0.641 . . . . 0.0 109.621 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.0 -58.55 6.37 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.39 -0.819 . . . . 0.0 109.472 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 t -72.08 -33.75 68.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.483 -0.761 . . . . 0.0 110.043 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -86.11 165.48 16.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.433 -0.792 . . . . 0.0 108.884 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.4 HG12 ' NE2' ' B' ' 5' ' ' HIS . 1.0 OUTLIER -110.99 69.81 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.286 -0.884 . . . . 0.0 109.043 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.7 m -64.98 178.74 0.78 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.53 -0.731 . . . . 0.0 109.753 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 50.1 m -72.9 115.0 11.67 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.918 HD11 HD21 ' B' ' 6' ' ' LEU . 0.3 OUTLIER -69.25 -8.18 43.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.667 -0.646 . . . . 0.0 110.975 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.445 ' CD1' ' HB3' ' A' ' 12' ' ' SER . 0.1 OUTLIER -67.28 -18.73 65.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.967 -1.083 . . . . 0.0 109.934 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.409 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 0.8 OUTLIER -69.35 -10.64 58.82 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.258 -0.901 . . . . 0.0 110.764 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.734 HD12 ' CD1' ' A' ' 13' ' ' LEU . 5.8 mt -65.47 -12.06 49.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.164 -0.96 . . . . 0.0 110.656 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -59.51 -19.53 48.8 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.105 -0.997 . . . . 0.0 110.196 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -97.13 29.61 3.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.288 -0.883 . . . . 0.0 109.775 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.454 ' CG ' HD23 ' A' ' 16' ' ' LEU . 9.0 m-85 -118.38 19.78 13.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.645 -0.659 . . . . 0.0 109.632 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.7 m -103.59 27.27 7.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.247 -0.908 . . . . 0.0 110.026 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.911 -1.042 . . . . 0.0 109.484 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.457 ' CB ' ' HB2' ' B' ' 14' ' ' ALA . 34.8 p90 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 120.613 0.244 . . . . 0.0 110.51 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 40.4 t -51.31 -38.86 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.005 -1.06 . . . . 0.0 110.55 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -134.03 30.01 3.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.439 -0.788 . . . . 0.0 109.668 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' B' ' 5' ' ' HIS . 18.6 mt-30 -117.66 -84.5 0.64 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.66 -0.65 . . . . 0.0 109.394 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.433 ' CG ' ' O ' ' B' ' 4' ' ' GLN . 0.6 OUTLIER -178.99 -172.53 0.25 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.449 -0.782 . . . . 0.0 109.059 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.918 HD21 HD11 ' A' ' 13' ' ' LEU . 40.3 mt -133.77 43.34 2.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.594 -0.691 . . . . 0.0 109.448 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 58.6 m -114.68 137.17 52.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.524 -0.735 . . . . 0.0 109.596 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.46 -140.58 23.75 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.3 -0.67 29.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.567 -0.961 . . . . 0.0 110.652 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -66.94 -31.18 71.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.013 -1.054 . . . . 0.0 109.271 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.508 HD22 HG22 ' A' ' 3' ' ' VAL . 63.4 tp -68.52 -57.43 5.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.576 -0.702 . . . . 0.0 109.182 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 24.7 t -51.65 -44.48 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.657 -0.652 . . . . 0.0 110.843 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -63.78 -34.45 77.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.449 -0.782 . . . . 0.0 109.646 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.457 ' HB2' ' CB ' ' B' ' 1' ' ' PHE . . . -68.9 -29.74 68.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.53 -0.731 . . . . 0.0 109.4 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.666 ' CD2' HD22 ' A' ' 16' ' ' LEU . 40.4 mt -70.71 -37.51 73.55 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -63.49 -41.62 98.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.66 -0.65 . . . . 0.0 109.505 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -63.31 -55.67 22.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.68 . . . . 0.0 109.603 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.642 HG21 ' HB3' ' A' ' 16' ' ' LEU . 43.6 t -55.59 -72.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.652 -0.655 . . . . 0.0 110.238 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.68 -74.28 0.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.835 . . . . 0.0 109.277 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.62 -16.11 61.87 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -60.42 160.95 7.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.171 -1.193 . . . . 0.0 109.841 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.53 108.65 17.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.642 -0.661 . . . . 0.0 109.512 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.2 40.19 61.62 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.1 -24.27 6.06 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -112.56 -175.63 2.72 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.437 -1.037 . . . . 0.0 109.964 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -52.02 138.84 24.17 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.481 -0.762 . . . . 0.0 110.138 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.11 93.15 31.16 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 N--CA 1.482 0.831 0 C-N-CA 122.264 1.976 . . . . 0.0 109.913 -179.798 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.726 HG13 HD22 ' B' ' 11' ' ' LEU . 40.2 t . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -61.09 -17.64 53.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.514 -0.741 . . . . 0.0 110.117 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -48.24 -60.57 2.54 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.233 -0.917 . . . . 0.0 111.294 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.929 ' CB ' HD23 ' B' ' 6' ' ' LEU . 4.1 m -111.56 7.48 20.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.393 -0.817 . . . . 0.0 110.477 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.663 ' SG ' HG12 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -71.61 -28.98 64.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.003 -1.061 . . . . 0.0 109.408 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 m -80.79 -52.96 6.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.474 -0.766 . . . . 0.0 109.802 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.18 -177.36 4.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.0 109.883 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.503 HG12 ' CD2' ' B' ' 5' ' ' HIS . 0.4 OUTLIER -84.78 136.46 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.4 p -122.58 -160.23 0.87 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.373 -0.829 . . . . 0.0 110.085 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.07 139.69 46.22 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.571 HD11 HG21 ' B' ' 18' ' ' VAL . 0.1 OUTLIER -66.05 -13.18 59.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.457 -0.777 . . . . 0.0 110.527 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -60.03 -20.22 56.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.846 -1.159 . . . . 0.0 109.979 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -88.8 -41.45 12.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.372 -0.83 . . . . 0.0 109.892 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.463 HD22 ' CD2' ' B' ' 15' ' ' LEU . 3.9 mt -66.15 -22.13 66.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.509 -0.744 . . . . 0.0 110.038 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.07 -19.18 41.81 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.189 -0.944 . . . . 0.0 110.378 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -94.98 29.66 2.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.242 -0.911 . . . . 0.0 109.688 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -106.62 10.72 31.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.481 -0.762 . . . . 0.0 109.922 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.9 m -95.21 36.15 1.25 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.176 -0.952 . . . . 0.0 109.823 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.6 -179.917 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.494 ' CB ' HD11 ' B' ' 6' ' ' LEU . 3.3 p90 . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 120.38 0.133 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.64 -35.08 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.792 -1.192 . . . . 0.0 108.496 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -150.35 22.35 0.83 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.473 ' O ' ' CG ' ' B' ' 5' ' ' HIS . 57.8 mt-30 -101.03 -94.54 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.902 ' O ' HD13 ' B' ' 6' ' ' LEU . 0.9 OUTLIER 178.12 168.27 0.77 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.267 -0.895 . . . . 0.0 109.029 178.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.929 HD23 ' CB ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -129.66 85.89 2.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.536 -0.728 . . . . 0.0 109.574 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.22 141.07 17.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.572 -0.705 . . . . 0.0 109.623 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.62 -106.01 2.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.6 p -109.25 -13.66 14.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.519 -0.989 . . . . 0.0 110.066 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -64.5 -34.24 77.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.111 -0.993 . . . . 0.0 109.34 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.726 HD22 HG13 ' A' ' 3' ' ' VAL . 58.4 tp -63.93 -54.83 28.48 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.402 HG23 ' H ' ' B' ' 12' ' ' VAL . 17.2 t -52.72 -50.16 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.607 -0.683 . . . . 0.0 110.745 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -30.66 68.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.476 -0.765 . . . . 0.0 109.801 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.814 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -73.27 -30.85 63.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.539 -0.726 . . . . 0.0 109.691 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.463 ' CD2' HD22 ' A' ' 16' ' ' LEU . 39.4 mt -69.37 -39.17 78.2 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.357 -0.839 . . . . 0.0 109.291 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -73.22 -29.62 62.93 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.682 -0.636 . . . . 0.0 109.99 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.3 -28.32 53.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.516 -0.74 . . . . 0.0 109.794 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.814 HG23 ' O ' ' B' ' 14' ' ' ALA . 41.3 t -79.46 -67.1 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.417 -0.802 . . . . 0.0 109.404 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -86.95 -60.05 2.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.586 -0.696 . . . . 0.0 109.352 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.72 30.21 40.38 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -86.36 160.52 19.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.646 -0.914 . . . . 0.0 109.079 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -83.59 82.3 8.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.568 -0.708 . . . . 0.0 109.116 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.52 53.27 3.28 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.81 27.78 5.35 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -165.03 -175.15 3.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.344 -1.092 . . . . 0.0 109.984 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -52.47 108.54 0.31 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.582 -0.698 . . . . 0.0 109.81 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.8 p -121.42 92.15 48.53 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.483 0.905 0 C-N-CA 122.611 2.207 . . . . 0.0 110.288 -179.679 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -59.39 -27.14 65.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.6 -0.688 . . . . 0.0 109.846 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -77.32 -31.13 54.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.421 -0.8 . . . . 0.0 109.336 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.6 m -108.65 30.65 6.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.483 -0.76 . . . . 0.0 109.877 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 46.0 t -114.27 -45.32 3.05 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.407 -0.808 . . . . 0.0 109.755 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 93.2 m -58.66 -82.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.414 -0.804 . . . . 0.0 110.289 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.7 m -84.87 -172.04 3.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.118 -0.989 . . . . 0.0 109.575 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.489 HD13 ' CE1' ' B' ' 5' ' ' HIS . 4.4 mm -84.35 101.36 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.55 -162.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.635 -0.665 . . . . 0.0 109.552 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.9 m -116.71 155.92 28.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.39 -0.818 . . . . 0.0 109.334 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.618 HD21 HG22 ' B' ' 18' ' ' VAL . 0.8 OUTLIER -66.88 -30.23 70.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.448 -0.782 . . . . 0.0 109.703 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -61.84 -27.74 68.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.529 -0.732 . . . . 0.0 109.684 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -67.99 -46.82 70.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.632 -0.667 . . . . 0.0 110.202 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.714 HD11 HD22 ' B' ' 6' ' ' LEU . 5.5 mt -66.38 -16.16 63.85 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.355 -0.841 . . . . 0.0 109.778 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.26 -19.02 42.4 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.226 -0.921 . . . . 0.0 110.101 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -94.31 29.98 2.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.189 -0.944 . . . . 0.0 109.909 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -115.01 9.31 16.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.445 -0.784 . . . . 0.0 110.359 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.0 m -108.15 34.45 3.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.04 -1.038 . . . . 0.0 109.153 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.232 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 8.8 p -46.56 -33.0 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.46 -0.775 . . . . 0.0 110.631 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -160.45 135.21 7.62 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.416 ' CB ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -99.33 43.53 1.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.131 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.489 ' CE1' HD13 ' A' ' 10' ' ' ILE . 3.0 m170 -106.8 129.76 54.61 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.714 HD22 HD11 ' A' ' 16' ' ' LEU . 3.3 mt -126.8 120.81 30.22 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.566 -0.709 . . . . 0.0 109.859 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.66 142.91 0.15 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.525 -0.734 . . . . 0.0 109.421 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.75 -111.24 4.02 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.64 -22.22 16.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.99 . . . . 0.0 109.529 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -58.11 -34.24 69.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.321 -0.862 . . . . 0.0 109.697 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' B' ' 6' ' ' LEU . 62.4 tp -63.67 -53.77 46.1 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -53.31 -55.47 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.564 -0.71 . . . . 0.0 110.657 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.4 -26.13 64.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.32 -0.863 . . . . 0.0 109.902 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.609 ' HB1' ' CD1' ' A' ' 16' ' ' LEU . . . -72.01 -34.94 69.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.479 -0.763 . . . . 0.0 109.524 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.665 HD23 HD22 ' A' ' 16' ' ' LEU . 24.8 mt -70.78 -34.91 72.29 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -73.02 -28.39 62.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.61 -0.682 . . . . 0.0 109.34 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -77.53 -29.89 52.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.681 . . . . 0.0 109.608 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.618 HG22 HD21 ' A' ' 13' ' ' LEU . 61.1 t -85.12 -72.03 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.526 -0.734 . . . . 0.0 109.432 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.16 -56.61 3.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.382 -0.824 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.49 28.15 55.95 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -83.66 150.06 26.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.454 -1.027 . . . . 0.0 109.326 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.425 ' NH1' ' HG3' ' B' ' 22' ' ' ARG . 1.3 mmm-85 -80.21 89.55 5.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.452 -0.78 . . . . 0.0 109.007 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.35 32.22 28.84 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.49 2.9 46.28 Favored Glycine 0 N--CA 1.492 2.396 0 O-C-N 121.512 -0.993 . . . . 0.0 110.985 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.649 ' HB2' HD13 ' B' ' 15' ' ' LEU . 5.1 p90 -143.7 -178.88 6.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.945 -1.326 . . . . 0.0 110.259 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.461 ' CE1' ' HD3' ' B' ' 28' ' ' PRO . 8.2 t80 -58.38 109.13 0.72 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.693 0.759 . . . . 0.0 110.429 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.84 91.43 6.64 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . 0.461 ' HD3' ' CE1' ' B' ' 26' ' ' TYR . 3.3 Cg_exo . . . . . 0 N--CA 1.49 1.267 0 C-N-CA 123.526 2.817 . . . . 0.0 111.433 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.615 HG22 HD22 ' B' ' 11' ' ' LEU . 26.3 t . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.211 0.529 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -74.83 -3.1 29.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.747 . . . . 0.0 111.026 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -90.59 -17.44 26.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.008 -1.058 . . . . 0.0 110.685 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.668 ' CB ' HD23 ' B' ' 6' ' ' LEU . 63.5 m -135.87 19.23 3.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.121 -0.987 . . . . 0.0 110.666 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.0 t -83.58 -32.31 25.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.216 -0.927 . . . . 0.0 109.508 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -73.35 -52.67 13.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.364 -0.835 . . . . 0.0 109.647 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.9 p -109.89 -169.38 1.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.629 -0.669 . . . . 0.0 109.721 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.651 HG23 ' O ' ' B' ' 4' ' ' GLN . 58.3 mt -110.0 99.95 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.696 -0.628 . . . . 0.0 109.766 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.1 m -61.95 -174.24 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.544 -0.723 . . . . 0.0 109.386 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.474 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -107.55 175.61 5.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.595 -0.691 . . . . 0.0 109.216 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -67.63 -12.13 59.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.728 -0.608 . . . . 0.0 110.792 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.474 ' CE2' ' HB2' ' A' ' 12' ' ' SER . 15.4 p90 -68.07 -22.34 64.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.127 -0.983 . . . . 0.0 110.412 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.06 -58.68 2.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.323 -0.861 . . . . 0.0 110.106 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.773 HD22 HD23 ' B' ' 15' ' ' LEU . 32.6 mt -64.31 -14.22 54.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.526 -0.734 . . . . 0.0 110.875 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -30.34 71.41 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.104 -0.997 . . . . 0.0 109.4 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -97.8 29.53 3.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.547 -0.721 . . . . 0.0 109.771 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -110.5 8.77 23.17 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.53 -0.731 . . . . 0.0 110.138 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.5 m -97.49 29.26 3.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.205 -0.934 . . . . 0.0 109.56 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.27 -179.958 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.587 ' CZ ' HD22 ' B' ' 17' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.482 HG23 ' ND2' ' B' ' 3' ' ' ASN . 17.3 m -88.98 -34.39 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.482 ' ND2' HG23 ' B' ' 2' ' ' VAL . 17.3 p30 -156.76 34.2 0.3 Allowed 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.651 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -123.69 155.85 37.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.779 -0.575 . . . . 0.0 109.826 -178.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.433 ' CE1' HG12 ' A' ' 10' ' ' ILE . 7.0 m80 -106.2 156.65 18.25 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 16' ' ' LEU . 2.0 mm? -109.12 101.14 10.22 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.248 -0.908 . . . . 0.0 109.997 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.61 120.61 0.05 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.82 -149.16 28.05 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.62 -15.72 63.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.539 -0.977 . . . . 0.0 110.047 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -60.86 -30.8 70.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.156 -0.965 . . . . 0.0 109.783 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.615 HD22 HG22 ' A' ' 3' ' ' VAL . 58.3 tp -70.89 -52.32 20.82 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.512 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 18.7 t -53.51 -49.43 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.506 -0.746 . . . . 0.0 110.401 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.02 -31.28 69.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.571 -0.705 . . . . 0.0 109.597 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.754 ' HB1' HD13 ' A' ' 16' ' ' LEU . . . -68.55 -34.16 75.35 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.773 HD23 HD22 ' A' ' 16' ' ' LEU . 23.9 mt -75.35 -25.51 57.82 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -74.34 -31.61 62.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 109.124 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.587 HD22 ' CZ ' ' B' ' 1' ' ' PHE . 0.2 OUTLIER -80.1 -33.99 38.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.639 -0.663 . . . . 0.0 109.538 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.576 HG23 ' O ' ' B' ' 14' ' ' ALA . 39.1 t -81.28 -69.27 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.654 -0.654 . . . . 0.0 109.784 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 55.7 m -57.94 -66.52 0.46 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.357 -0.839 . . . . 0.0 109.786 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.25 -38.3 3.22 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.6 -173.44 1.16 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.51 -0.994 . . . . 0.0 109.486 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.86 -64.71 1.02 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.557 -0.714 . . . . 0.0 109.703 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.86 41.79 2.29 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.01 35.04 5.18 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -176.11 -172.02 0.47 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.57 -0.959 . . . . 0.0 109.738 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -52.04 110.51 0.49 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.378 -0.827 . . . . 0.0 109.909 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.12 94.16 41.05 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.602 -0.686 . . . . 0.0 109.672 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.484 0.933 0 C-N-CA 122.476 2.117 . . . . 0.0 110.05 179.854 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.475 HG22 HD22 ' B' ' 11' ' ' LEU . 42.9 t . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.65 -22.19 61.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.684 -0.635 . . . . 0.0 110.262 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -63.55 -42.48 98.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.463 -0.773 . . . . 0.0 110.372 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.476 ' HB2' HD23 ' B' ' 6' ' ' LEU . 57.6 m -119.76 27.44 8.72 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.59 -43.62 15.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.75 . . . . 0.0 109.437 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 t -84.76 -27.85 26.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.604 -0.685 . . . . 0.0 109.965 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -116.99 168.47 10.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.473 -0.767 . . . . 0.0 109.362 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.457 HG12 ' CE1' ' B' ' 5' ' ' HIS . 10.7 mt -107.66 90.02 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.502 -0.749 . . . . 0.0 109.162 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.5 m -60.19 -169.44 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.367 -0.833 . . . . 0.0 109.602 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.468 ' CB ' ' CE2' ' A' ' 14' ' ' TYR . 48.7 m -94.21 160.4 14.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.612 -0.68 . . . . 0.0 109.249 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 13' ' ' LEU . 3.4 tm? -71.59 -26.6 62.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.627 -0.671 . . . . 0.0 109.904 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.468 ' CE2' ' CB ' ' A' ' 12' ' ' SER . 12.5 p90 -64.88 -18.16 64.94 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.495 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -78.77 -44.58 22.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.298 -0.876 . . . . 0.0 109.061 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.58 HD22 ' CD2' ' B' ' 15' ' ' LEU . 1.5 mt -64.88 -19.69 66.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.584 -0.697 . . . . 0.0 109.643 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -55.8 -21.28 18.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 0.0 110.563 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -94.49 32.78 1.51 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.284 -0.885 . . . . 0.0 109.644 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.462 ' CG ' HD23 ' A' ' 16' ' ' LEU . 8.3 m-85 -114.91 11.5 16.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.429 -0.795 . . . . 0.0 110.08 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' B' ' 25' ' ' PHE . 84.5 m -97.15 28.78 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.169 -0.957 . . . . 0.0 109.536 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 m120 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.548 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.808 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.711 HG12 ' CD1' ' B' ' 1' ' ' PHE . 7.5 p -161.68 -43.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 109.062 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.445 ' N ' HG13 ' B' ' 2' ' ' VAL . 17.4 m120 -156.98 29.16 0.31 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 109.159 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -143.42 131.8 22.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.534 -0.729 . . . . 0.0 109.568 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.457 ' CE1' HG12 ' A' ' 10' ' ' ILE . 79.3 m80 -81.51 164.04 22.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.649 -0.657 . . . . 0.0 109.476 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.701 HD22 ' N ' ' B' ' 6' ' ' LEU . 1.5 mm? -109.56 82.09 1.54 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.527 -0.733 . . . . 0.0 109.404 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 74.3 m -130.91 121.52 25.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.506 -0.746 . . . . 0.0 109.828 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.71 -128.32 8.4 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 93.4 p -84.43 -9.72 58.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.689 -0.889 . . . . 0.0 110.396 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -61.32 -27.89 68.81 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.011 -1.055 . . . . 0.0 109.348 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' B' ' 6' ' ' LEU . 56.3 tp -70.47 -61.97 1.57 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.466 -0.771 . . . . 0.0 108.94 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.402 ' H ' HG23 ' B' ' 12' ' ' VAL . 36.0 t -47.21 -49.74 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.724 -0.61 . . . . 0.0 111.454 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -56.53 -39.14 72.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.372 -0.83 . . . . 0.0 110.441 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.83 -28.88 64.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.441 -0.787 . . . . 0.0 109.886 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.58 ' CD2' HD22 ' A' ' 16' ' ' LEU . 50.8 mt -65.55 -38.5 89.77 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -66.01 -34.19 77.52 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.808 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 2.2 tp -61.39 -34.02 74.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.685 -0.634 . . . . 0.0 109.354 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.523 ' CG2' HD21 ' A' ' 13' ' ' LEU . 45.2 t -87.78 -75.19 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.527 -0.733 . . . . 0.0 109.951 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -75.74 -76.36 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.254 -0.904 . . . . 0.0 109.064 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.07 17.66 26.81 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.81 160.21 16.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.348 -1.089 . . . . 0.0 108.9 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -39.83 61.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.449 -0.782 . . . . 0.0 109.493 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.23 61.85 0.62 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.7 -41.0 0.36 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 21.3 p90 -102.87 -175.83 2.92 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.57 -0.959 . . . . 0.0 110.23 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -58.21 127.4 31.9 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.57 0.7 . . . . 0.0 110.326 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.73 94.77 31.02 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.483 0.857 0 C-N-CA 122.33 2.02 . . . . 0.0 110.244 -179.821 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 3' ' ' VAL . 23.8 t . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 120.38 0.133 . . . . 0.0 110.772 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -96.9 27.06 4.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.973 -1.079 . . . . 0.0 109.775 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.28 -30.66 7.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.0 9.36 6.3 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.548 -0.72 . . . . 0.0 110.505 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 46.6 t -82.01 84.82 6.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.087 -1.008 . . . . 0.0 108.964 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.7 m -160.95 -42.92 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.488 -0.758 . . . . 0.0 109.944 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.464 ' HA ' ' CE1' ' B' ' 5' ' ' HIS . 11.6 t -154.06 -125.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.731 . . . . 0.0 109.368 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.624 HD13 ' N ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -101.61 105.63 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.582 -1.324 . . . . 0.0 108.686 -179.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -82.13 155.72 24.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.673 -0.642 . . . . 0.0 109.512 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.2 p -95.65 151.78 19.04 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.853 HD13 ' O ' ' A' ' 13' ' ' LEU . 1.3 tm? -66.49 -26.72 67.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.647 -0.658 . . . . 0.0 109.437 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -51.94 -24.82 6.98 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.148 -0.97 . . . . 0.0 110.603 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -87.89 -44.23 11.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.348 -0.845 . . . . 0.0 109.966 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.717 HD11 HD21 ' B' ' 6' ' ' LEU . 4.2 mt -65.01 -16.21 63.18 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.436 -0.79 . . . . 0.0 110.5 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.15 -23.56 35.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.177 -0.952 . . . . 0.0 110.307 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -96.64 37.92 1.25 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.479 -0.763 . . . . 0.0 109.802 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.603 ' CG ' HD23 ' A' ' 16' ' ' LEU . 7.2 m-85 -115.99 -0.91 12.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.484 -0.76 . . . . 0.0 110.554 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.5 m -88.62 11.12 18.23 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.082 -1.011 . . . . 0.0 110.57 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.9 p30 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.098 -1.001 . . . . 0.0 109.581 179.879 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.631 ' CE1' HD23 ' A' ' 13' ' ' LEU . 9.1 p90 . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 120.473 0.178 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 35.1 m -63.09 -29.67 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.167 -0.958 . . . . 0.0 109.254 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -142.97 30.09 1.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -130.52 -179.21 5.14 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.464 ' CE1' ' HA ' ' A' ' 9' ' ' SER . 12.3 m-70 -109.15 149.55 29.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.338 -0.851 . . . . 0.0 109.524 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.717 HD21 HD11 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -93.28 100.01 12.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.563 -0.71 . . . . 0.0 110.123 -179.058 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.67 142.58 0.14 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.586 -0.696 . . . . 0.0 109.236 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.23 -115.33 4.08 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.38 -19.62 18.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.674 -0.898 . . . . 0.0 109.956 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -56.68 -28.18 60.27 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.012 -1.055 . . . . 0.0 109.445 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.524 HD22 ' HG ' ' B' ' 6' ' ' LEU . 0.6 OUTLIER -64.73 -60.03 3.56 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 25.2 t -52.62 -47.32 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.835 -0.541 . . . . 0.0 111.577 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -58.93 -30.77 68.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.292 -0.88 . . . . 0.0 110.353 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.805 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -77.92 -27.39 49.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.506 -0.747 . . . . 0.0 109.796 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.586 HD23 HD22 ' A' ' 16' ' ' LEU . 45.3 mt -70.49 -37.89 74.27 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.294 -0.879 . . . . 0.0 108.941 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -76.11 -34.55 59.48 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -30.01 69.71 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.805 HG23 ' O ' ' B' ' 14' ' ' ALA . 33.0 t -86.82 -69.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.531 -0.73 . . . . 0.0 109.479 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 11.6 m -88.68 -70.16 0.66 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.557 -0.714 . . . . 0.0 109.335 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.44 36.97 22.14 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -86.51 177.29 7.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.53 -0.982 . . . . 0.0 109.119 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -82.74 80.27 8.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.524 -0.735 . . . . 0.0 109.204 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.81 63.27 2.91 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.83 22.13 5.8 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -151.1 -173.19 4.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.263 -1.139 . . . . 0.0 109.573 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.404 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 3.6 t80 -49.95 101.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.54 -0.725 . . . . 0.0 110.085 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.42 90.91 36.32 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . 0.404 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 4.9 Cg_exo . . . . . 0 N--CA 1.482 0.816 0 C-N-CA 122.625 2.217 . . . . 0.0 110.094 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -70.17 -10.08 57.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.622 -0.674 . . . . 0.0 110.037 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.52 -65.7 0.51 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.074 -1.016 . . . . 0.0 110.004 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.0 m -129.68 36.83 4.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.478 -0.764 . . . . 0.0 110.336 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.0 t -54.17 -55.46 27.65 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.187 -0.946 . . . . 0.0 109.335 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -92.64 49.74 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.528 -0.733 . . . . 0.0 109.454 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -176.56 163.2 2.37 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.44 HG12 ' CE1' ' B' ' 5' ' ' HIS . 16.8 mt -103.69 86.81 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.426 -0.797 . . . . 0.0 109.166 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -178.83 0.1 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.765 -0.584 . . . . 0.0 110.079 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -91.71 166.12 12.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.708 -0.62 . . . . 0.0 109.623 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.737 HD13 ' O ' ' A' ' 13' ' ' LEU . 3.5 tm? -66.51 -32.11 73.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.669 -0.644 . . . . 0.0 109.679 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -27.14 63.99 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.335 -0.853 . . . . 0.0 109.694 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -67.39 -50.12 60.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.459 -0.776 . . . . 0.0 109.508 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.864 HD11 HD22 ' B' ' 6' ' ' LEU . 10.2 mt -65.43 -16.65 63.85 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.431 -0.793 . . . . 0.0 110.25 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.91 -19.41 42.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.249 -0.907 . . . . 0.0 110.354 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -96.27 30.63 2.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.264 -0.898 . . . . 0.0 109.801 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.486 ' HB3' HD22 ' B' ' 15' ' ' LEU . 6.4 m-85 -114.69 -14.91 11.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.6 -0.687 . . . . 0.0 110.026 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.9 m -73.56 -20.15 60.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.136 -0.978 . . . . 0.0 110.22 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.7 p30 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.415 179.78 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.919 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.574 HG23 ' CD1' ' B' ' 1' ' ' PHE . 18.4 t -83.48 -69.59 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.595 -1.316 . . . . 0.0 109.081 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.508 ' OD1' HG12 ' B' ' 2' ' ' VAL . 34.4 m120 -154.35 24.63 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.532 -0.73 . . . . 0.0 109.935 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -115.47 142.11 47.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.448 -0.782 . . . . 0.0 109.328 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.44 ' CE1' HG12 ' A' ' 10' ' ' ILE . 49.8 m80 -70.51 -178.47 1.78 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.63 -0.669 . . . . 0.0 109.866 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.864 HD22 HD11 ' A' ' 16' ' ' LEU . 38.0 mt -130.63 42.18 3.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.501 -0.749 . . . . 0.0 110.854 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.67 140.78 52.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.212 -0.93 . . . . 0.0 109.281 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.66 -144.61 21.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.3 -14.67 60.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.456 -1.026 . . . . 0.0 109.893 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -60.43 -37.86 82.26 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.082 -1.011 . . . . 0.0 109.126 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.457 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 2.5 tt -61.65 -58.5 7.81 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.806 -0.559 . . . . 0.0 109.696 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 t -49.56 -51.06 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.625 -0.672 . . . . 0.0 111.22 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -58.61 -33.65 70.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.368 -0.832 . . . . 0.0 110.092 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.447 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -70.45 -30.56 67.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.548 -0.72 . . . . 0.0 109.7 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.751 ' CD2' HD22 ' A' ' 16' ' ' LEU . 30.2 mt -69.25 -36.52 77.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.75 -29.94 66.31 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.919 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 1.5 tp -68.66 -35.47 77.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.602 -0.686 . . . . 0.0 109.436 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 14' ' ' ALA . 39.7 t -80.84 -69.81 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.543 -0.723 . . . . 0.0 109.726 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.56 -81.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.472 -0.768 . . . . 0.0 109.416 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 139.19 -52.05 0.73 Allowed Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.671 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -90.34 152.02 21.2 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.34 -1.094 . . . . 0.0 110.062 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 19.3 mtt180 -76.03 139.03 41.25 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.22 17.62 57.11 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.6 33.56 5.18 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.456 ' CD1' ' CB ' ' B' ' 15' ' ' LEU . 27.0 p90 -176.83 -169.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.717 -0.872 . . . . 0.0 109.016 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -51.52 99.93 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.294 -0.879 . . . . 0.0 109.82 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 19.5 p -132.61 89.88 34.55 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo . . . . . 0 C--N 1.322 -0.866 0 C-N-CA 122.394 2.062 . . . . 0.0 110.159 -179.78 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.504 HG23 ' OH ' ' A' ' 19' ' ' TYR . 23.6 t . . . . . 0 N--CA 1.494 1.738 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.25 -21.26 63.73 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.442 -0.786 . . . . 0.0 110.04 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -111.79 -3.52 14.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.383 -0.823 . . . . 0.0 110.951 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.4 m -121.26 18.78 11.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.983 -1.073 . . . . 0.0 110.529 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.02 21.68 13.57 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.164 -0.96 . . . . 0.0 109.828 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.6 m -129.73 -66.22 0.8 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 108.83 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.99 -164.88 1.21 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.585 HD13 ' NE2' ' B' ' 5' ' ' HIS . 4.5 mm -90.82 98.55 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.4 -0.813 . . . . 0.0 108.941 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -70.69 -167.76 0.21 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.671 -0.643 . . . . 0.0 109.747 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.02 156.12 44.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.509 -0.744 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.863 HD13 ' O ' ' A' ' 13' ' ' LEU . 3.2 tm? -66.78 -26.32 66.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.619 -0.676 . . . . 0.0 110.521 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.89 -22.32 14.41 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.073 -1.017 . . . . 0.0 110.561 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -86.39 -39.94 15.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.419 -0.801 . . . . 0.0 109.437 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.665 HD11 HD11 ' B' ' 6' ' ' LEU . 6.5 mt -68.64 -10.78 58.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.489 -0.757 . . . . 0.0 110.258 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -67.51 -28.43 67.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 109.412 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -71.01 -12.16 61.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.553 -0.717 . . . . 0.0 110.622 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.504 ' OH ' HG23 ' A' ' 3' ' ' VAL . 5.3 m-85 -74.59 -7.8 54.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.32 -0.862 . . . . 0.0 110.47 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 27.9 m -97.64 33.44 2.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.132 -0.98 . . . . 0.0 109.596 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.533 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.7 ' CD1' HD23 ' A' ' 13' ' ' LEU . 8.5 p90 . . . . . 0 N--CA 1.5 2.036 0 CA-C-O 120.464 0.173 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.94 -33.16 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.056 -1.027 . . . . 0.0 108.734 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -144.27 30.04 1.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -126.65 -159.5 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.585 ' NE2' HD13 ' A' ' 10' ' ' ILE . 20.3 m80 -115.97 -172.82 2.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.349 -0.844 . . . . 0.0 109.829 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.665 HD11 HD11 ' A' ' 16' ' ' LEU . 4.4 tp -130.45 43.57 3.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.572 -0.705 . . . . 0.0 110.178 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 59.5 m -122.86 136.29 54.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.509 -0.744 . . . . 0.0 109.464 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.94 -132.94 11.43 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -81.53 2.86 27.11 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.646 -0.914 . . . . 0.0 110.33 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -77.13 -37.18 54.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.053 -1.03 . . . . 0.0 108.733 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 36.9 tp -68.17 -63.69 1.01 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -52.54 -49.77 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.658 -0.651 . . . . 0.0 110.641 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -59.54 -30.79 68.86 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.329 -0.857 . . . . 0.0 109.658 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.42 -32.13 68.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.636 -0.665 . . . . 0.0 109.764 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.65 ' CD2' HD22 ' A' ' 16' ' ' LEU . 38.2 mt -68.92 -39.66 79.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.471 -0.768 . . . . 0.0 109.162 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -67.49 -34.0 76.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.692 . . . . 0.0 109.522 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.33 -46.21 74.13 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.553 -0.717 . . . . 0.0 109.677 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.629 ' CG2' HD21 ' A' ' 13' ' ' LEU . 44.3 t -67.42 -69.81 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.506 -0.746 . . . . 0.0 109.355 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.88 -79.46 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.483 -0.76 . . . . 0.0 108.992 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.44 -28.02 14.92 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.93 170.12 4.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.423 -1.045 . . . . 0.0 109.764 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.74 138.87 31.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.546 -0.721 . . . . 0.0 109.395 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.56 29.6 69.97 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.78 27.7 10.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.473 ' HB2' HD13 ' B' ' 15' ' ' LEU . 12.5 p90 -177.72 -177.32 0.65 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -1.073 . . . . 0.0 110.177 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -57.49 125.97 25.24 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.6 -0.687 . . . . 0.0 109.893 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 8.8 p -117.63 96.36 49.28 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.574 -0.703 . . . . 0.0 109.257 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo . . . . . 0 N--CA 1.483 0.878 0 C-N-CA 122.487 2.124 . . . . 0.0 110.169 -179.755 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.412 HG12 ' SG ' ' A' ' 7' ' ' CYS . 31.4 t . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -60.28 -18.51 49.68 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.58 -0.7 . . . . 0.0 110.082 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -52.64 -59.32 4.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.249 -0.907 . . . . 0.0 110.309 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -124.23 36.02 4.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.524 -0.735 . . . . 0.0 109.515 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' B' ' 6' ' ' LEU . 0.1 OUTLIER -62.59 -43.16 99.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.625 -0.672 . . . . 0.0 109.555 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 m -87.41 -33.67 19.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.534 -0.729 . . . . 0.0 109.75 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -94.45 -177.63 4.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.457 -0.777 . . . . 0.0 109.449 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.44 ' CG1' ' CE1' ' B' ' 5' ' ' HIS . 19.5 mt -114.73 99.95 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.377 -0.827 . . . . 0.0 109.409 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.33 -177.87 6.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.567 -0.708 . . . . 0.0 109.304 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.12 153.95 19.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.507 -0.746 . . . . 0.0 109.424 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.685 HD11 HG22 ' B' ' 18' ' ' VAL . 59.5 tp -57.86 -20.32 35.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.597 -0.689 . . . . 0.0 110.826 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -53.24 -28.19 26.05 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.22 -0.925 . . . . 0.0 111.697 -178.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.443 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 14.3 pt20 -80.06 -44.37 20.18 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.104 -0.997 . . . . 0.0 109.66 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.641 HD22 HD23 ' B' ' 15' ' ' LEU . 9.9 mt -67.0 -16.43 64.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.51 -0.744 . . . . 0.0 109.649 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.62 -17.92 50.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.173 -0.954 . . . . 0.0 109.84 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -93.27 27.28 2.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 0.0 109.869 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.493 ' CD2' HD22 ' B' ' 15' ' ' LEU . 6.3 m-85 -107.16 -20.59 13.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.365 -0.834 . . . . 0.0 109.966 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.3 m -75.88 -4.2 39.51 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.275 -0.89 . . . . 0.0 110.287 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p30 . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.004 -1.06 . . . . 0.0 109.548 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.859 ' CZ ' HD22 ' B' ' 17' ' ' LEU . 3.3 t80 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.684 HG12 ' ND2' ' B' ' 3' ' ' ASN . 9.0 t -46.35 -64.65 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 O-C-N 121.65 -0.656 . . . . 0.0 110.52 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.684 ' ND2' HG12 ' B' ' 2' ' ' VAL . 10.3 p30 -174.4 36.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -122.26 148.81 44.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.609 -0.682 . . . . 0.0 109.258 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.44 ' CE1' ' CG1' ' A' ' 10' ' ' ILE . 51.1 m80 -78.38 -178.31 5.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.642 -0.661 . . . . 0.0 109.576 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -142.42 131.96 23.83 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.95 -76.71 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.146 -0.971 . . . . 0.0 109.595 178.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.08 -121.59 0.06 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 22.3 p -73.58 -8.54 56.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.47 -1.018 . . . . 0.0 109.445 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -61.28 -41.82 97.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.877 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.473 ' CD1' HD21 ' A' ' 16' ' ' LEU . 67.2 tp -60.46 -56.29 23.14 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.485 -0.76 . . . . 0.0 109.682 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.4 t -49.76 -53.77 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.567 -0.708 . . . . 0.0 111.081 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -58.07 -31.93 67.55 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.437 -0.789 . . . . 0.0 110.188 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.424 ' HA ' ' CE1' ' B' ' 1' ' ' PHE . . . -69.13 -34.11 74.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.482 -0.762 . . . . 0.0 109.654 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.641 HD23 HD22 ' A' ' 16' ' ' LEU . 25.8 mt -70.81 -32.94 70.19 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -68.29 -33.72 74.87 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.859 HD22 ' CZ ' ' B' ' 1' ' ' PHE . 0.5 OUTLIER -69.14 -39.22 78.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.689 -0.632 . . . . 0.0 109.745 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.685 HG22 HD11 ' A' ' 13' ' ' LEU . 30.8 t -72.84 -68.2 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.57 -0.706 . . . . 0.0 110.135 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 10.6 m -65.15 -69.19 0.31 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.417 -0.802 . . . . 0.0 109.195 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.0 -36.52 3.52 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.28 167.43 12.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.338 -1.095 . . . . 0.0 109.928 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.56 -63.56 1.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.81 86.26 0.97 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -161.5 -41.38 0.02 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.531 ' O ' HG23 ' B' ' 27' ' ' THR . 28.0 p90 -116.43 -174.49 2.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.409 -1.053 . . . . 0.0 110.446 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.412 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 2.9 t80 -54.5 100.0 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.531 HG23 ' O ' ' B' ' 25' ' ' PHE . 40.4 p -113.1 92.46 21.74 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.653 -0.654 . . . . 0.0 109.57 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . 0.412 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 2.4 Cg_endo . . . . . 0 C--N 1.323 -0.808 0 C-N-CA 122.422 2.081 . . . . 0.0 109.776 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.808 HG22 ' CD2' ' B' ' 11' ' ' LEU . 19.0 t . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -74.81 -5.55 44.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.557 -0.715 . . . . 0.0 110.195 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -58.24 -63.21 1.35 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.196 -0.94 . . . . 0.0 110.013 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.553 ' SG ' HD12 ' B' ' 6' ' ' LEU . 4.5 p -120.48 27.32 8.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.477 -0.764 . . . . 0.0 110.279 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -32.09 54.36 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.217 -0.927 . . . . 0.0 109.389 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -113.42 -32.73 6.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.676 -0.64 . . . . 0.0 109.325 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.431 ' O ' ' CD2' ' B' ' 5' ' ' HIS . 0.4 OUTLIER -98.85 -171.41 2.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.449 -0.782 . . . . 0.0 108.926 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.482 HD13 ' NE2' ' B' ' 5' ' ' HIS . 1.7 mm -104.21 160.64 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.361 -0.837 . . . . 0.0 109.008 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.406 ' SG ' HD12 ' B' ' 6' ' ' LEU . 4.0 p -147.27 179.56 7.56 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.507 -0.746 . . . . 0.0 109.806 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.467 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -82.8 102.06 11.34 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.87 HD11 HD21 ' B' ' 6' ' ' LEU . 3.1 mm? -70.27 -14.61 62.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.545 -0.722 . . . . 0.0 110.859 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' A' ' 12' ' ' SER . 17.3 p90 -71.25 -18.92 62.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.088 -1.008 . . . . 0.0 109.779 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -84.18 -3.24 58.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.359 -0.838 . . . . 0.0 110.416 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.745 HD12 ' CD1' ' A' ' 13' ' ' LEU . 4.4 mt -65.7 -14.15 60.7 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.134 -0.979 . . . . 0.0 109.99 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -59.06 -19.65 46.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.164 -0.96 . . . . 0.0 110.002 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -96.89 31.95 2.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.296 -0.878 . . . . 0.0 109.438 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.598 ' CG ' HD23 ' A' ' 16' ' ' LEU . 6.4 m-85 -115.19 12.97 16.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.435 -0.79 . . . . 0.0 109.95 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.81 -56.11 5.12 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.231 -0.918 . . . . 0.0 109.571 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.297 -1.713 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.326 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.427 ' HE2' HD22 ' B' ' 17' ' ' LEU . 13.3 p90 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 120.613 0.244 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 24.5 t -51.89 -25.72 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 120.962 -1.087 . . . . 0.0 110.469 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -151.57 27.14 0.66 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 109.303 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' B' ' 5' ' ' HIS . 5.8 mp0 -107.24 -97.21 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.441 -0.787 . . . . 0.0 109.329 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.482 ' NE2' HD13 ' A' ' 10' ' ' ILE . 1.1 m80 -173.1 152.58 2.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.833 -1.167 . . . . 0.0 109.86 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.87 HD21 HD11 ' A' ' 13' ' ' LEU . 21.9 mt -115.11 86.15 2.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.635 -0.666 . . . . 0.0 109.511 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -150.2 129.95 13.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.48 -0.762 . . . . 0.0 109.481 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.29 -136.48 14.46 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.42 -6.81 57.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.494 -1.003 . . . . 0.0 110.364 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -66.57 -29.68 69.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 109.691 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.808 ' CD2' HG22 ' A' ' 3' ' ' VAL . 60.7 tp -71.25 -46.28 61.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.486 -0.759 . . . . 0.0 109.544 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.411 HG13 ' O ' ' B' ' 26' ' ' TYR . 39.3 t -60.66 -43.79 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.672 -0.643 . . . . 0.0 109.952 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.77 -39.51 94.41 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.435 -0.791 . . . . 0.0 109.302 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.768 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -66.32 -30.39 70.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.607 -0.683 . . . . 0.0 109.769 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.691 HD22 HD22 ' A' ' 16' ' ' LEU . 1.2 mt -70.4 -36.18 73.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.507 -0.745 . . . . 0.0 109.416 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -70.3 -32.55 70.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.581 -0.699 . . . . 0.0 109.607 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.427 HD22 ' HE2' ' B' ' 1' ' ' PHE . 0.3 OUTLIER -79.82 -24.67 41.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.477 -0.764 . . . . 0.0 110.086 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.768 HG23 ' O ' ' B' ' 14' ' ' ALA . 41.9 t -89.48 -68.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.246 -0.909 . . . . 0.0 109.801 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 m -53.71 -78.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.39 -0.819 . . . . 0.0 110.269 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.33 -40.42 1.56 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.84 176.02 1.03 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.287 -1.125 . . . . 0.0 109.593 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.42 -44.35 6.55 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.53 ' HA2' HG21 ' B' ' 27' ' ' THR . . . -118.75 42.97 1.68 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.28 38.16 3.21 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.477 ' CD1' ' HB2' ' B' ' 15' ' ' LEU . 52.5 p90 -178.4 -166.71 0.11 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.397 -1.061 . . . . 0.0 109.522 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.519 ' CB ' HD12 ' B' ' 15' ' ' LEU . 0.4 OUTLIER -47.29 94.38 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.868 -0.52 . . . . 0.0 110.188 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.53 HG21 ' HA2' ' B' ' 23' ' ' GLY . 0.8 OUTLIER -127.33 98.86 28.58 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.484 0.956 0 C-N-CA 122.3 2.0 . . . . 0.0 110.047 -179.62 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -90.52 53.58 2.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.233 -0.917 . . . . 0.0 109.044 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -142.22 -46.32 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.539 -0.726 . . . . 0.0 109.368 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.592 ' CB ' HD23 ' B' ' 6' ' ' LEU . 8.0 m -115.6 15.87 16.55 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.539 -0.726 . . . . 0.0 109.952 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 45.3 t -72.93 -35.77 67.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.09 -1.006 . . . . 0.0 109.314 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 m -73.22 -58.14 3.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.487 -0.758 . . . . 0.0 109.797 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.4 p -119.62 -167.86 1.49 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.502 -0.749 . . . . 0.0 109.815 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.423 HG12 ' CE1' ' B' ' 5' ' ' HIS . 7.4 mt -101.82 130.16 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.0 p -106.23 -172.9 2.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.31 -0.869 . . . . 0.0 110.429 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.57 144.8 55.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.573 -0.705 . . . . 0.0 110.787 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.825 HD13 ' O ' ' A' ' 13' ' ' LEU . 3.4 tm? -69.15 -30.25 68.44 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -22.29 22.09 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.489 -0.757 . . . . 0.0 109.94 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -72.45 -46.74 53.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.36 -0.838 . . . . 0.0 109.487 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.701 HD11 ' HG ' ' B' ' 6' ' ' LEU . 5.4 mt -65.4 -21.62 66.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.516 -0.74 . . . . 0.0 110.093 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.77 -26.92 58.69 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.226 -0.921 . . . . 0.0 110.308 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -97.74 35.88 1.61 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.377 -0.827 . . . . 0.0 109.672 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.453 ' HB3' HD22 ' B' ' 15' ' ' LEU . 7.1 m-85 -113.8 -0.98 14.04 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.501 -0.75 . . . . 0.0 110.383 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.2 m -81.15 1.77 30.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.145 -0.972 . . . . 0.0 110.469 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 120.999 -1.063 . . . . 0.0 109.571 -179.817 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.445 ' CD2' HD23 ' A' ' 13' ' ' LEU . 1.2 t80 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 28.8 m -50.49 172.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.444 -0.785 . . . . 0.0 110.703 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -58.59 92.54 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.464 -0.772 . . . . 0.0 109.901 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -130.4 104.99 7.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.556 -0.715 . . . . 0.0 109.385 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.423 ' CE1' HG12 ' A' ' 10' ' ' ILE . 70.9 m80 -74.4 135.07 42.39 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.835 ' HB3' HD13 ' B' ' 11' ' ' LEU . 0.2 OUTLIER -86.95 98.25 11.14 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.483 -0.761 . . . . 0.0 109.734 -179.274 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -178.46 127.36 0.11 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.694 . . . . 0.0 109.422 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.83 -141.17 26.95 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p -69.23 -16.66 63.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.561 -0.964 . . . . 0.0 110.169 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -67.81 -38.76 83.68 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.176 -0.953 . . . . 0.0 109.575 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.835 HD13 ' HB3' ' B' ' 6' ' ' LEU . 66.7 tp -68.69 -46.19 69.68 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.654 -0.654 . . . . 0.0 109.379 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.411 HG23 ' H ' ' B' ' 12' ' ' VAL . 8.7 t -55.97 -49.9 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.428 -0.795 . . . . 0.0 110.073 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -62.31 -26.33 68.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.556 -0.715 . . . . 0.0 109.578 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.745 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -71.85 -32.26 67.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.641 -0.662 . . . . 0.0 109.293 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.578 HD23 HD22 ' A' ' 16' ' ' LEU . 24.0 mt -79.33 -26.58 42.13 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.48 -29.79 61.58 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -83.35 -32.31 26.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.494 -0.754 . . . . 0.0 109.477 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.745 HG23 ' O ' ' B' ' 14' ' ' ALA . 45.3 t -81.28 -68.88 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.528 -0.732 . . . . 0.0 109.506 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 60.5 m -54.33 -73.29 0.05 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.496 -0.753 . . . . 0.0 110.428 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.76 -45.88 1.1 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 174.12 8.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.377 -1.072 . . . . 0.0 109.688 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.67 31.44 5.46 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.18 37.15 0.09 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.91 46.75 1.06 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.459 ' CG ' ' HB3' ' B' ' 15' ' ' LEU . 14.5 p90 -179.33 -173.62 0.28 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.465 -1.021 . . . . 0.0 109.877 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.4 ' HB3' ' CD1' ' B' ' 15' ' ' LEU . 4.8 t80 -54.46 108.36 0.37 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.509 -0.744 . . . . 0.0 109.482 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.78 93.32 46.09 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.715 -0.615 . . . . 0.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.484 0.952 0 C-N-CA 122.529 2.153 . . . . 0.0 109.979 -179.91 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.889 ' CG2' HD22 ' B' ' 11' ' ' LEU . 3.7 t . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.074 0.464 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.37 -8.87 54.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.431 -0.793 . . . . 0.0 110.866 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.69 -14.56 8.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.154 -0.966 . . . . 0.0 110.883 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.483 ' HB2' HD12 ' B' ' 6' ' ' LEU . 11.9 m -120.19 24.44 10.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.027 -1.046 . . . . 0.0 110.12 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -84.84 -42.9 14.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.348 -0.845 . . . . 0.0 109.301 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.9 m -78.91 -48.13 15.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.548 -0.72 . . . . 0.0 109.654 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -110.0 -177.91 3.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.689 . . . . 0.0 109.543 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.44 HG12 ' CE1' ' B' ' 5' ' ' HIS . 32.0 mt -106.25 135.23 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.7 m -94.99 -174.69 3.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.726 . . . . 0.0 110.129 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.8 m -91.84 166.36 12.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.661 -0.649 . . . . 0.0 109.962 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.474 HD11 HG13 ' B' ' 18' ' ' VAL . 45.5 tp -67.47 -24.81 65.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.673 -0.642 . . . . 0.0 110.174 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -58.67 -19.35 38.67 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.456 -0.778 . . . . 0.0 110.954 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -77.64 -69.35 0.55 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.084 -1.01 . . . . 0.0 110.375 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.677 HD22 ' CD2' ' B' ' 15' ' ' LEU . 24.4 mt -60.16 -17.66 42.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.405 -0.809 . . . . 0.0 109.992 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -64.75 -44.09 91.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 108.577 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -71.52 -9.99 59.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.649 -0.657 . . . . 0.0 109.737 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -89.29 22.56 2.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.4 -0.812 . . . . 0.0 110.45 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.8 m -109.31 40.79 1.77 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.166 -0.959 . . . . 0.0 109.691 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.1 m120 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.1 -0.952 . . . . 0.0 109.475 179.938 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.422 ' CE2' ' CB ' ' B' ' 4' ' ' GLN . 10.0 t80 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.624 HG12 ' ND2' ' B' ' 3' ' ' ASN . 10.7 t -42.96 113.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 122.017 -0.427 . . . . 0.0 110.792 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.624 ' ND2' HG12 ' B' ' 2' ' ' VAL . 2.7 p30 0.77 75.82 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.101 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.422 ' CB ' ' CE2' ' B' ' 1' ' ' PHE . 0.0 OUTLIER -142.5 131.79 23.48 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.616 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.44 ' CE1' HG12 ' A' ' 10' ' ' ILE . 74.6 m80 -91.16 172.63 8.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.785 . . . . 0.0 109.381 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.483 HD12 ' HB2' ' A' ' 6' ' ' CYS . 28.6 mt -126.31 121.02 31.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.473 -0.767 . . . . 0.0 110.263 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 179.78 105.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.8 -144.76 17.49 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 60.3 p -64.36 -19.73 65.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.562 -0.963 . . . . 0.0 109.98 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -57.46 -30.66 65.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.17 -0.956 . . . . 0.0 109.769 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.889 HD22 ' CG2' ' A' ' 3' ' ' VAL . 66.8 tp -68.63 -56.46 8.13 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 t -50.07 -48.09 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.643 -0.66 . . . . 0.0 111.107 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -62.16 -33.43 74.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.496 -0.752 . . . . 0.0 109.696 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.553 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -68.53 -28.61 67.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.557 -0.714 . . . . 0.0 109.555 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.677 ' CD2' HD22 ' A' ' 16' ' ' LEU . 30.4 mt -78.09 -29.45 49.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.477 -0.765 . . . . 0.0 109.11 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -69.59 -35.2 75.12 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.31 -54.86 6.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.697 -0.627 . . . . 0.0 109.547 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.553 HG23 ' O ' ' B' ' 14' ' ' ALA . 20.9 t -61.52 -66.51 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.539 -0.726 . . . . 0.0 109.805 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 45.4 m -59.61 -69.38 0.21 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.566 -0.709 . . . . 0.0 109.82 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.98 -27.34 18.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.77 142.77 40.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.467 -1.019 . . . . 0.0 109.608 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 117.26 20.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.581 -0.699 . . . . 0.0 109.272 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.5 31.78 49.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.94 32.17 5.76 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -167.95 -171.38 1.55 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.965 . . . . 0.0 109.618 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.425 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 3.1 t80 -52.97 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.493 -0.754 . . . . 0.0 109.765 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.8 92.47 48.76 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . 0.425 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 6.1 Cg_exo . . . . . 0 N--CA 1.482 0.839 0 C-N-CA 122.593 2.195 . . . . 0.0 110.059 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.666 HG22 ' HG ' ' B' ' 11' ' ' LEU . 18.0 t . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -57.56 -21.85 41.1 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.577 -0.702 . . . . 0.0 109.986 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -63.21 -41.8 99.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.448 -0.783 . . . . 0.0 110.098 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.448 ' HB3' HD12 ' B' ' 6' ' ' LEU . 85.1 m -113.53 20.85 15.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.429 -0.794 . . . . 0.0 111.072 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.7 t -93.29 43.74 1.13 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.04 -1.037 . . . . 0.0 109.611 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.485 HG23 ' N ' ' A' ' 9' ' ' SER . 3.2 t -138.92 -45.22 0.47 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.485 ' N ' HG23 ' A' ' 8' ' ' THR . 0.2 OUTLIER -134.07 -170.95 2.62 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.398 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.498 HD13 ' CE1' ' B' ' 5' ' ' HIS . 1.0 OUTLIER -97.39 102.1 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.182 -0.949 . . . . 0.0 109.601 -178.615 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.1 m -62.46 -174.46 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.321 0.581 . . . . 0.0 110.188 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.6 m -105.58 163.64 12.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.744 -0.597 . . . . 0.0 109.501 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.674 HD11 HG22 ' B' ' 18' ' ' VAL . 42.2 tp -66.51 -28.25 68.41 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.572 -0.705 . . . . 0.0 109.918 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -58.34 -22.85 54.81 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.486 -0.759 . . . . 0.0 110.285 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -80.51 -47.91 13.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.291 -0.88 . . . . 0.0 109.702 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.605 HD22 HD23 ' B' ' 15' ' ' LEU . 14.4 mt -66.97 -20.27 65.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.515 -0.74 . . . . 0.0 110.315 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -62.0 -22.39 65.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.251 -0.905 . . . . 0.0 110.022 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -98.53 33.38 2.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.84 . . . . 0.0 109.648 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -112.28 7.2 19.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.646 -0.659 . . . . 0.0 110.346 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.47 35.51 1.48 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.047 -0.977 . . . . 0.0 109.544 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.711 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.618 HG12 ' OD1' ' B' ' 3' ' ' ASN . 15.6 t -86.22 -58.06 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.662 -1.274 . . . . 0.0 109.316 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.618 ' OD1' HG12 ' B' ' 2' ' ' VAL . 0.6 OUTLIER -178.84 37.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.433 -0.792 . . . . 0.0 109.664 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -120.42 139.83 52.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.589 -0.694 . . . . 0.0 109.262 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.498 ' CE1' HD13 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -77.78 164.68 25.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.471 -0.768 . . . . 0.0 109.602 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.448 HD12 ' HB3' ' A' ' 6' ' ' CYS . 18.8 mt -120.34 112.3 18.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.568 -0.707 . . . . 0.0 110.463 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.461 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.1 OUTLIER 179.71 120.25 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.425 -0.797 . . . . 0.0 109.153 178.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.39 -147.33 19.07 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.5 t -65.73 -14.67 61.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.349 -1.089 . . . . 0.0 109.92 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.96 -29.95 67.55 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.139 -0.976 . . . . 0.0 109.194 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.666 ' HG ' HG22 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -65.52 -52.89 49.33 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.072 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 18.1 t -56.07 -37.58 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.802 -0.562 . . . . 0.0 110.699 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -74.8 -26.33 59.66 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.455 -0.778 . . . . 0.0 110.212 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.19 -31.25 64.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.605 HD23 HD22 ' A' ' 16' ' ' LEU . 40.3 mt -74.02 -39.76 63.37 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -61.55 -33.04 73.17 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.711 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 1.7 tp -67.87 -40.74 83.54 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.674 HG22 HD11 ' A' ' 13' ' ' LEU . 35.8 t -86.49 -75.12 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.671 -0.643 . . . . 0.0 110.134 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 14.0 m -64.78 -62.72 1.4 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 109.599 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.16 15.73 78.66 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -90.48 158.11 17.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -1.178 . . . . 0.0 109.16 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.85 117.34 26.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.529 -0.732 . . . . 0.0 109.29 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.03 36.25 93.02 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.96 -19.86 6.64 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.661 ' CE1' HG23 ' B' ' 27' ' ' THR . 34.5 p90 -127.42 -174.82 3.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.264 -1.139 . . . . 0.0 110.232 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.46 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 4.2 t80 -60.11 105.61 0.42 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.546 0.689 . . . . 0.0 109.47 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.661 HG23 ' CE1' ' B' ' 25' ' ' PHE . 0.0 OUTLIER -134.75 90.82 21.93 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . 0.46 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 8.7 Cg_endo . . . . . 0 N--CA 1.486 1.064 0 C-N-CA 122.857 2.371 . . . . 0.0 110.826 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.419 HG12 ' SG ' ' A' ' 7' ' ' CYS . 43.6 t . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -89.68 59.15 4.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.393 -0.817 . . . . 0.0 109.699 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.5 -45.96 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.478 -0.764 . . . . 0.0 109.143 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.467 ' HB2' HD12 ' B' ' 6' ' ' LEU . 59.1 m -115.35 16.14 16.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.662 -0.649 . . . . 0.0 110.058 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' HG12 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -73.89 -29.37 62.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.282 -0.887 . . . . 0.0 109.159 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -84.08 -49.15 9.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.584 -0.698 . . . . 0.0 110.212 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p -122.83 166.92 14.2 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.532 -0.73 . . . . 0.0 110.061 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.502 HD12 ' CE1' ' B' ' 5' ' ' HIS . 0.1 OUTLIER -86.81 120.9 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 87.7 m -82.8 -89.0 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.605 -0.684 . . . . 0.0 110.016 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.6 t -179.45 168.83 1.44 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.993 -1.067 . . . . 0.0 109.466 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.509 HD21 HG22 ' B' ' 18' ' ' VAL . 0.7 OUTLIER -67.24 -33.1 74.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.584 -0.698 . . . . 0.0 110.478 -179.289 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -21.54 61.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.264 -0.898 . . . . 0.0 110.208 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -76.74 -50.95 12.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.324 -0.86 . . . . 0.0 110.123 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.687 HD22 ' CD2' ' B' ' 15' ' ' LEU . 10.4 mt -66.81 -21.14 66.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.448 -0.783 . . . . 0.0 110.162 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -55.46 -22.5 20.89 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.239 -0.913 . . . . 0.0 110.466 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -98.02 35.33 1.75 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.366 -0.834 . . . . 0.0 109.808 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.428 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 6.6 m-85 -111.57 0.61 16.49 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.468 -0.77 . . . . 0.0 110.373 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.97 36.43 1.56 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.097 -1.002 . . . . 0.0 109.436 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.128 -0.939 . . . . 0.0 109.501 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.523 HG23 ' H ' ' B' ' 3' ' ' ASN . 0.2 OUTLIER -36.07 -72.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.581 0 O-C-N 122.053 -0.404 . . . . 0.0 112.022 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.523 ' H ' HG23 ' B' ' 2' ' ' VAL . 5.4 p30 -178.16 54.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.162 -0.961 . . . . 0.0 109.375 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -103.39 123.97 47.83 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.502 ' CE1' HD12 ' A' ' 10' ' ' ILE . 13.0 m80 -84.11 137.89 33.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.464 -0.773 . . . . 0.0 109.672 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.63 ' CD2' HD11 ' A' ' 16' ' ' LEU . 50.0 mt -81.78 95.52 7.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.875 -0.515 . . . . 0.0 110.413 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.05 120.41 0.44 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.666 -0.646 . . . . 0.0 109.35 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.21 -142.31 21.24 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 51.7 p -66.02 -23.83 66.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.942 . . . . 0.0 109.459 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -56.29 -29.9 61.81 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.241 -0.912 . . . . 0.0 109.112 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.431 ' CD1' HD11 ' B' ' 15' ' ' LEU . 0.4 OUTLIER -63.41 -60.35 3.48 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -51.12 -52.65 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.665 -0.647 . . . . 0.0 111.143 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -59.52 -29.25 67.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.37 -0.831 . . . . 0.0 110.346 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.76 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -73.08 -30.85 63.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.485 -0.759 . . . . 0.0 109.742 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.687 ' CD2' HD22 ' A' ' 16' ' ' LEU . 31.3 mt -77.2 -30.57 54.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.435 -0.791 . . . . 0.0 109.541 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -75.99 -30.86 58.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.568 -0.708 . . . . 0.0 109.42 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tp -80.18 -30.62 38.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.595 -0.69 . . . . 0.0 109.631 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.76 HG23 ' O ' ' B' ' 14' ' ' ALA . 43.3 t -82.66 -68.59 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.695 . . . . 0.0 109.195 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 33.8 m -67.74 -67.55 0.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.68 -0.638 . . . . 0.0 109.387 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.04 7.89 79.79 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -89.83 151.63 21.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.115 -1.227 . . . . 0.0 109.669 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.36 104.13 9.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.745 . . . . 0.0 108.99 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.81 42.51 30.91 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.07 -20.38 6.77 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.446 ' CE1' HG23 ' B' ' 27' ' ' THR . 37.2 p90 -115.41 -170.49 1.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.404 -1.056 . . . . 0.0 109.566 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.416 ' O ' ' CG ' ' B' ' 26' ' ' TYR . 0.5 OUTLIER -55.44 93.52 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.613 -0.68 . . . . 0.0 109.645 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.446 HG23 ' CE1' ' B' ' 25' ' ' PHE . 1.5 p -124.13 97.07 41.1 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . 0.405 ' HD3' ' CE1' ' B' ' 26' ' ' TYR . 6.1 Cg_exo . . . . . 0 N--CA 1.485 1.019 0 C-N-CA 122.621 2.214 . . . . 0.0 110.692 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.538 HG12 ' SG ' ' A' ' 7' ' ' CYS . 47.5 t . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -89.55 54.51 2.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.321 -0.862 . . . . 0.0 109.721 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -141.2 -50.48 0.43 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.497 -0.752 . . . . 0.0 108.993 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.3 m -128.41 32.72 4.81 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.538 ' SG ' HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -67.43 -57.17 7.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.69 -0.631 . . . . 0.0 110.272 -179.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 m -68.0 -28.21 67.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.505 -0.747 . . . . 0.0 110.899 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.44 ' HA ' ' CE1' ' B' ' 5' ' ' HIS . 1.2 m -116.98 -162.52 0.86 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.375 -0.828 . . . . 0.0 109.942 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.476 HG23 ' CD2' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -111.14 129.34 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.477 -0.764 . . . . 0.0 109.008 -179.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.91 -164.41 1.02 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.652 -0.655 . . . . 0.0 109.91 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.455 ' CB ' ' CE2' ' A' ' 14' ' ' TYR . 1.6 m -102.09 162.18 13.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.547 -0.721 . . . . 0.0 109.747 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.33 -35.4 80.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.624 -0.673 . . . . 0.0 110.387 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.455 ' CE2' ' CB ' ' A' ' 12' ' ' SER . 20.4 p90 -61.58 -23.33 65.92 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.389 -0.82 . . . . 0.0 110.058 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.404 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 5.8 tp60 -68.04 -57.11 6.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.419 -0.801 . . . . 0.0 109.494 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.693 HD22 HD23 ' B' ' 15' ' ' LEU . 23.0 mt -66.07 -14.24 61.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.576 -0.703 . . . . 0.0 110.222 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -62.23 -31.17 71.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.186 -0.946 . . . . 0.0 109.554 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -98.51 32.97 2.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.492 -0.755 . . . . 0.0 109.446 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 7.2 m-85 -113.42 -7.41 13.46 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.615 -0.678 . . . . 0.0 110.226 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.0 m -74.6 -22.07 59.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.081 -1.012 . . . . 0.0 110.357 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.54 -179.871 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.708 ' CD2' HG22 ' B' ' 2' ' ' VAL . 2.3 p90 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.708 HG22 ' CD2' ' B' ' 1' ' ' PHE . 27.4 m -50.09 -26.16 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.354 -1.467 . . . . 0.0 110.977 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -171.08 40.85 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.574 -0.704 . . . . 0.0 109.189 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.455 ' CB ' ' CE1' ' B' ' 1' ' ' PHE . 7.0 tp60 -136.38 108.04 7.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.583 -0.698 . . . . 0.0 109.912 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.476 ' CD2' HG23 ' A' ' 10' ' ' ILE . 14.3 m-70 -64.06 163.23 12.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.611 -0.681 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.689 HD11 HD11 ' A' ' 16' ' ' LEU . 2.5 mm? -114.42 55.35 0.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.501 -0.749 . . . . 0.0 109.596 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.86 129.01 33.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.522 -0.736 . . . . 0.0 109.333 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.56 -147.53 35.71 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 16.2 p -67.84 -12.21 60.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.553 -0.969 . . . . 0.0 110.489 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -60.69 -33.4 72.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.067 -1.021 . . . . 0.0 109.706 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.528 HD12 HD12 ' B' ' 6' ' ' LEU . 62.4 tp -65.07 -55.89 16.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.614 -0.679 . . . . 0.0 109.218 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.2 t -52.08 -47.67 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.544 -0.723 . . . . 0.0 110.813 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -62.22 -32.26 72.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.441 -0.787 . . . . 0.0 109.729 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.493 ' HB1' HD13 ' A' ' 16' ' ' LEU . . . -68.09 -31.94 71.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.557 -0.715 . . . . 0.0 109.153 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.693 HD23 HD22 ' A' ' 16' ' ' LEU . 31.7 mt -74.88 -28.56 60.7 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -70.17 -34.33 72.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.504 -0.748 . . . . 0.0 108.992 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.679 HD22 ' HZ ' ' B' ' 1' ' ' PHE . 0.5 OUTLIER -73.76 -42.37 61.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.721 -0.612 . . . . 0.0 109.6 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.426 HG23 ' O ' ' B' ' 14' ' ' ALA . 47.3 t -71.0 -71.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -77.91 0.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.457 -0.777 . . . . 0.0 108.979 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.53 -27.92 9.5 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.27 176.32 0.35 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.423 -1.045 . . . . 0.0 109.759 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -76.38 -63.16 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.593 -0.692 . . . . 0.0 109.386 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -119.41 48.02 0.98 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.62 26.12 25.59 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -162.06 -176.92 5.44 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.498 -1.001 . . . . 0.0 109.798 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -56.45 123.81 15.99 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.548 -0.72 . . . . 0.0 110.157 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.31 96.82 43.63 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.483 0.866 0 C-N-CA 122.386 2.057 . . . . 0.0 110.21 -179.523 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.656 HG22 HD22 ' B' ' 11' ' ' LEU . 32.2 t . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.408 0.623 . . . . 0.0 109.672 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.6 -30.79 67.49 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.651 -0.655 . . . . 0.0 110.274 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -76.16 -28.6 57.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.502 -0.749 . . . . 0.0 109.817 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.2 m -113.32 26.43 10.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.431 -0.793 . . . . 0.0 110.158 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.425 ' SG ' HG12 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -101.39 -32.09 10.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 0.0 109.197 179.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -85.79 -57.29 3.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.646 -0.658 . . . . 0.0 109.515 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.89 -160.67 0.82 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.631 -0.668 . . . . 0.0 109.358 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 11' ' ' CYS . 1.2 mm -93.88 -168.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.502 ' H ' HG22 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -170.54 168.28 7.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.414 -0.804 . . . . 0.0 109.106 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.48 162.13 13.14 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.872 HD13 ' O ' ' A' ' 13' ' ' LEU . 3.4 tm? -66.98 -23.48 65.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.679 -0.638 . . . . 0.0 110.261 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CE1' ' HG2' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -56.63 -20.74 22.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.128 -0.982 . . . . 0.0 110.803 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.443 ' HG2' ' CE1' ' A' ' 14' ' ' TYR . 5.3 mm100 -74.36 -46.27 41.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.41 -0.806 . . . . 0.0 109.843 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.654 HD22 ' CD2' ' B' ' 15' ' ' LEU . 68.9 mt -68.42 -10.0 52.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.436 -0.79 . . . . 0.0 110.722 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.94 -26.33 68.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.11 -0.994 . . . . 0.0 109.21 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -62.29 -32.74 73.51 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.747 0.784 . . . . 0.0 109.633 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.433 ' CD1' ' HB2' ' B' ' 26' ' ' TYR . 35.5 m-85 -81.66 -17.07 49.32 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.995 -0.441 . . . . 0.0 111.139 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -105.13 28.8 6.92 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.045 -1.034 . . . . 0.0 109.766 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.582 -179.871 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.741 ' CE1' HD23 ' A' ' 13' ' ' LEU . 3.0 p90 . . . . . 0 N--CA 1.5 2.033 0 CA-C-O 120.474 0.178 . . . . 0.0 110.771 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.22 -26.29 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.976 -1.078 . . . . 0.0 109.35 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -152.89 29.24 0.52 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.428 ' HG2' ' CE1' ' B' ' 10' ' ' HIS . 0.3 OUTLIER -118.7 -178.89 3.65 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -103.4 125.41 49.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.347 -0.846 . . . . 0.0 109.855 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.618 HD21 HD13 ' B' ' 11' ' ' LEU . 6.4 tp -83.95 94.1 8.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.706 -0.621 . . . . 0.0 110.08 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.88 134.4 2.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.419 -0.801 . . . . 0.0 109.334 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.3 -145.72 21.43 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 53.7 p -70.79 -9.0 56.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.496 -1.002 . . . . 0.0 110.31 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . 0.428 ' CE1' ' HG2' ' B' ' 4' ' ' GLN . 28.3 t60 -65.37 -31.08 72.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.087 -1.008 . . . . 0.0 108.944 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.656 HD22 HG22 ' A' ' 3' ' ' VAL . 56.0 tp -63.69 -57.31 10.41 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.5 t -53.45 -51.82 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.64 -0.662 . . . . 0.0 110.955 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -56.21 -28.61 58.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.346 -0.846 . . . . 0.0 110.217 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.588 ' HB1' HD13 ' A' ' 16' ' ' LEU . . . -76.58 -35.0 58.42 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.654 ' CD2' HD22 ' A' ' 16' ' ' LEU . 49.3 mt -64.56 -28.22 69.49 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -80.82 -35.72 32.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.527 -0.733 . . . . 0.0 109.137 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -65.42 -32.61 74.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.658 -0.651 . . . . 0.0 109.804 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.814 ' CG2' HD21 ' A' ' 13' ' ' LEU . 35.9 t -82.22 -55.68 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.601 -0.687 . . . . 0.0 109.405 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 4.7 m -69.19 -80.24 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.54 -0.725 . . . . 0.0 109.528 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.95 -56.56 0.66 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.96 172.23 8.73 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.454 -1.027 . . . . 0.0 109.426 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.25 -47.77 33.0 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.44 94.54 1.4 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -177.93 -35.85 0.06 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.473 ' CG ' ' HB3' ' B' ' 15' ' ' LEU . 44.5 p90 -124.83 -174.64 3.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -1.088 . . . . 0.0 110.867 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.433 ' HB2' ' CD1' ' A' ' 19' ' ' TYR . 7.1 t80 -58.45 111.0 1.08 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.853 -0.529 . . . . 0.0 109.828 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.3 p -122.88 92.2 49.28 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.553 -0.717 . . . . 0.0 109.372 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . 0.413 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 1.5 Cg_endo . . . . . 0 N--CA 1.484 0.965 0 C-N-CA 122.526 2.151 . . . . 0.0 109.858 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.53 HG22 ' HG ' ' B' ' 11' ' ' LEU . 44.7 t . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.17 3.76 22.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 0.0 109.956 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -63.42 1.23 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.117 -0.989 . . . . 0.0 110.039 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.498 ' SG ' HD23 ' B' ' 6' ' ' LEU . 12.6 p -136.27 25.61 3.22 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.978 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.1 t -52.45 -23.78 6.75 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.11 -0.994 . . . . 0.0 110.011 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 m -65.7 -68.49 0.36 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.353 -0.842 . . . . 0.0 111.033 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.4 -153.56 0.53 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.328 -0.858 . . . . 0.0 110.356 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.665 HD13 ' CE1' ' B' ' 5' ' ' HIS . 10.1 mm -83.65 168.21 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.096 -1.002 . . . . 0.0 108.728 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.479 ' H ' HG22 ' A' ' 10' ' ' ILE . 2.1 p -160.1 174.42 14.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.427 -0.796 . . . . 0.0 110.438 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -72.08 133.13 45.06 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.345 0.593 . . . . 0.0 109.747 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.478 HD12 ' HB2' ' B' ' 1' ' ' PHE . 4.6 mm? -68.43 -17.34 64.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.749 -0.594 . . . . 0.0 110.412 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -56.83 -22.46 36.74 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.139 -0.976 . . . . 0.0 109.86 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.26 -49.09 75.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.404 -0.81 . . . . 0.0 109.357 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.725 HD22 HD23 ' B' ' 15' ' ' LEU . 15.8 mt -68.9 -16.51 63.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.521 -0.737 . . . . 0.0 110.051 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.71 -26.75 65.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 109.174 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -89.25 13.12 14.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.379 -0.826 . . . . 0.0 110.078 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -97.77 20.62 11.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.102 -0.999 . . . . 0.0 109.179 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.3 m -109.97 23.88 13.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.328 -0.857 . . . . 0.0 109.987 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 117.903 -1.046 . . . . 0.0 109.427 -179.952 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.718 ' CZ ' HD22 ' B' ' 17' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.524 HG23 ' CD1' ' B' ' 1' ' ' PHE . 0.2 OUTLIER -118.27 172.23 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.924 -1.11 . . . . 0.0 108.163 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -59.44 92.98 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.317 -0.864 . . . . 0.0 109.376 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -142.03 174.4 10.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.502 -0.748 . . . . 0.0 110.203 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.665 ' CE1' HD13 ' A' ' 10' ' ' ILE . 3.6 m80 -119.12 146.45 45.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.613 -0.68 . . . . 0.0 109.248 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.683 HD12 HD11 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -100.77 90.44 4.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.504 -0.748 . . . . 0.0 109.439 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.3 154.23 10.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.625 -0.672 . . . . 0.0 109.719 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.03 -132.89 49.15 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.5 p -83.51 -13.8 53.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.947 . . . . 0.0 109.759 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -63.71 -33.09 74.87 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.132 -0.98 . . . . 0.0 108.944 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.612 ' C ' HD13 ' B' ' 11' ' ' LEU . 2.6 tm? -68.87 -54.51 15.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.813 -0.554 . . . . 0.0 109.771 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 t -53.74 -47.77 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.501 -0.749 . . . . 0.0 110.677 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.7 -29.07 70.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.484 -0.76 . . . . 0.0 109.396 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.72 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -71.67 -26.4 62.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.57 -0.706 . . . . 0.0 109.529 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.725 HD23 HD22 ' A' ' 16' ' ' LEU . 29.1 mt -78.85 -32.14 45.92 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.418 -0.801 . . . . 0.0 108.882 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.06 -32.99 67.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.595 -0.691 . . . . 0.0 110.012 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.718 HD22 ' CZ ' ' B' ' 1' ' ' PHE . 0.1 OUTLIER -80.58 -46.71 15.27 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.413 -0.804 . . . . 0.0 109.937 -179.434 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.72 HG23 ' O ' ' B' ' 14' ' ' ALA . 48.0 t -59.65 -56.93 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.419 -0.801 . . . . 0.0 109.386 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -74.89 0.1 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.21 -35.17 3.73 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -90.41 163.77 14.55 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.395 -1.062 . . . . 0.0 109.849 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.85 127.9 39.84 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.18 28.7 36.04 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.97 30.73 5.76 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.445 ' CD2' ' HB2' ' B' ' 15' ' ' LEU . 23.8 p90 -165.65 -173.2 2.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.454 -1.027 . . . . 0.0 109.512 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.454 ' HB3' HD13 ' B' ' 15' ' ' LEU . 7.5 t80 -54.33 109.58 0.51 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.574 -0.703 . . . . 0.0 109.562 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 2.0 p -122.88 91.86 49.49 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.483 0.91 0 C-N-CA 122.48 2.12 . . . . 0.0 110.143 -179.926 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 3' ' ' VAL . 30.4 t . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 120.42 0.152 . . . . 0.0 110.685 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -90.35 51.72 2.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.136 -0.978 . . . . 0.0 109.429 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -138.44 -43.79 0.5 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.498 -0.752 . . . . 0.0 109.379 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.1 m -118.59 15.57 13.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.543 -0.723 . . . . 0.0 110.399 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.61 -27.22 64.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.279 -0.888 . . . . 0.0 110.351 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 m -99.29 -67.83 0.83 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.351 -0.843 . . . . 0.0 110.907 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.2 p -74.99 171.81 13.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.279 -0.888 . . . . 0.0 110.229 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.858 HG23 ' O ' ' B' ' 4' ' ' GLN . 56.6 mt -102.52 91.16 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.6 m -61.74 -178.91 0.16 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.613 -0.68 . . . . 0.0 110.268 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.483 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 22.2 t -106.71 172.47 6.8 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.507 HD23 ' O ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -67.36 -26.14 66.33 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.403 -0.811 . . . . 0.0 111.415 -178.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 12' ' ' SER . 8.9 p90 -59.51 -20.51 55.95 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.997 -1.064 . . . . 0.0 110.042 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.93 -49.91 12.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.388 -0.82 . . . . 0.0 109.428 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.711 HD21 ' CD2' ' B' ' 11' ' ' LEU . 11.3 mt -67.45 -16.78 64.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.531 -0.731 . . . . 0.0 109.991 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -57.91 -20.72 39.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.187 -0.945 . . . . 0.0 110.219 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -96.95 33.21 1.94 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.84 . . . . 0.0 109.488 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.42 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 7.5 m-85 -113.27 -0.43 14.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.518 -0.739 . . . . 0.0 110.361 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.6 m -96.83 40.49 1.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.122 -0.986 . . . . 0.0 109.562 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.444 179.957 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.543 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 1.1 p90 . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 15.5 t -54.66 -26.7 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -160.69 31.62 0.15 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.858 ' O ' HG23 ' A' ' 10' ' ' ILE . 13.3 mt-30 -127.48 168.67 14.59 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.638 -0.664 . . . . 0.0 109.857 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.458 ' CE1' HG12 ' A' ' 10' ' ' ILE . 18.1 m80 -96.61 161.53 13.85 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.531 HD22 HD11 ' A' ' 16' ' ' LEU . 43.7 mt -109.44 -11.11 14.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.478 -0.764 . . . . 0.0 110.82 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.77 138.96 56.87 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.955 -1.091 . . . . 0.0 110.344 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.47 -159.33 33.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.0 p -64.7 -14.66 59.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.435 -1.038 . . . . 0.0 110.04 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -52.14 -27.98 16.26 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.891 -1.131 . . . . 0.0 110.323 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.711 ' CD2' HD21 ' A' ' 16' ' ' LEU . 3.2 tm? -72.5 -62.91 1.27 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.614 -0.679 . . . . 0.0 109.199 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 39.4 t -47.16 -52.64 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.839 -0.538 . . . . 0.0 111.445 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -57.53 -36.66 71.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.386 -0.821 . . . . 0.0 110.224 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.5 ' HB1' ' HD2' ' B' ' 1' ' ' PHE . . . -67.1 -31.63 72.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.346 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.644 HD23 HD22 ' A' ' 16' ' ' LEU . 40.6 mt -64.47 -40.64 96.07 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -63.66 -34.04 76.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.543 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 0.8 OUTLIER -65.23 -37.3 86.85 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 14' ' ' ALA . 40.5 t -74.12 -71.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.586 -0.696 . . . . 0.0 109.613 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 m -90.75 -58.25 2.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.455 -0.778 . . . . 0.0 109.408 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.37 32.78 68.23 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -88.62 -177.55 5.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.613 -0.933 . . . . 0.0 109.409 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.409 ' NH1' ' HG2' ' B' ' 22' ' ' ARG . 2.7 tpt180 -91.93 52.7 2.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.624 -0.672 . . . . 0.0 109.432 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.95 40.68 1.05 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.07 -28.21 6.62 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' CB ' ' B' ' 15' ' ' LEU . 29.2 p90 -105.36 -175.8 2.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.57 -0.959 . . . . 0.0 109.408 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -58.89 118.41 5.73 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.474 -0.766 . . . . 0.0 109.423 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 23.8 p -127.14 94.65 38.5 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.482 0.838 0 C-N-CA 122.343 2.029 . . . . 0.0 110.165 -179.592 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.792 HG13 HD12 ' B' ' 11' ' ' LEU . 25.0 t . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 120.672 0.272 . . . . 0.0 110.377 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -105.24 31.51 4.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.179 -0.951 . . . . 0.0 108.928 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -118.77 -33.76 4.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.674 -0.641 . . . . 0.0 109.985 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.0 m -130.33 19.13 5.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.471 -0.768 . . . . 0.0 110.459 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.7 t -91.29 -26.81 18.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 109.565 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -75.35 -27.69 59.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.474 -0.766 . . . . 0.0 110.182 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.4 p -134.64 -171.6 2.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 109.936 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.454 ' CG1' ' CE1' ' B' ' 5' ' ' HIS . 18.3 mt -102.31 95.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.27 -172.82 0.35 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.573 -0.704 . . . . 0.0 109.687 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.447 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 1.4 m -108.64 162.82 13.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.644 -0.66 . . . . 0.0 109.689 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.749 HD13 ' CD2' ' B' ' 1' ' ' PHE . 20.0 tp -71.11 -17.69 62.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.805 -0.559 . . . . 0.0 110.223 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.447 ' CE2' ' HB3' ' A' ' 12' ' ' SER . 10.8 p90 -87.54 11.29 15.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.088 -1.007 . . . . 0.0 110.422 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -105.5 -32.28 8.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.072 -1.017 . . . . 0.0 109.434 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.811 HD22 ' CD2' ' B' ' 15' ' ' LEU . 9.9 mt -66.16 -13.03 59.53 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.565 -0.71 . . . . 0.0 110.558 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.81 -19.19 39.0 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.08 -1.013 . . . . 0.0 110.124 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -93.53 28.79 2.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.204 -0.935 . . . . 0.0 110.191 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -115.08 10.89 16.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.173 -0.954 . . . . 0.0 110.456 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.31 33.12 2.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.273 -0.892 . . . . 0.0 109.343 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.389 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.906 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 34.3 t80 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.709 HG13 ' CD1' ' B' ' 1' ' ' PHE . 17.5 m -140.63 -162.43 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -52.75 -25.04 9.97 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.956 -1.09 . . . . 0.0 110.022 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.568 ' H ' HG23 ' B' ' 2' ' ' VAL . 12.3 mm-40 -71.87 144.11 49.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.519 -0.738 . . . . 0.0 109.109 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.454 ' CE1' ' CG1' ' A' ' 10' ' ' ILE . 13.0 m80 -68.25 160.6 28.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.552 -0.718 . . . . 0.0 109.493 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.415 HD11 HD11 ' A' ' 16' ' ' LEU . 19.7 tp -107.41 98.43 8.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.611 -0.681 . . . . 0.0 109.732 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.7 173.15 2.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.637 -0.664 . . . . 0.0 109.895 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.7 -154.02 39.78 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.1 p -63.8 -21.5 66.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.576 -0.955 . . . . 0.0 109.507 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -60.52 -34.13 73.65 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.869 . . . . 0.0 109.075 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.792 HD12 HG13 ' A' ' 3' ' ' VAL . 2.5 tt -61.86 -55.05 33.86 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.404 ' H ' HG23 ' B' ' 12' ' ' VAL . 21.2 t -53.74 -49.97 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.748 -0.595 . . . . 0.0 111.05 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -59.76 -27.48 66.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.446 -0.784 . . . . 0.0 110.631 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.11 -31.37 39.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 110.301 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.811 ' CD2' HD22 ' A' ' 16' ' ' LEU . 50.5 mt -66.72 -41.28 88.18 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -70.94 -31.38 67.95 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.906 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 1.1 mp -63.24 -34.46 77.71 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -84.77 -73.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.626 -0.671 . . . . 0.0 109.359 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 90.8 m -64.49 -82.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 108.852 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.16 23.26 9.84 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 120.136 -1.031 . . . . 0.0 111.533 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.26 -173.68 3.9 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 118.784 1.292 . . . . 0.0 109.165 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -93.44 50.74 1.52 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.532 -0.73 . . . . 0.0 109.51 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.73 71.99 0.63 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.28 35.49 2.17 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -167.08 -171.91 1.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.959 . . . . 0.0 109.607 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.415 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 3.8 t80 -57.69 98.85 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.582 -0.699 . . . . 0.0 109.167 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 2.2 p -114.33 91.87 25.51 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.591 -0.693 . . . . 0.0 109.666 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . 0.415 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 4.0 Cg_exo . . . . . 0 N--CA 1.482 0.843 0 C-N-CA 122.453 2.102 . . . . 0.0 110.074 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.749 HG23 ' CG ' ' A' ' 15' ' ' GLN . 4.0 mp -123.8 -50.61 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.554 -0.968 . . . . 0.0 109.758 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.4 t -74.21 -56.78 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.531 -0.731 . . . . 0.0 109.093 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.49 -18.3 58.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.652 -0.655 . . . . 0.0 110.049 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -42.1 82.38 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.253 -0.905 . . . . 0.0 109.987 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -146.53 43.49 1.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.45 -0.781 . . . . 0.0 109.897 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -63.3 -43.02 99.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.398 -0.814 . . . . 0.0 109.157 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -97.24 29.51 3.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.714 -0.616 . . . . 0.0 109.552 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p -161.07 -174.17 4.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.556 -0.715 . . . . 0.0 109.263 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.16 98.62 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 m -84.41 -85.76 0.13 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.587 -0.696 . . . . 0.0 110.423 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -173.97 151.43 1.76 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.068 -1.02 . . . . 0.0 109.975 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.747 HD13 ' O ' ' A' ' 13' ' ' LEU . 2.6 tm? -67.18 -21.51 65.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.648 -0.658 . . . . 0.0 110.106 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -24.78 34.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.064 -1.023 . . . . 0.0 109.91 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.749 ' CG ' HG23 ' A' ' 2' ' ' ILE . 3.5 tp60 -79.02 -47.28 16.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.384 -0.822 . . . . 0.0 109.218 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.699 HD22 ' CD2' ' B' ' 15' ' ' LEU . 9.0 mt -65.78 -15.14 62.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.632 -0.667 . . . . 0.0 110.129 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.38 -18.8 41.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.261 -0.899 . . . . 0.0 110.288 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -94.32 28.35 2.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.924 . . . . 0.0 109.988 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.539 ' CE1' HG21 ' A' ' 2' ' ' ILE . 6.4 m-85 -115.99 18.55 15.48 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.377 -0.827 . . . . 0.0 110.211 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.1 m -109.62 30.11 6.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m120 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.469 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.88 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 66.5 t80 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.814 HG12 ' HD2' ' B' ' 1' ' ' PHE . 13.3 p -165.34 -33.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.192 -0.942 . . . . 0.0 110.488 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.621 ' ND2' HG13 ' B' ' 2' ' ' VAL . 16.0 p30 -157.88 -42.26 0.06 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.012 -1.055 . . . . 0.0 109.587 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -76.06 159.91 30.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.473 -0.767 . . . . 0.0 109.012 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -83.26 -178.61 7.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.615 -0.678 . . . . 0.0 109.518 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.594 ' HB3' HD23 ' B' ' 11' ' ' LEU . 33.7 mt -127.4 53.53 1.73 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.546 -0.722 . . . . 0.0 110.422 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -135.53 132.16 36.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.407 -0.808 . . . . 0.0 109.181 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.28 -137.4 13.71 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 53.9 p -85.47 3.76 38.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.499 -1.0 . . . . 0.0 110.101 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -76.36 -34.23 58.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.101 -1.0 . . . . 0.0 109.211 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.611 HD21 HD21 ' A' ' 16' ' ' LEU . 3.5 tm? -66.53 -51.38 57.23 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.6 t -55.32 -48.31 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.587 -0.695 . . . . 0.0 110.17 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -60.55 -29.89 69.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.434 -0.791 . . . . 0.0 109.51 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.717 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -71.78 -32.08 67.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.518 -0.739 . . . . 0.0 109.453 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.699 ' CD2' HD22 ' A' ' 16' ' ' LEU . 41.4 mt -65.69 -41.27 92.58 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.47 -37.85 88.86 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.88 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 2.7 tp -64.71 -28.72 69.78 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.717 HG23 ' O ' ' B' ' 14' ' ' ALA . 42.0 t -73.22 -69.38 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 109.792 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -94.91 -76.37 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.478 -0.764 . . . . 0.0 109.288 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.87 -13.03 10.71 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.787 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -87.33 145.15 26.46 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.151 -1.205 . . . . 0.0 109.489 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -76.48 152.14 36.2 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.76 25.63 63.94 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.52 -28.11 4.15 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.582 ' CE1' HG22 ' B' ' 27' ' ' THR . 30.5 p90 -131.48 -173.94 3.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.621 -0.929 . . . . 0.0 109.569 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.413 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 9.5 t80 -61.73 108.61 1.03 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 109.491 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.582 HG22 ' CE1' ' B' ' 25' ' ' PHE . 45.6 p -123.48 87.98 51.82 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.413 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 1.6 Cg_endo -62.85 86.88 0.11 Allowed 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.709 2.272 . . . . 0.0 110.217 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.299 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.519 HG23 ' H ' ' A' ' 3' ' ' VAL . 7.7 tt -137.6 -56.39 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.604 -0.939 . . . . 0.0 109.361 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.519 ' H ' HG23 ' A' ' 2' ' ' ILE . 30.0 t -92.83 -27.35 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.054 -1.029 . . . . 0.0 109.688 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.02 42.16 1.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 109.677 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.14 -46.99 2.17 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.2 m -125.97 25.39 6.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.675 -0.641 . . . . 0.0 109.621 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.0 -58.55 6.37 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.39 -0.819 . . . . 0.0 109.472 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 t -72.08 -33.75 68.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.483 -0.761 . . . . 0.0 110.043 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -86.11 165.48 16.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.433 -0.792 . . . . 0.0 108.884 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.4 HG12 ' NE2' ' B' ' 5' ' ' HIS . 1.0 OUTLIER -110.99 69.81 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.286 -0.884 . . . . 0.0 109.043 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.7 m -64.98 178.74 0.78 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.53 -0.731 . . . . 0.0 109.753 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 50.1 m -72.9 115.0 11.67 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.918 HD11 HD21 ' B' ' 6' ' ' LEU . 0.3 OUTLIER -69.25 -8.18 43.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.667 -0.646 . . . . 0.0 110.975 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.445 ' CD1' ' HB3' ' A' ' 12' ' ' SER . 0.1 OUTLIER -67.28 -18.73 65.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.967 -1.083 . . . . 0.0 109.934 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.409 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 0.8 OUTLIER -69.35 -10.64 58.82 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.258 -0.901 . . . . 0.0 110.764 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.734 HD12 ' CD1' ' A' ' 13' ' ' LEU . 5.8 mt -65.47 -12.06 49.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.164 -0.96 . . . . 0.0 110.656 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -59.51 -19.53 48.8 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.105 -0.997 . . . . 0.0 110.196 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -97.13 29.61 3.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.288 -0.883 . . . . 0.0 109.775 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.502 ' CE2' HD11 ' A' ' 2' ' ' ILE . 9.0 m-85 -118.38 19.78 13.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.645 -0.659 . . . . 0.0 109.632 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.7 m -103.59 27.27 7.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.247 -0.908 . . . . 0.0 110.026 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.911 -1.042 . . . . 0.0 109.484 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.457 ' CB ' ' HB2' ' B' ' 14' ' ' ALA . 34.8 p90 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 120.613 0.244 . . . . 0.0 110.51 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 40.4 t -51.31 -38.86 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.005 -1.06 . . . . 0.0 110.55 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -134.03 30.01 3.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.439 -0.788 . . . . 0.0 109.668 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' B' ' 5' ' ' HIS . 18.6 mt-30 -117.66 -84.5 0.64 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.66 -0.65 . . . . 0.0 109.394 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.433 ' CG ' ' O ' ' B' ' 4' ' ' GLN . 0.6 OUTLIER -178.99 -172.53 0.25 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.449 -0.782 . . . . 0.0 109.059 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.918 HD21 HD11 ' A' ' 13' ' ' LEU . 40.3 mt -133.77 43.34 2.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.594 -0.691 . . . . 0.0 109.448 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 58.6 m -114.68 137.17 52.23 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.524 -0.735 . . . . 0.0 109.596 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.46 -140.58 23.75 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.3 -0.67 29.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.567 -0.961 . . . . 0.0 110.652 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -66.94 -31.18 71.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.013 -1.054 . . . . 0.0 109.271 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.508 HD22 HG22 ' A' ' 3' ' ' VAL . 63.4 tp -68.52 -57.43 5.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.576 -0.702 . . . . 0.0 109.182 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 24.7 t -51.65 -44.48 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.657 -0.652 . . . . 0.0 110.843 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -63.78 -34.45 77.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.449 -0.782 . . . . 0.0 109.646 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.457 ' HB2' ' CB ' ' B' ' 1' ' ' PHE . . . -68.9 -29.74 68.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.53 -0.731 . . . . 0.0 109.4 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.666 ' CD2' HD22 ' A' ' 16' ' ' LEU . 40.4 mt -70.71 -37.51 73.55 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -63.49 -41.62 98.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.66 -0.65 . . . . 0.0 109.505 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -63.31 -55.67 22.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.68 . . . . 0.0 109.603 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.642 HG21 ' HB3' ' A' ' 16' ' ' LEU . 43.6 t -55.59 -72.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.652 -0.655 . . . . 0.0 110.238 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.68 -74.28 0.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.835 . . . . 0.0 109.277 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.62 -16.11 61.87 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -60.42 160.95 7.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.171 -1.193 . . . . 0.0 109.841 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.53 108.65 17.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.642 -0.661 . . . . 0.0 109.512 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.2 40.19 61.62 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.1 -24.27 6.06 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -112.56 -175.63 2.72 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.437 -1.037 . . . . 0.0 109.964 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -52.02 138.84 24.17 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.481 -0.762 . . . . 0.0 110.138 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.11 93.15 31.16 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -58.48 -178.75 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.831 0 C-N-CA 122.264 1.976 . . . . 0.0 109.913 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.683 -179.869 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.775 HG23 HG23 ' A' ' 3' ' ' VAL . 15.2 tt -163.28 -44.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.678 -0.895 . . . . 0.0 109.319 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.775 HG23 HG23 ' A' ' 2' ' ' ILE . 40.2 t -90.37 -26.72 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.467 -0.77 . . . . 0.0 109.43 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -61.09 -17.64 53.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.514 -0.741 . . . . 0.0 110.117 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -48.24 -60.57 2.54 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.233 -0.917 . . . . 0.0 111.294 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.929 ' CB ' HD23 ' B' ' 6' ' ' LEU . 4.1 m -111.56 7.48 20.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.393 -0.817 . . . . 0.0 110.477 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.663 ' SG ' HG12 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -71.61 -28.98 64.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.003 -1.061 . . . . 0.0 109.408 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 m -80.79 -52.96 6.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.474 -0.766 . . . . 0.0 109.802 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.18 -177.36 4.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.0 109.883 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.503 HG12 ' CD2' ' B' ' 5' ' ' HIS . 0.4 OUTLIER -84.78 136.46 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.4 p -122.58 -160.23 0.87 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.373 -0.829 . . . . 0.0 110.085 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.07 139.69 46.22 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.571 HD11 HG21 ' B' ' 18' ' ' VAL . 0.1 OUTLIER -66.05 -13.18 59.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.457 -0.777 . . . . 0.0 110.527 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -60.03 -20.22 56.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.846 -1.159 . . . . 0.0 109.979 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -88.8 -41.45 12.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.372 -0.83 . . . . 0.0 109.892 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.463 HD22 ' CD2' ' B' ' 15' ' ' LEU . 3.9 mt -66.15 -22.13 66.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.509 -0.744 . . . . 0.0 110.038 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.07 -19.18 41.81 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.189 -0.944 . . . . 0.0 110.378 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -94.98 29.66 2.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.242 -0.911 . . . . 0.0 109.688 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -106.62 10.72 31.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.481 -0.762 . . . . 0.0 109.922 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.9 m -95.21 36.15 1.25 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.176 -0.952 . . . . 0.0 109.823 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.6 -179.917 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.494 ' CB ' HD11 ' B' ' 6' ' ' LEU . 3.3 p90 . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 120.38 0.133 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.64 -35.08 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.792 -1.192 . . . . 0.0 108.496 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -150.35 22.35 0.83 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.473 ' O ' ' CG ' ' B' ' 5' ' ' HIS . 57.8 mt-30 -101.03 -94.54 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.902 ' O ' HD13 ' B' ' 6' ' ' LEU . 0.9 OUTLIER 178.12 168.27 0.77 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.267 -0.895 . . . . 0.0 109.029 178.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.929 HD23 ' CB ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -129.66 85.89 2.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.536 -0.728 . . . . 0.0 109.574 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.22 141.07 17.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.572 -0.705 . . . . 0.0 109.623 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.62 -106.01 2.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.6 p -109.25 -13.66 14.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.519 -0.989 . . . . 0.0 110.066 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -64.5 -34.24 77.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.111 -0.993 . . . . 0.0 109.34 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.726 HD22 HG13 ' A' ' 3' ' ' VAL . 58.4 tp -63.93 -54.83 28.48 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.402 HG23 ' H ' ' B' ' 12' ' ' VAL . 17.2 t -52.72 -50.16 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.607 -0.683 . . . . 0.0 110.745 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -30.66 68.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.476 -0.765 . . . . 0.0 109.801 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.814 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -73.27 -30.85 63.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.539 -0.726 . . . . 0.0 109.691 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.463 ' CD2' HD22 ' A' ' 16' ' ' LEU . 39.4 mt -69.37 -39.17 78.2 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.357 -0.839 . . . . 0.0 109.291 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -73.22 -29.62 62.93 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.682 -0.636 . . . . 0.0 109.99 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.3 -28.32 53.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.516 -0.74 . . . . 0.0 109.794 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.814 HG23 ' O ' ' B' ' 14' ' ' ALA . 41.3 t -79.46 -67.1 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.417 -0.802 . . . . 0.0 109.404 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -86.95 -60.05 2.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.586 -0.696 . . . . 0.0 109.352 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.72 30.21 40.38 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -86.36 160.52 19.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.646 -0.914 . . . . 0.0 109.079 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -83.59 82.3 8.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.568 -0.708 . . . . 0.0 109.116 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.52 53.27 3.28 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.81 27.78 5.35 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -165.03 -175.15 3.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.344 -1.092 . . . . 0.0 109.984 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -52.47 108.54 0.31 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.582 -0.698 . . . . 0.0 109.81 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.8 p -121.42 92.15 48.53 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -57.87 121.88 10.78 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 122.611 2.207 . . . . 0.0 110.288 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 mttt . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.921 179.741 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.697 HG23 HG23 ' A' ' 3' ' ' VAL . 3.2 tp -115.47 -43.79 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.617 -0.931 . . . . 0.0 109.466 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.697 HG23 HG23 ' A' ' 2' ' ' ILE . 24.3 t -90.96 -44.19 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.395 -0.816 . . . . 0.0 109.6 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -59.39 -27.14 65.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.6 -0.688 . . . . 0.0 109.846 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -77.32 -31.13 54.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.421 -0.8 . . . . 0.0 109.336 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.6 m -108.65 30.65 6.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.483 -0.76 . . . . 0.0 109.877 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 46.0 t -114.27 -45.32 3.05 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.407 -0.808 . . . . 0.0 109.755 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 93.2 m -58.66 -82.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.414 -0.804 . . . . 0.0 110.289 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.7 m -84.87 -172.04 3.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.118 -0.989 . . . . 0.0 109.575 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.489 HD13 ' CE1' ' B' ' 5' ' ' HIS . 4.4 mm -84.35 101.36 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.55 -162.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.635 -0.665 . . . . 0.0 109.552 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.9 m -116.71 155.92 28.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.39 -0.818 . . . . 0.0 109.334 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.618 HD21 HG22 ' B' ' 18' ' ' VAL . 0.8 OUTLIER -66.88 -30.23 70.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.448 -0.782 . . . . 0.0 109.703 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -61.84 -27.74 68.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.529 -0.732 . . . . 0.0 109.684 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -67.99 -46.82 70.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.632 -0.667 . . . . 0.0 110.202 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.714 HD11 HD22 ' B' ' 6' ' ' LEU . 5.5 mt -66.38 -16.16 63.85 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.355 -0.841 . . . . 0.0 109.778 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.26 -19.02 42.4 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.226 -0.921 . . . . 0.0 110.101 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -94.31 29.98 2.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.189 -0.944 . . . . 0.0 109.909 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -115.01 9.31 16.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.445 -0.784 . . . . 0.0 110.359 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.0 m -108.15 34.45 3.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.04 -1.038 . . . . 0.0 109.153 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.232 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 8.8 p -46.56 -33.0 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.46 -0.775 . . . . 0.0 110.631 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -160.45 135.21 7.62 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.416 ' CB ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -99.33 43.53 1.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.131 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.489 ' CE1' HD13 ' A' ' 10' ' ' ILE . 3.0 m170 -106.8 129.76 54.61 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.714 HD22 HD11 ' A' ' 16' ' ' LEU . 3.3 mt -126.8 120.81 30.22 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.566 -0.709 . . . . 0.0 109.859 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.66 142.91 0.15 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.525 -0.734 . . . . 0.0 109.421 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.75 -111.24 4.02 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.64 -22.22 16.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.99 . . . . 0.0 109.529 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -58.11 -34.24 69.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.321 -0.862 . . . . 0.0 109.697 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.412 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 62.4 tp -63.67 -53.77 46.1 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -53.31 -55.47 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.564 -0.71 . . . . 0.0 110.657 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.4 -26.13 64.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.32 -0.863 . . . . 0.0 109.902 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.609 ' HB1' ' CD1' ' A' ' 16' ' ' LEU . . . -72.01 -34.94 69.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.479 -0.763 . . . . 0.0 109.524 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.665 HD23 HD22 ' A' ' 16' ' ' LEU . 24.8 mt -70.78 -34.91 72.29 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -73.02 -28.39 62.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.61 -0.682 . . . . 0.0 109.34 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -77.53 -29.89 52.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.681 . . . . 0.0 109.608 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.618 HG22 HD21 ' A' ' 13' ' ' LEU . 61.1 t -85.12 -72.03 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.526 -0.734 . . . . 0.0 109.432 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.16 -56.61 3.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.382 -0.824 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.49 28.15 55.95 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -83.66 150.06 26.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.454 -1.027 . . . . 0.0 109.326 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.425 ' NH1' ' HG3' ' B' ' 22' ' ' ARG . 1.3 mmm-85 -80.21 89.55 5.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.452 -0.78 . . . . 0.0 109.007 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.35 32.22 28.84 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.49 2.9 46.28 Favored Glycine 0 N--CA 1.492 2.396 0 O-C-N 121.512 -0.993 . . . . 0.0 110.985 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.649 ' HB2' HD13 ' B' ' 15' ' ' LEU . 5.1 p90 -143.7 -178.88 6.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.945 -1.326 . . . . 0.0 110.259 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.461 ' CE1' ' HD3' ' B' ' 28' ' ' PRO . 8.2 t80 -58.38 109.13 0.72 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.693 0.759 . . . . 0.0 110.429 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.84 91.43 6.64 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.461 ' HD3' ' CE1' ' B' ' 26' ' ' TYR . 3.3 Cg_exo -52.69 83.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 123.526 2.817 . . . . 0.0 111.433 -177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.076 179.634 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.51 HG23 ' H ' ' A' ' 3' ' ' VAL . 7.2 tt -167.53 -55.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.34 -1.094 . . . . 0.0 109.444 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.615 HG22 HD22 ' B' ' 11' ' ' LEU . 26.3 t -93.28 -31.25 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.12 -0.987 . . . . 0.0 110.007 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -74.83 -3.1 29.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.747 . . . . 0.0 111.026 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -90.59 -17.44 26.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.008 -1.058 . . . . 0.0 110.685 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.668 ' CB ' HD23 ' B' ' 6' ' ' LEU . 63.5 m -135.87 19.23 3.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.121 -0.987 . . . . 0.0 110.666 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.0 t -83.58 -32.31 25.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.216 -0.927 . . . . 0.0 109.508 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -73.35 -52.67 13.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.364 -0.835 . . . . 0.0 109.647 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.9 p -109.89 -169.38 1.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.629 -0.669 . . . . 0.0 109.721 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.651 HG23 ' O ' ' B' ' 4' ' ' GLN . 58.3 mt -110.0 99.95 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.696 -0.628 . . . . 0.0 109.766 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.1 m -61.95 -174.24 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.544 -0.723 . . . . 0.0 109.386 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.474 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -107.55 175.61 5.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.595 -0.691 . . . . 0.0 109.216 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -67.63 -12.13 59.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.728 -0.608 . . . . 0.0 110.792 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.474 ' CE2' ' HB2' ' A' ' 12' ' ' SER . 15.4 p90 -68.07 -22.34 64.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.127 -0.983 . . . . 0.0 110.412 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.06 -58.68 2.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.323 -0.861 . . . . 0.0 110.106 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.773 HD22 HD23 ' B' ' 15' ' ' LEU . 32.6 mt -64.31 -14.22 54.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.526 -0.734 . . . . 0.0 110.875 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -30.34 71.41 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.104 -0.997 . . . . 0.0 109.4 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -97.8 29.53 3.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.547 -0.721 . . . . 0.0 109.771 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -110.5 8.77 23.17 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.53 -0.731 . . . . 0.0 110.138 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.5 m -97.49 29.26 3.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.205 -0.934 . . . . 0.0 109.56 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.27 -179.958 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.587 ' CZ ' HD22 ' B' ' 17' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.482 HG23 ' ND2' ' B' ' 3' ' ' ASN . 17.3 m -88.98 -34.39 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.482 ' ND2' HG23 ' B' ' 2' ' ' VAL . 17.3 p30 -156.76 34.2 0.3 Allowed 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.651 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -123.69 155.85 37.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.779 -0.575 . . . . 0.0 109.826 -178.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.433 ' CE1' HG12 ' A' ' 10' ' ' ILE . 7.0 m80 -106.2 156.65 18.25 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 16' ' ' LEU . 2.0 mm? -109.12 101.14 10.22 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.248 -0.908 . . . . 0.0 109.997 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.61 120.61 0.05 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.82 -149.16 28.05 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.62 -15.72 63.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.539 -0.977 . . . . 0.0 110.047 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -60.86 -30.8 70.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.156 -0.965 . . . . 0.0 109.783 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.615 HD22 HG22 ' A' ' 3' ' ' VAL . 58.3 tp -70.89 -52.32 20.82 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.512 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 18.7 t -53.51 -49.43 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.506 -0.746 . . . . 0.0 110.401 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.02 -31.28 69.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.571 -0.705 . . . . 0.0 109.597 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.754 ' HB1' HD13 ' A' ' 16' ' ' LEU . . . -68.55 -34.16 75.35 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.773 HD23 HD22 ' A' ' 16' ' ' LEU . 23.9 mt -75.35 -25.51 57.82 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -74.34 -31.61 62.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 109.124 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.587 HD22 ' CZ ' ' B' ' 1' ' ' PHE . 0.2 OUTLIER -80.1 -33.99 38.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.639 -0.663 . . . . 0.0 109.538 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.576 HG23 ' O ' ' B' ' 14' ' ' ALA . 39.1 t -81.28 -69.27 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.654 -0.654 . . . . 0.0 109.784 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 55.7 m -57.94 -66.52 0.46 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.357 -0.839 . . . . 0.0 109.786 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.25 -38.3 3.22 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.6 -173.44 1.16 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.51 -0.994 . . . . 0.0 109.486 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.86 -64.71 1.02 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.557 -0.714 . . . . 0.0 109.703 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.86 41.79 2.29 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.01 35.04 5.18 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -176.11 -172.02 0.47 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.57 -0.959 . . . . 0.0 109.738 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -52.04 110.51 0.49 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.378 -0.827 . . . . 0.0 109.909 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.12 94.16 41.05 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.602 -0.686 . . . . 0.0 109.672 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.33 109.94 0.54 Allowed 'Trans proline' 0 N--CA 1.484 0.933 0 C-N-CA 122.476 2.117 . . . . 0.0 110.05 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.988 179.92 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.749 HG23 HG23 ' A' ' 3' ' ' VAL . 9.3 tt -141.37 -44.61 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.513 -0.992 . . . . 0.0 109.439 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.749 HG23 HG23 ' A' ' 2' ' ' ILE . 42.9 t -90.48 -46.36 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.534 -0.729 . . . . 0.0 109.118 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.65 -22.19 61.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.684 -0.635 . . . . 0.0 110.262 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -63.55 -42.48 98.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.463 -0.773 . . . . 0.0 110.372 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.476 ' HB2' HD23 ' B' ' 6' ' ' LEU . 57.6 m -119.76 27.44 8.72 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.59 -43.62 15.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.75 . . . . 0.0 109.437 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 t -84.76 -27.85 26.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.604 -0.685 . . . . 0.0 109.965 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -116.99 168.47 10.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.473 -0.767 . . . . 0.0 109.362 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.457 HG12 ' CE1' ' B' ' 5' ' ' HIS . 10.7 mt -107.66 90.02 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.502 -0.749 . . . . 0.0 109.162 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.5 m -60.19 -169.44 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.367 -0.833 . . . . 0.0 109.602 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.468 ' CB ' ' CE2' ' A' ' 14' ' ' TYR . 48.7 m -94.21 160.4 14.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.612 -0.68 . . . . 0.0 109.249 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.803 HD13 ' O ' ' A' ' 13' ' ' LEU . 3.4 tm? -71.59 -26.6 62.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.627 -0.671 . . . . 0.0 109.904 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.468 ' CE2' ' CB ' ' A' ' 12' ' ' SER . 12.5 p90 -64.88 -18.16 64.94 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.495 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -78.77 -44.58 22.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.298 -0.876 . . . . 0.0 109.061 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.58 HD22 ' CD2' ' B' ' 15' ' ' LEU . 1.5 mt -64.88 -19.69 66.04 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.584 -0.697 . . . . 0.0 109.643 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -55.8 -21.28 18.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 0.0 110.563 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -94.49 32.78 1.51 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.284 -0.885 . . . . 0.0 109.644 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.462 ' CG ' HD23 ' A' ' 16' ' ' LEU . 8.3 m-85 -114.91 11.5 16.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.429 -0.795 . . . . 0.0 110.08 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' B' ' 25' ' ' PHE . 84.5 m -97.15 28.78 3.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.169 -0.957 . . . . 0.0 109.536 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 m120 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.548 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.808 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.711 HG12 ' CD1' ' B' ' 1' ' ' PHE . 7.5 p -161.68 -43.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 109.062 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.445 ' N ' HG13 ' B' ' 2' ' ' VAL . 17.4 m120 -156.98 29.16 0.31 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 109.159 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -143.42 131.8 22.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.534 -0.729 . . . . 0.0 109.568 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.457 ' CE1' HG12 ' A' ' 10' ' ' ILE . 79.3 m80 -81.51 164.04 22.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.649 -0.657 . . . . 0.0 109.476 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.701 HD22 ' N ' ' B' ' 6' ' ' LEU . 1.5 mm? -109.56 82.09 1.54 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.527 -0.733 . . . . 0.0 109.404 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 74.3 m -130.91 121.52 25.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.506 -0.746 . . . . 0.0 109.828 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.71 -128.32 8.4 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 93.4 p -84.43 -9.72 58.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.689 -0.889 . . . . 0.0 110.396 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -61.32 -27.89 68.81 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.011 -1.055 . . . . 0.0 109.348 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' B' ' 6' ' ' LEU . 56.3 tp -70.47 -61.97 1.57 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.466 -0.771 . . . . 0.0 108.94 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.402 ' H ' HG23 ' B' ' 12' ' ' VAL . 36.0 t -47.21 -49.74 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.724 -0.61 . . . . 0.0 111.454 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -56.53 -39.14 72.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.372 -0.83 . . . . 0.0 110.441 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.83 -28.88 64.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.441 -0.787 . . . . 0.0 109.886 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.58 ' CD2' HD22 ' A' ' 16' ' ' LEU . 50.8 mt -65.55 -38.5 89.77 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -66.01 -34.19 77.52 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.808 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 2.2 tp -61.39 -34.02 74.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.685 -0.634 . . . . 0.0 109.354 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.523 ' CG2' HD21 ' A' ' 13' ' ' LEU . 45.2 t -87.78 -75.19 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.527 -0.733 . . . . 0.0 109.951 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -75.74 -76.36 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.254 -0.904 . . . . 0.0 109.064 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.07 17.66 26.81 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.81 160.21 16.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.348 -1.089 . . . . 0.0 108.9 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -39.83 61.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.449 -0.782 . . . . 0.0 109.493 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.23 61.85 0.62 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.7 -41.0 0.36 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 21.3 p90 -102.87 -175.83 2.92 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.57 -0.959 . . . . 0.0 110.23 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -58.21 127.4 31.9 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.57 0.7 . . . . 0.0 110.326 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.73 94.77 31.02 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -56.52 155.25 26.67 Favored 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 122.33 2.02 . . . . 0.0 110.244 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.514 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.761 HG23 HG23 ' A' ' 3' ' ' VAL . 3.2 tp -67.55 -43.73 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.655 -0.909 . . . . 0.0 109.574 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.761 HG23 HG23 ' A' ' 2' ' ' ILE . 23.8 t -90.24 0.03 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.465 -0.772 . . . . 0.0 110.772 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -96.9 27.06 4.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.973 -1.079 . . . . 0.0 109.775 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.28 -30.66 7.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.0 9.36 6.3 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.548 -0.72 . . . . 0.0 110.505 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 46.6 t -82.01 84.82 6.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.087 -1.008 . . . . 0.0 108.964 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.7 m -160.95 -42.92 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.488 -0.758 . . . . 0.0 109.944 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.464 ' HA ' ' CE1' ' B' ' 5' ' ' HIS . 11.6 t -154.06 -125.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.731 . . . . 0.0 109.368 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.624 HD13 ' N ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -101.61 105.63 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.582 -1.324 . . . . 0.0 108.686 -179.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -82.13 155.72 24.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.673 -0.642 . . . . 0.0 109.512 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.2 p -95.65 151.78 19.04 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.853 HD13 ' O ' ' A' ' 13' ' ' LEU . 1.3 tm? -66.49 -26.72 67.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.647 -0.658 . . . . 0.0 109.437 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -51.94 -24.82 6.98 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.148 -0.97 . . . . 0.0 110.603 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -87.89 -44.23 11.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.348 -0.845 . . . . 0.0 109.966 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.717 HD11 HD21 ' B' ' 6' ' ' LEU . 4.2 mt -65.01 -16.21 63.18 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.436 -0.79 . . . . 0.0 110.5 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.15 -23.56 35.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.177 -0.952 . . . . 0.0 110.307 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -96.64 37.92 1.25 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.479 -0.763 . . . . 0.0 109.802 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.603 ' CG ' HD23 ' A' ' 16' ' ' LEU . 7.2 m-85 -115.99 -0.91 12.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.484 -0.76 . . . . 0.0 110.554 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.5 m -88.62 11.12 18.23 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.082 -1.011 . . . . 0.0 110.57 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.9 p30 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.098 -1.001 . . . . 0.0 109.581 179.879 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.631 ' CE1' HD23 ' A' ' 13' ' ' LEU . 9.1 p90 . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 120.473 0.178 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 35.1 m -63.09 -29.67 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.167 -0.958 . . . . 0.0 109.254 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -142.97 30.09 1.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -130.52 -179.21 5.14 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.464 ' CE1' ' HA ' ' A' ' 9' ' ' SER . 12.3 m-70 -109.15 149.55 29.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.338 -0.851 . . . . 0.0 109.524 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.717 HD21 HD11 ' A' ' 16' ' ' LEU . 0.8 OUTLIER -93.28 100.01 12.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.563 -0.71 . . . . 0.0 110.123 -179.058 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.67 142.58 0.14 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.586 -0.696 . . . . 0.0 109.236 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.23 -115.33 4.08 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.38 -19.62 18.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.674 -0.898 . . . . 0.0 109.956 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -56.68 -28.18 60.27 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.012 -1.055 . . . . 0.0 109.445 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.524 HD22 ' HG ' ' B' ' 6' ' ' LEU . 0.6 OUTLIER -64.73 -60.03 3.56 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 25.2 t -52.62 -47.32 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.835 -0.541 . . . . 0.0 111.577 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -58.93 -30.77 68.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.292 -0.88 . . . . 0.0 110.353 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.805 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -77.92 -27.39 49.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.506 -0.747 . . . . 0.0 109.796 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.586 HD23 HD22 ' A' ' 16' ' ' LEU . 45.3 mt -70.49 -37.89 74.27 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.294 -0.879 . . . . 0.0 108.941 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -76.11 -34.55 59.48 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -30.01 69.71 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.805 HG23 ' O ' ' B' ' 14' ' ' ALA . 33.0 t -86.82 -69.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.531 -0.73 . . . . 0.0 109.479 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 11.6 m -88.68 -70.16 0.66 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.557 -0.714 . . . . 0.0 109.335 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.44 36.97 22.14 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -86.51 177.29 7.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.53 -0.982 . . . . 0.0 109.119 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -82.74 80.27 8.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.524 -0.735 . . . . 0.0 109.204 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.81 63.27 2.91 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.83 22.13 5.8 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -151.1 -173.19 4.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.263 -1.139 . . . . 0.0 109.573 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.404 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 3.6 t80 -49.95 101.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.54 -0.725 . . . . 0.0 110.085 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.42 90.91 36.32 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.404 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 4.9 Cg_exo -56.81 105.53 0.18 Allowed 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 122.625 2.217 . . . . 0.0 110.094 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.384 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.396 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.537 HG23 HG23 ' A' ' 3' ' ' VAL . 1.9 tt -62.63 -41.78 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.997 . . . . 0.0 109.022 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.537 HG23 HG23 ' A' ' 2' ' ' ILE . 21.3 t -87.5 -30.76 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.518 -0.739 . . . . 0.0 109.03 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -70.17 -10.08 57.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.622 -0.674 . . . . 0.0 110.037 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.52 -65.7 0.51 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.074 -1.016 . . . . 0.0 110.004 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.0 m -129.68 36.83 4.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.478 -0.764 . . . . 0.0 110.336 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.0 t -54.17 -55.46 27.65 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.187 -0.946 . . . . 0.0 109.335 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -92.64 49.74 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.528 -0.733 . . . . 0.0 109.454 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -176.56 163.2 2.37 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.44 HG12 ' CE1' ' B' ' 5' ' ' HIS . 16.8 mt -103.69 86.81 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.426 -0.797 . . . . 0.0 109.166 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -178.83 0.1 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.765 -0.584 . . . . 0.0 110.079 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -91.71 166.12 12.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.708 -0.62 . . . . 0.0 109.623 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.737 HD13 ' O ' ' A' ' 13' ' ' LEU . 3.5 tm? -66.51 -32.11 73.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.669 -0.644 . . . . 0.0 109.679 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -27.14 63.99 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.335 -0.853 . . . . 0.0 109.694 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -67.39 -50.12 60.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.459 -0.776 . . . . 0.0 109.508 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.864 HD11 HD22 ' B' ' 6' ' ' LEU . 10.2 mt -65.43 -16.65 63.85 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.431 -0.793 . . . . 0.0 110.25 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.91 -19.41 42.21 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.249 -0.907 . . . . 0.0 110.354 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -96.27 30.63 2.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.264 -0.898 . . . . 0.0 109.801 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.486 ' HB3' HD22 ' B' ' 15' ' ' LEU . 6.4 m-85 -114.69 -14.91 11.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.6 -0.687 . . . . 0.0 110.026 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.9 m -73.56 -20.15 60.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.136 -0.978 . . . . 0.0 110.22 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.7 p30 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.415 179.78 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.919 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.574 HG23 ' CD1' ' B' ' 1' ' ' PHE . 18.4 t -83.48 -69.59 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.595 -1.316 . . . . 0.0 109.081 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.508 ' OD1' HG12 ' B' ' 2' ' ' VAL . 34.4 m120 -154.35 24.63 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.532 -0.73 . . . . 0.0 109.935 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -115.47 142.11 47.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.448 -0.782 . . . . 0.0 109.328 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.44 ' CE1' HG12 ' A' ' 10' ' ' ILE . 49.8 m80 -70.51 -178.47 1.78 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.63 -0.669 . . . . 0.0 109.866 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.864 HD22 HD11 ' A' ' 16' ' ' LEU . 38.0 mt -130.63 42.18 3.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.501 -0.749 . . . . 0.0 110.854 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.67 140.78 52.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.212 -0.93 . . . . 0.0 109.281 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.66 -144.61 21.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.3 -14.67 60.93 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.456 -1.026 . . . . 0.0 109.893 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -60.43 -37.86 82.26 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.082 -1.011 . . . . 0.0 109.126 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.457 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 2.5 tt -61.65 -58.5 7.81 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.806 -0.559 . . . . 0.0 109.696 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 t -49.56 -51.06 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.625 -0.672 . . . . 0.0 111.22 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -58.61 -33.65 70.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.368 -0.832 . . . . 0.0 110.092 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.447 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -70.45 -30.56 67.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.548 -0.72 . . . . 0.0 109.7 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.751 ' CD2' HD22 ' A' ' 16' ' ' LEU . 30.2 mt -69.25 -36.52 77.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.75 -29.94 66.31 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.919 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 1.5 tp -68.66 -35.47 77.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.602 -0.686 . . . . 0.0 109.436 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 14' ' ' ALA . 39.7 t -80.84 -69.81 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.543 -0.723 . . . . 0.0 109.726 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.56 -81.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.472 -0.768 . . . . 0.0 109.416 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 139.19 -52.05 0.73 Allowed Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.671 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -90.34 152.02 21.2 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.34 -1.094 . . . . 0.0 110.062 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 19.3 mtt180 -76.03 139.03 41.25 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.22 17.62 57.11 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.6 33.56 5.18 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.456 ' CD1' ' CB ' ' B' ' 15' ' ' LEU . 27.0 p90 -176.83 -169.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.717 -0.872 . . . . 0.0 109.016 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -51.52 99.93 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.294 -0.879 . . . . 0.0 109.82 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 19.5 p -132.61 89.88 34.55 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.8 146.66 91.98 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 122.394 2.062 . . . . 0.0 110.159 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.6 mttt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.527 -179.949 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.424 HG21 ' CE1' ' A' ' 19' ' ' TYR . 4.3 mp -113.42 -55.81 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.585 -0.95 . . . . 0.0 109.735 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.504 HG23 ' OH ' ' A' ' 19' ' ' TYR . 23.6 t -65.99 -34.81 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.544 -0.723 . . . . 0.0 109.403 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.25 -21.26 63.73 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.442 -0.786 . . . . 0.0 110.04 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -111.79 -3.52 14.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.383 -0.823 . . . . 0.0 110.951 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.4 m -121.26 18.78 11.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.983 -1.073 . . . . 0.0 110.529 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.02 21.68 13.57 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.164 -0.96 . . . . 0.0 109.828 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.6 m -129.73 -66.22 0.8 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.332 -0.855 . . . . 0.0 108.83 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.99 -164.88 1.21 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.585 HD13 ' NE2' ' B' ' 5' ' ' HIS . 4.5 mm -90.82 98.55 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.4 -0.813 . . . . 0.0 108.941 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -70.69 -167.76 0.21 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.671 -0.643 . . . . 0.0 109.747 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.02 156.12 44.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.509 -0.744 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.863 HD13 ' O ' ' A' ' 13' ' ' LEU . 3.2 tm? -66.78 -26.32 66.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.619 -0.676 . . . . 0.0 110.521 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.89 -22.32 14.41 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.073 -1.017 . . . . 0.0 110.561 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -86.39 -39.94 15.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.419 -0.801 . . . . 0.0 109.437 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.665 HD11 HD11 ' B' ' 6' ' ' LEU . 6.5 mt -68.64 -10.78 58.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.489 -0.757 . . . . 0.0 110.258 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -67.51 -28.43 67.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 109.412 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -71.01 -12.16 61.37 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.553 -0.717 . . . . 0.0 110.622 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.504 ' OH ' HG23 ' A' ' 3' ' ' VAL . 5.3 m-85 -74.59 -7.8 54.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.32 -0.862 . . . . 0.0 110.47 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 27.9 m -97.64 33.44 2.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.132 -0.98 . . . . 0.0 109.596 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.533 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.7 ' CD1' HD23 ' A' ' 13' ' ' LEU . 8.5 p90 . . . . . 0 N--CA 1.5 2.036 0 CA-C-O 120.464 0.173 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.94 -33.16 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.056 -1.027 . . . . 0.0 108.734 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -144.27 30.04 1.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -126.65 -159.5 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.585 ' NE2' HD13 ' A' ' 10' ' ' ILE . 20.3 m80 -115.97 -172.82 2.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.349 -0.844 . . . . 0.0 109.829 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.665 HD11 HD11 ' A' ' 16' ' ' LEU . 4.4 tp -130.45 43.57 3.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.572 -0.705 . . . . 0.0 110.178 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 59.5 m -122.86 136.29 54.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.509 -0.744 . . . . 0.0 109.464 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.94 -132.94 11.43 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -81.53 2.86 27.11 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.646 -0.914 . . . . 0.0 110.33 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -77.13 -37.18 54.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.053 -1.03 . . . . 0.0 108.733 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 36.9 tp -68.17 -63.69 1.01 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -52.54 -49.77 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.658 -0.651 . . . . 0.0 110.641 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -59.54 -30.79 68.86 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.329 -0.857 . . . . 0.0 109.658 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.42 -32.13 68.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.636 -0.665 . . . . 0.0 109.764 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.65 ' CD2' HD22 ' A' ' 16' ' ' LEU . 38.2 mt -68.92 -39.66 79.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.471 -0.768 . . . . 0.0 109.162 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -67.49 -34.0 76.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.692 . . . . 0.0 109.522 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.33 -46.21 74.13 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.553 -0.717 . . . . 0.0 109.677 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.629 ' CG2' HD21 ' A' ' 13' ' ' LEU . 44.3 t -67.42 -69.81 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.506 -0.746 . . . . 0.0 109.355 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.88 -79.46 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.483 -0.76 . . . . 0.0 108.992 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.44 -28.02 14.92 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.93 170.12 4.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.423 -1.045 . . . . 0.0 109.764 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.74 138.87 31.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.546 -0.721 . . . . 0.0 109.395 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.56 29.6 69.97 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.78 27.7 10.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.473 ' HB2' HD13 ' B' ' 15' ' ' LEU . 12.5 p90 -177.72 -177.32 0.65 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -1.073 . . . . 0.0 110.177 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -57.49 125.97 25.24 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.6 -0.687 . . . . 0.0 109.893 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 8.8 p -117.63 96.36 49.28 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.574 -0.703 . . . . 0.0 109.257 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -57.79 162.46 10.82 Favored 'Trans proline' 0 N--CA 1.483 0.878 0 C-N-CA 122.487 2.124 . . . . 0.0 110.169 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.443 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.646 HG23 HG23 ' A' ' 3' ' ' VAL . 8.2 tt -171.99 -50.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.658 -0.907 . . . . 0.0 109.138 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.646 HG23 HG23 ' A' ' 2' ' ' ILE . 31.4 t -92.54 -61.38 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.365 -0.834 . . . . 0.0 109.122 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -60.28 -18.51 49.68 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.58 -0.7 . . . . 0.0 110.082 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -52.64 -59.32 4.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.249 -0.907 . . . . 0.0 110.309 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -124.23 36.02 4.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.524 -0.735 . . . . 0.0 109.515 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' B' ' 6' ' ' LEU . 0.1 OUTLIER -62.59 -43.16 99.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.625 -0.672 . . . . 0.0 109.555 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 m -87.41 -33.67 19.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.534 -0.729 . . . . 0.0 109.75 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -94.45 -177.63 4.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.457 -0.777 . . . . 0.0 109.449 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.44 ' CG1' ' CE1' ' B' ' 5' ' ' HIS . 19.5 mt -114.73 99.95 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.377 -0.827 . . . . 0.0 109.409 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.33 -177.87 6.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.567 -0.708 . . . . 0.0 109.304 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.12 153.95 19.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.507 -0.746 . . . . 0.0 109.424 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.685 HD11 HG22 ' B' ' 18' ' ' VAL . 59.5 tp -57.86 -20.32 35.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.597 -0.689 . . . . 0.0 110.826 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -53.24 -28.19 26.05 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.22 -0.925 . . . . 0.0 111.697 -178.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.443 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 14.3 pt20 -80.06 -44.37 20.18 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.104 -0.997 . . . . 0.0 109.66 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.641 HD22 HD23 ' B' ' 15' ' ' LEU . 9.9 mt -67.0 -16.43 64.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.51 -0.744 . . . . 0.0 109.649 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.62 -17.92 50.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.173 -0.954 . . . . 0.0 109.84 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -93.27 27.28 2.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 0.0 109.869 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.493 ' CD2' HD22 ' B' ' 15' ' ' LEU . 6.3 m-85 -107.16 -20.59 13.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.365 -0.834 . . . . 0.0 109.966 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.3 m -75.88 -4.2 39.51 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.275 -0.89 . . . . 0.0 110.287 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 p30 . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.004 -1.06 . . . . 0.0 109.548 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.859 ' CZ ' HD22 ' B' ' 17' ' ' LEU . 3.3 t80 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.684 HG12 ' ND2' ' B' ' 3' ' ' ASN . 9.0 t -46.35 -64.65 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 O-C-N 121.65 -0.656 . . . . 0.0 110.52 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.684 ' ND2' HG12 ' B' ' 2' ' ' VAL . 10.3 p30 -174.4 36.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -122.26 148.81 44.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.609 -0.682 . . . . 0.0 109.258 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.44 ' CE1' ' CG1' ' A' ' 10' ' ' ILE . 51.1 m80 -78.38 -178.31 5.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.642 -0.661 . . . . 0.0 109.576 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -142.42 131.96 23.83 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.95 -76.71 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.146 -0.971 . . . . 0.0 109.595 178.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.08 -121.59 0.06 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 22.3 p -73.58 -8.54 56.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.47 -1.018 . . . . 0.0 109.445 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -61.28 -41.82 97.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 109.877 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.473 ' CD1' HD21 ' A' ' 16' ' ' LEU . 67.2 tp -60.46 -56.29 23.14 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.485 -0.76 . . . . 0.0 109.682 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.4 t -49.76 -53.77 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.567 -0.708 . . . . 0.0 111.081 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -58.07 -31.93 67.55 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.437 -0.789 . . . . 0.0 110.188 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.424 ' HA ' ' CE1' ' B' ' 1' ' ' PHE . . . -69.13 -34.11 74.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.482 -0.762 . . . . 0.0 109.654 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.641 HD23 HD22 ' A' ' 16' ' ' LEU . 25.8 mt -70.81 -32.94 70.19 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -68.29 -33.72 74.87 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.859 HD22 ' CZ ' ' B' ' 1' ' ' PHE . 0.5 OUTLIER -69.14 -39.22 78.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.689 -0.632 . . . . 0.0 109.745 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.685 HG22 HD11 ' A' ' 13' ' ' LEU . 30.8 t -72.84 -68.2 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.57 -0.706 . . . . 0.0 110.135 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 10.6 m -65.15 -69.19 0.31 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.417 -0.802 . . . . 0.0 109.195 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.0 -36.52 3.52 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.28 167.43 12.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.338 -1.095 . . . . 0.0 109.928 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.56 -63.56 1.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.81 86.26 0.97 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -161.5 -41.38 0.02 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.531 ' O ' HG23 ' B' ' 27' ' ' THR . 28.0 p90 -116.43 -174.49 2.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.409 -1.053 . . . . 0.0 110.446 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.412 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 2.9 t80 -54.5 100.0 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.531 HG23 ' O ' ' B' ' 25' ' ' PHE . 40.4 p -113.1 92.46 21.74 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.653 -0.654 . . . . 0.0 109.57 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.412 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 2.4 Cg_endo -60.49 89.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 122.422 2.081 . . . . 0.0 109.776 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.518 -179.821 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.469 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.811 HG23 HG23 ' A' ' 3' ' ' VAL . 1.1 tp -128.21 -44.21 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.495 -1.003 . . . . 0.0 109.321 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.811 HG23 HG23 ' A' ' 2' ' ' ILE . 19.0 t -90.96 -28.83 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.645 -0.659 . . . . 0.0 109.406 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -74.81 -5.55 44.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.557 -0.715 . . . . 0.0 110.195 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -58.24 -63.21 1.35 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.196 -0.94 . . . . 0.0 110.013 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.553 ' SG ' HD12 ' B' ' 6' ' ' LEU . 4.5 p -120.48 27.32 8.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.477 -0.764 . . . . 0.0 110.279 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -32.09 54.36 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.217 -0.927 . . . . 0.0 109.389 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -113.42 -32.73 6.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.676 -0.64 . . . . 0.0 109.325 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.431 ' O ' ' CD2' ' B' ' 5' ' ' HIS . 0.4 OUTLIER -98.85 -171.41 2.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.449 -0.782 . . . . 0.0 108.926 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.482 HD13 ' NE2' ' B' ' 5' ' ' HIS . 1.7 mm -104.21 160.64 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.361 -0.837 . . . . 0.0 109.008 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.406 ' SG ' HD12 ' B' ' 6' ' ' LEU . 4.0 p -147.27 179.56 7.56 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.507 -0.746 . . . . 0.0 109.806 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.467 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -82.8 102.06 11.34 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.87 HD11 HD21 ' B' ' 6' ' ' LEU . 3.1 mm? -70.27 -14.61 62.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.545 -0.722 . . . . 0.0 110.859 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' A' ' 12' ' ' SER . 17.3 p90 -71.25 -18.92 62.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.088 -1.008 . . . . 0.0 109.779 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -84.18 -3.24 58.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.359 -0.838 . . . . 0.0 110.416 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.745 HD12 ' CD1' ' A' ' 13' ' ' LEU . 4.4 mt -65.7 -14.15 60.7 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.134 -0.979 . . . . 0.0 109.99 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -59.06 -19.65 46.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.164 -0.96 . . . . 0.0 110.002 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -96.89 31.95 2.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.296 -0.878 . . . . 0.0 109.438 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.77 ' CZ ' HD11 ' A' ' 2' ' ' ILE . 6.4 m-85 -115.19 12.97 16.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.435 -0.79 . . . . 0.0 109.95 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.81 -56.11 5.12 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.231 -0.918 . . . . 0.0 109.571 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.297 -1.713 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.326 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.427 ' HE2' HD22 ' B' ' 17' ' ' LEU . 13.3 p90 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 120.613 0.244 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 24.5 t -51.89 -25.72 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 120.962 -1.087 . . . . 0.0 110.469 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -151.57 27.14 0.66 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 109.303 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' B' ' 5' ' ' HIS . 5.8 mp0 -107.24 -97.21 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.441 -0.787 . . . . 0.0 109.329 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.482 ' NE2' HD13 ' A' ' 10' ' ' ILE . 1.1 m80 -173.1 152.58 2.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.833 -1.167 . . . . 0.0 109.86 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.87 HD21 HD11 ' A' ' 13' ' ' LEU . 21.9 mt -115.11 86.15 2.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.635 -0.666 . . . . 0.0 109.511 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -150.2 129.95 13.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.48 -0.762 . . . . 0.0 109.481 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.29 -136.48 14.46 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.42 -6.81 57.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.494 -1.003 . . . . 0.0 110.364 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -66.57 -29.68 69.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 109.691 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.808 ' CD2' HG22 ' A' ' 3' ' ' VAL . 60.7 tp -71.25 -46.28 61.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.486 -0.759 . . . . 0.0 109.544 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.411 HG13 ' O ' ' B' ' 26' ' ' TYR . 39.3 t -60.66 -43.79 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.672 -0.643 . . . . 0.0 109.952 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.77 -39.51 94.41 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.435 -0.791 . . . . 0.0 109.302 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.768 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -66.32 -30.39 70.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.607 -0.683 . . . . 0.0 109.769 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.691 HD22 HD22 ' A' ' 16' ' ' LEU . 1.2 mt -70.4 -36.18 73.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.507 -0.745 . . . . 0.0 109.416 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -70.3 -32.55 70.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.581 -0.699 . . . . 0.0 109.607 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.427 HD22 ' HE2' ' B' ' 1' ' ' PHE . 0.3 OUTLIER -79.82 -24.67 41.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.477 -0.764 . . . . 0.0 110.086 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.768 HG23 ' O ' ' B' ' 14' ' ' ALA . 41.9 t -89.48 -68.85 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.246 -0.909 . . . . 0.0 109.801 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 m -53.71 -78.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.39 -0.819 . . . . 0.0 110.269 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.33 -40.42 1.56 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -63.84 176.02 1.03 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.287 -1.125 . . . . 0.0 109.593 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.42 -44.35 6.55 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.53 ' HA2' HG21 ' B' ' 27' ' ' THR . . . -118.75 42.97 1.68 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.28 38.16 3.21 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.477 ' CD1' ' HB2' ' B' ' 15' ' ' LEU . 52.5 p90 -178.4 -166.71 0.11 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.397 -1.061 . . . . 0.0 109.522 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.519 ' CB ' HD12 ' B' ' 15' ' ' LEU . 0.4 OUTLIER -47.29 94.38 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.868 -0.52 . . . . 0.0 110.188 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.53 HG21 ' HA2' ' B' ' 23' ' ' GLY . 0.8 OUTLIER -127.33 98.86 28.58 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -56.95 142.14 93.61 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.3 2.0 . . . . 0.0 110.047 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.453 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.782 HG23 HG23 ' A' ' 3' ' ' VAL . 4.4 tt -67.04 -44.56 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.678 -0.895 . . . . 0.0 109.669 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.782 HG23 HG23 ' A' ' 2' ' ' ILE . 21.0 t -90.76 -13.23 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.445 -0.785 . . . . 0.0 110.221 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -90.52 53.58 2.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.233 -0.917 . . . . 0.0 109.044 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -142.22 -46.32 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.539 -0.726 . . . . 0.0 109.368 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.592 ' CB ' HD23 ' B' ' 6' ' ' LEU . 8.0 m -115.6 15.87 16.55 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.539 -0.726 . . . . 0.0 109.952 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 45.3 t -72.93 -35.77 67.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.09 -1.006 . . . . 0.0 109.314 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 m -73.22 -58.14 3.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.487 -0.758 . . . . 0.0 109.797 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.4 p -119.62 -167.86 1.49 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.502 -0.749 . . . . 0.0 109.815 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.423 HG12 ' CE1' ' B' ' 5' ' ' HIS . 7.4 mt -101.82 130.16 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.0 p -106.23 -172.9 2.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.31 -0.869 . . . . 0.0 110.429 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.57 144.8 55.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.573 -0.705 . . . . 0.0 110.787 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.825 HD13 ' O ' ' A' ' 13' ' ' LEU . 3.4 tm? -69.15 -30.25 68.44 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -22.29 22.09 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.489 -0.757 . . . . 0.0 109.94 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -72.45 -46.74 53.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.36 -0.838 . . . . 0.0 109.487 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.701 HD11 ' HG ' ' B' ' 6' ' ' LEU . 5.4 mt -65.4 -21.62 66.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.516 -0.74 . . . . 0.0 110.093 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.77 -26.92 58.69 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.226 -0.921 . . . . 0.0 110.308 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -97.74 35.88 1.61 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.377 -0.827 . . . . 0.0 109.672 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.453 ' HB3' HD22 ' B' ' 15' ' ' LEU . 7.1 m-85 -113.8 -0.98 14.04 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.501 -0.75 . . . . 0.0 110.383 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.2 m -81.15 1.77 30.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.145 -0.972 . . . . 0.0 110.469 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 120.999 -1.063 . . . . 0.0 109.571 -179.817 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.445 ' CD2' HD23 ' A' ' 13' ' ' LEU . 1.2 t80 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 28.8 m -50.49 172.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.444 -0.785 . . . . 0.0 110.703 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -58.59 92.54 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.464 -0.772 . . . . 0.0 109.901 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -130.4 104.99 7.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.556 -0.715 . . . . 0.0 109.385 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.423 ' CE1' HG12 ' A' ' 10' ' ' ILE . 70.9 m80 -74.4 135.07 42.39 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.835 ' HB3' HD13 ' B' ' 11' ' ' LEU . 0.2 OUTLIER -86.95 98.25 11.14 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.483 -0.761 . . . . 0.0 109.734 -179.274 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -178.46 127.36 0.11 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.59 -0.694 . . . . 0.0 109.422 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.83 -141.17 26.95 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p -69.23 -16.66 63.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.561 -0.964 . . . . 0.0 110.169 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -67.81 -38.76 83.68 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.176 -0.953 . . . . 0.0 109.575 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.835 HD13 ' HB3' ' B' ' 6' ' ' LEU . 66.7 tp -68.69 -46.19 69.68 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.654 -0.654 . . . . 0.0 109.379 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.411 HG23 ' H ' ' B' ' 12' ' ' VAL . 8.7 t -55.97 -49.9 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.428 -0.795 . . . . 0.0 110.073 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -62.31 -26.33 68.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.556 -0.715 . . . . 0.0 109.578 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.745 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -71.85 -32.26 67.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.641 -0.662 . . . . 0.0 109.293 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.578 HD23 HD22 ' A' ' 16' ' ' LEU . 24.0 mt -79.33 -26.58 42.13 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -74.48 -29.79 61.58 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -83.35 -32.31 26.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.494 -0.754 . . . . 0.0 109.477 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.745 HG23 ' O ' ' B' ' 14' ' ' ALA . 45.3 t -81.28 -68.88 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.528 -0.732 . . . . 0.0 109.506 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 60.5 m -54.33 -73.29 0.05 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.496 -0.753 . . . . 0.0 110.428 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.76 -45.88 1.1 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 174.12 8.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.377 -1.072 . . . . 0.0 109.688 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.67 31.44 5.46 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.18 37.15 0.09 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.91 46.75 1.06 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.459 ' CG ' ' HB3' ' B' ' 15' ' ' LEU . 14.5 p90 -179.33 -173.62 0.28 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.465 -1.021 . . . . 0.0 109.877 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.4 ' HB3' ' CD1' ' B' ' 15' ' ' LEU . 4.8 t80 -54.46 108.36 0.37 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.509 -0.744 . . . . 0.0 109.482 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.78 93.32 46.09 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.715 -0.615 . . . . 0.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -58.24 110.75 0.69 Allowed 'Trans proline' 0 N--CA 1.484 0.952 0 C-N-CA 122.529 2.153 . . . . 0.0 109.979 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 tptt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.393 179.943 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.559 HG23 HD13 ' B' ' 6' ' ' LEU . 0.3 OUTLIER -109.62 -48.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.561 -0.964 . . . . 0.0 108.881 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.889 ' CG2' HD22 ' B' ' 11' ' ' LEU . 3.7 t -83.68 -48.35 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.684 -0.635 . . . . 0.0 110.016 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.37 -8.87 54.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.431 -0.793 . . . . 0.0 110.866 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.69 -14.56 8.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.154 -0.966 . . . . 0.0 110.883 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.483 ' HB2' HD12 ' B' ' 6' ' ' LEU . 11.9 m -120.19 24.44 10.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.027 -1.046 . . . . 0.0 110.12 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -84.84 -42.9 14.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.348 -0.845 . . . . 0.0 109.301 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.9 m -78.91 -48.13 15.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.548 -0.72 . . . . 0.0 109.654 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -110.0 -177.91 3.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.689 . . . . 0.0 109.543 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.44 HG12 ' CE1' ' B' ' 5' ' ' HIS . 32.0 mt -106.25 135.23 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.7 m -94.99 -174.69 3.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.726 . . . . 0.0 110.129 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.8 m -91.84 166.36 12.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.661 -0.649 . . . . 0.0 109.962 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.474 HD11 HG13 ' B' ' 18' ' ' VAL . 45.5 tp -67.47 -24.81 65.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.673 -0.642 . . . . 0.0 110.174 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -58.67 -19.35 38.67 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.456 -0.778 . . . . 0.0 110.954 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -77.64 -69.35 0.55 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.084 -1.01 . . . . 0.0 110.375 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.677 HD22 ' CD2' ' B' ' 15' ' ' LEU . 24.4 mt -60.16 -17.66 42.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.405 -0.809 . . . . 0.0 109.992 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -64.75 -44.09 91.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 108.577 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -71.52 -9.99 59.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.649 -0.657 . . . . 0.0 109.737 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.419 ' CE2' HG13 ' A' ' 2' ' ' ILE . 6.9 m-30 -89.29 22.56 2.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.4 -0.812 . . . . 0.0 110.45 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.8 m -109.31 40.79 1.77 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.166 -0.959 . . . . 0.0 109.691 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.1 m120 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.1 -0.952 . . . . 0.0 109.475 179.938 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.422 ' CE2' ' CB ' ' B' ' 4' ' ' GLN . 10.0 t80 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.624 HG12 ' ND2' ' B' ' 3' ' ' ASN . 10.7 t -42.96 113.05 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 122.017 -0.427 . . . . 0.0 110.792 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.624 ' ND2' HG12 ' B' ' 2' ' ' VAL . 2.7 p30 0.77 75.82 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.101 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.422 ' CB ' ' CE2' ' B' ' 1' ' ' PHE . 0.0 OUTLIER -142.5 131.79 23.48 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.616 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.44 ' CE1' HG12 ' A' ' 10' ' ' ILE . 74.6 m80 -91.16 172.63 8.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.785 . . . . 0.0 109.381 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.559 HD13 HG23 ' A' ' 2' ' ' ILE . 28.6 mt -126.31 121.02 31.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.473 -0.767 . . . . 0.0 110.263 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 179.78 105.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.8 -144.76 17.49 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 60.3 p -64.36 -19.73 65.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.562 -0.963 . . . . 0.0 109.98 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -57.46 -30.66 65.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.17 -0.956 . . . . 0.0 109.769 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.889 HD22 ' CG2' ' A' ' 3' ' ' VAL . 66.8 tp -68.63 -56.46 8.13 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 t -50.07 -48.09 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.643 -0.66 . . . . 0.0 111.107 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -62.16 -33.43 74.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.496 -0.752 . . . . 0.0 109.696 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.553 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -68.53 -28.61 67.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.557 -0.714 . . . . 0.0 109.555 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.677 ' CD2' HD22 ' A' ' 16' ' ' LEU . 30.4 mt -78.09 -29.45 49.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.477 -0.765 . . . . 0.0 109.11 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -69.59 -35.2 75.12 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.31 -54.86 6.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.697 -0.627 . . . . 0.0 109.547 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.553 HG23 ' O ' ' B' ' 14' ' ' ALA . 20.9 t -61.52 -66.51 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.539 -0.726 . . . . 0.0 109.805 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 45.4 m -59.61 -69.38 0.21 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.566 -0.709 . . . . 0.0 109.82 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.98 -27.34 18.71 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.77 142.77 40.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.467 -1.019 . . . . 0.0 109.608 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 117.26 20.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.581 -0.699 . . . . 0.0 109.272 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.5 31.78 49.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.94 32.17 5.76 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -167.95 -171.38 1.55 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.965 . . . . 0.0 109.618 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.425 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 3.1 t80 -52.97 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.493 -0.754 . . . . 0.0 109.765 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.8 92.47 48.76 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.425 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 6.1 Cg_exo -58.05 161.89 12.49 Favored 'Trans proline' 0 N--CA 1.482 0.839 0 C-N-CA 122.593 2.195 . . . . 0.0 110.059 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 tttp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.427 -179.892 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.768 HG23 HG23 ' A' ' 3' ' ' VAL . 4.6 tt -146.7 -45.27 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.598 -0.942 . . . . 0.0 109.461 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.768 HG23 HG23 ' A' ' 2' ' ' ILE . 18.0 t -90.92 -34.28 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.396 -0.815 . . . . 0.0 109.399 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -57.56 -21.85 41.1 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.577 -0.702 . . . . 0.0 109.986 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -63.21 -41.8 99.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.448 -0.783 . . . . 0.0 110.098 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.448 ' HB3' HD12 ' B' ' 6' ' ' LEU . 85.1 m -113.53 20.85 15.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.429 -0.794 . . . . 0.0 111.072 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.7 t -93.29 43.74 1.13 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.04 -1.037 . . . . 0.0 109.611 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.485 HG23 ' N ' ' A' ' 9' ' ' SER . 3.2 t -138.92 -45.22 0.47 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.485 ' N ' HG23 ' A' ' 8' ' ' THR . 0.2 OUTLIER -134.07 -170.95 2.62 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.398 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.498 HD13 ' CE1' ' B' ' 5' ' ' HIS . 1.0 OUTLIER -97.39 102.1 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.182 -0.949 . . . . 0.0 109.601 -178.615 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.1 m -62.46 -174.46 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.321 0.581 . . . . 0.0 110.188 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.6 m -105.58 163.64 12.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.744 -0.597 . . . . 0.0 109.501 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.674 HD11 HG22 ' B' ' 18' ' ' VAL . 42.2 tp -66.51 -28.25 68.41 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.572 -0.705 . . . . 0.0 109.918 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -58.34 -22.85 54.81 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.486 -0.759 . . . . 0.0 110.285 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -80.51 -47.91 13.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.291 -0.88 . . . . 0.0 109.702 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.605 HD22 HD23 ' B' ' 15' ' ' LEU . 14.4 mt -66.97 -20.27 65.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.515 -0.74 . . . . 0.0 110.315 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -62.0 -22.39 65.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.251 -0.905 . . . . 0.0 110.022 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -98.53 33.38 2.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.84 . . . . 0.0 109.648 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -112.28 7.2 19.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.646 -0.659 . . . . 0.0 110.346 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.47 35.51 1.48 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.047 -0.977 . . . . 0.0 109.544 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.711 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.618 HG12 ' OD1' ' B' ' 3' ' ' ASN . 15.6 t -86.22 -58.06 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.662 -1.274 . . . . 0.0 109.316 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.618 ' OD1' HG12 ' B' ' 2' ' ' VAL . 0.6 OUTLIER -178.84 37.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.433 -0.792 . . . . 0.0 109.664 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -120.42 139.83 52.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.589 -0.694 . . . . 0.0 109.262 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.498 ' CE1' HD13 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -77.78 164.68 25.01 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.471 -0.768 . . . . 0.0 109.602 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.448 HD12 ' HB3' ' A' ' 6' ' ' CYS . 18.8 mt -120.34 112.3 18.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.568 -0.707 . . . . 0.0 110.463 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.461 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.1 OUTLIER 179.71 120.25 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.425 -0.797 . . . . 0.0 109.153 178.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.39 -147.33 19.07 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.5 t -65.73 -14.67 61.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.349 -1.089 . . . . 0.0 109.92 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.96 -29.95 67.55 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.139 -0.976 . . . . 0.0 109.194 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.666 ' HG ' HG22 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -65.52 -52.89 49.33 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.072 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 18.1 t -56.07 -37.58 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.802 -0.562 . . . . 0.0 110.699 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -74.8 -26.33 59.66 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.455 -0.778 . . . . 0.0 110.212 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.19 -31.25 64.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.605 HD23 HD22 ' A' ' 16' ' ' LEU . 40.3 mt -74.02 -39.76 63.37 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -61.55 -33.04 73.17 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.711 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 1.7 tp -67.87 -40.74 83.54 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.674 HG22 HD11 ' A' ' 13' ' ' LEU . 35.8 t -86.49 -75.12 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.671 -0.643 . . . . 0.0 110.134 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 14.0 m -64.78 -62.72 1.4 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 109.599 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.16 15.73 78.66 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -90.48 158.11 17.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -1.178 . . . . 0.0 109.16 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.85 117.34 26.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.529 -0.732 . . . . 0.0 109.29 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.03 36.25 93.02 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.96 -19.86 6.64 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.661 ' CE1' HG23 ' B' ' 27' ' ' THR . 34.5 p90 -127.42 -174.82 3.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.264 -1.139 . . . . 0.0 110.232 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.46 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 4.2 t80 -60.11 105.61 0.42 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.546 0.689 . . . . 0.0 109.47 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.661 HG23 ' CE1' ' B' ' 25' ' ' PHE . 0.0 OUTLIER -134.75 90.82 21.93 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.46 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 8.7 Cg_endo -68.35 83.15 0.49 Allowed 'Trans proline' 0 N--CA 1.486 1.064 0 C-N-CA 122.857 2.371 . . . . 0.0 110.826 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.052 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.152 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.712 HG23 HG23 ' A' ' 3' ' ' VAL . 14.8 tt -136.9 -48.26 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.582 -0.951 . . . . 0.0 109.793 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.712 HG23 HG23 ' A' ' 2' ' ' ILE . 43.6 t -92.05 -21.82 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.25 -0.906 . . . . 0.0 109.955 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -89.68 59.15 4.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.393 -0.817 . . . . 0.0 109.699 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.5 -45.96 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.478 -0.764 . . . . 0.0 109.143 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.467 ' HB2' HD12 ' B' ' 6' ' ' LEU . 59.1 m -115.35 16.14 16.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.662 -0.649 . . . . 0.0 110.058 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' HG12 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -73.89 -29.37 62.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.282 -0.887 . . . . 0.0 109.159 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -84.08 -49.15 9.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.584 -0.698 . . . . 0.0 110.212 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 p -122.83 166.92 14.2 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.532 -0.73 . . . . 0.0 110.061 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.502 HD12 ' CE1' ' B' ' 5' ' ' HIS . 0.1 OUTLIER -86.81 120.9 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 87.7 m -82.8 -89.0 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.605 -0.684 . . . . 0.0 110.016 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.6 t -179.45 168.83 1.44 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.993 -1.067 . . . . 0.0 109.466 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.509 HD21 HG22 ' B' ' 18' ' ' VAL . 0.7 OUTLIER -67.24 -33.1 74.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.584 -0.698 . . . . 0.0 110.478 -179.289 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -21.54 61.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.264 -0.898 . . . . 0.0 110.208 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -76.74 -50.95 12.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.324 -0.86 . . . . 0.0 110.123 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.687 HD22 ' CD2' ' B' ' 15' ' ' LEU . 10.4 mt -66.81 -21.14 66.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.448 -0.783 . . . . 0.0 110.162 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -55.46 -22.5 20.89 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.239 -0.913 . . . . 0.0 110.466 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -98.02 35.33 1.75 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.366 -0.834 . . . . 0.0 109.808 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.428 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 6.6 m-85 -111.57 0.61 16.49 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.468 -0.77 . . . . 0.0 110.373 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.97 36.43 1.56 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.097 -1.002 . . . . 0.0 109.436 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.128 -0.939 . . . . 0.0 109.501 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.523 HG23 ' H ' ' B' ' 3' ' ' ASN . 0.2 OUTLIER -36.07 -72.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.581 0 O-C-N 122.053 -0.404 . . . . 0.0 112.022 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.523 ' H ' HG23 ' B' ' 2' ' ' VAL . 5.4 p30 -178.16 54.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.162 -0.961 . . . . 0.0 109.375 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -103.39 123.97 47.83 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.502 ' CE1' HD12 ' A' ' 10' ' ' ILE . 13.0 m80 -84.11 137.89 33.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.464 -0.773 . . . . 0.0 109.672 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.63 ' CD2' HD11 ' A' ' 16' ' ' LEU . 50.0 mt -81.78 95.52 7.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.875 -0.515 . . . . 0.0 110.413 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.05 120.41 0.44 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.666 -0.646 . . . . 0.0 109.35 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.21 -142.31 21.24 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 51.7 p -66.02 -23.83 66.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.942 . . . . 0.0 109.459 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -56.29 -29.9 61.81 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.241 -0.912 . . . . 0.0 109.112 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.431 ' CD1' HD11 ' B' ' 15' ' ' LEU . 0.4 OUTLIER -63.41 -60.35 3.48 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -51.12 -52.65 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.665 -0.647 . . . . 0.0 111.143 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -59.52 -29.25 67.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.37 -0.831 . . . . 0.0 110.346 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.76 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -73.08 -30.85 63.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.485 -0.759 . . . . 0.0 109.742 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.687 ' CD2' HD22 ' A' ' 16' ' ' LEU . 31.3 mt -77.2 -30.57 54.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.435 -0.791 . . . . 0.0 109.541 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -75.99 -30.86 58.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.568 -0.708 . . . . 0.0 109.42 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tp -80.18 -30.62 38.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.595 -0.69 . . . . 0.0 109.631 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.76 HG23 ' O ' ' B' ' 14' ' ' ALA . 43.3 t -82.66 -68.59 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.695 . . . . 0.0 109.195 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 33.8 m -67.74 -67.55 0.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.68 -0.638 . . . . 0.0 109.387 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.04 7.89 79.79 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -89.83 151.63 21.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.115 -1.227 . . . . 0.0 109.669 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.36 104.13 9.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.507 -0.745 . . . . 0.0 108.99 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.81 42.51 30.91 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.07 -20.38 6.77 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.446 ' CE1' HG23 ' B' ' 27' ' ' THR . 37.2 p90 -115.41 -170.49 1.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.404 -1.056 . . . . 0.0 109.566 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.416 ' O ' ' CG ' ' B' ' 26' ' ' TYR . 0.5 OUTLIER -55.44 93.52 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.613 -0.68 . . . . 0.0 109.645 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.446 HG23 ' CE1' ' B' ' 25' ' ' PHE . 1.5 p -124.13 97.07 41.1 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.405 ' HD3' ' CE1' ' B' ' 26' ' ' TYR . 6.1 Cg_exo -57.64 -172.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.019 0 C-N-CA 122.621 2.214 . . . . 0.0 110.692 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.442 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.779 HG23 HG23 ' A' ' 3' ' ' VAL . 16.1 tt -143.42 -47.4 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.518 -0.989 . . . . 0.0 109.385 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.779 HG23 HG23 ' A' ' 2' ' ' ILE . 47.5 t -92.93 -18.41 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.437 -0.789 . . . . 0.0 110.075 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -89.55 54.51 2.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.321 -0.862 . . . . 0.0 109.721 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -141.2 -50.48 0.43 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.497 -0.752 . . . . 0.0 108.993 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.3 m -128.41 32.72 4.81 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.538 ' SG ' HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -67.43 -57.17 7.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.69 -0.631 . . . . 0.0 110.272 -179.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 m -68.0 -28.21 67.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.505 -0.747 . . . . 0.0 110.899 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.44 ' HA ' ' CE1' ' B' ' 5' ' ' HIS . 1.2 m -116.98 -162.52 0.86 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.375 -0.828 . . . . 0.0 109.942 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.476 HG23 ' CD2' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -111.14 129.34 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.477 -0.764 . . . . 0.0 109.008 -179.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.91 -164.41 1.02 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.652 -0.655 . . . . 0.0 109.91 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.455 ' CB ' ' CE2' ' A' ' 14' ' ' TYR . 1.6 m -102.09 162.18 13.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.547 -0.721 . . . . 0.0 109.747 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.33 -35.4 80.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.624 -0.673 . . . . 0.0 110.387 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.455 ' CE2' ' CB ' ' A' ' 12' ' ' SER . 20.4 p90 -61.58 -23.33 65.92 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.389 -0.82 . . . . 0.0 110.058 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.404 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 5.8 tp60 -68.04 -57.11 6.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.419 -0.801 . . . . 0.0 109.494 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.693 HD22 HD23 ' B' ' 15' ' ' LEU . 23.0 mt -66.07 -14.24 61.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.576 -0.703 . . . . 0.0 110.222 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -62.23 -31.17 71.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.186 -0.946 . . . . 0.0 109.554 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -98.51 32.97 2.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.492 -0.755 . . . . 0.0 109.446 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.471 ' CE2' HD11 ' A' ' 2' ' ' ILE . 7.2 m-85 -113.42 -7.41 13.46 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.615 -0.678 . . . . 0.0 110.226 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.0 m -74.6 -22.07 59.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.081 -1.012 . . . . 0.0 110.357 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.54 -179.871 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.708 ' CD2' HG22 ' B' ' 2' ' ' VAL . 2.3 p90 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.708 HG22 ' CD2' ' B' ' 1' ' ' PHE . 27.4 m -50.09 -26.16 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.354 -1.467 . . . . 0.0 110.977 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -171.08 40.85 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.574 -0.704 . . . . 0.0 109.189 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.455 ' CB ' ' CE1' ' B' ' 1' ' ' PHE . 7.0 tp60 -136.38 108.04 7.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.583 -0.698 . . . . 0.0 109.912 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.476 ' CD2' HG23 ' A' ' 10' ' ' ILE . 14.3 m-70 -64.06 163.23 12.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.611 -0.681 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.689 HD11 HD11 ' A' ' 16' ' ' LEU . 2.5 mm? -114.42 55.35 0.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.501 -0.749 . . . . 0.0 109.596 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.86 129.01 33.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.522 -0.736 . . . . 0.0 109.333 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.56 -147.53 35.71 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 16.2 p -67.84 -12.21 60.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.553 -0.969 . . . . 0.0 110.489 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -60.69 -33.4 72.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.067 -1.021 . . . . 0.0 109.706 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.528 HD12 HD12 ' B' ' 6' ' ' LEU . 62.4 tp -65.07 -55.89 16.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.614 -0.679 . . . . 0.0 109.218 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.2 t -52.08 -47.67 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.544 -0.723 . . . . 0.0 110.813 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -62.22 -32.26 72.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.441 -0.787 . . . . 0.0 109.729 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.493 ' HB1' HD13 ' A' ' 16' ' ' LEU . . . -68.09 -31.94 71.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.557 -0.715 . . . . 0.0 109.153 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.693 HD23 HD22 ' A' ' 16' ' ' LEU . 31.7 mt -74.88 -28.56 60.7 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -70.17 -34.33 72.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.504 -0.748 . . . . 0.0 108.992 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.679 HD22 ' HZ ' ' B' ' 1' ' ' PHE . 0.5 OUTLIER -73.76 -42.37 61.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.721 -0.612 . . . . 0.0 109.6 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.426 HG23 ' O ' ' B' ' 14' ' ' ALA . 47.3 t -71.0 -71.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -77.91 0.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.457 -0.777 . . . . 0.0 108.979 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.53 -27.92 9.5 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.27 176.32 0.35 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.423 -1.045 . . . . 0.0 109.759 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -76.38 -63.16 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.593 -0.692 . . . . 0.0 109.386 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -119.41 48.02 0.98 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.62 26.12 25.59 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -162.06 -176.92 5.44 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.498 -1.001 . . . . 0.0 109.798 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -56.45 123.81 15.99 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.548 -0.72 . . . . 0.0 110.157 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.31 96.82 43.63 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.78 165.04 5.21 Favored 'Trans proline' 0 N--CA 1.483 0.866 0 C-N-CA 122.386 2.057 . . . . 0.0 110.21 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 2.5 pttt . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.708 -179.895 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.522 ' CG2' HG23 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -170.73 -53.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.608 -0.936 . . . . 0.0 109.195 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.656 HG22 HD22 ' B' ' 11' ' ' LEU . 32.2 t -92.36 -53.51 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.344 -0.848 . . . . 0.0 109.672 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.6 -30.79 67.49 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.651 -0.655 . . . . 0.0 110.274 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -76.16 -28.6 57.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.502 -0.749 . . . . 0.0 109.817 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.2 m -113.32 26.43 10.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.431 -0.793 . . . . 0.0 110.158 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.425 ' SG ' HG12 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -101.39 -32.09 10.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 0.0 109.197 179.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -85.79 -57.29 3.1 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.646 -0.658 . . . . 0.0 109.515 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.89 -160.67 0.82 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.631 -0.668 . . . . 0.0 109.358 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 11' ' ' CYS . 1.2 mm -93.88 -168.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.502 ' H ' HG22 ' A' ' 10' ' ' ILE . 0.8 OUTLIER -170.54 168.28 7.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.414 -0.804 . . . . 0.0 109.106 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.48 162.13 13.14 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.872 HD13 ' O ' ' A' ' 13' ' ' LEU . 3.4 tm? -66.98 -23.48 65.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.679 -0.638 . . . . 0.0 110.261 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CE1' ' HG2' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -56.63 -20.74 22.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.128 -0.982 . . . . 0.0 110.803 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.443 ' HG2' ' CE1' ' A' ' 14' ' ' TYR . 5.3 mm100 -74.36 -46.27 41.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.41 -0.806 . . . . 0.0 109.843 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.654 HD22 ' CD2' ' B' ' 15' ' ' LEU . 68.9 mt -68.42 -10.0 52.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.436 -0.79 . . . . 0.0 110.722 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.94 -26.33 68.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.11 -0.994 . . . . 0.0 109.21 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -62.29 -32.74 73.51 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.747 0.784 . . . . 0.0 109.633 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.433 ' OH ' HG21 ' A' ' 2' ' ' ILE . 35.5 m-85 -81.66 -17.07 49.32 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.995 -0.441 . . . . 0.0 111.139 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -105.13 28.8 6.92 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.045 -1.034 . . . . 0.0 109.766 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.582 -179.871 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.741 ' CE1' HD23 ' A' ' 13' ' ' LEU . 3.0 p90 . . . . . 0 N--CA 1.5 2.033 0 CA-C-O 120.474 0.178 . . . . 0.0 110.771 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.22 -26.29 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.976 -1.078 . . . . 0.0 109.35 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -152.89 29.24 0.52 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.428 ' HG2' ' CE1' ' B' ' 10' ' ' HIS . 0.3 OUTLIER -118.7 -178.89 3.65 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -103.4 125.41 49.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.347 -0.846 . . . . 0.0 109.855 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.618 HD21 HD13 ' B' ' 11' ' ' LEU . 6.4 tp -83.95 94.1 8.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.706 -0.621 . . . . 0.0 110.08 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.88 134.4 2.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.419 -0.801 . . . . 0.0 109.334 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.3 -145.72 21.43 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 53.7 p -70.79 -9.0 56.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.496 -1.002 . . . . 0.0 110.31 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . 0.428 ' CE1' ' HG2' ' B' ' 4' ' ' GLN . 28.3 t60 -65.37 -31.08 72.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.087 -1.008 . . . . 0.0 108.944 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.656 HD22 HG22 ' A' ' 3' ' ' VAL . 56.0 tp -63.69 -57.31 10.41 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.5 t -53.45 -51.82 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.64 -0.662 . . . . 0.0 110.955 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -56.21 -28.61 58.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.346 -0.846 . . . . 0.0 110.217 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.588 ' HB1' HD13 ' A' ' 16' ' ' LEU . . . -76.58 -35.0 58.42 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.654 ' CD2' HD22 ' A' ' 16' ' ' LEU . 49.3 mt -64.56 -28.22 69.49 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -80.82 -35.72 32.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.527 -0.733 . . . . 0.0 109.137 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -65.42 -32.61 74.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.658 -0.651 . . . . 0.0 109.804 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.814 ' CG2' HD21 ' A' ' 13' ' ' LEU . 35.9 t -82.22 -55.68 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.601 -0.687 . . . . 0.0 109.405 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 4.7 m -69.19 -80.24 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.54 -0.725 . . . . 0.0 109.528 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.95 -56.56 0.66 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.96 172.23 8.73 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.454 -1.027 . . . . 0.0 109.426 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.25 -47.77 33.0 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.44 94.54 1.4 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -177.93 -35.85 0.06 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.473 ' CG ' ' HB3' ' B' ' 15' ' ' LEU . 44.5 p90 -124.83 -174.64 3.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -1.088 . . . . 0.0 110.867 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.433 ' HB2' ' CD1' ' A' ' 19' ' ' TYR . 7.1 t80 -58.45 111.0 1.08 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.853 -0.529 . . . . 0.0 109.828 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.3 p -122.88 92.2 49.28 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.553 -0.717 . . . . 0.0 109.372 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.413 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 1.5 Cg_endo -61.87 129.0 25.96 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 C-N-CA 122.526 2.151 . . . . 0.0 109.858 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 22.4 mttp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.53 179.938 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.806 HG23 HG23 ' A' ' 3' ' ' VAL . 4.5 tt -172.89 -44.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.588 -0.948 . . . . 0.0 109.248 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.806 HG23 HG23 ' A' ' 2' ' ' ILE . 44.7 t -91.58 -9.51 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.576 -0.702 . . . . 0.0 110.358 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.17 3.76 22.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 0.0 109.956 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -63.42 1.23 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.117 -0.989 . . . . 0.0 110.039 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.498 ' SG ' HD23 ' B' ' 6' ' ' LEU . 12.6 p -136.27 25.61 3.22 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.978 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.1 t -52.45 -23.78 6.75 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.11 -0.994 . . . . 0.0 110.011 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 m -65.7 -68.49 0.36 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.353 -0.842 . . . . 0.0 111.033 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.4 -153.56 0.53 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.328 -0.858 . . . . 0.0 110.356 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.665 HD13 ' CE1' ' B' ' 5' ' ' HIS . 10.1 mm -83.65 168.21 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.096 -1.002 . . . . 0.0 108.728 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.479 ' H ' HG22 ' A' ' 10' ' ' ILE . 2.1 p -160.1 174.42 14.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.427 -0.796 . . . . 0.0 110.438 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -72.08 133.13 45.06 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.345 0.593 . . . . 0.0 109.747 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.478 HD12 ' HB2' ' B' ' 1' ' ' PHE . 4.6 mm? -68.43 -17.34 64.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.749 -0.594 . . . . 0.0 110.412 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -56.83 -22.46 36.74 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.139 -0.976 . . . . 0.0 109.86 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.26 -49.09 75.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.404 -0.81 . . . . 0.0 109.357 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.725 HD22 HD23 ' B' ' 15' ' ' LEU . 15.8 mt -68.9 -16.51 63.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.521 -0.737 . . . . 0.0 110.051 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.71 -26.75 65.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 109.174 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -89.25 13.12 14.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.379 -0.826 . . . . 0.0 110.078 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -97.77 20.62 11.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.102 -0.999 . . . . 0.0 109.179 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.3 m -109.97 23.88 13.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.328 -0.857 . . . . 0.0 109.987 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 117.903 -1.046 . . . . 0.0 109.427 -179.952 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.718 ' CZ ' HD22 ' B' ' 17' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.524 HG23 ' CD1' ' B' ' 1' ' ' PHE . 0.2 OUTLIER -118.27 172.23 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.924 -1.11 . . . . 0.0 108.163 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -59.44 92.98 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.317 -0.864 . . . . 0.0 109.376 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -142.03 174.4 10.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.502 -0.748 . . . . 0.0 110.203 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.665 ' CE1' HD13 ' A' ' 10' ' ' ILE . 3.6 m80 -119.12 146.45 45.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.613 -0.68 . . . . 0.0 109.248 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.683 HD12 HD11 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -100.77 90.44 4.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.504 -0.748 . . . . 0.0 109.439 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.3 154.23 10.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.625 -0.672 . . . . 0.0 109.719 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.03 -132.89 49.15 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.5 p -83.51 -13.8 53.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.947 . . . . 0.0 109.759 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -63.71 -33.09 74.87 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.132 -0.98 . . . . 0.0 108.944 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.612 ' C ' HD13 ' B' ' 11' ' ' LEU . 2.6 tm? -68.87 -54.51 15.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.813 -0.554 . . . . 0.0 109.771 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 t -53.74 -47.77 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.501 -0.749 . . . . 0.0 110.677 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.7 -29.07 70.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.484 -0.76 . . . . 0.0 109.396 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.72 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -71.67 -26.4 62.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.57 -0.706 . . . . 0.0 109.529 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.725 HD23 HD22 ' A' ' 16' ' ' LEU . 29.1 mt -78.85 -32.14 45.92 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.418 -0.801 . . . . 0.0 108.882 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.06 -32.99 67.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.595 -0.691 . . . . 0.0 110.012 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.718 HD22 ' CZ ' ' B' ' 1' ' ' PHE . 0.1 OUTLIER -80.58 -46.71 15.27 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.413 -0.804 . . . . 0.0 109.937 -179.434 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.72 HG23 ' O ' ' B' ' 14' ' ' ALA . 48.0 t -59.65 -56.93 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.419 -0.801 . . . . 0.0 109.386 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -74.89 0.1 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.21 -35.17 3.73 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -90.41 163.77 14.55 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.395 -1.062 . . . . 0.0 109.849 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.85 127.9 39.84 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.18 28.7 36.04 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.97 30.73 5.76 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.445 ' CD2' ' HB2' ' B' ' 15' ' ' LEU . 23.8 p90 -165.65 -173.2 2.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.454 -1.027 . . . . 0.0 109.512 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.454 ' HB3' HD13 ' B' ' 15' ' ' LEU . 7.5 t80 -54.33 109.58 0.51 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.574 -0.703 . . . . 0.0 109.562 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 2.0 p -122.88 91.86 49.49 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -57.31 142.21 94.8 Favored 'Trans proline' 0 N--CA 1.483 0.91 0 C-N-CA 122.48 2.12 . . . . 0.0 110.143 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.455 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.808 HG23 HG23 ' A' ' 3' ' ' VAL . 5.0 tt -172.26 -44.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.667 -0.902 . . . . 0.0 109.583 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.808 HG23 HG23 ' A' ' 2' ' ' ILE . 30.4 t -91.32 -9.24 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.342 -0.849 . . . . 0.0 110.685 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -90.35 51.72 2.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.136 -0.978 . . . . 0.0 109.429 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -138.44 -43.79 0.5 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.498 -0.752 . . . . 0.0 109.379 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.1 m -118.59 15.57 13.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.543 -0.723 . . . . 0.0 110.399 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.61 -27.22 64.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.279 -0.888 . . . . 0.0 110.351 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 m -99.29 -67.83 0.83 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.351 -0.843 . . . . 0.0 110.907 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.2 p -74.99 171.81 13.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.279 -0.888 . . . . 0.0 110.229 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.858 HG23 ' O ' ' B' ' 4' ' ' GLN . 56.6 mt -102.52 91.16 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.6 m -61.74 -178.91 0.16 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.613 -0.68 . . . . 0.0 110.268 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.483 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 22.2 t -106.71 172.47 6.8 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.507 HD23 ' O ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -67.36 -26.14 66.33 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.403 -0.811 . . . . 0.0 111.415 -178.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 12' ' ' SER . 8.9 p90 -59.51 -20.51 55.95 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.997 -1.064 . . . . 0.0 110.042 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.93 -49.91 12.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.388 -0.82 . . . . 0.0 109.428 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.711 HD21 ' CD2' ' B' ' 11' ' ' LEU . 11.3 mt -67.45 -16.78 64.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.531 -0.731 . . . . 0.0 109.991 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -57.91 -20.72 39.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.187 -0.945 . . . . 0.0 110.219 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -96.95 33.21 1.94 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.84 . . . . 0.0 109.488 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.426 ' CE2' HD11 ' A' ' 2' ' ' ILE . 7.5 m-85 -113.27 -0.43 14.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.518 -0.739 . . . . 0.0 110.361 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.6 m -96.83 40.49 1.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.122 -0.986 . . . . 0.0 109.562 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.444 179.957 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.543 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 1.1 p90 . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 15.5 t -54.66 -26.7 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -160.69 31.62 0.15 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.858 ' O ' HG23 ' A' ' 10' ' ' ILE . 13.3 mt-30 -127.48 168.67 14.59 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.638 -0.664 . . . . 0.0 109.857 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.458 ' CE1' HG12 ' A' ' 10' ' ' ILE . 18.1 m80 -96.61 161.53 13.85 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.531 HD22 HD11 ' A' ' 16' ' ' LEU . 43.7 mt -109.44 -11.11 14.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.478 -0.764 . . . . 0.0 110.82 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.77 138.96 56.87 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.955 -1.091 . . . . 0.0 110.344 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.47 -159.33 33.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.0 p -64.7 -14.66 59.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.435 -1.038 . . . . 0.0 110.04 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -52.14 -27.98 16.26 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.891 -1.131 . . . . 0.0 110.323 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.711 ' CD2' HD21 ' A' ' 16' ' ' LEU . 3.2 tm? -72.5 -62.91 1.27 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.614 -0.679 . . . . 0.0 109.199 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 39.4 t -47.16 -52.64 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.839 -0.538 . . . . 0.0 111.445 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -57.53 -36.66 71.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.386 -0.821 . . . . 0.0 110.224 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.5 ' HB1' ' HD2' ' B' ' 1' ' ' PHE . . . -67.1 -31.63 72.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.346 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.644 HD23 HD22 ' A' ' 16' ' ' LEU . 40.6 mt -64.47 -40.64 96.07 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -63.66 -34.04 76.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.543 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 0.8 OUTLIER -65.23 -37.3 86.85 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 14' ' ' ALA . 40.5 t -74.12 -71.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.586 -0.696 . . . . 0.0 109.613 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 m -90.75 -58.25 2.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.455 -0.778 . . . . 0.0 109.408 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.37 32.78 68.23 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -88.62 -177.55 5.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.613 -0.933 . . . . 0.0 109.409 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.409 ' NH1' ' HG2' ' B' ' 22' ' ' ARG . 2.7 tpt180 -91.93 52.7 2.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.624 -0.672 . . . . 0.0 109.432 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.95 40.68 1.05 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.07 -28.21 6.62 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' CB ' ' B' ' 15' ' ' LEU . 29.2 p90 -105.36 -175.8 2.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.57 -0.959 . . . . 0.0 109.408 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -58.89 118.41 5.73 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.474 -0.766 . . . . 0.0 109.423 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 23.8 p -127.14 94.65 38.5 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.72 118.87 5.83 Favored 'Trans proline' 0 N--CA 1.482 0.838 0 C-N-CA 122.343 2.029 . . . . 0.0 110.165 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 mtpp . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.91 179.88 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.535 HG23 HG23 ' A' ' 3' ' ' VAL . 1.3 tp -73.89 -32.56 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.577 -0.955 . . . . 0.0 109.378 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.792 HG13 HD12 ' B' ' 11' ' ' LEU . 25.0 t -90.32 12.44 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.642 -0.661 . . . . 0.0 110.377 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -105.24 31.51 4.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.179 -0.951 . . . . 0.0 108.928 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -118.77 -33.76 4.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.674 -0.641 . . . . 0.0 109.985 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.0 m -130.33 19.13 5.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.471 -0.768 . . . . 0.0 110.459 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.7 t -91.29 -26.81 18.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 109.565 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 m -75.35 -27.69 59.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.474 -0.766 . . . . 0.0 110.182 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.4 p -134.64 -171.6 2.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 109.936 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.454 ' CG1' ' CE1' ' B' ' 5' ' ' HIS . 18.3 mt -102.31 95.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.27 -172.82 0.35 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.573 -0.704 . . . . 0.0 109.687 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.447 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 1.4 m -108.64 162.82 13.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.644 -0.66 . . . . 0.0 109.689 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.749 HD13 ' CD2' ' B' ' 1' ' ' PHE . 20.0 tp -71.11 -17.69 62.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.805 -0.559 . . . . 0.0 110.223 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.447 ' CE2' ' HB3' ' A' ' 12' ' ' SER . 10.8 p90 -87.54 11.29 15.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.088 -1.007 . . . . 0.0 110.422 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -105.5 -32.28 8.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.072 -1.017 . . . . 0.0 109.434 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.811 HD22 ' CD2' ' B' ' 15' ' ' LEU . 9.9 mt -66.16 -13.03 59.53 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.565 -0.71 . . . . 0.0 110.558 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.81 -19.19 39.0 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.08 -1.013 . . . . 0.0 110.124 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -93.53 28.79 2.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.204 -0.935 . . . . 0.0 110.191 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -115.08 10.89 16.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.173 -0.954 . . . . 0.0 110.456 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.31 33.12 2.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.273 -0.892 . . . . 0.0 109.343 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.389 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.906 ' CZ ' HD23 ' B' ' 17' ' ' LEU . 34.3 t80 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.709 HG13 ' CD1' ' B' ' 1' ' ' PHE . 17.5 m -140.63 -162.43 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -52.75 -25.04 9.97 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.956 -1.09 . . . . 0.0 110.022 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.568 ' H ' HG23 ' B' ' 2' ' ' VAL . 12.3 mm-40 -71.87 144.11 49.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.519 -0.738 . . . . 0.0 109.109 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.454 ' CE1' ' CG1' ' A' ' 10' ' ' ILE . 13.0 m80 -68.25 160.6 28.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.552 -0.718 . . . . 0.0 109.493 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.415 HD11 HD11 ' A' ' 16' ' ' LEU . 19.7 tp -107.41 98.43 8.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.611 -0.681 . . . . 0.0 109.732 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.7 173.15 2.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.637 -0.664 . . . . 0.0 109.895 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.7 -154.02 39.78 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.1 p -63.8 -21.5 66.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.576 -0.955 . . . . 0.0 109.507 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -60.52 -34.13 73.65 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.869 . . . . 0.0 109.075 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.792 HD12 HG13 ' A' ' 3' ' ' VAL . 2.5 tt -61.86 -55.05 33.86 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.404 ' H ' HG23 ' B' ' 12' ' ' VAL . 21.2 t -53.74 -49.97 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.748 -0.595 . . . . 0.0 111.05 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -59.76 -27.48 66.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.446 -0.784 . . . . 0.0 110.631 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.11 -31.37 39.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 110.301 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.811 ' CD2' HD22 ' A' ' 16' ' ' LEU . 50.5 mt -66.72 -41.28 88.18 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -70.94 -31.38 67.95 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.906 HD23 ' CZ ' ' B' ' 1' ' ' PHE . 1.1 mp -63.24 -34.46 77.71 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -84.77 -73.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.626 -0.671 . . . . 0.0 109.359 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 90.8 m -64.49 -82.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 108.852 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.16 23.26 9.84 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 120.136 -1.031 . . . . 0.0 111.533 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.26 -173.68 3.9 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 118.784 1.292 . . . . 0.0 109.165 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 mtm-85 -93.44 50.74 1.52 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.532 -0.73 . . . . 0.0 109.51 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.73 71.99 0.63 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.28 35.49 2.17 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -167.08 -171.91 1.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.959 . . . . 0.0 109.607 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.415 ' CZ ' ' HG3' ' B' ' 28' ' ' PRO . 3.8 t80 -57.69 98.85 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.582 -0.699 . . . . 0.0 109.167 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 2.2 p -114.33 91.87 25.51 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.591 -0.693 . . . . 0.0 109.666 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.415 ' HG3' ' CZ ' ' B' ' 26' ' ' TYR . 4.0 Cg_exo -59.24 -171.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.482 0.843 0 C-N-CA 122.453 2.102 . . . . 0.0 110.074 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.571 179.961 . . . . . . . . 1 1 . 1 stop_ save_